mice: B01.050.150.900.649.865.635.505.500
animals: B01.050
: 
thioredoxins: D12.776.915
cadmium: D01.268.556.137, D01.268.956.061, D01.552.544.137
metallothionein: D12.776.556.670
oxidation-reduction: G02.149.767.650, G02.842.750.650, G03.495.335.531
cell survival: G04.299.316
cytochalasin d: D03.438.473.231.450, D23.946.587.370.450
zinc: D01.268.556.940, D01.268.956.906, D01.552.544.940
oxidative stress: G03.495.710, G07.700.830.750
actins: D05.750.078.730.250, D12.776.210.500.100, D12.776.220.525.255
polymerization: G02.149.883
cell nucleus: A11.284.430.106, A11.284.430.214.190.875.117
signal transduction: G02.111.087.800, G02.149.115.800, G04.299.880
protein transport: G03.495.166.700
inflammation: C23.550.470
cell death: G04.299.139
cell biology: H01.158.100.433, H01.158.273.190
bees: B01.050.500.131.617.479.387
catalase: D08.811.682.732.332
superoxide dismutase: D08.811.682.881
lipid peroxidation: G02.111.087.520, G02.149.115.520, G03.495.335.531.587
propolis: D05.750.078.840.762, D20.215.721.500.762
glutathione: D12.644.456.448
phenylethyl alcohol: D02.033.375.650
caffeic acids: D02.241.223.200.054
antioxidants: D27.505.519.217, D27.505.696.706.125, D27.720.799.047
kidney: A05.810.453
environmental pollutants: D27.888.284
carcinogens: D27.888.569.100
humans: B01.050.150.900.649.801.400.112.400.400
mitogen-activated protein kinase 1: D08.811.913.696.620.682.700.567.342.500, D08.811.913.696.620.682.700.646.750.249.500, D12.644.360.450.169.500, D12.776.476.450.169.500
mitogen-activated protein kinases: D08.811.913.696.620.682.700.567, D08.811.913.696.620.682.700.646.750, D12.644.360.450, D12.776.476.450
mitogen-activated protein kinase 7: D08.811.913.696.620.682.700.567.342.937, D08.811.913.696.620.682.700.646.750.249.937, D12.644.360.450.169.937, D12.776.476.450.169.937
phosphorylation: G02.111.087.677, G02.149.115.677, G02.149.465.700, G02.607.750.700, G03.495.790
cadmium chloride: D01.142.175, D01.210.450.150.125
cyclic amp response element-binding protein: D12.776.260.108.184, D12.776.930.127.184
proto-oncogene proteins c-fos: D12.776.260.108.765, D12.776.624.664.700.179, D12.776.660.760, D12.776.930.127.765
activating transcription factor 1: D12.776.260.108.061.500, D12.776.930.127.061.500
poly(adp-ribose) polymerases: D08.811.913.400.725.115.690
nucleosomes: A11.284.430.106.279.345.190.160.180.625, D12.776.664.224.550, G05.360.160.180.625
transcription factors: D12.776.930
protein c: D08.622.705, D12.776.124.650, D12.776.395.635, D23.113.700
mitogen-activated protein kinase 3: D08.811.913.696.620.682.700.567.342.750, D08.811.913.696.620.682.700.646.750.249.750, D12.644.360.450.169.750, D12.776.476.450.169.750
indoles: D03.438.473
aniline compounds: D02.092.146
apoptosis: G04.299.139.160
genetics: H01.158.273.343
rats: B01.050.150.900.649.865.635.505.700
ursidae: B01.050.150.900.649.147.890
rna, messenger: D13.444.735.544
cadmium poisoning: C25.723.165
liver: A03.620
female: 
copper: D01.268.556.195, D01.268.956.170, D01.552.544.195
iron: D01.268.556.412, D01.268.956.287, D01.552.544.412
arvicolinae: B01.050.150.900.649.865.635.070
population density: N01.224.600, N06.850.505.400.600
kidney diseases: C12.777.419, C13.351.968.419
diet: G07.610.240
physiological processes: G07.700
hepatocytes: A11.436.348
caspase 3: D08.811.277.656.262.500.126.350.300, D08.811.277.656.300.200.126.350.300, D12.644.360.075.405.350.300, D12.776.476.075.405.350.300
caspase 9: D08.811.277.656.262.500.126.550.900, D08.811.277.656.300.200.126.550.900, D12.644.360.075.405.550.900, D12.776.476.075.405.550.900
caspase 12: D08.811.277.656.262.500.126.550.920, D08.811.277.656.300.200.126.550.920, D12.644.360.075.405.550.920, D12.776.476.075.405.550.920
caspases: D08.811.277.656.262.500.126, D08.811.277.656.300.200.126, D12.644.360.075.405, D12.776.476.075.405
calcium: D01.268.552.100, D01.552.539.288, D23.119.100
drinking water: D01.455.900.300, D01.650.550.925.199, J02.200.418
glutamic acid: D12.125.067.625.349, D12.125.119.409.349, D12.125.427.300
endoplasmic reticulum stress: G03.495.710.344, G04.299.486, G04.434
bcl-2-associated x protein: D12.644.360.075.718.400, D12.776.476.075.718.400
lanthanum: D01.268.477.500, D01.268.558.362.500, D01.552.550.399.500
hsp70 heat-shock proteins: D12.776.580.216.375
membrane proteins: D12.776.543
hippocampus: A08.186.211.464.405, A08.186.211.730.885.287.500.345
cognition: F02.463.188
lactation: G08.686.702.500, G08.686.785.420
pregnancy: G08.686.785.760.769
olfactory marker protein: D12.644.360.543, D12.776.476.543, D12.776.641.652
olfactory receptor neurons: A04.531.520.573.580, A04.760.600.640.640, A08.663.650.915.500.540, A08.800.950.500.540, A09.531.623.580, A10.615.550.760.600.640.640, A11.671.650.915.500.540
tubulin: D05.750.078.734.800, D12.776.220.600.800, D12.776.641.920
smell: F02.830.816.643, G11.561.600.810.643
down-regulation: G02.111.087.225, G02.149.115.225, G05.355.315.200, G07.690.812.230, G07.700.680.230
cilia: A11.284.180.165
electrons: G01.249.335, G01.358.500.750
olfactory mucosa: A04.531.520.573, A04.760.600.640, A09.531.623, A10.615.550.760.600.640
blotting, western: E05.196.401.143, E05.301.300.096, E05.393.525.262, E05.478.566.320.200, E05.601.495.320.200
male: 
tert-butyl alcohol: D02.033.415.110.855, D10.289.110.855
drinking: G07.610.593.260.249, G07.700.620.260.249, G10.261.326.240.249
regeneration: G16.100.856
globulins: D12.776.377
ethers: D02.355
endocrine disruptors: D27.505.696.353, D27.888.141
incidence: E05.318.308.985.525.375, L01.280.975.525.375, N01.224.935.597.500, N06.850.505.400.975.525.375, N06.850.520.308.985.525.375
nipples: A01.236.500
risk assessment: E05.318.740.600.800.715, N04.452.871.715, N05.715.360.750.625.700.690, N06.850.505.715, N06.850.520.830.600.800.715
zineb: D02.241.081.251.869.265.908, D02.691.975, D02.886.706.250.950
maneb: D02.241.081.251.869.265.441, D02.691.600, D02.886.706.250.500
triazoles: D03.383.129.799
imidazoles: D03.383.129.308
epoxy compounds: D02.355.291.411
bicyclo compounds: D02.455.426.100.080, D04.075.080
sexual development: G07.700.320.750, G08.686.785.880
pesticides: D27.720.031.700, D27.720.723, D27.888.723
adult: M01.060.116
child: M01.060.406
tetrachloroethylene: D02.455.526.439.880
color vision: F02.830.816.964.124, G11.561.600.810.964.124, G14.640.816.124
retrospective studies: E05.318.760.500.500.500, E05.318.760.500.750.750, N05.715.360.775.175.200.710, N05.715.360.775.175.250.815, N06.850.520.450.500.500.500, N06.850.520.450.500.750.825
contrast sensitivity: E01.370.380.850.950.500, F02.463.593.932.869.435.110, F02.463.593.932.901.500, G14.940.500
confidence intervals: E05.318.740.275, N05.715.360.750.220, N06.850.520.830.275
water pollution: N06.850.460.790
occupational exposure: N06.850.460.350.600
housing: N01.224.791.400, N06.230.150.360, N06.850.505.400.800.400
massachusetts: Z01.107.567.875.550.510
vision disorders: C10.597.751.941, C11.966, C23.888.592.763.941
confusion: C10.597.606.337, C23.888.592.604.339, F01.700.250
paraquat: D03.383.725.762.621
herbicides: D27.720.031.700.366, D27.720.723.366, D27.888.723.366
insecticides: D27.720.031.700.491, D27.720.723.491, D27.888.723.491
risk factors: E05.318.740.600.800.725, N05.715.350.200.700, N05.715.360.750.625.700.700, N06.850.490.625.750, N06.850.520.830.600.800.725
parkinson disease: C10.228.140.079.862.500, C10.228.662.600.400, C10.574.812
organophosphates: D02.705.400
prospective studies: E05.318.760.500.750.500.650, N05.715.360.775.175.250.630, N06.850.520.450.500.750.650
solvents: D27.720.844
case-control studies: E05.318.760.500.500, N05.715.360.775.175.200, N06.850.520.450.500.500
risk: E05.318.740.600.800, G17.680.750, N05.715.360.750.625.700, N06.850.520.830.600.800
caenorhabditis elegans: B01.050.500.500.294.700.700.660.250.250
dopamine: D02.092.211.215.311.342, D02.092.311.342
manganese: D01.268.556.484, D01.268.956.374, D01.552.544.484
serotonin: D02.092.211.215.801.852, D03.438.473.914.814, D23.469.050.650
soil: D20.721, G01.311.820, G16.500.275.815, N06.230.600
nerve degeneration: C23.550.737
neurons: A08.663, A11.671
dimethoate: D02.705.400.625.220, D02.705.539.345.220, D02.886.300.692.220
candida: B01.300.381.147, B01.300.930.176
arthropods: B01.050.500.131
insects: B01.050.500.131.617
toxicity tests: E05.940
wounds and injuries: C26
diethylhexyl phthalate: D02.241.223.805.250
testis: A05.360.444.849, A05.360.576.782, A06.407.312.782
testosterone: D04.808.054.079.429.824, D06.472.334.851.968.984
esters: D02.241.400
phthalic acids: D02.241.223.805
dibutyl phthalate: D02.241.223.805.225
body weight: C23.888.144, E01.370.600.115.100.160.120, E05.041.124.160.750, G07.100.100.160.120, G07.700.320.249.314.120
preoptic area: A08.186.211.730.317.357.342.450
poa: B01.650.940.800.575.100.822.793
sexual maturation: G07.700.320.750.750, G08.686.785.880.750
benzhydryl compounds: D02.455.426.559.389.115
phenols: D02.455.426.559.389.657
estradiol: D04.808.365.415.248, D06.472.334.851.437.500
reproduction: G08.686.785.760
sexual behavior: F01.145.802
puberty: G08.686.760, G08.686.785.880.374
hexachlorobenzene: D02.455.426.559.389.261.400, D02.455.526.439.202.400
lindane: D02.455.526.439.600
polychlorinated biphenyls: D02.455.426.559.389.185.698, D02.455.526.439.773
avena sativa: B01.650.940.800.575.100.822.060, J02.500.200.066, J02.500.300.100.088
gynecology: H02.403.810.310
semen: A12.200.732
obstetrics: H02.403.810.450
spouses: F01.829.263.500.660, I01.880.225.500.670, M01.816
ddt: D02.455.526.439.255
chromatography, gas: E05.196.181.349
fertility: G08.686.210
infertility: C12.294.365, C13.351.500.365
spermatozoa: A05.360.490.890, A11.497.760
diagnosis: E01
insulin receptor substrate proteins: D12.644.360.024.301, D12.776.157.057.039, D12.776.476.024.382
hexokinase: D08.811.913.696.620.300
hydrogen peroxide: D01.248.497.158.685.750.424, D01.339.431.374.424, D01.650.550.750.400
insulin: D06.472.699.587.200.500.625, D12.644.548.586.200.500.625
glucose: D09.546.359.448
spermatocytes: A05.360.490.890.880, A11.497.760.700
plastics: D05.750.716, D25.720.716, J01.637.051.720.716
spermatids: A05.360.490.890.860, A11.497.760.600
spermatogenesis: G04.299.151.650.624, G08.686.785.760.310.760
phosphofructokinase-1: D08.811.913.696.620.225.850.500
homeostasis: G07.700.345
mercury: D01.268.556.504, D01.268.956.437, D01.552.544.504
reference values: E05.978.810
hong kong: Z01.252.474.164.450
semen analysis: E01.370.225.992, E05.200.992
sperm count: E01.370.225.500.195.870, E01.370.225.992.624, E05.200.500.195.870, E05.200.992.624, E05.242.195.870, G04.170.870
bodily secretions: A12.200
pulse: E01.370.370.380.650, E01.370.600.650, G09.330.380.750
radio waves: G01.358.500.505.810, G01.750.250.810, G01.750.770.721
cellular phone: L01.178.847.698.300
radiation: G01.750
paresthesia: C10.597.751.791.875, C23.888.592.763.770.875
neural conduction: G07.265.337.600, G07.700.240.600, G11.561.600.620
sensation: F02.830.816, G11.561.600.810
radiotherapy: E02.815
reference standards: E05.978.808
electromagnetic fields: G01.358.500.260, G01.358.750.500
cross-over studies: E05.318.780.150, N05.715.360.780.150, N06.850.520.445.150
healthy volunteers: M01.774.500, M01.955.236
visual perception: F02.463.593.932
temporal lobe: A08.186.211.730.885.287.500.863
reaction time: F02.830.650, F04.669.817, G11.561.677
attention: F02.830.104.214
double-blind method: E05.318.780.300, E05.581.500.300, N05.715.360.780.320, N06.850.520.445.300
human rights: I01.880.604.473, N03.706.437
microwaves: G01.358.500.505.810.500, G01.750.250.810.500, G01.750.770.721.500
water: D01.455.900, D01.650.550.925
outcome assessment (health care): H01.770.644.145.431, N04.761.559.590, N05.715.360.575.575
memory: F02.463.425.540
cross-sectional studies: E05.318.760.500.875, N05.715.360.775.175.275, N06.850.520.450.500.875
headache: C10.597.617.470, C23.888.592.612.441, C23.888.646.487
confounding factors (epidemiology): N05.715.350.240, N06.850.490.718
sleep: F02.830.855, G11.561.600.815
family characteristics: F01.829.263.315, I01.240.361, I01.880.225.423, N01.224.361, N01.824.308, N06.850.505.400.400
fear: F01.470.361
uncertainty: E05.318.740.600.900, F02.463.785.373.820, G17.680.875, N05.715.360.750.625.850, N06.850.520.830.600.900
brain: A08.186.211
behavior: F01.145
questionnaires: E05.318.308.750, L01.280.800, N05.715.360.300.695, N06.850.520.308.750
dizziness: C10.597.751.237, C23.888.592.763.237
problem solving: F02.463.425.725, F02.463.785.810
depression: F01.145.126.350
tremor: C10.597.350.850, C23.888.592.350.850
prevalence: E05.318.308.985.525.750, L01.280.975.525.750, N01.224.935.597.750, N06.850.505.400.975.525.750, N06.850.520.308.985.525.750
control groups: E05.318.780.074, E05.581.500.149
egypt: Z01.058.266.317, Z01.586.035.200, Z01.586.500.300
neurologic examination: E01.370.376.550, E01.370.600.550
nervous system: A08
occupations: N01.824.547
personality: F01.752
united states: Z01.107.567.875
styrene: D02.455.426.559.389.150.750.800
butadienes: D02.455.326.271.665.146.240
esophageal neoplasms: C04.588.274.476.205, C04.588.443.353, C06.301.371.205, C06.405.117.430, C06.405.249.205
stomach neoplasms: C04.588.274.476.767, C06.301.371.767, C06.405.249.767, C06.405.748.789
polymers: D05.750, D25.720, J01.637.051.720
cause of death: E05.318.308.985.550.250, L01.280.975.550.250, N01.224.935.698.100, N06.850.505.400.975.550.250, N06.850.520.308.985.550.250
rheumatic heart disease: C01.252.410.890.731.649, C14.280.874
neoplasms: C04
leukemia: C04.557.337
industry: J01.576
canada: Z01.107.567.176
hematologic neoplasms: C04.588.448, C15.378.400
gastrointestinal tract: A03.556
petroleum: D20.345.630, N06.230.132.258.630
uterine cervical neoplasms: C04.588.945.418.948.850, C13.351.500.852.593.131, C13.351.500.852.762.850, C13.351.937.418.875.850
life tables: E05.318.308.985.475, E05.318.740.100.500, L01.280.975.475, N01.224.935.530, N06.850.505.400.975.475, N06.850.520.308.985.475
urinary bladder: A05.810.890
hydrocarbons: D02.455
intestines: A03.556.124
life style: F01.829.458
pneumonia: C08.381.677, C08.730.610
duodenum: A03.556.124.684.124, A03.556.875.249
esophagus: A03.556.875.500
stomach: A03.556.875.875
gasoline: D20.345.630.540, N06.230.132.258.630.540
comet assay: E05.196.401.153.150, E05.301.300.100.150, E05.393.560.150, E05.940.560.150
formaldehyde: D02.047.407
methyl ethers: D02.355.601
l-lactate dehydrogenase: D08.811.682.047.551.400, D08.811.682.047.820.493
dna damage: G05.355.180
dna: D13.444.308
leydig cells: A05.360.444.849.513, A06.407.312.782.513, A11.382.906, A11.436.513
plant oils: D10.627.700, D20.215.784.750
testicular neoplasms: C04.588.322.762, C04.588.945.440.915, C12.294.260.937, C12.758.409.937, C19.344.762, C19.391.829.782
biological assay: E05.091
sarcoma: C04.557.450.795
chironomidae: B01.050.500.131.617.289.260
aquatic organisms: B05.080, G16.500.275.810.650.075
surface-active agents: D27.720.877
alkanesulfonic acids: D02.455.326.146.100, D02.886.645.600.055
fluorocarbons: D02.455.526.510.435
caprylates: D02.241.081.222, D10.251.122
life cycle stages: B05.500, G07.700.320.500.550.500
mutagens: D27.888.569.468
ethylene oxide: D02.355.291.411.417
acrylamide: D02.065.122.015, D02.241.081.069.094.015
germ cells: A05.360.490, A11.497
mutation: G05.365.590
mammals: B01.050.150.900.649
methylmethacrylate: D02.241.081.069.800.550.450, D05.750.716.822.111.650.605.450, D25.720.716.822.111.650.605.450, J01.637.051.720.716.822.111.650.605.450
isoenzymes: D08.811.348, D12.776.800.300
joint prosthesis: E07.695.400
hip: A01.378.610.400
lung: A04.411
methacrylates: D02.241.081.069.600
cobalt: D01.268.556.185, D01.268.956.155, D01.552.544.185
blood pressure: E01.370.600.875.249, G09.330.380.076
hypertension: C14.907.489
cardiovascular diseases: C14
coronary disease: C14.280.647.250, C14.907.585.250
trace elements: D27.505.696.377.605.555, J02.500.631.555
developed countries: I01.615.500.250
cardiomyopathies: C14.280.238
atherosclerosis: C14.907.137.126.307
salmonella typhimurium: B03.440.450.425.800.200.825, B03.660.250.150.710.160.760
flame retardants: D27.720.361
nadp: D03.438.759.646.138.749, D08.211.625, D13.695.667.138.749, D13.695.827.068.749
oxygen: D01.268.185.550, D01.362.670
kinetics: G01.374.661, G02.111.325
propanols: D02.033.755
cytochrome p-450 enzyme system: D08.244.453, D08.811.682.690.708.170, D12.776.422.220.453
phosphates: D01.029.260.700.675.374, D01.248.497.158.730, D01.695.625.675.650
sperm motility: E01.370.225.992.812, E05.200.992.812, G04.299.283.750
pyrethrins: D02.455.849.575.812
nitriles: D02.626
epididymis: A05.360.444.371
toluene 2,4-diisocyanate: D02.455.426.559.389.832.500, D02.500.800
radioallergosorbent test: E01.370.225.812.735.830, E05.200.812.735.830, E05.478.566.380.810, E05.478.566.639.810, E05.478.594.760.830, E05.601.495.380.810, E05.601.495.639.810
methacholine chloride: D02.092.877.883.555.500, D02.675.276.534.500
isoproterenol: D02.033.100.291.439, D02.092.063.291.439, D02.092.311.649
serum albumin: D12.776.034.841, D12.776.124.050.700, D12.776.124.727
histamine release: G12.425.431
antibodies: D12.776.124.486.485.114, D12.776.124.790.651.114, D12.776.377.715.548.114
environmental monitoring: N06.850.460.350.080, N06.850.780.375
longitudinal studies: E05.318.760.500.750.500, N05.715.360.775.175.250.450, N06.850.520.450.500.750.500
adenosine monophosphate: D03.438.759.646.138.180, D13.695.667.138.180, D13.695.827.068.180
leukocytes: A11.118.637, A15.145.229.637, A15.382.490
skin tests: E01.370.225.812.871, E05.200.812.871, E05.478.594.890
immunoglobulin e: D12.776.124.486.485.114.619.312, D12.776.124.790.651.114.619.312, D12.776.377.715.548.114.619.312
allergy and immunology: H02.403.044
sheep: B01.050.150.900.649.077.380.791
leptophos: D02.705.429.812.500, D02.705.539.692.500, D02.886.300.846.500
chlorpyrifos: D02.705.400.625.100, D02.705.539.345.100, D02.886.300.692.100
tetrachlorvinphos: D02.705.400.750
cholinesterases: D08.811.277.352.100.170
chickens: B01.050.150.900.248.350.150, B01.050.150.900.248.617.192
monoamine oxidase: D08.811.682.664.750
organothiophosphorus compounds: D02.705.539, D02.886.300
carboxylic ester hydrolases: D08.811.277.352.100
ataxia: C10.597.350.090, C23.888.592.350.090
adolescent: M01.060.057
testosterone propionate: D04.808.054.079.429.824.832, D06.472.334.851.968.984.750
methyltestosterone: D04.808.054.079.429.824.664
dichlorodiphenyl dichloroethylene: D02.455.526.439.292
seminal vesicles: A05.360.444.713
prostate: A05.360.444.575, A10.336.707
5-alpha reductase inhibitors: D27.505.519.389.074
bulbourethral glands: A05.360.444.123, A10.336.197
japan: Z01.252.474.463, Z01.639.595
androgens: D27.505.696.399.472.161
oxazoles: D03.383.129.462
dichloroethylenes: D02.455.326.271.367.300, D02.455.526.439.350
penis: A05.360.444.492
oxidoreductases: D08.811.682
asthma: C08.127.108, C08.381.495.108, C08.674.095, C20.543.480.680.095
androgen antagonists: D06.347.065, D27.505.696.399.450.065
linuron: D02.455.426.559.389.703.515, D02.948.681.515
united states environmental protection agency: I01.409.137.500.937, N03.540.348.500.500.937
hypospadias: C12.294.494.400, C12.706.516, C13.351.875.466, C16.131.939.516
complex mixtures: D20
food quality: J01.576.423.850.730, N06.850.601
sister chromatid exchange: G05.355.760.615.750
bone marrow: A15.382.216
zinc acetate: D02.241.081.018.165.750
lethal dose 50: E05.940.402, G07.690.520
cytogenetic analysis: E01.370.225.500.385, E05.200.500.385, E05.242.385, E05.393.285
organometallic compounds: D02.691
acetates: D02.241.081.018, D10.251.400.045
human activities: I03
skin absorption: G03.495.023.750, G13.750.829.820
bromine: D01.268.380.112
teratology: H01.158.100.529.500, H01.158.273.200.350.500
half-life: G01.910.405
polybrominated biphenyls: D02.455.426.559.389.185.680, D02.455.526.368.700
halogenated diphenyl ethers: D02.355.726.601, D02.455.426.559.389.657.654.601
irritants: D27.720.400, D27.720.821.498, D27.888.569.300, D27.888.569.734.498
bone marrow cells: A11.148, A15.378.316
adipose tissue: A10.165.114
parents: F01.829.263.500.320, I01.880.225.500.340, M01.620
feces: A12.459
rabbits: B01.050.150.900.649.521.700
glucuronidase: D08.811.277.450.426
polysorbates: D02.033.455.250.700.690, D05.750.741.700, D25.720.741.700, J01.637.051.720.741.700
acid phosphatase: D08.811.277.352.650.025
hydroxyproline: D12.125.072.401.623.478
hyperplasia: C23.550.444
naphthols: D02.455.426.559.847.638.638, D04.615.638.638
acetylesterase: D08.811.277.352.100.050
leucyl aminopeptidase: D08.811.277.656.350.100.511, D08.811.277.656.350.555.700, D08.811.277.656.675.555.700
proline oxidase: D08.811.682.662.640, D08.811.682.664.500.810
bronchi: A04.411.125
pulmonary emphysema: C08.381.495.389.750
emphysema: C23.550.325
necrobiotic disorders: C17.300.200.495, C17.800.550
racemases and epimerases: D08.811.399.894
metaplasia: C23.550.589
patch tests: E01.370.225.812.871.610, E05.200.812.871.610, E05.478.594.890.610
dermatitis, contact: C17.800.174.255, C17.800.815.255
ethylenes: D02.455.326.271.367
flowers: A18.024.249.500
vinyl chloride: D02.455.326.271.884.750, D02.455.526.439.975
trichloroethylene: D02.455.526.439.939
nucleosides: D09.408.595, D13.570
hydrolysis: G02.111.087.505, G02.149.115.505, G02.149.395, G03.495.508
nucleoside-triphosphatase: D08.811.277.040.465
alkylation: G02.111.087.029, G02.149.115.029, G02.149.465.040, G02.607.750.040, G03.495.130
proteins: D12.776
microsomes: A11.284.835.540
rna: D13.444.735
ketones: D02.522
biological transport: G03.495.166
ion transport: G03.495.166.500
osmolar concentration: G02.640, G02.842.640
molar: A14.549.167.860.525
malondialdehyde: D02.047.700
reactive oxygen species: D01.339.431, D01.650.775
nitric oxide: D01.339.387, D01.625.550.500, D01.625.700.500, D01.650.550.587.600
mitochondrial swelling: G04.299.580
sulfhydryl compounds: D02.886.489
membrane potentials: G01.154.535, G04.580, G07.265.750, G11.561.570
protective agents: D27.505.696.706, D27.720.799
mitochondria: A11.284.430.214.190.875.564, A11.284.835.626
transcription factor chop: D12.776.260.108.124.875, D12.776.660.167.875, D12.776.930.127.124.875
activating transcription factor 4: D12.776.260.108.061.937, D12.776.930.127.061.937
eukaryotic initiation factor-2: D12.776.835.725.868.249
prokaryotic initiation factor-2: D12.776.835.725.934.562
extracellular signal-regulated map kinases: D08.811.913.696.620.682.700.567.342, D08.811.913.696.620.682.700.646.750.249, D12.644.360.450.169, D12.776.476.450.169
mitogen-activated protein kinase 9: D08.811.913.696.620.682.700.567.513.750, D08.811.913.696.620.682.700.646.750.374.750, D12.644.360.450.340.750, D12.776.476.450.340.750
in situ nick-end labeling: E05.393.475
autophagy: G04.299.139.399, G04.299.482.350.091
cinnamates: D02.241.223.200
thiourea: D02.886.904, D02.948.898
endoplasmic reticulum: A11.284.430.214.190.875.248
benzo(a)pyrene: D02.455.426.559.847.799.306.300, D04.615.799.306.300
molecular weight: G02.842.580
cholinesterase reactivators: D27.505.519.405.347, D27.505.519.625.120.400, D27.505.696.577.120.400
carbofuran: D02.241.081.251.583.166
atropine: D02.145.074.722.229.199, D03.132.760.180.572.199, D03.132.889.180.648.199, D03.605.869.229.199, D04.075.080.875.099.722.229.199
carbamates: D02.241.081.251
pyridinium compounds: D03.383.725.762
pyrimidines: D03.383.742
carbaryl: D02.241.081.251.150, D02.455.426.559.847.638.162, D04.615.638.162
cytochromes: D08.244, D12.776.422.220
poisoning: C25.723
haplotypes: G05.380.360
alleles: G05.360.340.024.340.030
smoking: F01.145.466.349.750, F01.145.928.500
asian continental ancestry group: M01.686.508.200
genotype: G05.380
exons: G05.360.340.024.340.137.232
helicobacter pylori: B03.440.500.550, B03.660.150.280.550
achlorhydria: C06.405.748.045, C18.452.076.087
gerbillinae: B01.050.150.900.649.865.635.300
hepcidins: D12.776.494.249, D12.776.543.695.054.425
hydrogen: D01.268.406, D01.362.340, D01.435
potassium: D01.268.549.550, D01.552.528.652
interleukin-1: D12.644.276.374.465.501, D12.644.276.374.500.400, D12.776.467.374.465.501, D12.776.467.374.500.400, D23.529.374.465.501, D23.529.374.500.400
up-regulation: G02.111.087.880, G02.149.115.880, G05.355.315.850, G07.690.812.925, G07.700.680.925
carcinogenesis: C04.697.098, C23.550.727.098
gastritis: C06.405.205.697, C06.405.748.398
h(+)-k(+)-exchanging atpase: D08.811.277.040.025.325.625, D12.776.157.530.450.250.875.500.625, D12.776.543.585.450.250.875.500.625
helicobacter infections: C01.252.400.466
epidemiologic studies: E05.318.760.500, N05.715.360.775.175, N06.850.520.450.500
adenocarcinoma: C04.557.470.200.025
oncogene proteins: D12.776.624.664
adenosine: D03.438.759.590.138, D13.570.583.138, D13.570.800.096
systole: G09.330.190.541.880, G11.427.590.540.570.880
magnetic resonance angiography: E01.370.350.500.500, E01.370.350.825.500.500, E01.370.370.050.500
magnetic resonance imaging: E01.370.350.500, E01.370.350.825.500
magnetic resonance spectroscopy: E05.196.867.519
heart diseases: C14.280
hypertrophy: C23.300.775
middle aged: M01.060.116.630
positron-emission tomography: E01.370.350.350.800.700, E01.370.350.600.350.800.399, E01.370.350.710.800.399, E01.370.350.825.800.399, E01.370.384.730.800.399
sodium: D01.268.549.750, D01.552.528.850
ammonia: D01.362.075, D01.625.050
siblings: F01.829.263.500.490, I01.880.225.500.505, M01.781
twins: M01.438.873
heart: A07.541
regression analysis: E05.318.740.750, N05.715.360.750.695, N06.850.520.830.750
demography: I01.240, N01.224, N06.850.505.400
vasodilator agents: D27.505.954.411.918
radionuclide imaging: E01.370.350.710, E01.370.384.730
coronary vessels: A07.231.114.269, A07.231.908.194
infarction: C23.550.513.355, C23.550.717.489
electrocardiography: E01.370.370.380.240, E01.370.405.240
myocardial infarction: C14.280.647.500, C14.907.585.500
cardiomegaly: C14.280.195, C23.300.775.250
brachial artery: A07.231.114.139
hyperemia: C14.907.474
fasting: F01.145.407.400, G07.610.240.587
dilatation: E05.284
vasodilation: G09.330.190.400.925
postprandial period: G10.261.700
manometry: E05.559
renin: D08.811.277.656.074.500.780, D08.811.277.656.300.048.780, D08.811.277.656.837.750
aldosterone: D04.808.745.745.654.062, D06.472.040.585.353.118
map kinase kinase kinase 5: D08.811.913.696.620.682.700.559.500, D12.644.360.400.500, D12.776.476.400.500
superoxides: D01.248.497.158.685.750.850, D01.339.431.374.850, D01.339.431.750, D01.650.550.750.800
acetylcholine: D02.092.211.111
natriuresis: G08.852.796.241.557
vascular system injuries: C14.907.937, C26.940
fibrosis: C23.550.355
transforming growth factors: D12.644.276.954.800, D12.644.276.963, D12.776.467.942.800, D12.776.467.960, D23.529.942.800, D23.529.960
prenatal exposure delayed effects: C13.703.824.500
rotarod performance test: E05.017.449
fetus: A16.378
teratogens: D27.888.569.864
respiratory hypersensitivity: C08.674, C20.543.480.680
litter size: G08.686.530, G08.686.785.760.769.498.300
embryo implantation: G08.686.785.760.170.104.500
fetal death: C13.703.243, C23.550.260.460
magnetic fields: G01.358.750
corn oil: D10.212.302.380.370, D10.212.507.340, D10.627.700.240, D20.215.784.750.240, J02.500.375.400.250
gait: E01.370.600.250, G11.427.590.530.389
urinary incontinence: C12.777.934.852, C13.351.968.934.814, C23.888.942.343.800
organogenesis: G07.700.320.500.325.377, G08.686.785.760.170.450
dust: D20.633.222
talc: D01.524.500.850, D01.578.725.500.800, D01.837.725.700.760.535.800
insufflation: E01.370.450, E02.583
australia: Z01.338, Z01.639.100, Z01.678.100.373
vaginal smears: E01.370.225.500.384.100.800, E01.370.225.998.054.800, E01.370.378.900, E04.074.800, E05.200.500.384.100.800, E05.200.998.054.800, E05.242.384.100.800
uterus: A05.360.319.679
estrus: G08.686.195.500
vagina: A05.360.319.779
epithelial cells: A11.436
endometrium: A05.360.319.679.490
chlorobenzenes: D02.455.426.559.389.261, D02.455.526.439.202
brain diseases: C10.228.140
residual volume: E01.370.386.700.485.750.275.650, G09.772.850.390.820
silver: D01.268.556.812, D01.268.956.843, D01.552.544.812
capillaries: A07.231.461.165
respiratory function tests: E01.370.386.700
lung volume measurements: E01.370.386.700.485
alloys: D01.552.033, D25.058, J01.637.051.058
gonadotropin-releasing hormone: D06.472.699.327.740.320, D12.644.400.400.740.320, D12.644.456.460, D12.644.548.365.740.320, D12.776.641.650.405.740.320
prolactin: D06.472.699.322.576.773, D06.472.699.631.525.525, D12.644.548.691.525.525
inhibins: D06.472.334.968, D06.472.699.337, D12.644.548.387, D12.776.395.439
progesterone: D04.808.745.745.654.829, D06.472.334.734.623, D06.472.334.851.687.750
sesame oil: D10.212.302.380.775, D10.212.507.775, D10.627.700.865, D20.215.784.750.865, J02.500.375.400.725
estrogens: D27.505.696.399.472.277
decapitation: C26.986.224
hypothalamus: A08.186.211.464.482, A08.186.211.730.317.357
pituitary gland: A06.407.747, A06.688.357.750, A08.186.211.730.317.357.352.435.500, A08.713.357.750
luteinizing hormone: D06.472.699.322.576.463, D06.472.699.631.525.343.463, D12.644.548.691.525.343.463
diamond: D01.268.150.200
threshold limit values: N03.706.615.917, N06.850.460.350.600.807
spirometry: E01.370.386.700.750
occupational diseases: C24
pulmonary fibrosis: C08.381.765
biological products: D20.215
isocyanates: D02.500
receptors, interleukin-2: D12.776.543.750.705.852.420.320
prednisolone: D04.808.745.432.769.795
cough: C08.618.248, C23.888.852.293
x-ray film: E07.960
x-rays: G01.358.500.505.970, G01.750.250.970, G01.750.750.918
paint: J01.637.597
dyspnea: C08.618.326, C23.888.852.371
biopsy: E01.370.225.500.384.100, E01.370.225.998.054, E01.370.388.100, E04.074, E05.200.500.384.100, E05.200.998.054, E05.242.384.100
enzyme-linked immunosorbent assay: E05.478.566.350.170, E05.478.566.380.360, E05.478.583.400.170, E05.601.495.350.170, E05.601.495.380.360
immunoglobulin g: D12.776.124.486.485.114.619.393, D12.776.124.790.651.114.619.393, D12.776.377.715.548.114.619.393
forced expiratory volume: E01.370.386.700.660.230, G09.772.650.430
follow-up studies: E05.318.760.500.750.500.350, N05.715.360.775.175.250.350, N06.850.520.450.500.750.350
vital capacity: E01.370.386.700.485.750.900, G09.772.850.970
polyurethanes: D02.241.081.251.944.750, D05.750.716.650, D25.720.327.782, D25.720.716.650, J01.637.051.720.327.782, J01.637.051.720.716.650, J01.637.412.700
respiratory system: A04
peak expiratory flow rate: E01.370.386.700.660.225.600, G09.772.650.300.790
airway obstruction: C08.618.846.185
intermediate filaments: A11.284.430.214.190.750.410
paclitaxel: D02.455.426.392.368.242.888.777, D02.455.849.291.850.777
pregnenolone: D04.808.745.745.725, D06.472.040.585.745, D06.472.334.851.687.500
colchicine: D03.132.225
vimentin: D05.750.078.593.900, D12.776.220.475.900
colforsin: D02.455.849.291.300
adrenocorticotropic hormone: D06.472.699.327.935.059, D06.472.699.327.935.531.500, D06.472.699.631.525.600.059, D06.472.699.631.525.600.531.500, D12.644.400.400.935.059, D12.644.400.400.935.531.500, D12.644.548.365.935.059, D12.644.548.365.935.531.500, D12.644.548.691.525.690.059, D12.644.548.691.525.690.531.500, D12.776.641.650.405.935.059, D12.776.641.650.405.935.531.500
cholesterol: D04.808.247.222.284, D04.808.247.808.197, D10.570.938.208, D10.851.208
microtubules: A11.284.430.214.190.750.602
actin cytoskeleton: A11.284.430.214.190.750.050
steroids: D04.808
silicon dioxide: D01.578.750, D01.650.550.825, D01.837.725
silicosis: C08.381.483.581.760, C08.381.520.702.760, C24.800.834
scleroderma, systemic: C17.300.799, C17.800.784
radiography: E01.370.350.700
organ size: E01.370.600.115.100.660, E05.041.124.715, G07.100.100.660, G07.700.320.249.690
hemangiosarcoma: C04.557.450.795.390, C04.557.645.390
histiocytic sarcoma: C04.557.227.380, C15.604.250.390.380
national cancer institute (u.s.): I01.409.137.500.600.480.150, N03.540.348.500.500.600.480.150
inhalation exposure: N06.850.460.350.112
spleen: A10.549.700, A15.382.520.604.700
weight gain: C23.888.144.243.926, G07.700.320.249.314.120.200.926
survival rate: E05.318.308.985.550.900, L01.280.975.550.900, N01.224.935.698.826, N06.850.505.400.975.550.900, N06.850.520.308.985.550.900
urinalysis: E01.370.225.124.810, E01.370.390.810, E05.200.124.810
polyuria: C12.777.934.616, C13.351.968.934.616, C23.888.942.600
polytetrafluoroethylene: D05.750.395.616, D25.720.395.616, J01.637.051.720.395.616
liver neoplasms: C04.588.274.623, C06.301.623, C06.552.697
cell proliferation: G04.299.233.750, G07.700.320.249.410.750
estrous cycle: G08.686.195
erythrocytes: A11.118.290, A11.443.240, A15.145.229.334
proteinuria: C12.777.934.734, C13.351.968.934.734, C23.888.942.750
hemangioma: C04.557.645.375
hematology: H02.403.429.445
cataract: C11.510.245
anemia: C15.378.071
birth weight: C23.888.144.186, E01.370.600.115.100.160.120.186, E05.041.124.160.750.149, G07.100.100.160.120.186, G07.700.320.249.314.120.186
gestational age: G07.700.320.500.325.235.968, G08.686.320
fragaria: B01.650.940.800.575.100.842.500.266
linear models: E05.318.740.500.500, E05.318.740.750.425, E05.599.835.750, N05.715.360.750.530.460, N05.715.360.750.695.460, N06.850.520.830.500.500, N06.850.520.830.750.425
geographic information systems: L01.470.750.750.462, L01.700.508.300.314
mothers: F01.829.263.500.320.200, I01.880.225.500.340.270, M01.620.630
fetal development: G07.700.320.500.325.235, G08.686.785.760.170.157
fetal growth retardation: C13.703.277.370, C16.300.390, C23.550.393.450
cohort studies: E05.318.760.500.750, N05.715.360.775.175.250, N06.850.520.450.500.750
california: Z01.107.567.875.580.200, Z01.107.567.875.760.200
environmental exposure: N06.850.460.350
interleukin-8: D12.644.276.374.200.120.800, D12.644.276.374.465.508, D12.776.467.374.200.120.800, D12.776.467.374.465.508, D23.125.300.120.800, D23.469.200.120.800, D23.529.374.200.120.800, D23.529.374.465.508
tumor necrosis factor-alpha: D12.644.276.374.500.800, D12.644.276.374.750.626, D12.644.276.972.626, D12.776.124.900, D12.776.395.930, D12.776.467.374.500.800, D12.776.467.374.750.626, D12.776.467.972.626, D23.529.374.500.800, D23.529.374.750.626, D23.529.972.626
complement factor b: D08.622.200, D08.811.277.656.300.760.198, D08.811.277.656.959.350.198, D12.776.124.486.274.900
macrophage inflammatory proteins: D12.644.276.374.200.600, D12.776.467.374.200.600, D23.125.300.600, D23.469.200.600, D23.529.374.200.600
lung neoplasms: C04.588.894.797.520, C08.381.540, C08.785.520
allergens: D23.050.063
castor bean: B01.650.940.800.575.100.350.650.300
acaridae: B01.050.500.131.166.132.419.050
coffee: D20.215.784.249, J02.200.325
england: Z01.542.363.300, Z01.639.280.300
bronchial provocation tests: E01.370.386.700.125
agriculture: J01.040
employment: N01.824.245
fungi: B01.300
aspartame: D12.644.456.345.190
convulsants: D27.505.696.282.224, D27.505.954.427.220.224
carboxymethylcellulose sodium: D09.698.365.180.663.329
phenylalanine: D12.125.072.050.685, D12.125.142.666
learning: F02.463.425, F02.784.629.529
motor activity: F01.145.632, G11.427.590.530.698
reflex: E01.370.376.550.650, E01.370.600.550.650, F02.830.702, G11.561.600.765
dextroamphetamine: D02.092.471.683.152.110.200
trialkyltin compounds: D02.691.850.900
swimming: G11.427.590.530.568.800, G11.427.590.530.698.277.875, I03.450.642.845.869
organotin compounds: D02.691.850
oxidative phosphorylation: G02.111.087.677.550, G02.149.115.677.550, G03.495.335.631, G03.495.790.550
uncoupling agents: D27.505.519.389.936
peroxisome proliferators: D27.888.569.100.675
adenine nucleotides: D03.438.759.646.138, D13.695.667.138, D13.695.827.068
mitochondrial membranes: A11.284.149.450.349, A11.284.835.514.349
hexanols: D02.033.415.510, D02.033.480, D10.289.510
perfusion: E05.680
adenosine diphosphate: D03.438.759.646.138.124, D13.695.667.138.124, D13.695.827.068.124
adenosine triphosphate: D03.438.759.646.138.236, D13.695.667.138.236, D13.695.827.068.236
s100 calcium binding protein g: D12.776.157.125.090.500, D12.776.157.125.750.750
mifepristone: D04.808.365.415.580
calbindins: D12.776.157.125.090
calcium-binding proteins: D12.776.157.125
world health: N01.400.910
progestins: D27.505.696.399.472.858
coinfection: C01.539.218, C02.219, C03.202
metal nanoparticles: J01.637.512.600.500
ecosystem: G16.500.275.157, N06.230.124
citrates: D02.241.081.901.434
edema: C23.888.277
optic atrophy: C10.292.700.225, C11.640.451
cytochalasin b: D03.438.473.231.370, D23.946.587.370.370
bromodeoxyuridine: D03.383.742.680.852.300.150, D13.570.230.430.196, D13.570.685.852.300.150
concanavalin a: D12.776.503.499.500, D12.776.765.678.500
chromatids: A11.284.430.106.279.345.190.160.175, G05.360.160.175
s phase: G02.111.087.222.880, G02.149.115.222.880, G04.299.134.500.800, G05.355.200.880
chromosome aberrations: C23.550.210, G05.365.590.175
acrylates: D02.241.081.069
cell division: G04.299.134.220, G04.299.233.750.500, G05.355.105, G07.700.320.249.410.750.500
cell cycle: G04.299.134
arterial pressure: G09.330.380.076.347
sodium chloride: D01.210.450.150.875, D01.857.650
diuretics: D27.505.696.560.500
denervation: E04.525.210
sertoli cells: A05.360.444.849.789, A11.382.952, A11.436.837
seminiferous epithelium: A05.360.444.849.700.700, A10.272.700
creatine: D02.078.370.280, D12.125.373
creatinine: D03.383.129.308.207
ethane: D02.455.326.146.379
microscopy: E01.370.350.515, E05.595, H01.671.617.562
dinitrobenzenes: D02.455.426.559.389.565.225, D02.640.529.240
antimony: D01.268.513.124, D01.268.556.050, D01.552.544.050
amyotrophic lateral sclerosis: C10.228.854.139, C10.574.562.250, C10.574.950.050, C10.668.467.250, C18.452.845.800.050
welding: J01.576.370.400.900
rural population: N01.600.725
patient selection: E05.581.500.653, N04.590.731
solubility: G02.842.800
magnesium oxide: D01.524.490, D01.650.550.575
aluminum oxide: D01.056.050, D01.650.550.050
oxides: D01.248.497.158.685, D01.650.550
guinea pigs: B01.050.150.900.649.865.550
xylenes: D02.455.426.559.389.948
phosphatidylethanolamines: D10.570.755.375.760.400.840
toluene: D02.455.426.559.389.832
lipids: D10
ethanolamine: D02.033.100.291.375, D02.033.375.291.375, D02.092.063.291.375
trichloroethanes: D02.455.526.439.927
fatty acids: D10.251
glutathione peroxidase: D08.811.682.732.500
l-iditol 2-dehydrogenase: D08.811.682.047.150.700.475
alkaline phosphatase: D08.811.277.352.650.035
rectum: A03.556.124.526.767, A03.556.249.249.767
rectal neoplasms: C04.588.274.476.411.307.790, C06.301.371.411.307.790, C06.405.249.411.307.790, C06.405.469.491.307.790, C06.405.469.860.180.500
colonic neoplasms: C04.588.274.476.411.307.180, C06.301.371.411.307.180, C06.405.249.411.307.180, C06.405.469.158.356.180, C06.405.469.491.307.180
gastrointestinal neoplasms: C04.588.274.476, C06.301.371, C06.405.249
italy: Z01.542.489
colon: A03.556.124.526.356, A03.556.249.249.356
swine: B01.050.150.900.649.077.880
zea mays: B01.650.940.800.575.100.822.966, J02.500.200.909, J02.500.300.100.977
fusarium: B01.300.381.366
pulmonary edema: C08.381.742
hydrothorax: C08.528.476
fumonisins: D02.455.326.146.432, D23.946.587.385
sus scrofa: B01.050.150.900.649.077.880.399
permethrin: D02.455.849.575.812.636
diaphragm: A02.633.567.900.300
demyelinating diseases: C10.314
chromates: D01.220.150, D01.248.497.158.235
chromium: D01.268.556.175, D01.268.956.124, D01.552.544.175
metyrapone: D03.383.725.463
phenobarbital: D03.383.742.698.253.650
airway resistance: E01.370.386.700.050, G09.772.060
paintings: K01.093.646
methods: E05.581
electron transport complex iv: D05.500.562.374, D08.811.600.250.687, D08.811.682.285, D12.776.157.530.450.250.875.304, D12.776.543.277.687, D12.776.543.585.450.250.875.484
malates: D02.241.081.337.463, D02.241.511.505
nad: D03.438.759.646.138.694, D08.211.589, D13.695.667.138.694, D13.695.827.068.694
oxygen consumption: G03.730
carbonates: D01.045.125, D01.200.275.150, D01.248.497.158.165
phenylenediamines: D02.092.146.651, D02.092.782.258.651
cerebrum: A08.186.211.730.885.287
centrifugation: E05.181
cerebellum: A08.186.211.132.810.428.200, A08.186.211.865.428.200
construction industry: J01.576.262
confined spaces: G16.500.275.074, N06.230.074
carnitine: D02.092.877.883.099
carnitine acyltransferases: D08.811.913.050.350
pyruvic acid: D02.241.755.812.800
succinic acid: D02.241.081.337.759.625
muscular dystrophies: C05.651.534.500, C10.668.491.175.500, C16.320.577
muscles: A02.633, A10.690
hydroxybutyrates: D02.241.081.114.937, D02.241.511.429, D10.251.400.143.781
palmitates: D10.251.694.600
carbon tetrachloride: D02.455.526.439.150
chloroform: D02.455.526.439.224, D02.455.526.913.810
ethylene dibromide: D02.455.526.368.225
thyroid gland: A06.407.900
intubation: E02.585, E05.497
cats: B01.050.150.900.649.147.354.250.125
splanchnic nerves: A08.800.050.050.800, A08.800.050.800.800, A08.800.800.060.800
peripheral nervous system diseases: C10.668.829
nerve fibers: A08.663.542
myelin sheath: A08.637.600.500, A08.637.800.500, A08.663.542.512.560, A08.800.800.690.500, A10.755.503, A11.284.149.165.600, A11.650.600.500, A11.650.800.500, A11.671.514.553
axons: A08.663.542.145, A11.284.180.075, A11.671.137
erectile dysfunction: C12.294.644.486, F03.800.800.400
raynaud disease: C14.907.617.812
acro-osteolysis: C05.116.099.052, C05.116.264.579.052
lymphatic diseases: C15.604
pigmentation: E01.370.600.620, G16.690
adhesives: D27.720.013, J01.637.016
peripheral nerves: A08.800.800
hexanes: D02.455.326.146.500
spinal cord: A08.186.854
follicle stimulating hormone: D06.472.699.322.576.288, D06.472.699.631.525.343.288, D12.644.548.691.525.343.288
porphobilinogen synthase: D08.811.520.241.300.550
protoporphyrins: D03.383.129.578.840.500.725, D03.549.909.500.725, D04.345.783.500.725, D23.767.727.725
fructose: D09.546.359.250, D09.546.465.354
citric acid: D02.241.081.901.434.249
croatia: Z01.542.248.295, Z01.586.980.295
alcohol drinking: F01.145.317.269
sperm head: A05.360.490.890.820, A11.497.760.400
biological markers: D23.101
dogs: B01.050.150.900.649.147.153.200
propranolol: D02.033.100.624.698.711, D02.033.755.624.698.711, D02.092.063.624.698.711, D02.455.426.559.847.638.945, D04.615.638.945
lactic acid: D02.241.511.459.450
pentobarbital: D03.383.742.698.253.593
succinylcholine: D02.092.877.883.333.780, D02.241.081.337.759.875, D02.675.276.232.780
cardiac output: E01.370.370.380.150, G09.330.380.124
anoxia: C23.888.852.079
lactates: D02.241.511.459
blood gas analysis: E01.370.225.124.100.100, E01.370.386.700.100, E05.200.124.100.100
blood: A12.207.152, A15.145
daphnia: B01.050.500.131.365.150.200
population growth: I01.240.600.660, N01.224.625.660, N06.850.505.400.700.660
benzene: D02.455.426.559.389.023
tetradecanoylphorbol acetate: D02.455.849.291.500.510.850
allyl compounds: D02.455.326.271.122
acetaldehyde: D02.047.064
propane: D02.455.326.146.800
vitellogenins: D12.776.092.500.925, D12.776.290.812.500, D12.776.744.925
flutamide: D02.065.199.420
xenopus laevis: B01.050.150.900.090.180.610.500.562
keratins: D05.750.078.593.450, D12.776.220.475.450, D12.776.860.607
forearm: A01.378.800.585
breeding: E05.820.150, G05.355.090
epidermis: A10.272.497, A17.815.250
histidine: D12.125.072.329, D12.125.142.308
textiles: J01.576.885.800
tartrazine: D02.172.950
aspirin: D02.455.426.559.389.657.410.595.176
food additives: D27.720.368, J02.500.512
drug hypersensitivity: C20.543.206, C25.100.468
urticaria: C17.800.862.945, C20.543.480.904
nephrotic syndrome: C12.777.419.630.643, C13.351.968.419.630.643
plasmodium malariae: B01.043.075.380.611.661
kidney glomerulus: A05.810.453.324.359, A05.810.453.736.520
live birth: G08.686.785.760.769.530.249
blastocyst: A16.254.500
quinuclidinyl benzilate: D02.241.223.601.238.306.740, D02.241.511.085.740, D03.605.687.800
spiperone: D02.455.426.559.847.885.800, D02.522.352.800, D04.615.885.800
acetylcholinesterase: D08.811.277.352.100.170.176
diazepam: D03.438.079.080.070.216
ligands: D27.720.470.480
corpus striatum: A08.186.211.730.885.287.249.487
protein deficiency: C18.654.521.500.708
causality: N05.715.350.200, N06.850.490.625
cholinergic agents: D27.505.519.625.120, D27.505.696.577.120
bronchoconstriction: G09.772.770.755.700.080
bronchial hyperreactivity: C08.127.210
immunization: E02.095.465.425.400, E05.478.550, N02.421.726.758.310, N06.850.780.200.425, N06.850.780.680.310
olea: B01.650.940.800.575.100.782.666
helianthus: B01.650.940.800.575.100.100.400, J02.500.300.100.287
vegetables: B01.650.510.956, J02.500.850
heparin: D09.698.373.400
triglycerides: D10.351.801
polyethylene glycols: D02.033.455.250.700, D05.750.741, D25.720.741, J01.637.051.720.741
lipase: D08.811.277.352.100.400
chromium compounds: D01.220
lymphocytes: A11.118.637.555.567, A15.145.229.637.555.567, A15.382.490.555.567
fluorometry: E05.196.712.516.600
hydroxides: D01.045.250, D01.248.497.158.459, D01.455
glucosephosphate dehydrogenase: D08.811.682.047.150.300
bronchoalveolar lavage fluid: E05.927.100.500
diethylnitrosamine: D02.654.442.200
gamma-glutamyltransferase: D08.811.913.050.200.500
glutathione transferase: D08.811.913.225.500
stereoisomerism: G02.607.500.682
image cytometry: E01.370.225.500.386.400, E05.196.712.516.600.240.400, E05.200.500.386.400, E05.242.386.400
glutamine: D12.125.068.330, D12.125.095.461, D12.125.154.424
astrocytes: A08.637.200, A11.650.200
extracellular space: A10.082.500, A11.284.295
methylmercury compounds: D02.691.750.100.738
glutamates: D12.125.067.625, D12.125.119.409
synapses: A08.850, A11.284.149.165.420.780
alanine transaminase: D08.811.913.477.700.100
ethylene glycols: D02.033.455.250
staining and labeling: E01.370.225.500.620.670, E01.370.225.750.600.670, E05.200.500.620.670, E05.200.750.600.670
aspartate aminotransferases: D08.811.913.477.700.225
carcinogenicity tests: E05.940.150
ethanol: D02.033.375
phosphines: D01.695.525, D02.705.621
myoclonus: C10.597.350.500, C23.888.592.350.500
clonazepam: D03.438.079.080.070.150
carbidopa: D02.092.311.200.538.200, D02.442.200
gamma-aminobutyric acid: D02.241.081.114.500.350, D12.125.190.350
ovary: A05.360.319.114.630, A05.360.576.497, A06.407.312.497
tritolyl phosphates: D02.455.426.559.389.657.239.900, D02.705.400.875
propantheline: D02.092.877.700, D02.675.276.700, D03.494.953.558
ethylene glycol: D02.033.455.250.268
oxalic acid: D02.241.081.337.593.750
ovarian follicle: A05.360.319.114.630.535, A06.407.312.497.535
propylene glycols: D02.033.455.706
homovanillic acid: D02.241.223.601.521
hydroxyindoleacetic acid: D03.066.288.478, D03.438.473.404.478
apomorphine: D03.132.098.038.290, D03.438.531.085.030.290, D03.549.095.290
haloperidol: D02.522.352.506
receptors, dopamine: D12.776.543.750.070.300.400, D12.776.543.750.100.150.400, D12.776.543.750.720.300.300.400
microdialysis: E05.196.353.500
pharmaceutical preparations: D26
heart ventricles: A07.541.560
hazardous substances: D27.888.426
renal dialysis: E02.870.300, E02.912.800
neostriatum: A08.186.211.730.885.287.249.487.550
neurotransmitter agents: D27.505.519.625, D27.505.696.577
therapeutic irrigation: E02.533.500, E05.927
fura-2: D03.383.129.462.285, D03.438.127.250
thymocytes: A11.118.637.555.567.569.360.800, A11.148.378.294.750.800, A11.872.378.294.750.800, A11.900
fluorescence: G01.358.500.505.650.665.500, G01.590.540.665.500
cytosol: A11.284.430.214.200, A11.284.430.429.200, A11.284.835.450.200
hydroquinones: D02.455.426.559.389.657.393
chlorides: D01.210.450.150, D01.248.497.158.215
cell membrane: A11.284.149
adenosine triphosphatases: D08.811.277.040.025
nickel: D01.268.556.607, D01.268.956.625, D01.552.544.607
phospholipids: D10.570.755, D10.695
muramidase: D08.811.277.450.642
pulmonary surfactants: D27.505.954.796.600
metals: D01.552
aerosols: D20.280.055, D26.255.165.055, D27.720.280.165.055
physiology: H01.158.782
metabolism: G03.495
pulmonary alveoli: A04.411.715
macrophages: A11.329.372, A11.627.482, A11.733.397, A15.382.680.397, A15.382.812.522
stainless steel: D01.490.800.900, D01.552.033.847.681, D25.058.807.681, J01.637.051.058.807.681
acetylglucosaminidase: D08.811.277.450.483.180.500
beta 2-microglobulin: D12.776.124.790.223.100, D12.776.377.715.182.100
retinol-binding proteins: D12.776.157.700
transferrin: D12.776.124.050.800, D12.776.124.790.223.839, D12.776.157.427.750.500, D12.776.377.715.182.839, D12.776.556.579.750.500
albumins: D12.776.034
psychometrics: F04.711.780
polyesters: D05.750.728, D25.720.728, J01.637.051.720.728
mandelic acids: D02.241.223.475, D02.241.511.536
glyoxylates: D02.241.152.367
angiotensin ii: D06.472.699.094.078, D12.644.400.070.078, D12.644.456.073.041, D12.644.548.058.078, D12.776.641.650.070.078, D23.469.050.050.050
protein kinase c: D08.811.913.696.620.682.700.725
ionomycin: D10.251.355.391
calcimycin: D03.438.221.173
myristates: D10.251.640.610
blood platelets: A11.118.188, A15.145.229.188
methionine: D02.886.030.676, D12.125.142.557, D12.125.154.549, D12.125.166.676
electrophoresis: E05.196.401, E05.301.300
protein isoforms: D12.776.800
phorbols: D02.455.849.291.500
eye protective devices: E07.700.260, J01.637.708.260
ethnic groups: M01.686.754, N01.224.317
pharynx: A03.556.750, A04.623, A14.724
cadaver: C23.550.260.224
dissection: E01.370.225.998.221, E04.221, E05.200.998.221
laboratories: N02.278.487
mouth: A01.456.505.631, A03.556.500, A14.549
carbon disulfide: D01.200.210, D01.875.350.850.074
occupational medicine: H02.403.720.750.510
psychological tests: F04.711
education: I02
melanins: D12.125.072.050.875.379, D23.767.620
nitric oxide synthase type ii: D08.811.682.664.500.772.500
monophenol monooxygenase: D08.811.682.690.708.125.500
doxorubicin: D02.455.426.559.847.562.050.200.175, D04.615.562.050.200.175, D09.408.051.059.200.175
cyclin d1: D12.644.360.262.150.100, D12.776.167.218.150.100, D12.776.476.262.150.100, D12.776.624.664.700.100
anthraquinones: D02.455.426.559.847.117.159, D02.806.100, D04.615.117.159
emodin: D02.455.426.559.847.117.159.205.400, D02.806.100.205.400, D04.615.117.159.205.400
melanocytes: A11.436.613
cell line: A11.251.210
morinda: B01.650.940.800.575.100.850.566
aloe: B01.650.940.800.575.100.027
liver function tests: E01.370.372.460
transaminases: D08.811.913.477.700
united states food and drug administration: I01.409.137.500.600.650.760, N03.540.348.500.500.600.650.760
dietary supplements: J02.500.456
jaundice: C23.550.429.500, C23.888.885.375
hepatitis: C06.552.380
latex: D05.750.078.625, D20.215.721.124, D25.720.099.625, D25.720.099.750.500, D25.720.327.840.239, J01.637.051.720.099.625, J01.637.051.720.540
escherichia coli: B03.440.450.425.325.300, B03.660.250.150.180.100
sos response (genetics): G02.111.087.219.830, G02.149.115.219.830, G05.355.195.830
mutagenesis: G05.355.600
salmonella: B03.440.450.425.800, B03.660.250.150.710
beverages: J02.200
workplace: N01.824.245.925, N04.452.677.975
oxidants: D27.720.642, D27.888.569.540
logistic models: E05.318.740.500.525, E05.318.740.600.800.450, E05.318.740.750.450, E05.599.835.875, N05.715.360.750.530.480, N05.715.360.750.625.700.450, N05.715.360.750.695.470, N06.850.520.830.500.525, N06.850.520.830.600.800.450, N06.850.520.830.750.450
india: Z01.252.245.393
nose: A01.456.505.733, A04.531, A09.531
methyl chloride: D02.455.526.439.632
fixatives: D27.720.355
seizures: C10.228.140.490.631, C10.597.742, C23.888.592.742
hemoglobinuria: C12.777.934.734.634, C13.351.968.934.734.634, C23.888.942.750.634
zona fasciculata: A06.407.071.140.950
nasal cavity: A04.531.449
diarrhea: C23.888.821.214
mercuric chloride: D01.210.450.150.525, D01.538.500
capillary resistance: G09.330.380.921.327
osmotic pressure: G01.374.715.578, G02.640.249, G02.685.661, G02.842.640.249, G02.842.700.661
nephrons: A05.810.453.736
hemodynamics: G09.330.190.400, G09.330.380
acute kidney injury: C12.777.419.780.050, C13.351.968.419.780.050
colloids: D20.280, D26.255.165, D27.720.280.165
lung diseases, interstitial: C08.381.483
hindlimb: A13.473
glucagon: D06.472.699.587.469.500, D12.644.548.586.469.500
epinephrine: D02.033.100.291.310, D02.092.063.291.310, D02.092.211.215.311.461, D02.092.311.461
histamine: D02.092.211.215.501, D02.092.471.440, D03.383.129.308.373, D23.469.050.300
norepinephrine: D02.033.100.291.502, D02.092.063.480, D02.092.211.215.311.560, D02.092.311.461.484
hydrocortisone: D04.808.745.745.654.600, D06.472.040.585.353.476, D06.472.040.585.478.392
overweight: C23.888.144.699, E01.370.600.115.100.160.120.699, G07.100.100.160.120.699
hypersensitivity: C20.543
cysteine: D02.886.030.230, D02.886.489.155, D12.125.154.299, D12.125.166.230
electron transport: G02.111.087.240, G02.149.115.240, G03.495.335.531.403, G03.495.553.350
ouabain: D04.808.155.160.861.600, D04.808.155.580.130.750.600, D09.408.180.810.600
nystatin: D02.540.505.575
cytochromes c: D08.244.286.100, D12.776.422.220.286.100
goals: F01.658.500
alpha-linolenic acid: D10.212.302.380.410.100, D10.251.355.310.640.400, D10.251.355.337.100, D10.251.355.450.400
linoleic acid: D10.251.355.310.515.500, D10.251.355.343.500.500
membrane lipids: D10.570
cerebral cortex: A08.186.211.730.885.287.500
stearic acids: D10.251.882
anesthetics: D27.505.696.277.100, D27.505.954.427.210.100
chromosome breakage: C23.550.210.170, G05.355.180.210.170, G05.365.590.175.175
aneuploidy: C23.550.210.050, G05.365.590.175.050, G05.700.131
lymphoma: C04.557.386, C15.604.515.569, C20.683.515.761
goblet cells: A03.556.124.369.320, A04.329.597.320, A04.531.520.320, A04.760.259, A10.615.550.444.321, A10.615.550.760.520.320, A10.615.550.760.600.320, A11.436.298
nasal mucosa: A04.531.520, A04.760.600, A10.615.550.760.600
glycolates: D02.241.081.018.386, D02.241.511.316
hemoglobins: D12.776.124.400, D12.776.422.316.762
sulfates: D01.248.497.158.845, D01.875.800.800.850
urine: A12.207.927
aminooxyacetic acid: D02.092.570.050, D02.241.081.018.207
succinate dehydrogenase: D05.500.562.750.249.500, D08.811.600.250.500.750.500, D08.811.600.250.875.249.500, D08.811.682.660.385.500, D08.811.682.660.750, D08.811.682.830.249.500, D12.776.157.427.374.375.909.500, D12.776.331.199.750.500, D12.776.543.277.500.750.500, D12.776.543.277.875.249.500, D12.776.556.579.374.375.141.500
lyases: D08.811.520
respiratory insufficiency: C08.618.846
disulfides: D01.248.497.158.874.390, D01.875.350.850.150, D02.886.520.150
ranvier's nodes: A08.637.800.500.700, A08.663.542.512.560.700, A08.800.800.690.500.700, A10.755.503.700, A11.284.149.165.760, A11.650.800.500.700, A11.671.514.553.640
action potentials: G04.580.100, G07.265.750.100, G11.561.570.100
schwann cells: A08.637.800, A08.800.800.690, A11.650.800
sciatic nerve: A08.800.800.720.450.760
permeability: G02.685, G02.842.700
neuroma: C04.557.580.600.610
paresis: C10.597.636, C23.888.592.643
arsenic: D01.268.067, D01.268.513.249
occupational health: N01.400.525
osmeriformes: B01.050.150.900.493.595
metallurgy: J01.576.370.400
bone screws: E07.695.130, E07.858.442.660.115, E07.858.690.650.115
tibia: A02.835.232.043.650.883
bone density: G11.427.100
femur: A02.835.232.043.650.247
prostheses and implants: E07.695
ammonium compounds: D01.625.062
ammonium sulfate: D01.625.062.374, D01.875.800.800.850.050
urea: D02.948
methylcholanthrene: D02.455.426.559.847.149.500, D04.615.149.500
mutagenicity tests: E05.393.560, E05.940.560
fetal weight: C23.888.144.300, E01.370.600.115.100.160.120.300, E05.041.124.160.750.300, G07.100.100.160.120.300, G07.700.320.249.314.120.300, G07.700.320.500.325.235.937, G08.686.280
glycols: D02.033.455
ether: D02.355.417.332
cardiovascular system: A07
ribs: A02.835.232.904.567
selenium: D01.268.185.850, D01.578.700
neutron activation analysis: E05.196.039.564
autopsy: E01.370.060, E05.070, I01.198.780.937.120
medical records: E05.318.308.940.968, L01.280.900.968, N04.452.859.564, N05.715.360.300.715.500, N06.850.520.308.940.968
pyrenes: D02.455.426.559.847.799, D04.615.799
plasticizers: D27.720.760
testicular diseases: C12.294.829, C19.391.829
structure-activity relationship: G02.111.830, G07.690.830
phthalic anhydrides: D02.113.600, D02.241.223.805.800
adipates: D02.241.081.337.052
anthracenes: D02.455.426.559.847.117, D04.615.117
peroxisomes: A11.284.430.214.190.500.585.600, A11.284.430.214.190.875.190.190.755.600
hypolipidemic agents: D27.505.519.186.071, D27.505.954.557.500
fibric acids: D02.241.081.114.968.500, D02.355.726.305, D02.455.426.559.389.657.654.305
peptides: D12.644
longevity: G07.540, G07.700.320.124.519
foundations: N03.219.483.311, N03.540.630.180
nanoparticles: J01.637.512.600
fullerenes: D01.268.150.250, J01.637.512.600.612.350
antineoplastic agents: D27.505.954.248
feeding behavior: F01.145.113.547, F01.145.407
economics: I01.261, N03.219
weaning: G07.610.220.500.750, G07.610.593.762, G07.700.620.762
maternal mortality: E05.318.308.985.550.500, L01.280.975.550.500, N01.224.935.698.653, N06.850.505.400.975.550.500, N06.850.520.308.985.550.500
coitus: F01.145.802.188, G08.686.785.760.041
osteogenesis: G07.700.320.500.325.377.625.100.729, G11.427.590.560.100.729
spine: A02.835.232.834
barium: D01.268.552.050, D01.268.556.062, D01.552.539.124, D01.552.544.062
lymphocyte activation: E01.370.225.812.482, E05.200.812.482, E05.478.594.530, G12.425.747, G12.450.050.400.545
thymidine: D03.383.742.680.705, D13.570.230.855, D13.570.685.705
angiotensin-converting enzyme inhibitors: D27.505.519.389.745.085
enalapril: D12.644.456.345.360
heart rate: E01.370.600.875.500, G09.330.380.500
natriuretic agents: D27.505.696.560, D27.505.954.411.455
atrial natriuretic factor: D06.472.699.584.500, D12.644.548.585.500
heroin: D03.132.577.249.562.445, D03.549.686.607.490, D03.605.497.607.490, D04.615.723.795.576.445
pulmonary embolism: C08.381.746, C14.907.355.350.700
dioxins: D03.383.231
chloracne: C17.800.030.575, C17.800.271.125.800
tetrachlorodibenzodioxin: D03.383.231.900
accidents: N06.850.135
odds ratio: E05.318.740.600.600, G17.680.500, N05.715.360.750.625.590, N06.850.520.830.600.600
sweden: Z01.542.808.843
finland: Z01.542.267
denmark: Z01.542.808.224
abortion, spontaneous: C13.703.039
infant, low birth weight: M01.060.703.520.460
scandinavia: Z01.542.808
norway: Z01.542.808.618
antihypertensive agents: D27.505.954.411.162
ethylamines: D02.092.471
kidney papillary necrosis: C12.777.419.493, C13.351.968.419.493
sympathetic nervous system: A08.800.050.800
binding sites: G02.111.570.120
brain stem: A08.186.211.132
quartz: D01.578.750.600, D01.650.550.825.600, D01.837.725.600
zymosan: D09.698.365.089.750
coal ash: D20.633.110
ferric compounds: D01.490.100, D02.691.550.100
minerals: D01.578
fatal outcome: E05.318.308.985.550.325, L01.280.975.550.325, N01.224.935.698.201, N06.850.505.400.975.550.325, N06.850.520.308.985.550.325
adrenal cortex hormones: D06.472.040
free radicals: D01.339, D02.389
eosinophils: A11.118.637.415.345, A11.627.340.345, A15.145.229.637.415.345, A15.382.490.315.251
neutrophils: A11.118.637.415.583, A11.627.340.583, A11.733.689, A15.145.229.637.415.583, A15.382.490.315.583, A15.382.680.689
basement membrane: A10.272.220, A10.615.179
cell count: E01.370.225.500.195, E05.200.500.195, E05.242.195, G04.170
powders: D26.255.779, D27.720.280.779
tungsten: D01.268.556.887, D01.268.956.882, D01.552.544.887
tungsten compounds: D01.940
lung diseases: C08.381
endothelin-1: D12.644.276.400.225, D12.776.467.400.225, D23.529.400.225
renal circulation: G08.852.796.700, G09.330.190.163.812
vascular resistance: G09.330.380.921
nih 3t3 cells: A11.251.210.100.550, A11.329.228.100.550
codon: D13.444.735.544.355, G05.360.335.355, G05.360.340.024.340.137.190
base sequence: G02.111.570.080, G05.360.080, L01.453.245.667.080
proto-oncogenes: G05.360.340.024.340.375.500.791
polymerase chain reaction: E05.393.620.500
transfection: E05.393.350.810, G05.355.760.860
smoke: D20.633.937
chromium alloys: D01.220.175, D01.552.033.182, D25.058.224, D25.339.208.224, J01.637.051.058.224, J01.637.051.339.208.224
polyethylene: D02.455.326.271.665.550.500, D05.750.716.507.500, D25.720.716.507.500, J01.637.051.720.716.507.500
titanium: D01.268.557.800, D01.268.956.878, D01.552.547.800
dinoprostone: D10.251.355.255.100.637.250.200, D10.251.355.255.550.250.200, D23.469.050.175.725.780.200
polyethylenes: D02.455.326.271.665.550, D05.750.716.507, D25.720.716.507, J01.637.051.720.716.507
hip prosthesis: E07.695.400.400
bone resorption: C05.116.264, G11.427.590.195.150
death certificates: E05.318.308.940.350, L01.280.900.350, N04.452.859.264, N05.715.360.300.715.315, N06.850.520.308.940.350
trachea: A04.889
styrenes: D02.455.426.559.389.150.750
elastomers: D25.720.327, J01.637.051.720.327, J01.637.412
hematopoietic system: A15.378
international classification of diseases: L01.453.245.945.400
electricity: G01.358.500.249
vital statistics: E05.318.308.985, L01.280.975, N01.224.935, N06.850.505.400.975, N06.850.520.308.985
brain neoplasms: C04.588.614.250.195, C10.228.140.211, C10.551.240.250
telephone: L01.178.847.698
registries: E05.318.308.970, L01.280.950, N04.452.859.819, N05.715.360.300.715.700, N06.850.520.308.970
dimethyl sulfoxide: D02.886.640.150
keratoacanthoma: C17.800.417
papilloma: C04.557.470.700.600
methylnitronitrosoguanidine: D02.078.370.649.400, D02.654.567.400
fibroblasts: A11.329.228
harderian gland: A13.445
public health: H02.403.720, N01.400.550, N06.850
malathion: D02.705.400.625.500, D02.705.539.345.500, D02.886.300.692.500
organophosphorus compounds: D02.705
thiocarbamates: D02.241.081.251.869, D02.886.706
chlortetracycline: D02.455.426.559.847.562.900.146, D04.615.562.900.146
streptomycin: D09.408.051.885
diet therapy: E02.642.249
hydra: B01.050.500.308.485.400
invertebrates: B01.050.500
fishes: B01.050.150.900.493
no-observed-adverse-effect level: E05.940.600, G07.690.620
ulcer: C23.550.891
polycythemia: C15.378.738
respiratory mucosa: A04.760, A10.615.550.760
larynx: A04.329
polyps: C23.300.825
alpha-chlorohydrin: D02.033.260.100, D02.033.455.706.100
pneumoconiosis: C08.381.483.581, C08.381.520.702, C24.800
laboratory personnel: M01.526.502
dental prosthesis: E06.780.345, E07.695.190
myocardium: A02.633.580, A07.541.704, A10.690.552.750
nandrolone: D04.808.365.415.638, D06.472.334.851.968.976
drug therapy: E02.319
salivation: G07.610.593.220.800, G07.700.620.220.800, G10.261.326.222.800
anorexia: C23.888.821.108
biotransformation: G03.495.244, G07.690.812.097, G07.700.680.097
triclosan: D02.355.726.900, D02.455.426.559.389.657.654.900
anti-infective agents: D27.505.954.122
cosmetics: D27.720.269, J01.516.213
flumethasone: D04.808.745.432.769.465, D04.808.908.359
oligospermia: C12.294.365.700.508
azoospermia: C12.294.365.700.380
amenorrhea: C23.550.568.500
pancytopenia: C15.378.700
hot flashes: C23.888.475
physical examination: E01.370.600
aneugens: D27.888.569.468.060
metaphase: G04.299.134.220.220.750, G04.299.134.220.220.781.625, G05.355.105.220.750, G05.355.105.220.781.625
chromosomes: A11.284.187, A11.284.430.106.279.345.190, G05.360.162
macaca mulatta: B01.050.150.900.649.801.400.112.199.120.510.550
haplorhini: B01.050.150.900.649.801.400
mastication: G07.610.593.260.500, G07.700.620.260.500, G10.261.326.240.500
neurotoxicity syndromes: C10.720, C25.723.705
eating: G07.610.593.260, G07.700.620.260, G10.261.326.240
glucose-6-phosphate isomerase: D08.811.399.475.200.350
blood urea nitrogen: E01.370.225.124.100.115, E01.370.390.400.100, E05.200.124.100.115
coma: C10.597.606.358.800.200, C23.888.592.604.359.800.200
monkey diseases: C22.735.500
macaca: B01.050.150.900.649.801.400.112.199.120.510
pulmonary atelectasis: C08.381.730
history: K01.400
gastropoda: B01.050.500.644.400
fresh water: G16.500.275.280, N06.230.232
starlings: B01.050.150.900.248.620.750.712
ovum: A05.360.490.690, A11.497.497, A16.690
eggs: J02.500.470
rubiaceae: B01.650.940.800.575.100.850
cromolyn sodium: D03.438.150.266.300, D03.830.219.266.300
food preservatives: D27.720.368.385, J02.500.512.700
sodium benzoate: D02.241.223.100.120.500, D02.455.426.559.389.127.117.500
benzoates: D02.241.223.100, D02.455.426.559.389.127
sulfur dioxide: D01.362.810, D01.650.550.850.925, D01.875.825.925
citrus sinensis: B01.650.940.800.575.100.875.177.769
food hypersensitivity: C20.543.480.370
maximum allowable concentration: N06.850.460.350.210, N06.850.460.350.600.615
larva: B05.500.500, G07.700.320.500.550.500.500
diptera: B01.050.500.131.617.289
oviposition: G08.686.785.760.480
butylated hydroxyanisole: D02.355.601.200.324, D02.355.726.158.324, D02.455.426.559.389.657.654.158.324
butylated hydroxytoluene: D02.455.426.559.389.657.239.216
erythrosine: D02.455.426.559.847.885.347.350, D03.494.953.275.350, D04.615.885.347.350
nasal polyps: C08.460.572, C09.603.557, C23.300.825.557
indigo carmine: D03.438.473.396
coloring agents: D27.720.233, D27.720.470.330
azo compounds: D02.172
benzenesulfonates: D02.455.426.559.389.097, D02.886.645.600.080.050.100
amaranth dye: D02.172.025, D02.455.426.559.847.638.555.200, D02.886.645.600.080.050.650.012, D04.615.638.555.200
transferases: D08.811.913
aquaporin 5: D12.776.157.530.400.500.040.484, D12.776.543.550.425.730.040.484, D12.776.543.585.400.730.040.600
proteasome inhibitors: D27.505.519.389.745.705
proteasome endopeptidase complex: D05.500.562.500, D08.811.277.656.918, D08.811.600.730
hypoxia-inducible factor 1: D12.776.260.103.625, D12.776.930.125.625
real-time polymerase chain reaction: E05.393.620.500.706
acetylcysteine: D02.886.030.230.259, D12.125.166.230.259
water supply: H01.158.273.248.875.500
birth certificates: E05.318.308.940.250, L01.280.900.250, N04.452.859.132, N05.715.360.300.715.175, N06.850.520.308.940.250
maternal exposure: N06.850.460.350.145
software: L01.224.900
catecholamines: D02.092.211.215.311, D02.092.311
poisons: D27.720.777, D27.888.569.612
drug users: M01.169
hypertension, pulmonary: C08.381.423
beer: J02.200.100.200
blood glucose: D09.546.359.448.500
diabetic ketoacidosis: C18.452.076.176.652.500, C18.452.394.750.535, C19.246.099.812
carica: B01.650.940.800.575.100.192.500
forestry: J01.576.430
colorado: Z01.107.567.875.760.210
hawaii: Z01.107.567.875.580.375, Z01.639.760.815.482
nitroprusside: D01.248.497.158.291.350.550, D01.490.100.300.550, D01.625.400.100.325.550
phentolamine: D03.383.129.308.754
vasoconstriction: G09.330.190.400.920
nerve endings: A08.800.550
stroke: C10.228.140.300.775, C14.907.253.855
thioacetamide: D02.065.064.786, D02.065.900.890, D02.241.081.018.110.786, D02.886.685.800
clofibrate: D02.241.081.114.968.500.500.195, D02.355.726.305.500.195, D02.455.426.559.389.657.654.305.500.195
aflatoxin b1: D03.438.150.119.075, D03.830.219.119.075, D23.946.587.142.075
aldrin: D02.455.526.439.042
benzidines: D02.455.426.559.389.185.100
dna replication: G02.111.087.222, G02.149.115.222, G05.355.200
teratogenesis: C23.550.863
oxazines: D03.383.533
mixed function oxygenases: D08.811.682.690.708
tetanus toxin: D12.776.097.872, D23.946.123.893
axonal transport: G03.495.166.355.040, G04.299.418.040, G11.561.600.085
sensory receptor cells: A08.663.650.915, A08.800.950, A11.671.650.915
endrin: D02.455.526.439.416
water quality: N06.850.460.350.080.750, N06.850.460.790.730
cyprinidae: B01.050.150.900.493.200.244
epithelium: A10.272
pathology: H02.403.650
kidney neoplasms: C04.588.945.947.535, C12.758.820.750, C12.777.419.473, C13.351.937.820.535, C13.351.968.419.473
isotonic solutions: D26.776.498
moles: B01.050.150.900.649.473.450
chloramphenicol: D02.033.455.706.300, D02.455.426.559.389.565.175, D02.640.529.175
carbon-sulfur lyases: D08.811.520.300
mitochondrial proteins: D12.776.575
andrology: H02.403.059
nuclear family: F01.829.263.500, I01.880.225.500
pneumocytes: A04.411.715.512, A11.436.714
atmosphere: G16.500.275.063, N06.230.300.100
chlorine: D01.268.380.150, D01.362.225
visual pathways: A08.612.220.860
central nervous system: A08.186
aldehydes: D02.047
anticonvulsants: D27.505.954.427.080
papio: B01.050.150.900.649.801.400.112.199.120.610
papio papio: B01.050.150.900.649.801.400.112.199.120.610.600
senegal: Z01.058.290.190.710
epilepsy: C10.228.140.490
ranidae: B01.050.150.900.090.180.708
atrophy: C23.300.070
potassium dichromate: D01.220.150.650, D01.745.650
ankle: A01.378.610.250.149
electromyography: E01.370.405.255, E01.370.530.255
vibration: G01.374.676.930, G01.595.540.930
leg: A01.378.610.500
toes: A01.378.610.250.300.792
polyneuropathies: C10.668.829.800
retina: A09.371.729
electroretinography: E01.370.380.225, E01.370.405.270
tobacco: B01.650.940.800.575.100.905.900
microspheres: E07.565
phagocytosis: G04.299.482.350, G09.188.124.780, G12.425.899, G12.450.564.809
bronchoalveolar lavage: E05.927.100
aryl hydrocarbon hydroxylases: D08.244.453.040, D08.811.682.690.708.170.040, D12.776.422.220.453.040
cardenolides: D04.808.155.160, D04.808.155.580.130
saponins: D09.408.782
retroviridae: B04.820.650, B04.909.574.807, B04.909.777.731
thymus neoplasms: C04.588.894.949, C15.604.861
pharmacokinetics: G02.111.325.500, G03.787, G07.690.725
acetone: D02.522.064, D02.522.585.342
glucose-6-phosphatase: D08.811.277.352.650.225
glutamate dehydrogenase: D08.811.682.664.500.398
cyclohexanones: D02.455.426.392.368.367.340, D02.522.400
methyl n-butyl ketone: D02.522.520.500
wing: A13.395.823
drosophila melanogaster: B01.050.500.131.617.289.310.250.500
constriction: E05.225
nervous system diseases: C10
estrogen receptor alpha: D12.776.260.698.750.350.174, D12.776.826.750.350.174, D12.776.930.669.750.350.174
ethinyl estradiol: D04.808.668.651.568.291, D06.472.334.851.437.968.500
medroxyprogesterone acetate: D04.808.745.745.654.829.614.500
urethra: A05.360.444.492.726, A05.810.876
estradiol congeners: D06.472.334.851.437
virilism: C23.888.971
analysis of variance: E05.318.740.150, N05.715.360.750.125, N06.850.520.830.150
granuloma: C15.604.515.292, C23.550.382
saccharomyces cerevisiae: B01.300.107.795.785.800, B01.300.930.705.655
ziram: D02.241.081.251.869.210.925, D02.886.706.175.950
pheromones: D23.641
thiram: D02.241.081.251.869.210.800, D02.886.706.175.900
beta-galactosidase: D08.811.277.450.410.100
captan: D03.438.513.124
haploidy: G05.700.456
diploidy: G05.700.264
peptide hormones: D06.472.699, D12.644.548
oxyquinoline: D03.438.810.350.625
lac operon: G05.360.340.024.686.545, G05.360.340.358.207.500.545
fibrinogen: D12.776.124.050.250, D12.776.124.125.500, D12.776.811.300, D23.119.490
lung injury: C08.381.520, C26.891.554
vacuoles: A11.284.430.214.190.875.190.920
thyroxine: D06.472.931.812, D12.125.072.050.767
metabolic syndrome x: C18.452.394.968.500.570, C18.452.625
exploratory behavior: F01.145.387, F01.658.370
zebrafish: B01.050.150.900.493.200.244.828
morpholinos: D03.383.533.640.562, D13.695.578.424.337
inosine triphosphate: D03.438.759.646.616.800, D13.695.667.616.800, D13.695.827.519.800
hominidae: B01.050.150.900.649.801.400.112.400
pyrazoles: D03.383.129.539
basic helix-loop-helix transcription factors: D12.776.260.103, D12.776.930.125
luciferases: D08.811.682.517, D12.776.532.510
phenotype: G05.695
fluorocarbon polymers: D05.750.395, D25.720.395, J01.637.051.720.395
europe: Z01.542
north america: Z01.107.567
culture media: D27.720.470.305, E07.206
mass spectrometry: E05.196.566
simazine: D03.383.931.819
relaxin: D06.472.334.734.769, D06.472.699.715, D12.644.548.762
oligonucleotide array sequence analysis: E05.196.630.570.660, E05.393.525.640, E05.393.661.640, E05.393.760.640, E05.588.570.660, E05.601.640
nitric oxide synthase: D08.811.682.664.500.772
groundwater: G01.311.355
horseradish peroxidase: D08.811.682.732.512
botulinum toxins: D08.811.277.656.300.480.153, D08.811.277.656.675.374.153, D12.776.097.156, D23.946.123.179
motor neurons: A08.663.655.500, A11.671.655.500
trigeminal nuclei: A08.186.211.132.931
sural nerve: A08.800.800.720.450.760.820.820
lumbosacral region: A01.923.176.519
acrylamides: D02.065.122, D02.241.081.069.094
methane: D02.455.326.146.571
biphenyl compounds: D02.455.426.559.389.185
soybeans: B01.650.940.800.575.100.401.750, J02.500.300.100.900, J02.500.850.500.700
soybean oil: D10.212.302.380.800, D10.212.507.800, D10.627.700.880, D20.215.784.750.880, J02.500.375.400.750
survivors: M01.643.836, M01.860
pregnancy outcome: E01.789.700, G08.686.785.760.769.530
general surgery: H02.403.810.300
cost of illness: I01.137, N03.219.151.165
poecilia: B01.050.150.900.493.850.280.680
ejaculation: G08.686.785.760.084
xenobiotics: D26.969
plethysmography: E01.370.370.610, E01.370.610
forelimb: A13.395
cochlea: A09.246.631.246
organ of corti: A09.246.631.246.577
hearing: F02.830.816.263, G11.561.600.810.263
sound: G01.750.770.776
cricetinae: B01.050.150.900.649.865.635.150
cricetulus: B01.050.150.900.649.865.635.150.250
scintillation counting: E05.799.700
dna repair: G02.111.087.219, G02.149.115.219, G05.355.195
fatty acids, unsaturated: D10.251.355
fetal viability: G07.280, G07.700.320.500.325.235.875, G08.686.220
sex ratio: G05.815, I01.240.800.815, N01.224.803.815, N06.850.505.400.850.815
methylene chloride: D02.455.526.439.642
carboxyhemoglobin: D12.776.124.400.141, D12.776.422.316.762.149
salivary glands: A03.556.500.760, A10.336.779, A14.549.760
amyloidosis: C18.452.845.500
trypan blue: D02.172.975, D02.455.426.559.847.638.555.875, D02.886.645.600.080.050.650.875, D04.615.638.555.875
dna fragmentation: G05.355.180.230
sepharose: D09.698.813
egtazic acid: D02.092.782.258.368.257, D02.241.081.018.269
chelating agents: D27.505.519.914.500, D27.720.832.500
quercetin: D03.438.150.266.450.284.777, D03.830.219.266.450.284.777
kaempferols: D03.438.150.266.450.284.388, D03.830.219.266.450.284.388
glycosides: D09.408
senna plant: B01.650.940.800.575.100.401.718
glycoside hydrolases: D08.811.277.450
methylmethacrylates: D02.241.081.069.800.550, D05.750.716.822.111.650.605, D25.720.716.822.111.650.605, J01.637.051.720.716.822.111.650.605
bone cements: D05.750.716.822.300, D25.720.716.822.300, D27.720.102.158, J01.637.051.720.716.822.300
heart block: C14.280.067.558, C23.550.073.425
sunscreening agents: D27.505.696.706.776.800, D27.505.954.444.695, D27.720.269.800, D27.720.799.763.764
4-aminobenzoic acid: D02.241.223.100.050.500.640, D02.455.426.559.389.127.020.937.640
new york: Z01.107.567.875.075.437, Z01.107.567.875.350.530, Z01.107.567.875.500.530
benzophenones: D02.455.426.559.389.115.124, D02.522.223
coumarins: D03.438.150.446, D03.830.219.446
perfume: D27.720.269.700
dichlorodiphenyldichloroethane: D02.455.526.439.294
suicide: F01.145.126.980.875, I01.880.735.856
cheilitis: C07.465.409.215
epichlorohydrin: D02.355.291.411.400
neuropsychological tests: F04.711.513
dentists: M01.526.485.330, N02.360.330
motilin: D06.472.317.525, D06.472.699.500, D12.644.400.470, D12.644.548.500, D12.776.641.650.463
somatostatin: D06.472.699.327.700.875, D06.472.699.587.780, D12.644.400.400.700.875, D12.644.548.365.700.875, D12.644.548.586.780, D12.776.641.650.405.700.875
trees: B01.650.915
substance p: D12.644.276.812.900.866, D12.644.400.800.750, D12.644.456.800.866, D12.776.467.812.900.866, D12.776.641.650.800.750, D23.469.050.375.850.890, D23.529.812.900.866
nitrogen: D01.268.604, D01.362.625
agrochemicals: D27.720.031
lithuania: Z01.542.248.136.580, Z01.586.950.140.580
piperazines: D03.383.606
enteroendocrine cells: A06.390, A11.382.625, A11.436.294
insulins: D06.472.699.587.200, D12.644.548.586.200
parathyroid hormone: D06.472.699.590, D12.644.548.587
kidney function tests: E01.370.390.400
vitamin d: D04.808.812.768
ships: J01.937.817
glass: J01.637.241.400, J01.637.437
personality inventory: F04.711.647.513
intelligence: F01.752.543
mesocricetus: B01.050.150.900.649.865.635.150.500
methylnitrosourea: D02.654.692.480, D02.948.594.490
acetamides: D02.065.064, D02.241.081.018.110
gallbladder: A03.159.439
gallstones: C06.130.409.633, C06.130.564.332.500, C23.300.175.525
portal vein: A07.231.908.670.567
cholelithiasis: C06.130.409
tumor necrosis factors: D12.644.276.374.750, D12.644.276.972, D12.776.467.374.750, D12.776.467.972, D23.529.374.750, D23.529.972
penicillium: B01.300.381.662
neurotoxins: D27.888.569.504
mycotoxins: D23.946.587
trichothecenes: D02.455.849.765.850, D04.345.891, D23.946.587.933
trichloroacetic acid: D02.241.081.018.214.750, D02.455.526.439.196.750
glucuronides: D02.241.081.844.915.162.500, D02.241.152.811.162.750, D02.241.511.902.915.162.750, D09.811.922.162.750
glucuronosyltransferase: D08.811.913.400.450.480
ethylene chlorohydrin: D02.033.260.350, D02.033.375.310
chloral hydrate: D02.033.455.250.130
glucuronates: D02.241.081.844.915.162, D02.241.152.811.162, D02.241.511.902.915.162, D09.811.922.162
new zealand: Z01.639.760.747, Z01.678.100.747
evoked potentials: G07.265.500, G11.561.270
steel: D01.490.800, D01.552.033.847, D25.058.807, J01.637.051.058.807
evoked potentials, auditory: G07.265.500.370, G11.561.270.370
electroencephalography: E01.370.376.300, E01.370.405.245
parkinsonian disorders: C10.228.140.079.862, C10.228.662.600
creatine kinase: D08.811.913.696.640.150
radius: A02.835.232.087.090.700
recognition (psychology): F02.463.425.540.706
writing: L01.143.506.423.906
gibberella: B01.300.107.501.400
dichloroacetic acid: D02.241.081.018.214.500, D02.455.526.439.196.500
crown-rump length: E01.370.600.115.100.160.100.500, E05.041.124.160.500.500, G07.100.100.160.100.500, G07.100.100.250, N06.850.505.200.100.400
fertilization in vitro: E02.875.800.750, E05.820.800.750
gonads: A05.360.576, A06.407.312
aorta: A07.231.114.056
protein s: D12.776.124.670, D12.776.395.642, D23.113.725
s100 proteins: D12.776.157.125.750, D12.776.641.655
methyl methanesulfonate: D02.455.326.146.100.050.500.500, D02.886.645.600.055.050.510.500
nadh tetrazolium reductase: D08.811.682.608.530
spinal nerve roots: A08.800.800.720.725
weight loss: C23.888.144.243.963, G07.700.320.249.314.120.200.963
mercury poisoning: C25.723.647
collodion: D25.720.099.500.439, J01.637.051.720.099.500.439
haptens: D23.050.550.480
body burden: E05.799.638.231, N06.850.460.200
porphyrins: D03.383.129.578.840.500, D03.549.909.500, D04.345.783.500, D23.767.727
artifacts: E05.047
porphyrias: C16.320.565.708, C17.800.849.617, C18.452.648.708, C18.452.811, C18.452.880.617
porphyrias, hepatic: C06.552.830, C16.320.565.708.400, C16.320.850.742, C17.800.827.742, C17.800.849.617.400, C18.452.648.708.400, C18.452.811.400, C18.452.880.617.400
cattle: B01.050.150.900.649.077.380.271
colostrum: A12.200.194
milk: A12.200.455, J02.200.700, J02.500.350.525
pilot projects: E05.318.760.750, E05.337.737, N05.715.360.775.625, N06.850.520.450.720
protons: D01.248.497.300.459.700, D01.435.550, G01.249.765
migraine disorders: C10.228.140.546.399.750
gastric mucosa: A03.556.875.875.440, A10.615.550.291
arthroplasty: E04.555.110
thallium: D01.268.556.847, D01.552.544.847
neurites: A08.663.256.500, A08.663.542.145.500, A11.284.180.610, A11.671.543
piperonyl butoxide: D03.383.246.118.600, D03.438.115.600
trigeminal nerve: A08.800.800.120.760
face: A01.456.505
docosahexaenoic acids: D10.212.302.380.410.210, D10.251.355.337.250, D10.627.430.450.375
arachidonic acid: D10.251.355.096.100, D10.251.355.255.100.100, D10.251.355.310.166.100
carbon: D01.268.150
ethanolamines: D02.033.100.291, D02.033.375.291, D02.092.063.291
central nervous system neoplasms: C04.588.614.250, C10.551.240
mesothelioma: C04.557.470.035.510, C04.557.470.660.510
rodentia: B01.050.150.900.649.865
cytoplasm: A11.284.430.214
dendritic cells: A11.066.270, A11.436.270, A15.382.066.270, A15.382.812.260
ethylene dichlorides: D02.455.326.146.379.350, D02.455.526.439.458
resorcinols: D02.455.426.559.389.657.852
hypopharynx: A04.623.490, A14.724.490
washington: Z01.107.567.875.560.900, Z01.107.567.875.580.900
air pollutants: D27.888.284.101
alcohols: D02.033
lead: D01.268.556.435, D01.552.544.435
trimethyltin compounds: D02.691.850.900.950
aminoquinolines: D03.438.810.050
ion channels: D12.776.157.530.400, D12.776.543.550.425, D12.776.543.585.400
endonucleases: D08.811.277.352.355
respiratory sounds: C23.888.852.779, E01.370.386.720, G09.772.775
tobacco use disorder: C25.775.912, F03.900.912
new england: Z01.107.567.875.550
pyramidal cells: A08.186.211.464.405.700, A08.186.211.730.885.287.500.345.700, A08.186.211.730.885.287.500.766, A08.663.790, A11.671.790
dentate gyrus: A08.186.211.464.405.200, A08.186.211.730.885.287.500.345.200
hallucinations: C10.597.606.762.300, C23.888.592.604.764.300, F01.700.750.300
antipsychotic agents: D27.505.696.277.950.040, D27.505.954.427.210.950.040, D27.505.954.427.700.872.331
street drugs: D26.878
substance-related disorders: C25.775, F03.900
psychotic disorders: F03.700.675
deoxyuridine: D03.383.742.680.852.300, D13.570.230.430, D13.570.685.852.300
containment of biohazards: E05.235
micronucleus tests: E05.393.560.598
phosphorus: D01.268.666
human body: I01.076.201.450.560, K01.093.378
kidney pelvis: A05.810.453.537
androgen receptor antagonists: D06.347.065.249, D27.505.696.399.450.065.249
sex differentiation: G07.700.320.500.325.377.843, G07.700.320.750.500, G08.686.785.880.500
phenol: D02.455.426.559.389.657.595
colombia: Z01.107.757.284
food: J02.500
guaiacol: D02.355.601.536, D02.355.726.453, D02.455.426.559.389.657.166.453, D02.455.426.559.389.657.654.453
prostaglandins: D10.251.355.255.100.637, D10.251.355.255.550, D23.469.050.175.725
thromboxane a2: D10.251.355.255.100.825.800, D23.469.050.175.800.800
epoprostenol: D10.251.355.255.100.637.550.500, D10.251.355.255.550.550.500, D23.469.050.175.725.895.500
mineralocorticoids: D27.505.696.399.472.673
indomethacin: D03.438.473.420
ketone bodies: D02.522.585
3-hydroxybutyric acid: D02.241.081.114.937.349, D02.241.511.429.349, D02.522.585.087, D10.251.400.143.781.500
oleic acid: D10.251.355.325.600.525
acetoacetates: D02.241.755.080, D02.522.585.175
alcohol dehydrogenase: D08.811.682.047.820.250
alkane 1-monooxygenase: D08.811.682.690.708.170.035
caproates: D02.241.081.193, D10.251.400.326
lipid metabolism: G03.495.520
chemical industry: J01.576.207
nose neoplasms: C04.588.149.721.600, C04.588.443.665.650, C05.116.231.754.600, C08.460.669, C08.785.600, C09.603.669, C09.647.685
carcinoma in situ: C04.557.470.200.240
asbestos: D01.578.725.050, D01.837.725.700.760.070
myocardial ischemia: C14.280.647, C14.907.585
pancreatic neoplasms: C04.588.274.761, C04.588.322.475, C06.301.761, C06.689.667, C19.344.421
salaries and fringe benefits: N01.824.417.700, N04.452.677.800
seasons: G01.910.645.661, G16.500.275.071.590, N06.230.300.100.250.525
oocytes: A05.360.490.690.680, A11.497.497.600
nitrilotriacetic acid: D02.241.081.018.588
salts: D01.786
dentistry: E06, H02.163
dental amalgam: D25.339.208.291, J01.637.051.339.208.291
bile: A12.200.087
clinical chemistry tests: E01.370.225.124, E05.200.124
macaca fascicularis: B01.050.150.900.649.801.400.112.199.120.510.520
pleural neoplasms: C04.588.894.797.640, C08.528.694, C08.785.640
oils: D10.627
glutamate-ammonia ligase: D08.811.464.259.200.600
glycerolphosphate dehydrogenase: D08.811.682.047.150.700.400
prosencephalon: A08.186.211.730
chromatin: A11.284.430.106.279.345.190.160.180, D12.776.664.224, G05.360.160.180
nitrosamines: D02.654.442
anxiety: F01.470.132
thiobarbituric acid reactive substances: D02.047.700.700, D27.720.470.410.750
ascorbic acid: D02.241.081.844.107, D02.241.511.902.107, D09.811.100
ornithine carbamoyltransferase: D08.811.913.555.275.600
ornithine: D12.125.068.665, D12.125.095.765
chick embryo: A13.350.150, A16.331.200
hydroxyl radical: D01.248.497.158.459.300, D01.339.431.249, D01.455.432
conalbumin: D12.776.034.180, D12.776.157.427.750.124, D12.776.256.317.180, D12.776.290.180, D12.776.556.579.750.124
aminolevulinic acid: D02.241.755.547.276, D12.125.262
gene expression: G05.355.310
5-aminolevulinate synthetase: D08.811.913.050.276
cisplatin: D01.210.375, D01.625.125, D01.710.100
glutethimide: D03.383.621.808.425
poland: Z01.542.248.679
seminiferous tubules: A05.360.444.849.700
glycogen: D05.750.078.562.388, D09.698.365.388
anesthesia: E03.155
pentylenetetrazole: D03.383.066.600
electroshock: E05.723.402.403, F04.669.224
oxaloacetic acid: D02.241.081.337.593.812.750, D02.241.755.648.750
hexanones: D02.522.520
cell respiration: G03.495.278, G04.299.305
crassostrea: B01.050.500.644.080.643.150
seawater: G16.500.275.810, N06.230.580
hemolymph: A13.453
ostreidae: B01.050.500.644.080.643
salinity: G02.640.500, G02.842.640.500
anions: D01.248.497.158
hypochlorous acid: D01.029.260.365, D01.210.465, D01.339.431.311, D01.650.550.400
trihalomethanes: D02.455.526.913
disinfection: N06.850.780.200.450.850.375
maternal death: C13.703.401, C23.550.260.730.500, I01.880.735.607.500
levocardia: C14.240.400.701, C14.280.400.701, C16.131.240.400.701, C16.131.810.700
orbit: A02.835.232.781.324.690
sex characteristics: G08.686.815
incisor: A14.549.167.860.425
achievement: F01.658.059, F02.784.629.054
discriminant analysis: E05.318.740.350, N05.715.360.750.325, N06.850.520.830.350
psychomotor performance: F02.808, G11.427.700, G11.561.623
hand: A01.378.800.667
african continental ancestry group: M01.686.508.100
european continental ancestry group: M01.686.508.400
adrenergic agents: D27.505.519.625.050, D27.505.696.577.050
lethargy: C10.597.606.441, C23.888.592.604.444, F01.700.470
kidney cortex: A05.810.453.324
posture: G11.427.695
emaciation: C23.888.144.243.963.500
hair: A17.360
pyruvates: D02.241.755.812
research design: E05.581.500, H01.770.644.728
suspensions: D20.280.810, D26.255.165.810, D27.720.280.165.810
intestinal mucosa: A03.556.124.369, A10.615.550.444
collagenases: D08.811.277.656.300.480.205, D08.811.277.656.675.374.205
cyclophosphamide: D02.455.526.728.650.730.243, D02.705.672.500.243
coculture techniques: E05.240.374
neuroblastoma: C04.557.465.625.600.590.650.550, C04.557.470.670.590.650.550, C04.557.580.625.600.590.650.550
glioma: C04.557.465.625.600.380, C04.557.470.670.380, C04.557.580.625.600.380
chromosome disorders: C16.131.260, C16.320.180
p-aminohippuric acid: D02.065.277.431.192.100, D02.241.223.100.050.500.650, D02.241.223.100.100.100.100, D02.241.755.360.192.100, D02.455.426.559.389.127.020.937.650, D02.455.426.559.389.127.085.067.100
tetraethylammonium: D02.092.877.787.500, D02.675.276.787.500
beta-naphthoflavone: D03.438.150.266.450.175.100, D03.830.219.266.450.175.100
cations: D01.248.497.300
dipeptides: D12.644.456.345
halothane: D02.455.526.340
enflurane: D02.355.601.400
central venous pressure: G09.330.380.076.732.336
pulmonary artery: A07.231.114.715
electrophysiologic techniques, cardiac: E01.370.370.380.245, E01.370.405.267
cyanates: D02.262
leukocytosis: C15.378.553.475, C23.550.526
egg yolk: A16.690.325, J02.500.470.800
densitometry: E05.196.712.224
hydroxylation: G02.111.087.512, G02.149.115.512, G02.149.465.410, G02.607.750.410, G03.495.510
microbodies: A11.284.430.214.190.500.585, A11.284.430.214.190.875.190.190.755
hepatomegaly: C06.552.416, C23.300.775.525
lauric acids: D10.251.500
verbal learning: F02.463.425.952
hypesthesia: C10.597.751.791.500, C23.888.592.763.770.500
pruritus: C17.800.685, C23.888.885.625
ferrochelatase: D08.811.520.500, D12.776.157.427.374.375.957, D12.776.556.579.374.375.617, D12.776.575.562
hydroxymethylbilane synthase: D08.811.913.225.575
uroporphyrinogens: D03.383.129.578.840.500.700.900, D03.549.909.500.700.900, D04.345.783.500.700.900
heme: D03.383.129.578.840.500.640.587, D03.549.909.500.640.587, D04.345.783.500.640.587, D23.767.727.640.587
decarboxylation: G02.111.087.210, G02.149.115.210, G02.149.465.220, G02.607.750.220, G03.495.315
carboxy-lyases: D08.811.520.224.125
acrolein: D02.047.122
hydrochloric acid: D01.029.260.326, D01.210.450
respiratory rate: E01.370.600.875.875, G09.772.770.755.730
dimethylamines: D02.092.668.387
ethyl methanesulfonate: D02.455.326.146.100.050.500.300, D02.886.645.600.055.050.510.300
hypoxanthine phosphoribosyltransferase: D08.811.913.400.725.450
methoxsalen: D03.438.150.446.794.500, D03.494.770.500, D03.830.219.446.794.500
thioguanine: D03.438.759.854
ethylnitrosourea: D02.654.692.300, D02.948.594.310
4-nitroquinoline-1-oxide: D02.640.820.600, D03.438.810.470.450, D03.661.243.500
mitomycin: D02.806.400.249.350, D03.383.097.500.350, D03.438.473.412.249.350
intercalating agents: D27.720.470.410.360
quinacrine mustard: D02.455.526.728.650.760, D03.494.046.250.760.750
carbazilquinone: D02.806.250.180, D03.383.097.217.300
sorbic acid: D10.251.355.840
propiolactone: D02.540.600
triethylenemelamine: D03.383.097.217.924, D03.383.931.915
platinum: D01.268.556.690, D01.268.956.734, D01.552.544.690
thiotepa: D02.705.672.875, D03.383.097.217.935.960
alkylating agents: D27.505.519.124, D27.888.569.035
ultraviolet rays: G01.358.500.505.650.891, G01.590.540.891, G01.750.250.650.891, G01.750.750.659, G01.750.770.578.891, G16.500.275.063.725.525.600, G16.500.750.775.525.600, N06.230.300.100.725.525.600
bleomycin: D09.400.420.110, D12.644.233.110
nitrosourea compounds: D02.654.692, D02.948.594
sulfuric acid esters: D02.886.645.655.850
mesylates: D02.455.326.146.100.050.500, D02.886.645.600.055.050.510
tars: D20.749
hypoxanthines: D03.438.759.758.399
guanine: D03.438.759.758.399.454
pennsylvania: Z01.107.567.875.075.550, Z01.107.567.875.350.550, Z01.107.567.875.500.550
air pollution: N06.850.460.100
phosphatidylcholines: D10.570.755.375.760.400.800
cell size: G04.325
agar: D09.698.360.041
hot temperature: G01.906.595.543, G16.500.275.063.725.710.380, G16.500.750.775.710.380, N06.230.300.100.725.232, N06.230.300.100.725.710.380
mucous membrane: A10.615.550
micrococcus: B03.510.024.049.475.500, B03.510.400.500.500
postpartum period: G08.686.702
electrolytes: D01.248
gene expression profiling: E05.393.332
parabens: D02.241.223.100.300.460, D02.241.511.390.460, D02.455.426.559.389.127.281.460, D02.455.426.559.389.657.410.460
contraceptive agents: D27.505.696.875.360, D27.505.954.705.360
spermatocidal agents: D27.505.696.138.569, D27.505.696.875.360.276.827, D27.505.954.705.360.276.827, D27.888.569.071.569
fluorine: D01.268.380.300
mononuclear phagocyte system: A15.382.812
glycerol kinase: D08.811.913.696.620.275
glycerol: D02.033.800.421, D09.853.421
mannitol: D02.033.800.609, D09.853.609
fructokinases: D08.811.913.696.620.225
esterases: D08.811.277.352
walking: G11.427.590.530.568.900, G11.427.590.530.698.277.937, I03.450.642.845.940
hand strength: E01.370.600.425.500, G11.427.560.500
infant: M01.060.703
dimethylpolysiloxanes: D02.715.650.700.150, D05.750.900.850.150, D25.720.900.850.150, J01.637.051.720.900.850.150
transplantation: E04.936
hemolysis: C23.550.403, G12.425.143.545
pesticide synergists: D27.720.031.700.748, D27.720.723.748, D27.888.723.748
pulmonary wedge pressure: G09.330.380.076.695
thromboxane b2: D10.251.355.255.100.825.810, D23.469.050.175.800.810
extravascular lung water: A12.207.270.300
leukotriene b4: D10.251.355.255.100.450.411, D23.469.050.175.450.415
partial pressure: G01.374.715.714
smoke inhalation injury: C26.200.322.800
lymph: A12.207.270.606, A15.382.520.150
blood proteins: D12.776.124
cleft palate: C05.500.460.185, C05.660.207.540.460.185, C07.320.440.185, C07.465.525.185, C07.650.500.460.185, C07.650.525.185, C16.131.621.207.540.460.185, C16.131.850.500.460.185, C16.131.850.525.185
blinking: G11.561.600.765.127, G14.640.182
guanidines: D02.078.370
chromatography: E05.196.181
genomics: H01.158.273.180.350, H01.158.273.343.350
peptidyl-dipeptidase a: D08.811.277.656.350.350.687, D23.050.301.264.035.585, D23.101.100.110.585
kallikreins: D08.811.277.656.300.760.442, D08.811.277.656.959.350.442, D12.776.124.125.597, D23.119.597
glomerulonephritis: C12.777.419.570.363, C13.351.968.419.570.363
lysosomes: A11.284.430.214.190.875.190.550
aspartic acid: D12.125.067.500, D12.125.119.170, D12.125.427.040
axotomy: E04.525.210.145
retrograde degeneration: C23.550.737.500
yolk sac: A10.615.284.981, A16.254.750.981, A16.331.800
choroid: A09.371.894.223
dermatan sulfate: D09.698.373.200.380
chondroitin sulfates: D09.698.373.200.300
elastin: D05.750.078.421, D12.776.860.300.350
hyaluronic acid: D09.698.373.475
heparitin sulfate: D09.698.373.425
proteoglycans: D09.698.735, D12.776.395.650
glycosaminoglycans: D09.698.373
collagen: D05.750.078.280, D12.776.860.300.250
connective tissue: A10.165
motor cortex: A08.186.211.730.885.287.500.270.548
wakefulness: F02.830.104.821, G11.561.600.042.738
learning disorders: C10.597.606.150.550, C23.888.592.604.150.550, F03.550.350.500, F03.550.450
sleep stages: F02.830.855.796, G11.561.600.815.754
acyl-coa oxidase: D08.811.682.660.150.200, D12.776.331.149
callithrix: B01.050.150.900.649.801.400.600.150.150.114
cyanides: D01.248.497.158.291, D01.625.400.100
perineum: A01.719
boston: Z01.107.567.875.550.510.210, Z01.433.210
ovarian neoplasms: C04.588.322.455, C13.351.500.056.630.705, C13.351.937.418.685, C19.344.410, C19.391.630.705
hygiene: E02.547, N06.850.670
orosomucoid: D12.776.124.050.600, D12.776.124.790.106.640, D12.776.377.715.085.640, D12.776.395.560.742
autoantibodies: D12.776.124.486.485.114.323, D12.776.124.790.651.114.323, D12.776.377.715.548.114.323
hexosaminidases: D08.811.277.450.483
immunoglobulin a: D12.776.124.486.485.114.619.026, D12.776.124.790.651.114.619.026, D12.776.377.715.548.114.619.026
immune system: A15.382
immunoglobulin m: D12.776.124.486.485.114.619.574, D12.776.124.790.651.114.619.574, D12.776.377.715.548.114.619.574
palmitoyl coenzyme a: D03.438.759.646.138.382.300.700, D08.211.211.300.700, D10.251.694.600.500, D13.695.667.138.382.300.700, D13.695.827.068.382.300.700
eosinophilia: C15.378.553.231
multiple myeloma: C04.557.595.500, C14.907.454.460, C15.378.147.780.650, C15.378.463.515.460, C20.683.515.845, C20.683.780.650
sea urchins: B01.050.500.408.578
fertilization: G08.686.785.760.277
bivalvia: B01.050.500.644.080
lipolysis: G02.111.087.530, G02.149.115.530, G03.495.520.500
theophylline: D03.132.960.751, D03.438.759.758.824.751
starch: D05.750.078.562.855, D09.698.365.855
lipid mobilization: G03.495.520.500.500
adipocytes: A11.329.114
aromatase: D08.244.453.915.099, D08.811.682.690.708.170.915.099, D08.811.682.690.708.783.099, D12.776.422.220.453.915.099
3-hydroxysteroid dehydrogenases: D08.811.682.047.436.350
photoperiod: G01.910.675
cytochrome p-450 cyp1a1: D08.244.453.040.555, D08.811.682.690.708.170.040.332, D12.776.422.220.453.040.332
tandem mass spectrometry: E05.196.566.880
chlorophenols: D02.455.426.559.389.261.190, D02.455.426.559.389.657.190
sperm capacitation: G08.686.785.760.277.760
acrosome reaction: G08.686.785.760.277.800.100
genistein: D03.438.150.266.450.400.375, D03.830.219.266.450.400.375
zinc oxide: D01.650.550.975, D01.975.975
tissue distribution: G03.787.917, G07.690.725.949
food packaging: J01.576.423.200.375, J01.576.423.850.600, J01.576.761.400
hep g2 cells: A11.251.860.180.432, A11.436.348.500
chromans: D03.438.150.240, D03.830.219.240
neurogenesis: G04.299.151.912, G07.700.320.500.325.377.687, G08.686.785.760.170.450.500
thyroid hormones: D06.472.931
hypothyroidism: C19.874.482
interneurons: A08.663.358, A11.671.358
lead poisoning: C25.723.589
ferrets: B01.050.150.900.649.147.550.350
cell enlargement: G04.299.233.500, G07.700.320.249.410.500
nanotechnology: H01.603, J01.897.520.600
blood-brain barrier: A07.035, A08.186.211.035
gliosis: C23.550.369
quadriplegia: C10.597.622.760, C23.888.592.636.786
intellectual disability: C10.597.606.643, C23.888.592.604.646, F01.700.687, F03.550.600
meat: J02.500.600
visual fields: F02.463.593.932.934, G14.950
proprioception: F02.830.816.541, G11.561.600.810.541
endothelins: D12.644.276.400, D12.776.467.400, D23.529.400
urinary bladder neoplasms: C04.588.945.947.960, C12.758.820.968, C12.777.829.813, C13.351.937.820.945, C13.351.968.829.707
algorithms: G17.035, L01.224.050
glomerular basement membrane: A05.810.453.324.359.372.400, A05.810.453.736.520.224, A10.615.179.625, A11.284.295.310.279
albuminuria: C12.777.934.734.269, C13.351.968.934.734.269, C23.888.942.750.269
respiration: G09.772.770.755
movement: G07.700.560, G11.427.590.530
pharmacology: H01.158.703, H02.628
classification: L01.100, L01.453.245.275
deoxyguanosine: D03.438.759.590.454.240, D13.570.230.360, D13.570.583.454.240
zinc sulfate: D01.875.800.800.850.950, D01.975.987
micronutrients: D27.505.696.377.605, J02.500.631
environmental pollution: N06.850.460
blood pressure determination: E01.370.370.140, E01.370.600.100
diastole: G09.330.190.541.295, G11.427.590.540.554.250, G11.427.590.540.570.295
furosemide: D02.065.884.725.300, D02.092.146.807.300, D02.886.590.700.725.300
uric acid: D03.132.960.877, D03.438.759.758.824.877
vascular diseases: C14.907
angiotensins: D06.472.699.094, D12.644.400.070, D12.644.456.073, D12.644.548.058, D12.776.641.650.070, D23.469.050.050
angiotensin i: D06.472.699.094.075, D12.644.400.070.075, D12.644.456.073.021, D12.644.548.058.075, D12.776.641.650.070.075, D23.469.050.050.025
peptide fragments: D12.644.541
carotid arteries: A07.231.114.186
telemetry: E01.370.520.750, E05.925, L01.178.847.675
sclerosis: C23.550.823
soy foods: J02.500.850.500.700.500
liddle syndrome: C12.777.419.815.683, C13.351.968.419.815.683, C16.320.565.861.698, C18.452.648.861.698
epithelial sodium channels: D12.776.157.530.400.875.200, D12.776.543.550.425.875.200, D12.776.543.585.400.875.200
choroid plexus: A08.186.211.276.298
amiloride: D03.383.679.149
endocytosis: G04.299.482
glomerular filtration rate: E01.370.390.400.300, G08.852.357
phenylpropionates: D02.241.223.701
pyridazines: D03.383.710
rho-associated kinases: D08.811.913.696.620.682.700.814, D12.644.360.590, D12.776.476.595
adrenalectomy: E04.270.115
dexamethasone: D04.808.745.432.769.344, D04.808.908.238
cyclic n-oxides: D03.661.243
spin labels: D02.389.678
inuits: M01.686.508.150.675, M01.686.754.520
anthropometry: E01.370.600.024, E05.041, N06.850.505.200.100
brain-derived neurotrophic factor: D12.644.276.860.100, D12.776.467.860.100, D12.776.641.600.100, D23.529.850.100
prefrontal cortex: A08.186.211.730.885.287.500.270.700
uridine: D03.383.742.680.852, D13.570.685.852, D13.570.800.892
memory disorders: C10.597.606.525, C23.888.592.604.529, F01.700.625
pleurodesis: E02.319.694
kaolin: D01.056.050.075.350, D01.578.725.025.350, D01.650.550.050.075.350, D01.837.725.700.760.050.400
time: G01.910
biomedical research: H01.770.644.145
allylisopropylacetamide: D02.065.064.189, D02.241.081.018.110.189, D02.455.326.271.122.272
heme oxygenase (decyclizing): D08.811.682.690.708.410
secobarbital: D03.383.742.698.253.762
cycloheximide: D03.383.621.808.240
etiocholanolone: D04.808.054.040.368, D04.808.578.502.583, D06.472.040.502.583, D06.472.334.851.968.968
aroclors: D02.455.526.439.773.292, D02.455.526.439.785.292
ligases: D08.811.464
maleates: D02.241.081.337.502
sputum: A12.200.808
haemophilus influenzae: B03.440.450.600.450.330, B03.660.250.550.290.330
nurses: M01.526.485.650, N02.360.650
nursing staff: M01.526.485.680, N02.360.680
reye syndrome: C06.552.241.649, C10.228.140.163.780, C18.452.132.780
status epilepticus: C10.228.140.490.690
subcutaneous tissue: A10.165.887
drug-induced liver injury: C06.552.195, C25.100.562, C25.723.260
adenoma: C04.557.470.035
renin-angiotensin system: G03.495.805, G09.330.190.400.750
desoxycorticosterone acetate: D04.808.745.745.654.339.700, D06.472.040.585.611.700
diuresis: G08.852.796.241
luteal cells: A05.360.319.114.630.278.400, A06.407.312.497.278.400, A11.382.921, A11.436.566
corpus luteum: A05.360.319.114.630.278, A06.407.312.497.278
endoplasmic reticulum, smooth: A11.284.430.214.190.875.248.310
golgi apparatus: A11.284.430.214.190.875.336
polyribosomes: A11.284.430.214.190.875.811.740
phenytoin: D03.383.129.308.432.555.730
cortisone: D04.808.745.745.183, D06.472.040.585.478.195
vitamin b 12: D03.383.129.578.840.437.777, D03.549.909.437.777, D04.345.783.437.777
depressive disorder: F03.600.300
fanft: D02.640.600.290, D02.886.675.250, D03.383.129.708.250, D03.383.312.649.290
urethane: D02.241.081.251.944
skin neoplasms: C04.588.805, C17.800.882
skin: A17.815
formamides: D02.065.463, D02.241.081.420.500
nitroblue tetrazolium: D03.383.129.617.700.500
acute lung injury: C08.381.520.500
thyroidectomy: E04.270.856
hyalin: A12.580
probenecid: D02.065.884.625, D02.886.590.700.625
leukocyte count: E01.370.225.500.195.107.595, E01.370.225.625.107.595, E05.200.500.195.107.595, E05.200.625.107.595, E05.242.195.107.595, G04.170.107.595, G09.188.105.595
tidal volume: E01.370.386.700.485.750.900.350.750, G09.772.850.970.500.700
ethoxyquin: D03.438.810.200
propyl gallate: D02.241.223.100.300.200.600, D02.241.511.390.200.600, D02.455.426.559.389.127.281.200.600, D02.455.426.559.389.657.410.200.600
alpha-tocopherol: D03.438.150.909.750.249, D03.830.219.909.750.249
butylhydroxybutylnitrosamine: D02.654.442.100
anisoles: D02.355.601.200, D02.355.726.158, D02.455.426.559.389.657.654.158
ancylostoma: B01.050.500.500.294.700.775.100.100
ancylostomatoidea: B01.050.500.500.294.700.775.100
calcium chloride: D01.146.300, D01.210.450.150.150
hookworm infections: C03.335.508.700.775.455
anthelmintics: D27.505.954.122.250.075
erythroid precursor cells: A11.148.378.590.837.250, A11.443.240.497, A11.872.378.590.817.250, A15.378.316.378.590.837.250
granulocyte-macrophage progenitor cells: A11.148.378.590.675, A11.627.635.675, A11.872.378.590.635, A15.378.316.378.590.675
granulocytes: A11.118.637.415, A11.148.350, A11.627.340, A15.145.229.637.415, A15.378.316.340, A15.382.490.315
cell differentiation: G04.299.151
erythrocyte count: E01.370.225.500.195.107.330, E01.370.225.625.107.330, E05.200.500.195.107.330, E05.200.625.107.330, E05.242.195.107.330, G04.170.107.330, G09.188.105.330
immunoglobulins: D12.776.124.486.485, D12.776.124.790.651, D12.776.377.715.548
cesarean section: E04.520.252.500
corneal opacity: C11.204.299
connexin 43: D12.776.543.585.250.200
occludin: D12.776.543.488.500, D12.776.543.984.750
tight junctions: A11.284.149.165.420.820
cadherins: D12.776.395.550.200.200, D12.776.543.550.200.200, D23.050.301.350.200
gossypol: D02.455.849.765.444
rolipram: D03.383.773.812.785
pentachlorophenol: D02.455.426.559.389.657.190.633
dieldrin: D02.455.526.439.371
phosphodiesterase inhibitors: D27.505.519.389.735
intercellular junctions: A11.284.149.165.420
purinones: D03.438.759.758
fluorescent antibody technique: E01.370.225.500.607.512.240, E01.370.225.750.551.512.240, E05.200.500.607.512.240, E05.200.750.551.512.240, E05.478.412, E05.478.583.375
motor skills: F02.808.260
dental auxiliaries: M01.526.485.067.105, N02.360.067.105
gases: D01.362
tobacco use: F01.145.928
pregnancy rate: E05.318.308.985.775, G08.686.705, L01.280.975.775, N01.224.935.849, N06.850.505.400.975.775, N06.850.520.308.985.775
cooperative behavior: F01.145.813.115
stromal cells: A11.329.830
rosette formation: E01.370.225.812.706, E05.200.812.706, E05.478.594.730
animal experimentation: E05.017, H01.770.644.053
chills: C23.888.208
tachycardia: C14.280.067.845, C23.550.073.845
acrosome: A05.360.490.890.820.100, A11.284.430.214.190.875.190.550.040, A11.497.760.400.100
calcium ionophores: D27.505.519.562.374.100, D27.720.395.100
bicarbonates: D01.200.275.150.100, D01.248.497.158.165.100
flow cytometry: E01.370.225.500.363.342, E01.370.225.500.386.350, E05.196.712.516.600.240.350, E05.200.500.363.342, E05.200.500.386.350, E05.242.363.342, E05.242.386.350
peanut agglutinin: D12.776.503.499.625, D12.776.765.678.625
nucleic acid denaturation: E05.393.640, G02.111.087.615, G02.149.115.615, G05.355.720
cryopreservation: E01.370.225.500.620.760.160, E01.370.225.750.600.760.160, E02.792.156, E05.200.500.620.760.160, E05.200.750.600.760.160, E05.760.156
fluoresceins: D02.455.426.559.847.885.347, D03.494.953.275, D04.615.885.347
isothiocyanates: D02.500.375, D02.886.250
fumigation: N06.850.780.200.300
sulfinic acids: D01.029.260.877.700, D01.875.800.700, D02.886.645.585
deoxyglucose: D09.254.229
vitamin k: D02.455.426.559.847.638.721.374, D02.455.849.291.523.500, D04.615.638.721.374
endotoxins: D23.946.123.329
coagulase: D08.811.277.656.300.174, D12.776.097.181
poultry: B01.050.050.116.625, B01.050.150.900.248.617, J02.500.600.750
alveolitis, extrinsic allergic: C08.381.483.125, C08.674.055, C20.543.480.680.075
complement system proteins: D12.776.124.486.274
bacteria: B03
tuberculosis: C01.252.410.040.552.846
nasopharyngeal neoplasms: C04.588.443.665.710.650, C07.550.350.650, C07.550.745.650, C09.647.710.650, C09.775.350.650, C09.775.549.650
picrotoxin: D02.455.426.392.368.367.800, D02.540.552
perforant pathway: A08.186.211.464.730, A08.612.600
lidocaine: D02.065.199.092.500
mephenesin: D02.033.455.706.517
receptors, gaba-a: D12.776.157.530.400.175.562, D12.776.157.530.400.400.100.100, D12.776.543.550.425.175.562, D12.776.543.550.425.500.100.100, D12.776.543.585.400.175.562, D12.776.543.585.400.500.100.100, D12.776.543.750.051.500, D12.776.543.750.720.200.300.300
hunger: F01.658.293.391, G07.610.390, G10.261.390
capsules: D26.255.150, D27.720.280.150
visual analog scale: E01.370.928
mental recall: F02.463.425.540.641
waste disposal facilities: N06.850.780.200.800.800.900.449, N06.850.860.510.900.700
illinois: Z01.107.567.875.350.350, Z01.107.567.875.510.350
tetraploidy: C23.550.210.702.249, G05.365.590.175.677.249, G05.700.740.249
ploidies: G05.700
cocaine: D02.145.074.722.388, D03.132.889.354, D03.605.869.388, D04.075.080.875.099.722.388
breakfast: F01.145.407.432.500.100, F01.145.466.349.500.100, J02.500.590.120
stroop test: F04.711.513.703
virtues: F01.829.500.840, K01.559.840, K01.752.566.840
killifishes: B01.050.150.900.493.850.280.500
waste water: D20.944.932, N06.850.460.710.865
estrogen receptor modulators: D06.347.360, D27.505.696.399.450.360
feminization: C23.888.378
levonorgestrel: D04.808.668.651.693.762.450
propidium: D03.494.633.700
bisbenzimidazole: D03.438.103.145
proliferating cell nuclear antigen: D12.776.660.740, D23.050.290.750, D23.101.840.600
immunohistochemistry: E01.370.225.500.607.512, E01.370.225.750.551.512, E05.200.500.607.512, E05.200.750.551.512, E05.478.583, H01.158.100.656.234.512, H01.158.201.344.512, H01.158.201.486.512, H01.181.122.573.512, H01.181.122.605.512
reproductive health: N01.400.625
endothelial cells: A11.436.275
auditory pathways: A08.612.220.110
chlormerodrin: D02.691.750.100.229
sarcolemma: A11.284.149.707
organomercury compounds: D02.691.750
octanols: D02.033.415.600, D10.289.600
sulfonic acids: D01.029.260.877.740, D01.875.800.740, D02.886.645.600
menstruation: G08.686.605.428, G08.686.785.560
menorrhagia: C13.351.500.852.691.449, C23.550.568.875
workload: N04.452.677.950
libido: F02.739.794.511
menstruation disturbances: C23.550.568
south carolina: Z01.107.567.875.075.662, Z01.107.567.875.750.700
cellulose: D05.750.078.562.180, D09.698.365.180, D25.720.099.500, J01.637.051.720.099.500
biliary tract neoplasms: C04.588.274.120, C06.130.320, C06.301.120
biliary tract: A03.159
melanoma: C04.557.465.625.650.510, C04.557.580.625.650.510, C04.557.665.510
nadph-ferrihemoprotein reductase: D08.811.682.608.191.500
cytochromes b5: D08.244.187.500, D12.776.422.220.187.500
particle size: G02.842.680
peptidyl transferases: D08.811.913.050.200.700
microvilli: A11.284.180.565
guanosine triphosphate: D03.438.759.646.454.504, D13.695.667.454.504, D13.695.827.426.504
bezafibrate: D02.065.277.067, D02.241.081.114.968.500.249, D02.241.223.100.100.120, D02.241.223.100.200.249, D02.355.726.305.249, D02.455.426.559.389.127.085.101, D02.455.426.559.389.127.250.249, D02.455.426.559.389.657.654.305.249
lymphoma, non-hodgkin: C04.557.386.480, C15.604.515.569.480, C20.683.515.761.480
digestive system neoplasms: C04.588.274, C06.301
platelet aggregation: G09.188.124.552.624, G09.188.124.560.600.640
intracranial thrombosis: C10.228.140.300.525.425, C14.907.253.566.350, C14.907.355.590.213.350, C14.907.355.830.850.213.350
blood cell count: E01.370.225.500.195.107, E01.370.225.625.107, E05.200.500.195.107, E05.200.625.107, E05.242.195.107, G04.170.107, G09.188.105
glucose tolerance test: E01.370.225.124.100.355, E01.370.374.355, E05.200.124.100.355
alloxan: D03.383.742.698.122
corticosterone: D04.808.745.745.654.237, D06.472.040.585.353.237
carbohydrate metabolism: G02.111.087.160, G02.149.115.160, G03.495.256
shellfish: J02.500.600.875.700
peripheral arterial disease: C14.907.137.126.307.500, C14.907.617.671
seafood: J02.500.600.875
mollusca: B01.050.500.644
birds: B01.050.150.900.248
pachytene stage: G04.299.134.220.220.687.444.600, G04.299.134.220.220.875.500.600, G05.355.105.220.687.500.600, G05.355.105.220.875.500.600
spermatogonia: A05.360.490.890.900, A11.497.760.800
synaptonemal complex: A11.284.430.106.279.345.190.160.830, G04.299.134.220.220.687.444.299.500, G04.299.134.220.220.875.500.299.500, G05.355.105.220.687.500.299.500, G05.355.105.220.875.500.299.500, G05.360.160.830
inhibitory concentration 50: E05.940.350, G07.690.420
organoselenium compounds: D02.712
selenium compounds: D01.810
17-hydroxysteroid dehydrogenases: D08.811.682.047.436.375
unfolded protein response: G02.111.087.675.871.790.600.962, G02.111.087.693.600.850, G02.149.115.675.871.790.600.850, G02.149.115.693.600.925, G03.495.770.871.790.600.850, G05.355.315.670.600.850
heat-shock proteins: D12.776.580.216
placenta: A16.710
interleukin-6: D12.644.276.374.465.506, D12.776.467.374.465.506, D23.529.374.465.506
interleukin-10: D12.644.276.374.465.510, D12.776.467.374.465.510, D23.529.374.465.510
peroxidase: D08.811.682.732.700
cytokines: D12.644.276.374, D12.776.467.374, D23.529.374
thiosemicarbazones: D02.845.746.703, D02.886.803
oximes: D02.092.570.665
diacetyl: D02.522.296.400
olfactory bulb: A08.186.211.464.699.573, A08.186.211.730.885.600.573
olfactory nerve: A08.800.800.120.640
vascular endothelial growth factor a: D12.644.276.100.800.200, D12.776.467.100.800.200, D23.529.100.800.200
butter: D10.212.302.199, J02.500.350.100, J02.500.375.200
claudin-1: D12.776.543.984.200.100
tracheitis: C08.730.848, C08.907.763
rhinitis: C08.460.799, C08.730.674, C09.603.799
pentanones: D02.522.720
sugar alcohol dehydrogenases: D08.811.682.047.150.700
necrosis: C23.550.717, G04.299.139.638
food industry: J01.576.423
bronchitis: C08.127.446, C08.381.495.146, C08.730.099
median nerve: A08.800.800.720.050.500
juxtaglomerular apparatus: A05.810.453.324.359.520, A05.810.453.736.520.520
plasma volume: G09.188.130.610, G09.330.380.092.610
loop of henle: A05.810.453.736.560.610
suction: E04.237.890
kidney tubules: A05.810.453.736.560
gonadal hormones: D06.472.334
uroporphyrins: D03.383.129.578.840.500.880, D03.549.909.500.880, D04.345.783.500.880, D23.767.727.880
coproporphyrins: D03.383.129.578.840.500.250, D03.549.909.500.250, D04.345.783.500.250, D23.767.727.250
bone and bones: A02.835.232, A10.165.265
texas: Z01.107.567.875.760.750
lymphoid tissue: A10.549, A15.382.520.604
temperature: G01.906.595, G16.500.275.063.725.710, G16.500.750.775.710, N06.230.150.450, N06.230.300.100.725.710
naltrexone: D03.132.577.249.706.550, D03.549.686.750.550, D03.605.497.750.550, D04.615.723.795.706.550
narcotic antagonists: D27.505.696.543, D27.505.696.663.850.512, D27.505.954.427.550
choline: D02.033.100.291.211, D02.092.063.291.211, D02.092.877.883.333, D02.675.276.232
receptors, cholinergic: D12.776.543.750.720.360
frontal lobe: A08.186.211.730.885.287.500.270
hyponatremia: C18.452.950.620
long-term care: E02.760.476, N02.421.585.476
azotemia: C12.777.419.936.231, C13.351.968.419.936.231, C23.550.145
renal artery obstruction: C12.777.419.775, C13.351.968.419.775, C14.907.137.727
acromegaly: C05.116.132.082, C10.228.140.617.738.250.100, C19.700.355.179
enzyme inhibitors: D27.505.519.389
hyperaldosteronism: C19.053.800.604
maternal-fetal exchange: G08.686.785.760.769.455
sweetening agents: D27.720.364.609, D27.720.888, J02.500.512.400.700
precipitating factors: N05.715.350.200.650, N06.850.490.625.500
carbohydrates: D09
criminals: M01.142
insulin-like growth factor i: D12.644.276.937.400, D12.776.124.862.400, D12.776.467.937.400, D23.529.937.400
prostatic neoplasms: C04.588.945.440.770, C12.294.260.750, C12.294.565.625, C12.758.409.750
precipitins: D12.776.124.486.485.114.837, D12.776.124.790.651.114.837, D12.776.377.715.548.114.837
immunoassay: E05.478.566, E05.601.495
allethrin: D02.455.849.575.812.272
radioactivity: G01.595.815
cyclin b: D12.644.360.262.120, D12.776.167.218.120, D12.776.476.262.120
cdc25 phosphatases: D08.811.277.352.650.625.225.100, D08.811.277.352.650.775.250.100, D08.811.641.755.100, D12.644.360.268.100, D12.776.167.100, D12.776.476.268.100
cdc2 protein kinase: D08.811.913.696.620.682.700.200.067.249, D08.811.913.696.620.682.700.200.580.500, D12.644.360.250.067.249, D12.644.360.250.580.500, D12.776.167.200.067.249, D12.776.167.200.580.500, D12.776.476.250.067.249, D12.776.476.250.580.500, D12.776.744.360
glycine: D12.125.481
cell cycle checkpoints: G04.299.134.109
bone diseases, metabolic: C05.116.198
hematocrit: E01.370.225.625.400, E05.200.625.400, G09.188.370.374
erythrocyte membrane: A11.118.290.270, A11.284.149.356, A15.145.229.334.270
aldehyde dehydrogenase: D08.811.682.657.163.249
sucrose: D09.698.629.305.770
exercise: G11.427.590.530.698.277, I03.350
entorhinal cortex: A08.186.211.464.710.225, A08.186.211.730.885.287.500.863.648.225
frozen sections: E01.370.225.500.620.530.160.260, E01.370.225.750.600.530.160.260, E05.200.500.620.530.160.260, E05.200.750.600.530.160.260
dendrites: A08.663.256, A11.284.180.225, A11.671.240
paternal exposure: N06.850.460.350.700
lifting: G01.374.676.530, G01.595.540.530
fruit: A18.024.500, J02.500.562
food storage: J01.576.423.200.387
food habits: F01.145.407.432, F01.145.466.349
horses: B01.050.150.900.649.709.235.472
amygdala: A08.186.211.464.090, A08.186.211.730.885.287.249.152
mitogens: D27.505.519.593.624
killer cells, natural: A11.118.637.555.567.537, A15.145.229.637.555.567.537, A15.382.490.555.567.537
judgment: F02.463.785.626
microcomputers: L01.224.230.260.550
decanoic acids: D10.251.175
phosphofructokinase-2: D08.811.277.352.650.622, D08.811.641.843, D08.811.913.696.620.225.850.750
alternative splicing: G02.111.087.750.700.100, G02.149.115.750.700.100, G03.495.839.700.100, G05.355.315.700.700.100
glycolysis: G02.111.087.160.750, G02.149.115.160.750, G03.495.256.750, G03.495.335.436, G03.495.553.360
pulmonary ventilation: E01.370.386.700.660, G09.772.650
bleeding time: E01.370.225.625.625.100, E05.200.625.625.100, G09.188.087
rivers: G01.311.750, G16.500.275.280.650, N06.230.232.650
carps: B01.050.150.900.493.200.244.248
ohio: Z01.107.567.875.075.512, Z01.107.567.875.350.540, Z01.107.567.875.510.540
rana pipiens: B01.050.150.900.090.180.708.310
wetlands: G16.500.275.960, N06.230.124.625
zooplankton: B05.080.500.980
european union: I01.615.500.250.300, Z01.586.300
cladocera: B01.050.500.131.365.150
biota: G16.500.275.157.049.100, N06.230.124.049.100
adult children: F01.829.263.065, I01.880.225.281, M01.055
conditioning (psychology): F02.463.425.179
fibula: A02.835.232.043.650.321
bone development: G07.700.320.500.325.377.625.100, G11.427.590.560.100
nitrosoguanidines: D02.078.370.649, D02.654.567
aminopyrine n-demethylase: D08.811.682.662.582.276
aniline hydroxylase: D08.244.453.040.050, D08.811.682.690.708.170.040.050, D12.776.422.220.453.040.050
hexobarbital: D03.383.742.698.253.317
sulfur: D01.268.185.900
sulfones: D02.886.590
sulfides: D01.248.497.158.874, D01.875.350.850, D02.886.520
fetal resorption: C13.703.243.300, C23.550.260.460.260
food chain: G16.500.275.157.250, N06.230.124.250
neural tube: A16.630
neural tube defects: C10.500.680, C16.131.666.680
folic acid: D03.438.733.631.400
phosphoric monoester hydrolases: D08.811.277.352.650
neuroglia: A08.637, A11.650
cyclic amp: D03.438.759.646.138.395, D13.695.462.200, D13.695.667.138.395, D13.695.827.068.395
adenomatous polyps: C04.557.470.035.215
phenolsulfonphthalein: D02.455.426.559.389.657.625.560
deferoxamine: D02.092.570.394.265, D02.241.511.372.265
sodium compounds: D01.857
nitrates: D01.248.497.158.606, D01.625.525.550, D02.583
charcoal: D01.268.150.150
sewage: D20.944.932.500
fertilizers: D27.720.031.400
biological availability: G03.787.151, G07.690.725.129
baroreflex: G09.330.190.400.090, G11.561.600.765.063
bradykinin: D12.644.276.812.169, D12.644.400.090, D12.644.456.193, D12.776.467.812.169, D12.776.641.650.090, D23.469.050.375.110, D23.529.812.169
hexamethonium: D02.092.877.250.592.400, D02.675.276.558.592.500
thiopental: D03.383.742.698.253.800.810
ventricular pressure: G09.330.190.962.950, G09.330.380.937
vasoconstrictor agents: D27.505.954.411.793
myocardial contraction: G09.330.190.541, G11.427.590.540.570
vagotomy: E04.525.210.080.600.850, E04.525.210.850
blister: C17.800.865.187, C23.300.122
escherichia: B03.440.450.425.325, B03.660.250.150.180
lateral ventricles: A08.186.211.276.650
syndrome: C23.550.288.500
subarachnoid space: A08.186.566.166.686
substantia nigra: A08.186.211.132.659.822.731, A08.186.211.653.822.731
choline o-acetyltransferase: D08.811.913.050.134.180
olfactory pathways: A08.186.211.464.699, A08.186.211.730.885.600, A08.612.220.640
manganese poisoning: C10.720.475.500, C25.723.618
thermography: E01.370.350.800, E05.933.500
electrodes: E07.305.250
vertigo: C09.218.568.900.883, C10.597.951, C23.888.592.958
vestibular function tests: E01.370.382.900
hyperglycemia: C18.452.394.952
hyperglycemic hyperosmolar nonketotic coma: C19.246.099.750.490
diabetes mellitus: C18.452.394.750, C19.246
amniotic fluid: A12.098, A16.378.149
fetal blood: A12.207.152.200, A15.145.300, A16.378.200
muscle strength: E01.370.600.425, G11.427.560
sternum: A02.835.232.904.766
skull: A02.835.232.781
endosulfan: D02.886.092.408, D03.438.197.408
oligochaeta: B01.050.500.091.657
biomass: G16.500.275.157.100, N06.230.124.100
aldicarb: D02.241.081.251.046
mannose: D09.546.359.588
calcium channels: D12.776.157.530.400.150, D12.776.543.550.425.150, D12.776.543.585.400.150
potassium channels: D12.776.157.530.400.600, D12.776.543.550.425.750, D12.776.543.585.400.750
mannose-binding lectins: D12.776.503.311
ions: D01.248.497
silicon: D01.268.513.937
lithium: D01.268.549.450, D01.552.528.480
spectrophotometry: E05.196.712.726, E05.196.867.826
pulmonary heart disease: C14.280.832
hyperuricemia: C23.550.449
gout: C05.550.114.423, C05.799.414, C16.320.565.798.368, C18.452.648.798.368
coal tar: D20.749.354
chlorofluorocarbons: D02.455.526.439.220, D02.455.526.510.140
tibial nerve: A08.800.800.720.450.760.820
minors: M01.416
saccharin: D02.886.675.687, D03.383.129.708.089.708, D03.438.185.708
running: G11.427.590.530.568.610, G11.427.590.530.698.277.750, I03.450.642.845.610
rosa: B01.650.940.800.575.100.842.500.750
phosphorylase a: D08.811.913.400.450.460.400.280
glycogenolysis: G02.111.087.160.625, G02.149.115.160.625, G03.495.256.625
cathepsins: D08.811.277.656.224
phosphorylases: D08.811.913.400.450.460.400
organelles: A11.284.430.214.190.875
choice behavior: F02.463.785.373.346
nephritis: C12.777.419.570, C13.351.968.419.570
fatty liver: C06.552.241
polystyrenes: D02.455.426.559.389.150.750.800.830, D05.750.716.579, D25.720.716.579, J01.637.051.720.716.579
anniversaries and special events: K01.400.095, N04.452.822.070
benzene derivatives: D02.455.426.559.389
dealkylation: G02.111.087.200, G02.149.115.200, G02.149.465.200, G02.607.750.200, G03.495.305
haversian system: A10.165.265.507
bone remodeling: G11.427.590.195, G16.100.856.150
diazinon: D02.705.400.625.200, D02.705.539.345.200, D02.886.300.692.200
chlordan: D02.455.526.439.180
cholinesterase inhibitors: D27.505.519.389.275, D27.505.519.625.120.300, D27.505.696.577.120.300
thoracic vertebrae: A02.835.232.834.892
avoidance learning: F02.463.425.097
escape reaction: F01.145.113.448, F01.145.367
copper sulfate: D01.875.800.800.850.150
organ culture techniques: E05.240.484
potoroidae: B01.050.150.900.649.573.600
spermatic cord: A05.360.444.777
macropodidae: B01.050.150.900.649.573.500
marsupialia: B01.050.150.900.649.573
ryanodine receptor calcium release channel: D12.776.157.530.400.150.800, D12.776.210.500.800, D12.776.543.550.425.150.800, D12.776.543.585.400.150.800
carrier proteins: D12.776.157
senna extract: D02.455.426.559.847.117.159.750, D02.806.100.750, D20.215.784.500.860
cho cells: A11.251.210.200, A11.436.155
mutation rate: G05.355.044.250.750, G05.365.590.612, G16.100.178.250.750
frameshift mutation: G05.365.590.265
serum: A12.207.152.846, A15.145.846
ulnar nerve: A08.800.800.720.050.850
least-squares analysis: E05.318.740.750.400, N05.715.360.750.695.440, N06.850.520.830.750.400
limit of detection: E05.318.740.872.374, N05.715.360.750.725.500, N06.850.520.830.872.500
sexual abstinence: F01.145.802.900
belgium: Z01.542.115
great britain: Z01.542.363, Z01.639.280
5'-nucleotidase: D08.811.277.352.650.600.600, D23.050.301.264.035.570, D23.101.100.110.570
atrazine: D03.383.931.247
androstenedione: D04.808.054.079.329, D04.808.578.502.112, D06.472.040.502.112, D06.472.334.851.968.875
chorionic gonadotropin: D06.472.699.322.326, D06.472.699.649.367, D12.644.548.726.367, D12.776.780.400
steroidogenic factor 1: D12.776.260.698.925, D12.776.826.925, D12.776.930.669.925
phosphoproteins: D12.776.744
steroid 17-alpha-hydroxylase: D08.244.453.915.748, D08.811.682.690.708.170.915.748, D08.811.682.690.708.783.745, D12.776.422.220.453.915.748
chorion: A10.615.284.473, A16.254.750.473
dna nucleotidylexotransferase: D08.811.913.696.445.308.325
oviparity: G08.686.650
cyprinodontiformes: B01.050.150.900.493.850.280
lipid peroxides: D02.389.338.450, D02.737.450, D10.440
receptors, estrogen: D12.776.260.698.750.350, D12.776.826.750.350, D12.776.930.669.750.350
epoxy resins: D05.750.716.822.461, D25.720.716.822.461, J01.637.051.720.716.822.461
polycarboxylate cement: D25.339.291.700, J01.637.051.339.291.700
ribonucleases: D08.811.277.352.700
diethylstilbestrol: D02.455.426.559.389.150.700.175
dimethylnitrosamine: D02.654.442.225
cytochrome p-450 cyp2b1: D08.244.453.040.888, D08.811.682.690.708.170.040.499, D12.776.422.220.453.040.777
steroid hydroxylases: D08.244.453.915, D08.811.682.690.708.170.915, D08.811.682.690.708.783, D12.776.422.220.453.915
histiocytes: A11.329.372.385, A11.627.482.385, A11.733.397.385, A15.382.680.397.385, A15.382.812.522.385
cathepsin d: D08.811.277.656.074.500.180, D08.811.277.656.224.187, D08.811.277.656.300.048.180
alpha 1-antichymotrypsin: D12.644.822.750.030, D12.644.861.030, D12.776.124.050.050, D12.776.124.790.106.050, D12.776.377.715.085.050, D12.776.395.045, D12.776.645.750.030, D12.776.872.030
electron probe microanalysis: E01.370.350.515.402.250, E05.196.867.800.360, E05.595.402.250, E05.799.830.360
lymph nodes: A10.549.400, A15.382.520.604.412
histiocytosis: C15.604.250
lymph node excision: E04.446
prostatectomy: E04.950.774.860.625
joint diseases: C05.550
photosensitivity disorders: C17.800.600
chalcones: D02.522.818.222, D03.438.150.266.450.221, D03.830.219.266.450.221
phenothiazines: D02.886.369, D03.494.741
vitamins: D27.505.696.377.605.600, J02.500.631.600
amino acids: D12.125
descemet membrane: A09.371.060.217.271, A10.615.179.437
rana catesbeiana: B01.050.150.900.090.180.708.180
cornea: A09.371.060.217
microscopy, electron: E01.370.350.515.402, E05.595.402
endothelium: A10.272.491
ornithine decarboxylase: D08.811.520.224.125.425
chemistry: H01.181
tooth eruption: G10.549.235.726
proportional hazards models: E05.318.740.500.700, E05.318.740.600.700, E05.318.740.750.725, E05.318.740.998.825, E05.599.835.900, N05.715.360.750.530.650, N05.715.360.750.625.650, N05.715.360.750.695.650, N05.715.360.750.795.825, N06.850.520.830.500.700, N06.850.520.830.600.700, N06.850.520.830.750.725
prognosis: E01.789
olfactory perception: F02.463.593.485
reading: L01.143.506.423.557
multivariate analysis: E05.318.740.150.500, N05.715.360.750.125.500, N06.850.520.830.150.500
mathematics: H01.548
acridine orange: D03.494.046.250.150
spinal curvatures: C05.116.900.800
hypopigmentation: C17.800.621.440
hematopoietic stem cells: A11.148.378, A11.872.378, A15.378.316.378
garcinia kola: B01.650.940.800.575.100.928.249.333.400
triiodothyronine: D06.472.931.740.385, D12.125.072.050.767.741.894
biflavonoids: D03.438.150.266.450.190, D03.830.219.266.450.190
seeds: A18.024.500.750, J02.500.775
flavonoids: D03.438.150.266.450, D03.830.219.266.450
hydrocephalus: C10.228.140.602, C10.228.140.631.450
methylene blue: D02.886.369.517, D03.494.741.517
hepatopancreas: A13.463
national institute for occupational safety and health (u.s.): I01.409.137.500.600.650.225.520, N03.540.348.500.500.600.650.225.520
research personnel: M01.526.839, M01.770
gastrointestinal diseases: C06.405
buthionine sulfoximine: D02.886.030.676.620.125, D12.125.166.676.620.125
pentanols: D02.033.415.640, D10.289.640
dental assistants: M01.526.485.067.105.250, N02.360.067.105.250
reproductive history: E01.370.510.700, N05.715.350.575, N06.850.490.812
x-ray diffraction: E05.196.309.742, E05.196.822.950, G01.595.861.950, G02.149.767.915, G02.842.750.915
optic nerve: A08.800.800.120.680
plasmalogens: D10.570.755.375.760.400.985.820
lysophosphatidylcholines: D10.570.755.375.760.550.550
lecithins: D10.570.755.375.760.400.800.806, D20.215.784.500.492
lysophospholipids: D10.570.755.375.760.550
central nervous system depressants: D27.505.696.277, D27.505.954.427.210
2-acetylaminofluorene: D02.065.064.150, D02.241.081.018.110.080, D02.455.426.559.847.389.050, D04.615.389.050
safrole: D03.383.246.118.750, D03.438.115.750
2-naphthylamine: D02.092.710, D02.455.426.559.847.638.850, D04.615.638.850
azaserine: D12.125.837.075
dimethylhydrazines: D02.442.600.400
dioxanes: D03.383.231.388
nasal septum: A04.531.591
carcinoma, squamous cell: C04.557.470.200.400, C04.557.470.700.400
stem cells: A11.872
pluripotent stem cells: A11.872.700
benzopyrene hydroxylase: D08.244.453.040.110, D08.811.682.690.708.170.040.110, D12.776.422.220.453.040.110
cytochromes b: D08.244.187.249, D12.776.422.220.187.249
aminopyrine: D03.383.129.539.850.077
video games: I03.450.642.693.930, L01.224.900.930
friends: M01.252
agnosia: C10.597.606.762.100, C23.888.592.604.764.100, F01.700.750.100
strabismus: C10.292.562.887, C11.590.810
dinoprost: D10.251.355.255.100.637.400.200, D10.251.355.255.550.400.200, D23.469.050.175.725.790.185
radioimmunoassay: E01.370.384.700, E05.478.566.639, E05.601.495.639
glutathione reductase: D08.811.682.667.092
fluconazole: D03.383.129.799.450
tyrosine 3-monooxygenase: D08.811.682.690.708.923, D12.776.556.579.374.925
mesencephalon: A08.186.211.132.659, A08.186.211.653
ethylenebis(dithiocarbamates): D02.241.081.251.869.265, D02.886.706.250
acetaminophen: D02.065.199.092.040
hypertriglyceridemia: C18.452.584.500.500.851
republic of korea: Z01.252.474.557.750
sinusitis: C08.460.692.752, C08.730.749, C09.603.692.752
retention (psychology): F02.463.425.540.772
calcium channel blockers: D27.505.519.562.249, D27.505.954.411.192
streptozocin: D02.654.692.768, D02.948.594.768, D09.408.051.900
insulin resistance: C18.452.394.968.500, G07.690.320.617
diabetes mellitus, experimental: C18.452.394.750.074, C19.246.240, E05.598.500.374
hyperinsulinism: C18.452.394.968
nafenopin: D02.241.081.751.512
coenzyme a ligases: D08.811.464.267.500
acyl coenzyme a: D03.438.759.646.138.382.300, D08.211.211.300, D13.695.667.138.382.300, D13.695.827.068.382.300
osteoclasts: A11.329.372.700, A11.627.482.700
giant cells: A11.500
carbachol: D02.092.877.883.333.115, D02.675.276.232.115
eosinophil peroxidase: D08.811.682.732.440, D12.776.124.486.379.600
adoptive transfer: E02.095.465.425.400.330.050, E05.478.550.520.050
liver regeneration: G10.261.326.520, G16.100.856.468
liver glycogen: D05.750.078.562.388.518, D09.698.365.388.518
liver diseases: C06.552
tissue kallikreins: D08.811.277.656.300.760.442.875, D08.811.277.656.959.350.442.875, D23.101.840.870
kininogens: D12.644.276.812.654, D12.776.124.125.635, D12.776.467.812.654, D12.776.811.420, D23.119.630, D23.469.050.375.425, D23.529.812.654
alpha 1-antitrypsin: D12.644.822.750.035, D12.644.861.035, D12.776.124.050.070, D12.776.124.790.106.085, D12.776.377.715.085.085, D12.776.395.068, D12.776.645.750.035, D12.776.872.035
galium: B01.650.940.800.575.100.850.377
kinins: D12.644.276.812, D12.776.467.812, D23.469.050.375, D23.529.812
breast neoplasms: C04.588.180, C17.800.090.500
social class: I01.880.552, I01.880.840.755, N01.824.782
chlordecone: D02.455.526.439.190
methoxychlor: D02.455.526.439.610
acrylonitrile: D02.626.095
cytostatic agents: D27.888.569.199
benomyl: D02.241.081.251.125, D03.438.103.140
alkalies: D01.045
ng-nitroarginine methyl ester: D12.125.068.050.525, D12.125.095.104.525
death: C23.550.260
rubber: D25.720.099.750, D25.720.327.840, J01.637.051.720.099.750, J01.637.051.720.327.840, J01.637.412.767
arteriosclerosis: C14.907.137.126
coronary artery disease: C14.280.647.250.260, C14.907.137.126.339, C14.907.585.250.260
protein disulfide-isomerases: D08.811.399.475.800.550
neurokinin a: D12.644.276.812.900.500, D12.644.400.800.500, D12.644.456.800.500, D12.776.467.812.900.500, D12.776.641.650.800.500, D23.469.050.375.850.550, D23.529.812.900.500
capsaicin: D02.065.160.500, D02.455.326.271.060.222, D02.455.426.559.389.657.166.099, D03.132.760.200, D10.251.355.325.190
tachykinins: D12.644.276.812.900, D12.644.400.800, D12.644.456.800, D12.776.467.812.900, D12.776.641.650.800, D23.469.050.375.850, D23.529.812.900
neuropeptides: D12.644.400, D12.776.641.650
paraffin: D02.455.612
adrenergic neurons: A08.663.100, A11.671.050
cerebellar nuclei: A08.186.211.132.810.428.200.337, A08.186.211.865.428.200.337
wrist: A01.378.800.667.715
motor neuron disease: C10.574.562, C10.668.467
fathers: F01.829.263.500.320.100, I01.880.225.500.340.210, M01.620.390
ecotoxicology: H01.158.273.248.500, H01.158.703.795.211, H01.277.249.500, H02.628.795.211
benzimidazoles: D03.438.103
magnesium: D01.268.552.437, D01.268.557.500, D01.552.547.500
femoral neck fractures: C26.404.061.425.500, C26.558.276.425.500
osteoporosis: C05.116.198.579
buffaloes: B01.050.150.900.649.077.380.135
body mass index: E01.370.600.115.100.125, E05.041.124.125, G07.100.100.125, N06.850.505.200.100.175
premenopause: G08.686.157.500.812, G08.686.785.880.249.500.812
lumbar vertebrae: A02.835.232.834.519
hispanic americans: M01.686.754.441
osteocalcin: D12.776.157.125.700
cholecalciferol: D04.808.247.222.159, D04.808.247.808.146, D04.808.812.768.196, D10.570.938.146
integrin-binding sialoprotein: D12.776.395.700.675, D12.776.744.527, D12.776.860.300.562
bone morphogenetic protein 2: D12.644.276.954.200.200, D12.776.467.942.200.200, D23.529.942.200.200
rna-directed dna polymerase: D08.811.913.696.445.308.300.750, D12.776.964.775.375.750, D12.776.964.970.600.850.375.750
reverse transcriptase polymerase chain reaction: E05.393.620.500.725
core binding factor alpha 1 subunit: D12.776.930.155.200.100
osteoblasts: A11.329.629
multiple sclerosis: C10.114.375.500, C10.314.350.500, C20.111.258.250.500
mortality: E05.318.308.985.550, L01.280.975.550, N01.224.935.698, N06.850.505.400.975.550, N06.850.520.308.985.550
epidemiology: H02.403.720.500
valinomycin: D04.345.566.297.500, D12.644.641.297.500
iron overload: C18.452.565.500
follicular fluid: A05.360.319.114.630.535.150, A06.407.312.497.535.150, A12.207.270.340
centers for disease control and prevention (u.s.): I01.409.137.500.600.650.225, N03.540.348.500.500.600.650.225
flurothyl: D02.355.417.515
valine: D12.125.070.950, D12.125.142.930
tyrosine: D12.125.072.050.875
methanol: D02.033.623
dietary proteins: D12.776.256, J02.500.428
hematopoiesis: G04.299.151.825, G09.188.124.544
nephrectomy: E04.950.774.435
benzoquinones: D02.806.250
catechols: D02.455.426.559.389.657.166
vinblastine: D03.132.436.681.827.650, D03.438.473.402.681.827.650
peroxiredoxin vi: D08.811.277.352.100.680.750.937.300.500, D08.811.277.352.100.680.750.937.625.624, D08.811.641.773, D08.811.682.732.850.500
proteomics: H01.158.201.843, H01.158.273.180.350.700, H01.158.273.343.350.700, H01.181.122.738
peroxiredoxins: D08.811.682.732.850
alkenes: D02.455.326.271
isoxazoles: D03.383.129.385
speech: F01.145.209.908.677, G11.561.600.825, L01.143.506.423.676
hearing loss: C09.218.458.341, C10.597.751.418.341, C23.888.592.763.393.341
aminobiphenyl compounds: D02.455.426.559.389.185.060
trifluridine: D03.383.742.680.705.900, D13.570.230.855.900, D13.570.685.705.900
coumaphos: D02.705.400.625.120, D02.705.539.345.120, D02.886.300.692.120, D03.438.150.446.912.326, D03.830.219.446.912.326
sodium dodecyl sulfate: D02.033.415.220.720, D02.886.645.600.055.050.632, D10.289.220.720
zearalenone: D02.455.426.559.389.657.852.900, D02.540.950, D23.946.587.989
rotenone: D03.438.150.266.450.400.843, D03.549.825, D03.830.219.266.450.400.843
trichlorfon: D02.705.429.937
reserpine: D03.132.436.681.933.500, D03.438.473.402.681.933.500
heptachlor: D02.455.526.439.516
boric acids: D01.029.260.093, D01.132.250, D02.203.130
benzyl alcohol: D02.033.160.100, D02.455.426.559.389.140.200.100
cytarabine: D03.383.742.680.245.453, D13.570.065.300, D13.570.685.245.453
dapsone: D02.886.590.263
benzyl compounds: D02.455.426.559.389.140
ethyl ethers: D02.355.417
toluidines: D02.092.146.859, D02.455.426.559.389.832.559
triazines: D03.383.931
nitrogen mustard compounds: D02.455.526.728.650
benzilates: D02.241.223.601.238.306, D02.241.511.085
phthalimides: D02.241.223.805.810, D02.478.600, D03.438.513.750
quinolines: D03.438.810
furans: D03.383.312
erythrocyte indices: E01.370.225.625.230, E05.200.625.230, G09.188.260
reticulocytes: A11.118.290.760, A11.148.790, A11.443.240.665, A15.145.229.334.760, A15.378.316.790
sex distribution: I01.240.800, N01.224.803, N06.850.505.400.850
parity: G08.686.677, G08.686.785.760.769.472, N06.850.490.812.600
censuses: I01.240.205, N01.224.175, N06.850.505.400.225
transportation: J01.937
leydig cell tumor: C04.557.475.750.847.249, C04.588.322.762.500.249, C04.588.945.440.915.500.249, C12.294.260.937.500.249, C12.758.409.937.500.249, C19.344.762.500.249, C19.391.829.782.500.249
siloxanes: D01.837.800, D02.715.650, D05.750.900, D25.720.900, J01.637.051.720.900
silicones: D02.715.650.700, D05.750.900.850, D25.720.900.850, J01.637.051.720.900.850
urine specimen collection: E01.370.225.998.762, E05.200.998.762
exsanguination: C23.550.414.734
thinness: C23.888.144.828, E01.370.600.115.100.160.120.828, G07.100.100.160.120.828
euthanasia: E02.760.905.199, I01.880.735.344.500, N02.421.585.905.199
angioedema: C14.907.079, C17.800.862.945.066, C20.543.480.904.066
cryptorchidism: C12.294.829.258, C12.706.258, C16.131.939.258, C19.391.829.258
organ specificity: G07.650
adrenal cortex: A06.407.071.140
nephrosis: C12.777.419.630, C13.351.968.419.630
thalamus: A08.186.211.730.317.826
uroporphyrinogen decarboxylase: D08.811.520.224.125.900
tellurium: D01.268.185.950, D01.268.513.968
vitamin e: D03.438.150.909, D03.830.219.909
vanadium: D01.268.556.920, D01.268.956.886, D01.552.544.920
vanadates: D01.248.497.158.952, D01.960.960
vitamin e deficiency: C18.654.521.500.133.841
enteritis: C06.405.205.462, C06.405.469.326
cystitis: C12.777.829.495, C13.351.968.829.495
molybdenum: D01.268.556.555, D01.268.956.500, D01.552.544.555
aluminum: D01.268.557.050, D01.552.547.050
body fluids: A12.207
vinyl compounds: D02.455.326.271.884
air: G16.500.275.063.150, N06.230.300.100.150
nucleic acids: D13.444
mitosis: G04.299.134.220.220.781, G05.355.105.220.781
nausea: C23.888.821.712
gastrointestinal contents: A12.519
amylases: D08.811.277.450.066
disinfectants: D27.505.954.122.425, D27.720.274
benzoic acid: D02.241.223.100.120, D02.455.426.559.389.127.117
switzerland: Z01.542.883
purpura: C15.378.100.802, C23.550.414.950, C23.888.885.687
equidae: B01.050.150.900.649.709.235
fructosephosphates: D09.894.417.313
nerve tissue: A08.561, A10.755
adrenergic fibers: A08.663.542.075
hemorrhage: C23.550.414
abdominal cavity: A01.923.047.025
hematoma: C23.550.414.838
endocrine system: A06
pupa: B05.500.700, G07.700.320.500.550.500.700
biological control agents: D20.215.191, J01.040.226
abdomen: A01.923.047
acidosis: C18.452.076.176
acid-base equilibrium: G02.111.029, G02.300.176, G03.030, G07.700.345.110, G09.188.050
myometrium: A02.633.570.500, A05.360.319.679.690, A10.690.467.500
obstetric labor, premature: C13.703.420.491
premature birth: C13.703.420.491.500
macaca radiata: B01.050.150.900.649.801.400.112.199.120.510.570
asbestosis: C08.381.483.581.125, C08.381.520.702.125, C24.800.127
mining: J01.576.370.500
carbon tetrachloride poisoning: C25.723.177
adams-stokes syndrome: C14.280.067.558.137, C23.550.073.425.025
antimony sodium gluconate: D02.241.081.844.322.060, D02.241.511.902.322.060, D02.691.080, D09.811.308.060
cyclin-dependent kinase 2: D08.811.913.696.620.682.700.200.323, D08.811.913.696.620.682.700.646.500.750, D12.644.360.250.323, D12.776.167.200.323, D12.776.476.250.323
cyclin b1: D12.644.360.262.120.100, D12.776.167.218.120.100, D12.776.476.262.120.100
mcf-7 cells: A11.251.210.190.630
breast: A01.236
age of onset: N05.715.350.075.100, N06.850.490.250.100
cities: G16.500.275.069, N06.230.069, Z01.433
new jersey: Z01.107.567.875.500.525
bulgaria: Z01.542.248.180
alanine: D12.125.042
alcoholic intoxication: C25.775.100.175, F03.900.100.300
quinones: D02.806
area under curve: E05.318.740.200, G03.787.101, G07.690.725.064, N06.850.520.830.200
ketoglutaric acids: D02.241.081.337.351.502, D02.241.755.465
amphipoda: B01.050.500.131.365.055
crustacea: B01.050.500.131.365
oceans and seas: G01.311.625, G16.500.275.810.650, Z01.756
angiotensinogen: D12.644.456.073.070, D12.644.822.750.020, D12.644.861.020, D12.776.645.750.020, D12.776.811.070, D12.776.872.020
glucose clamp technique: E01.370.225.124.100.350, E05.196.500, E05.200.124.100.350
obesity: C18.654.726.500, C23.888.144.699.500, E01.370.600.115.100.160.120.699.500, G07.100.100.160.120.699.500
urochordata: B01.050.150.200.727, B01.050.500.272.727
gastrula: A16.331.600
blastomeres: A11.104, A16.094
morula: A16.615
cytoskeleton: A11.284.430.214.190.750
soot: D20.633.937.339
lipopolysaccharides: D09.400.500, D09.698.718.450, D10.494, D23.050.161.616.525, D23.946.123.329.500
cell culture techniques: E01.370.225.500.223, E05.200.500.223, E05.240.249, E05.242.223
alzheimer disease: C10.228.140.380.100, C10.574.945.249, F03.087.400.100
dementia: C10.228.140.380, F03.087.400
cognition disorders: F03.087.250
probability: E05.318.740.600, G17.680, N05.715.360.750.625, N06.850.520.830.600
retrocaval ureter: C12.706.811, C13.351.875.811, C16.131.939.915
loss of heterozygosity: G05.365.590.029.530
small-area analysis: E05.318.740.250.675, N05.715.360.750.200.750, N06.850.520.830.250.675
television: J01.897.280.500.898, L01.178.590.875, L01.178.820.090.898, L01.178.847.823
leukemia, hairy cell: C04.557.337.415, C15.604.515.553, C20.683.515.517
steam: D01.455.900.800, D01.650.550.925.800, G16.500.887, N06.230.650
wood: A18.700.888, J01.637.241.900
physostigmine: D02.241.081.251.583.682, D03.132.436.545, D03.438.473.402.545
cholinergic agonists: D27.505.519.625.120.140, D27.505.696.577.120.140
pyridines: D03.383.725
interleukin-3: D12.644.276.374.410.240.400, D12.644.276.374.465.503, D12.776.395.240.400, D12.776.467.374.410.240.400, D12.776.467.374.465.503, D23.529.374.410.240.400, D23.529.374.465.503
granulocyte-macrophage colony-stimulating factor: D12.644.276.374.410.240.375, D12.776.395.240.300, D12.776.467.374.410.240.375, D23.529.374.410.240.375
macrophage colony-stimulating factor: D12.644.276.374.410.240.500, D12.776.395.240.500, D12.776.467.374.410.240.500, D23.529.374.410.240.500
digoxin: D04.808.155.160.349, D04.808.155.580.130.500.436, D09.408.180.261.436
glial fibrillary acidic protein: D05.750.078.593.400, D12.776.220.475.400
phosphopyruvate hydratase: D08.811.520.241.300.500
hexachlorophene: D02.455.426.559.389.261.190.350, D02.455.426.559.389.657.190.350
heptanes: D02.455.326.146.485
base pairing: G02.111.087.620.500, G02.111.570.790.486.100, G02.149.115.620.500, G05.360.580.100
lac repressors: D12.776.097.521, D12.776.260.703.600, D12.776.930.700.781
sequence analysis: E05.393.760
triallate: D02.241.081.251.869.820, D02.886.706.850
trifluralin: D02.092.146.859.717, D02.455.426.559.389.832.767
gelatin: D12.776.860.476
rumen: A13.869.804
hormones: D06.472, D27.505.696.399.472
cysts: C04.182, C23.300.306
germany: Z01.542.315, Z01.586.315
bronchioles: A04.411.125.500
hepatectomy: E04.210.556
dna adducts: D13.444.308.135, G05.355.180.104
nucleotides: D09.408.620, D13.695
nervous system neoplasms: C04.588.614, C10.551
maryland: Z01.107.567.875.075.418, Z01.107.567.875.500.500
birth rate: E05.318.308.985.775.500, L01.280.975.775.500, N01.224.935.849.500, N06.850.505.400.975.775.500, N06.850.520.308.985.775.500
propionates: D02.241.081.751, D10.251.400.706
carboxylesterase: D08.811.277.352.100.100
7-alkoxycoumarin o-dealkylase: D08.811.682.690.708.170.040.024
coturnix: B01.050.150.900.248.350.650.350
quail: B01.050.150.900.248.350.650
epoxide hydrolases: D08.811.277.340
biosynthetic pathways: G02.111.087.126, G02.149.115.126, G03.495.553.100
lactose: D09.698.629.305.340
chronic disease: C23.550.291.500
carbon monoxide: D01.200.250, D01.362.200, D01.650.550.250
total lung capacity: E01.370.386.700.485.750, G09.772.850
functional residual capacity: E01.370.386.700.485.750.275, G09.772.850.390
hempa: D02.705.672.249
leukemia l5178: C04.557.337.372.602, C04.619.531.602
propoxur: D02.241.081.251.583.788
putamen: A08.186.211.730.885.287.249.487.550.784
cerebrovascular circulation: G09.330.190.163.159
facial nerve: A08.800.050.050.275, A08.800.050.600.149, A08.800.800.060.275, A08.800.800.120.250
tonic pupil: C10.597.690.575, C11.710.800, C23.888.592.708.575
facial muscles: A02.633.567.400, A14.363
pupil: A09.371.060.450.780, A09.371.894.513.780
myokymia: C10.597.613.650, C23.888.592.608.650
mmpi: F04.711.647.513.607
adie syndrome: C10.177.045, C10.292.600.200, C11.590.436.200, C11.710.800.180
troleandomycin: D02.540.505.600.800
chloranil: D02.806.250.210
psychiatry: F04.096.544, H02.403.690
coke: D20.345.108.110, N06.230.132.258.108.110
coal: D20.345.108, N06.230.132.258.108
odors: G16.500.275.640, N06.230.480
vanilla: B01.650.940.800.575.100.787.888
recovery of function: G16.757
locomotion: G07.700.560.500, G11.427.590.530.568
formates: D02.241.081.420
volunteers: M01.955
4-aminopyridine: D02.092.080.060, D03.383.725.050.060
myotonia: C10.597.613.700, C23.888.592.608.700
tetrodotoxin: D03.438.786.910, D23.946.580.910
uranyl nitrate: D01.625.525.550.950, D01.950.950
muscle contraction: G11.427.590.540
autoradiography: E01.370.225.750.132, E05.200.750.132, E05.799.256
heterografts: A01.941.875
mucus: A12.200.503
estrone: D04.808.365.415.414, D04.808.578.502.497, D06.472.040.502.497, D06.472.334.851.437.996
equilin: D04.808.365.415.220, D04.808.578.502.475, D06.472.334.851.437.374
norethindrone: D04.808.668.651.693.651
norgestrel: D04.808.668.651.693.762
pentanes: D02.455.326.146.770
intestinal neoplasms: C04.588.274.476.411, C06.301.371.411, C06.405.249.411, C06.405.469.491
neopterin: D03.438.733.631.202.500, D08.211.090.500
bronchial spasm: C08.127.321
bleaching agents: D27.720.642.315
sulfuric acids: D01.029.260.877.800, D01.875.800.800, D02.886.645.655
benzofurans: D03.438.127
anti-asthmatic agents: D27.505.954.796.050
trout: B01.050.150.900.493.817.750.825
oncorhynchus mykiss: B01.050.150.900.493.817.750.825.580.600
antibodies, monoclonal: D12.776.124.486.485.114.224, D12.776.124.790.651.114.224, D12.776.377.715.548.114.224
antigens: D23.050
bile canaliculi: A03.159.183.158.125, A03.620.150.125
pituitary hormone-releasing hormones: D06.472.699.327.740, D12.644.400.400.740, D12.644.548.365.740, D12.776.641.650.405.740
reproductive behavior: F01.145.688, G08.686.785.760.891
halogenation: G02.111.087.485, G02.149.115.485, G03.495.496
aborted fetus: A16.378.099
nitrosomethylurethane: D02.241.081.251.944.500, D02.654.585
encephalocele: C10.500.680.488, C16.131.666.680.488, C23.300.707.186
ethylenethiourea: D02.948.898.323, D03.383.129.308.432.500
kyphosis: C05.116.900.800.500
bronchoconstrictor agents: D27.505.696.663.050.100, D27.505.954.796.170
salicylates: D02.241.223.100.300.595, D02.241.511.390.595, D02.455.426.559.389.127.281.595, D02.455.426.559.389.657.410.595
heating: N06.230.150.300
headache disorders: C10.228.140.546
erythema: C17.800.229
splenomegaly: C23.300.775.750
venules: A07.231.461.920, A07.231.908.952
immunomodulation: E02.095.465, G12.425.746
toothpastes: D25.376.711, J01.637.051.376.711
detergents: D27.720.877.265, J01.516.381
propylene glycol: D02.033.455.706.725
drosophila: B01.050.500.131.617.289.310.250
dysuria: C23.888.942.343.274
friend murine leukemia virus: B04.820.650.375.525.225, B04.909.574.807.375.525.225, B04.909.777.731.375.525.225
ants: B01.050.500.131.617.479.205
polyploidy: C23.550.210.702, G05.365.590.175.677, G05.700.740
g2 phase: G04.299.134.500.340
respiratory tract neoplasms: C04.588.894.797, C08.785
multivesicular bodies: A11.284.430.214.190.875.190.880.337.500
ligation: E04.426
bis(chloromethyl) ether: D02.355.601.250
pre-eclampsia: C13.703.395.249
matched-pair analysis: E05.318.740.475, E05.318.780.485, N05.715.360.750.500, N05.715.360.780.500, N06.850.520.445.485, N06.850.520.830.475
electric impedance: G01.358.500.249.277.350
exhalation: G09.772.770.755.700.275
saccades: G14.640.260.500
eye movements: G11.427.590.530.140, G14.640.260
drug-related side effects and adverse reactions: C25.100
porphobilinogen: D03.383.129.578.617
catechin: D03.438.150.240.190, D03.438.150.266.450.206, D03.830.219.240.190, D03.830.219.266.450.206
silymarin: D03.438.150.266.450.268.777, D03.830.219.266.450.268.777
sodium glutamate: D12.125.067.625.349.850, D12.125.119.409.349.575
primates: B01.050.150.900.649.801
china: Z01.252.474.164
gentamicins: D09.408.051.374
renal insufficiency: C12.777.419.780, C13.351.968.419.780
bromides: D01.139.300.050, D01.248.497.158.125
ophthalmic solutions: D26.255.775.645, D26.776.708.645, D27.505.954.578.645, D27.720.280.775.645
anterior capsule of the lens: A09.371.061
consciousness: F02.463.188.409, F02.830.233
unconsciousness: C10.597.606.358.800, C23.888.592.604.359.800
embryonic development: G07.700.320.500.325.180, G08.686.785.760.170.104
embryonic stem cells: A11.872.190
autonomic nervous system: A08.800.050
cadmium compounds: D01.142
drug compounding: E05.916.270
industrial waste: D20.944.420, N06.850.460.710.420
personality tests: F04.711.647
saralasin: D12.644.456.073.041.800, D23.469.050.050.050.700
masks: E07.325.877.500, E07.700.500, E07.858.594.750, J01.637.708.500
superovulation: E02.875.800.984.500, E05.820.800.984.500, G08.686.785.760.690.768
ovulation: G08.686.785.760.690
drug combinations: D26.310
onions: B01.650.940.800.575.100.610.100.600, J02.500.850.100.500
mitotic index: E01.370.225.500.385.500, E05.200.500.385.500, E05.242.385.500
meiosis: G04.299.134.220.220.687, G05.355.105.220.687
nutrition surveys: E05.318.308.250.600, E05.318.308.585.550, N05.715.360.300.375.560, N05.715.360.300.560.565, N06.850.520.308.250.600, N06.850.520.308.585.550
health behavior: F01.145.488
curcumin: D02.455.326.146.485.222.222, D02.455.426.559.389.657.166.200, D02.455.426.559.694.222
bangladesh: Z01.252.245.131
specific gravity: G02.842.810
microsatellite instability: C23.550.362.590, G05.365.590.335.590, G05.370.590
dna mismatch repair: G02.111.087.219.220, G02.149.115.219.220, G05.355.195.220
microsatellite repeats: G02.111.570.080.708.800.500, G05.360.080.708.800.500, G05.360.340.024.850.500
polycystic ovary syndrome: C04.182.612.765, C13.351.500.056.630.580.765, C19.391.630.580.765
international agencies: N03.540.514
bilirubin: D03.383.129.578.840.249.184, D03.549.909.249.184, D04.345.783.249.184, D23.767.193.184
molluginaceae: B01.650.940.800.575.100.740
cervix uteri: A05.360.319.679.256
tongue neoplasms: C04.588.443.591.925, C07.465.565.925, C07.465.910.874
socioeconomic factors: I01.880.840, N01.824
alkanes: D02.455.326.146
population control: I01.240.600.650, N01.224.625.650, N06.850.505.400.700.650
meningioma: C04.557.580.520, C04.557.645.520, C04.588.614.250.580.500, C10.551.240.500.500
arizona: Z01.107.567.875.760.100
meningeal neoplasms: C04.588.614.250.580, C10.551.240.500
michigan: Z01.107.567.875.350.500, Z01.107.567.875.510.500
minnesota: Z01.107.567.875.350.510, Z01.107.567.875.510.510
wisconsin: Z01.107.567.875.350.900, Z01.107.567.875.510.900
iowa: Z01.107.567.875.510.370
quebec: Z01.107.567.176.791
dehydroepiandrosterone: D04.808.054.079.429.625, D04.808.578.502.400, D06.472.040.502.400, D06.472.334.851.968.952
pressoreceptors: A08.663.650.915.750.750, A08.800.050.800.900.700, A08.800.950.750.750, A11.671.650.915.750.750
phenylephrine: D02.033.100.291.617, D02.092.063.291.617
microinjections: E02.319.267.530.690, E05.591.570
medulla oblongata: A08.186.211.132.810.406, A08.186.211.865.467.500
electric stimulation: E05.723.402
neuroeffector junction: A08.800.550.550, A08.850.550, A11.284.149.165.420.780.550
synaptic transmission: G02.111.087.800.850, G02.149.115.800.850, G04.299.880.850, G07.265.337.900, G07.700.240.900, G11.561.600.835
cerebrospinal fluid: A12.207.270.210
solitary nucleus: A08.186.211.132.810.406.750, A08.186.211.865.467.500.750
n-methylaspartate: D12.125.067.500.400, D12.125.119.170.400
apnea: C08.618.085, C23.888.852.130
hypotension: C14.907.514
cecum: A03.556.124.526.209, A03.556.249.249.209
military personnel: M01.526.625
arrhythmias, cardiac: C14.280.067, C23.550.073
leishmania: B01.268.475.868.488
malnutrition: C18.654.521
nucleus accumbens: A08.186.211.730.885.287.249.683
clonidine: D03.383.129.308.436.500
stereotyped behavior: F01.145.896
pituitary neoplasms: C04.588.322.609, C04.588.614.250.195.885.500.600, C10.228.140.211.885.500.600, C10.228.140.617.477.600, C10.228.140.617.738.675, C10.551.240.250.700.500.500, C19.344.609, C19.700.734
maximum tolerated dose: E05.940.481, G07.690.570
chlorodiphenyl (54% chlorine): D02.455.526.439.773.292.077, D02.455.526.439.785.292.077
valproic acid: D02.241.081.944.509.900, D10.251.400.895.593.900
mineral oil: D02.455.699.500
embryo loss: C13.703.039.711, C23.550.260.440
autolysis: C23.550.260.224.617.236
urination: G08.852.796.877
tubocurarine: D02.092.877.922, D02.675.276.922, D03.132.098.916, D03.438.531.085.944, D03.438.531.820.875
neurofilament proteins: D05.750.078.593.630, D12.776.220.475.630, D12.776.641.630
calcitonin gene-related peptide: D12.644.400.097, D12.776.641.650.097
urinary retention: C12.777.934.880, C13.351.968.934.880
ureter: A05.810.776
motor endplate: A08.800.550.550.550.500, A08.850.550.550.500, A11.284.149.165.420.780.550.550.500
arm: A01.378.800.075
dreams: F02.463.188.634.309, F02.830.855.268
respiratory tract diseases: C08
omega-n-methylarginine: D12.125.068.050.650, D12.125.095.104.650, D12.125.142.087.500
rats, inbred dahl: B01.050.050.157.760.165, B01.050.050.199.520.760.165, B01.050.150.900.649.865.635.505.700.400.165
arginine: D12.125.068.050, D12.125.095.104, D12.125.142.087
citrulline: D12.125.095.226
cyclic gmp: D03.438.759.646.454.160, D13.695.462.275, D13.695.667.454.160, D13.695.827.426.160
atenolol: D02.033.100.624.698.070, D02.033.755.624.698.070, D02.092.063.624.698.070
sodium chloride symporter inhibitors: D27.505.519.562.812, D27.505.696.560.500.863
hydrochlorothiazide: D02.886.590.700.135.261.476, D02.886.655.500.261.476, D03.438.174.261.476
vasopressins: D06.472.699.631.692.781, D12.644.400.900, D12.644.456.925, D12.644.548.691.692.781, D12.776.641.650.937
pain: C10.597.617, C23.888.592.612, C23.888.646, F02.830.816.444, G11.561.600.810.444
interior design and furnishings: J01.086.339.290
cell degranulation: G04.299.490.160
calmodulin: D12.644.360.381.249, D12.776.157.125.412.249, D12.776.476.387.249
thrombin: D08.811.277.656.300.760.855, D08.811.277.656.959.350.855, D12.776.124.125.890, D23.119.960
phosphoric diester hydrolases: D08.811.277.352.640
fibronectins: D12.776.377.715.390, D12.776.395.550.350, D12.776.543.550.350, D12.776.860.300.450
neutrophil infiltration: G12.425.898
sarcoidosis: C15.604.515.827
solitary pulmonary nodule: C04.588.894.797.520.966, C08.381.540.933, C08.381.884, C08.785.520.933
deglutition disorders: C06.405.117.119, C09.775.174
pharyngitis: C07.550.781, C08.730.561, C09.775.649
amphetamine: D02.092.471.683.152.110
pattern recognition, automated: L01.725
freezing: G01.595.680.500, G01.906.595.272.437, G02.149.767.680.466, G02.842.750.680.466
xenopus: B01.050.150.900.090.180.610.500
digestive system abnormalities: C06.198, C16.131.314
intestinal volvulus: C06.405.469.531.568, C23.300.970.500
alkynes: D02.455.326.397
cyclamates: D02.455.426.392.368.367.204
ice: D01.455.900.400, D01.650.550.925.400, G16.500.275.410, G16.500.750.775.342, N06.230.291
lunch: F01.145.407.432.500.550, F01.145.466.349.500.550, J02.500.590.560
glucans: D05.750.078.562, D09.698.365
affect: F01.470.047
interpersonal relations: F01.829.401
polyribonucleotides: D13.695.578.550
nigeria: Z01.058.290.190.565
respiration disorders: C08.618
klebsiella pneumoniae: B03.440.450.425.425.600, B03.660.250.150.400.590
klebsiella: B03.440.450.425.425, B03.660.250.150.400
thymidine kinase: D08.811.913.696.620.750
netherlands: Z01.542.651
violence: I01.198.240.856, I01.880.735.900
turbinates: A02.835.232.781.324.948, A04.531.898
videotape recording: J01.897.280.500.846.734, J01.897.280.500.898.840, L01.178.590.875.840, L01.178.820.090.846.734, L01.178.820.090.898.840, L01.240.940.840, L01.240.960.880
psittacula: B01.050.150.900.248.710.672.650.650
parakeets: B01.050.150.900.248.710.672.650
spermatocele: C12.294.731, C23.300.306.750
gels: D20.280.320, D26.255.165.320, D27.720.280.165.320
urogenital system: A05
p38 mitogen-activated protein kinases: D08.811.913.696.620.682.700.567.878, D08.811.913.696.620.682.700.646.750.843, D12.644.360.450.835, D12.776.476.450.835
jnk mitogen-activated protein kinases: D08.811.913.696.620.682.700.567.513, D08.811.913.696.620.682.700.646.750.374, D12.644.360.450.340, D12.776.476.450.340
caspase 8: D08.811.277.656.262.500.126.550.800, D08.811.277.656.300.200.126.550.800, D12.644.360.075.405.550.800, D12.776.476.075.405.550.800
bcl-x protein: D12.644.360.075.718.937, D12.776.476.075.718.875
proteome: D12.776.817
microfilament proteins: D05.750.078.730, D12.776.220.525
glutathione disulfide: D12.644.456.448.500
peroxidases: D08.811.682.732
ozone: D01.362.670.600
microglia: A08.637.400, A11.650.400
triose-phosphate isomerase: D08.811.399.475.200.775
protein carbonylation: G02.111.087.682, G02.149.115.682, G03.495.710.690
immunoblotting: E05.478.566.320, E05.601.495.320
biological processes: G16.100
selective estrogen receptor modulators: D06.347.360.827, D27.505.696.399.450.360.827
tamoxifen: D02.455.426.559.389.150.700.900
excitatory amino acid transporter 2: D12.776.157.530.200.249.500.500.750, D12.776.157.530.450.625.147.750, D12.776.157.530.562.374.781.750, D12.776.543.585.200.249.500.500.750, D12.776.543.585.450.625.147.750, D12.776.543.585.562.374.781.750
neuroprotective agents: D27.505.696.706.548, D27.505.954.427.575
selection bias: N05.715.350.150.775, N06.850.490.500.500
recommended dietary allowances: G07.610.620.500, I01.655.500.608.400.650.500, I01.880.604.825.608.400.650.500, N03.623.500.608.428.650.500
early diagnosis: E01.390
glycyrrhiza: B01.650.940.800.575.100.401.300
11-beta-hydroxysteroid dehydrogenases: D08.811.682.047.436.174, D08.811.682.047.820.100
angiotensin receptor antagonists: D27.505.519.162
alkalosis: C18.452.076.354
glutathione s-transferase pi: D08.811.913.225.500.500
cytochrome p-450 cyp1a2: D08.244.453.040.777, D08.811.682.690.708.170.040.443, D12.776.422.220.453.040.555
stroke volume: E01.370.370.380.150.700, G09.330.380.124.882
collagen type i: D05.750.078.280.300.100, D12.776.860.300.250.300.100
hypertrophy, left ventricular: C14.280.195.400, C23.300.775.250.400
connexins: D12.776.543.585.250
gap junctions: A11.284.149.165.420.471
glucose transporter type 1: D12.776.157.530.500.500.500, D12.776.543.585.500.500.500
glucose transport proteins, facilitative: D12.776.157.530.500.500, D12.776.543.585.500.500
porphyria cutanea tarda: C06.552.830.250, C16.320.565.708.400.250, C16.320.850.742.250, C17.800.827.742.250, C17.800.849.617.400.250, C18.452.648.708.400.250, C18.452.811.400.250, C18.452.880.617.400.250
genetic predisposition to disease: C23.550.291.687.500, G05.380.355
lod score: G05.540.750
hepatitis viruses: B04.450
breast implants: E07.695.140
erythropoiesis: G04.299.151.825.414, G09.188.124.544.414
food handling: J01.576.423.200
astrocytoma: C04.557.465.625.600.380.080, C04.557.470.670.380.080, C04.557.580.625.600.380.080
amoeba: B01.046.500.100.700.089
actinobacteria: B03.510.024, B03.510.460.400.400.049
actinomyces: B03.510.024.049.050.050, B03.510.460.400.400.049.049.178
legionella: B03.440.400.425.450.450, B03.660.250.460.460
bacillus: B03.300.390.400.158.218, B03.510.100.100.218, B03.510.415.400.158.218, B03.510.460.410.158.218
hyperoxia: C23.888.852.567
r factors: G05.360.600.600
taste: F02.830.816.724, G11.561.600.810.724
purkinje cells: A08.186.211.132.810.428.200.212.600, A08.186.211.865.428.200.212.600, A08.663.784, A11.671.784
autoimmunity: G12.450.192
wales: Z01.542.363.914, Z01.639.280.914
tobacco smoke pollution: D20.633.937.680, N06.850.460.100.555
deuterium: D01.435.256, D01.496.289
nerve growth factor: D12.644.276.860.437, D12.776.467.860.437, D12.776.641.600.437, D23.529.850.437
nerve growth factors: D12.644.276.860, D12.776.467.860, D12.776.641.600, D23.529.850
plasminogen inactivators: D12.644.822.750.695, D12.644.861.695, D12.776.645.750.695, D12.776.872.695, D23.119.832
bisphenol a-glycidyl methacrylate: D02.241.081.069.600.150, D02.455.426.559.389.657.100, D05.750.716.822.308.200, D25.339.816.500.200, D25.720.716.822.308.200, J01.637.051.339.816.500.200, J01.637.051.720.716.822.308.200
composite resins: D05.750.716.822.308, D25.339.816.500, D25.720.716.822.308, J01.637.051.339.816.500, J01.637.051.720.716.822.308
acrylic resins: D05.750.716.822.111, D25.720.716.822.111, J01.637.051.720.716.822.111
mannans: D09.698.550
hydroxyestrones: D02.455.426.559.389.657.166.350.350, D04.808.365.415.414.400, D04.808.578.502.497.400, D06.472.334.851.437.984.350
cichlids: B01.050.150.900.493.602.200
body size: E01.370.600.115.100.160, E05.041.124.160, G07.100.100.160, G07.700.320.249.314
reinforcement schedule: F02.463.425.770.644
reward: F02.463.425.770.836
ciliary body: A09.371.060.160, A09.371.894.280
saimiri: B01.050.150.900.649.801.400.600.150.710.710
eye: A01.456.505.420, A09.371
optic disk: A08.800.800.120.680.660, A09.371.729.690
calcaneus: A02.835.232.043.300.710.300
metacarpus: A01.378.800.667.572
ultrasonics: H01.671.031.849
attention deficit disorder with hyperactivity: F03.550.150.150
psychomotor agitation: C10.597.350.600, C10.597.606.881.700, C23.888.592.350.600, C23.888.592.604.882.700, F01.700.875.700
hyperkinesis: C10.597.350.350, C23.888.592.350.350
naphthalenesulfonates: D02.455.426.559.847.638.555, D02.886.645.600.080.050.650, D04.615.638.555
centromere: A11.284.430.106.279.345.190.160.165, G05.360.160.165
middle cerebral artery: A07.231.114.228.550
vas deferens: A05.360.444.930
freedom: I01.880.604.473.380, N03.706.437.380
cytogenetics: H01.158.273.343.180
proventriculus: A13.853.710
hodgkin disease: C04.557.386.355, C15.604.515.569.355, C20.683.515.761.355
anatomists: M01.526.485.133, N02.360.133
parasitic diseases: C03
oropharynx: A04.623.603, A14.724.603
background radiation: G01.750.750.115
gamma rays: G01.358.500.505.300, G01.750.250.300, G01.750.750.400
glioblastoma: C04.557.465.625.600.380.080.335, C04.557.470.670.380.080.335, C04.557.580.625.600.380.080.335
myeloid cells: A11.627
nitrendipine: D03.383.725.203.590
nifedipine: D03.383.725.203.540
nimodipine: D03.383.725.203.570, D03.383.725.547.570
nisoldipine: D03.383.725.203.580
parathyroidectomy: E04.270.694
silver staining: E01.370.225.500.620.670.780, E01.370.225.750.600.670.780, E05.200.500.620.670.780, E05.200.750.600.670.780
neutral red: D03.494.704.600
methionine sulfoximine: D02.886.030.676.620, D12.125.166.676.620
retinitis pigmentosa: C11.270.684, C11.768.585.658.500, C16.320.290.684
foreign-body reaction: C23.550.470.251, C26.392.560
t-lymphocytes: A11.118.637.555.567.569, A15.145.229.637.555.567.569, A15.382.490.555.567.569
lymphokines: D12.644.276.374.480, D12.776.467.374.480, D23.529.374.480
bromobenzenes: D02.455.426.559.389.220, D02.455.526.368.150
estrogen receptor beta: D12.776.260.698.750.350.262, D12.776.826.750.350.262, D12.776.930.669.750.350.262
pituitary hormones: D06.472.699.631, D12.644.548.691
granulosa cells: A05.360.319.114.630.535.200, A06.407.312.497.535.300, A11.382.812, A11.436.329
baths: E02.056.110, E02.779.249.110
veratrine: D03.132.920.256.815, D03.549.256.815
veratrum alkaloids: D03.132.920
sodium channels: D12.776.157.530.400.875, D12.776.543.550.425.875, D12.776.543.585.400.875
time factors: G01.910.857
radiometry: E05.799
postural balance: G11.427.690, G11.561.600.810.541.595
seer program: E05.318.308.970.725, L01.280.950.725, N04.452.859.819.725, N05.715.360.300.715.700.725, N06.850.520.308.970.725
receptors, aryl hydrocarbon: D12.776.260.698.209.715, D12.776.826.209.715, D12.776.930.662, D12.776.930.669.209.715
nad(p)h dehydrogenase (quinone): D08.811.682.608.800.500
dithiothreitol: D02.033.800.196, D02.886.740.224, D09.853.196
pc12 cells: A11.251.210.190.750, A11.251.860.180.750, A11.299.500
oxidopamine: D02.092.311.342.478.650
culture media, conditioned: D27.720.470.305.250, E07.206.250
hydroxydopamines: D02.092.311.342.478
hyperprolactinemia: C10.228.140.617.738.250.450, C19.700.355.600
lactotrophs: A06.407.747.500.812, A06.688.357.750.500.812, A08.186.211.730.317.357.352.435.500.500.812, A08.713.357.750.500.812, A11.382.875, A11.436.507
radon: D01.268.271.800, D01.268.613.700, D01.362.641.745
methylcellulose: D09.698.365.180.663
vomiting: C23.888.821.937
connecticut: Z01.107.567.875.550.200
menopause: G08.686.157.500, G08.686.785.880.249.500
nephrocalcinosis: C12.777.419.590, C13.351.968.419.590, C18.452.174.130.560
insulin-like growth factor ii: D12.644.276.937.420, D12.776.124.862.425, D12.776.467.937.420, D23.529.937.420
steroid 21-hydroxylase: D08.244.453.915.760, D08.811.682.690.708.170.915.760, D08.811.682.690.708.783.760, D12.776.422.220.453.915.760
somatomedins: D12.644.276.937, D12.776.124.862, D12.776.467.937, D23.529.937
salmon: B01.050.150.900.493.817.750.705
receptor, igf type 1: D08.811.913.696.620.682.725.400.185, D12.776.543.750.060.468, D12.776.543.750.750.400.780.400
rna isoforms: D13.444.735.064
immunoenzyme techniques: E05.478.566.350, E05.478.583.400, E05.601.495.350
calcium oxalate: D02.241.081.337.593.750.500
kidney calculi: C12.777.419.600.500, C12.777.967.249.500, C12.777.967.500.503, C13.351.968.419.600.500, C13.351.968.967.249.500, C13.351.968.967.500.503, C23.300.175.850.550
carbon dioxide: D01.200.200, D01.362.150, D01.650.550.200
crystallization: E05.196.300, G02.149.767.505, G02.842.750.505
calcium phosphates: D01.029.260.700.675.374.075, D01.146.360, D01.695.625.675.650.075
vitamin a: D02.455.326.271.665.202.495.818, D02.455.426.392.368.367.379.249.700.860, D02.455.849.131.495.818, D23.767.261.700.860
gabexate: D02.078.370.380
levodopa: D02.092.311.200.480, D12.125.072.050.685.400.500, D12.125.072.050.875.130.500
movement disorders: C10.228.662
dyskinesias: C10.228.662.262, C10.597.350, C23.888.592.350
1-(5-isoquinolinesulfonyl)-2-methylpiperazine: D02.886.590.700.545, D03.383.606.527, D03.438.531.400
cyclic amp-dependent protein kinases: D08.811.913.696.620.682.700.150.125, D12.644.360.200.125, D12.776.476.200.125
polycyclic hydrocarbons, aromatic: D02.455.426.559.847, D04.615
leukemia, myeloid: C04.557.337.539
myelodysplastic syndromes: C15.378.190.625
anaphylaxis: C20.543.480.099
hair dyes: D27.720.233.688, D27.720.269.430.430
hypnotics and sedatives: D27.505.696.277.350, D27.505.696.410, D27.505.954.427.210.350
tranquilizing agents: D27.505.696.277.950, D27.505.954.427.210.950, D27.505.954.427.700.872
analgesics: D27.505.696.663.850.014, D27.505.954.427.040
kupffer cells: A11.329.372.588, A11.627.482.588, A11.733.397.588, A15.382.680.397.588, A15.382.812.522.588
free radical scavengers: D27.505.519.217.500
viscera: A01.960
reproducibility of results: E05.318.780.725, E05.337.851, N05.715.360.780.685, N06.850.520.445.725
fingers: A01.378.800.667.430
hobbies: I03.450.642.469
procollagen: D12.776.811.690, D12.776.860.300.250.600
eczema: C17.800.174.620, C17.800.815.620
laminin: D12.776.395.550.530, D12.776.543.550.500, D12.776.860.300.675
oligopeptides: D12.644.456
beta-thromboglobulin: D12.644.276.374.200.070, D12.776.124.125.050, D12.776.124.790.223.160, D12.776.377.715.182.160, D12.776.467.374.200.070, D23.119.050, D23.125.300.070, D23.469.200.070, D23.529.374.200.070
eagles: B01.050.150.900.248.250.200, B01.050.150.900.248.815.350.200
lakes: G01.311.580, G16.500.275.280.500, N06.230.232.500
feathers: A13.370
british columbia: Z01.107.567.176.160
catalytic domain: G02.111.570.120.704, G02.111.570.790.709.610.189
gold: D01.268.556.322, D01.268.956.186, D01.552.544.322
hyperthyroidism: C19.874.397
porphyrinogens: D03.383.129.578.840.500.700, D03.549.909.500.700, D04.345.783.500.700
pregnancy maintenance: G08.686.785.760.769.520
eosinophil cationic protein: D08.811.277.352.700.350.262, D12.776.124.486.379.249
volatile organic compounds: D02.974
butanols: D02.033.415.110, D10.289.110
health surveys: E05.318.308.250, N05.715.360.300.375, N06.850.520.308.250
octanes: D02.455.326.146.720
motor vehicles: J01.937.500
topoisomerase ii inhibitors: D27.505.519.389.892.750, D27.505.954.248.794.750
etoposide: D02.455.426.559.847.638.960.675.250, D04.615.638.960.675.250, D09.408.348.275
laxatives: D27.505.954.483.620
dna topoisomerases, type ii: D08.811.399.403.741
color: G01.590.540.199
plants: B01.650
disease outbreaks: N06.850.290
electron spin resonance spectroscopy: E05.196.867.519.274
lomustine: D02.654.692.440, D02.948.594.440
polyvinyl chloride: D02.455.326.271.884.533.565, D05.750.716.721.812, D25.720.327.811, D25.720.716.721.812, J01.637.051.720.716.721.812
intensive care units: N02.278.388.493
information storage and retrieval: L01.470, L01.700.508.280
lower extremity: A01.378.610
species specificity: G16.824
dna breaks: G05.355.180.210
stachybotrys: B01.300.381.840
platelet count: E01.370.225.500.195.107.740, E01.370.225.625.107.700, E01.370.225.625.625.625, E05.200.500.195.107.740, E05.200.625.107.700, E05.200.625.625.625, E05.242.195.107.740, G04.170.107.740, G09.188.105.700
lactams: D02.065.589, D03.383.411
immunosuppressive agents: D27.505.696.477.656
spores: A11.870, B05.775
optic neuritis: C10.292.700.550, C11.640.576
deodorants: D27.720.269.385
iron metabolism disorders: C18.452.565
protamines: D12.776.660.750, D12.776.664.750
hypercholesterolemia: C18.452.584.500.500.396
fructans: D09.698.350
pesticide residues: D27.888.723.697, N06.850.460.200.700
thiadiazines: D02.886.665.785, D03.383.855.785
ubiquinone: D02.806.250.900, D08.211.935
emotions: F01.470
polymethyl methacrylate: D02.241.081.069.800.550.500, D05.750.716.822.111.650.605.500, D25.720.716.822.111.650.605.500, J01.637.051.720.716.822.111.650.605.500
butyrylcholinesterase: D08.811.277.352.100.170.250
ca(2+) mg(2+)-atpase: D08.811.277.040.025.095
synaptosomes: A11.284.835.859
calcium-transporting atpases: D08.811.277.040.025.125, D12.776.157.530.450.250.500, D12.776.543.585.450.250.500
oogenesis: G04.299.151.650.249, G08.686.785.760.310.500
thyrotropin: D06.472.699.631.525.883, D12.644.548.691.525.883
vitellogenesis: G04.299.151.650.249.880, G08.686.785.760.310.500.880
hydrazines: D02.442
egg proteins: D12.776.290
magnetic phenomena: G01.358
benzphetamine: D02.092.471.683.152.619.307
blood-testis barrier: A05.360.444.849.700.349, A07.045
biotinylation: E05.393.525.085, G02.111.087.157, G02.149.115.157, G03.495.233
potassium compounds: D01.745
diet records: N04.452.859.360
sulfanilic acids: D02.455.426.559.389.750, D02.886.645.600.080.850
circadian rhythm: G07.180.562.190
manganese compounds: D01.530
polyglycolic acid: D05.750.728.780, D25.720.728.780, J01.637.051.720.728.780
imines: D02.491
propylamines: D02.092.831
cyclohexenes: D02.455.426.392.368.367.379
neodymium: D01.268.477.625, D01.268.558.362.625, D01.552.550.399.625
cerium: D01.268.477.249, D01.268.558.362.249, D01.552.550.399.249
lignin: D05.750.078.562.180.515, D05.750.078.687, D20.538, D25.720.099.687, J01.637.051.720.099.687
sex factors: N05.715.350.675, N06.850.490.875
ferritins: D12.776.157.427.249, D12.776.556.579.249
hemin: D03.383.129.578.840.500.640.587.462, D03.549.909.500.640.587.462, D04.345.783.500.640.587.462, D23.767.727.640.587.462
cereals: B01.650.510.253, J02.500.200
triticum: B01.650.940.800.575.100.822.918, J02.500.200.875
cicatrix: A10.165.450.300, C23.550.355.274, G16.100.856.891.249
hirsutism: C17.800.329.750, C23.888.971.468
turkey: Z01.252.245.500.850, Z01.586.500.850
facies: C23.550.291.812, E01.370.600.230
hyperpigmentation: C17.800.621.430
arthritis: C05.550.114
seedling: A18.550
cells, cultured: A11.251
cytoplasmic granules: A11.284.430.214.190.500, A11.284.430.214.190.875.190.190
energy metabolism: G03.495.335
chloride channels: D12.776.157.530.400.175, D12.776.543.550.425.175, D12.776.543.585.400.175
carnitine o-acetyltransferase: D08.811.913.050.134.150, D08.811.913.050.350.170
carnitine o-palmitoyltransferase: D08.811.913.050.350.200
jejunum: A03.556.124.684.500, A03.556.249.750
ileum: A03.556.124.684.249, A03.556.249.124
dermatoglyphics: E05.256, I01.198.780.937.343
rats, inbred f344: B01.050.050.157.760.200, B01.050.050.199.520.760.200, B01.050.150.900.649.865.635.505.700.400.200
cyanamide: D01.625.400.100.150, D02.491.203.362
electroplating: E05.301.250.348
taurine: D02.455.326.146.100.850, D02.886.645.600.055.850
fluorides: D01.248.497.158.380, D01.303.350.300
ideal body weight: E01.370.600.115.100.160.120.499, E05.041.124.160.750.650, G07.100.100.160.120.499, G07.700.320.249.314.120.650
lipofuscin: D10.460, D23.767.550
antigens, cd95: D12.776.543.750.073.500, D12.776.543.750.705.852.760.195, D23.050.301.264.035.195, D23.101.100.110.195
ukraine: Z01.542.248.960, Z01.586.200.960, Z01.586.950.960
greenland: Z01.107.567.403, Z01.639.400
pneumothorax: C08.528.778
habits: F01.145.466
antipyrine: D03.383.129.539.850.088
esterification: G02.111.087.451, G02.149.115.451, G02.149.465.270, G02.607.750.270, G03.495.475
trypsin: D08.811.277.656.300.760.895, D08.811.277.656.959.350.895
dinitrochlorobenzene: D02.455.426.559.389.261.250, D02.455.426.559.389.565.250, D02.455.526.439.202.200, D02.640.529.240.250, D23.050.550.480.350
catalysis: G02.149.170, G02.149.767.500, G02.842.750.500
enzyme induction: G05.355.315.320.200
vitamin k 3: D02.455.426.559.847.638.721.374.922, D02.455.849.291.523.500.922, D02.806.550.875, D04.615.638.721.374.922
iproniazid: D02.442.372, D03.066.349.390, D03.383.725.394.414
lysine: D12.125.068.555, D12.125.095.647, D12.125.142.497
oxygenases: D08.811.682.690
naphthalenes: D02.455.426.559.847.638, D04.615.638
kidney medulla: A05.810.453.466
methylamines: D02.092.668
aziridines: D03.383.097.217
glycosuria: C12.777.934.363, C13.351.968.934.363, C18.452.394.937
electrocoagulation: E02.154.402, E04.014.170.402
operating rooms: N02.278.388.700
body temperature: E01.370.600.875.374, G07.110
lymphocyte depletion: E02.095.465.425.450.521, E05.478.610.570
brain edema: C10.228.140.187
laryngeal neoplasms: C04.588.443.665.481, C08.360.369, C08.785.481, C09.400.369, C09.647.481
cyanoacrylates: D02.241.081.069.366, D02.626.290, D05.750.259, D25.720.259, D25.919.367, J01.637.051.720.259, J01.637.051.919.367
femur neck: A02.835.232.043.650.247.510
cementation: E05.170, E06.095.170
particulate matter: D20.633
neuritis: C10.668.829.650
emergency treatment: E02.365
sodium-potassium-exchanging atpase: D08.811.277.040.025.810, D12.776.157.530.450.162.780, D12.776.157.530.450.250.880, D12.776.543.585.450.162.800, D12.776.543.585.450.250.890
ointments: D26.255.640, D27.720.280.640
antidepressive agents: D27.505.954.427.700.122
desipramine: D03.494.240.281
doxepin: D02.355.291.852.500, D03.494.382.393
prednisone: D04.808.745.432.719.702
drug eruptions: C17.800.174.600, C20.543.206.380, C25.100.468.380
histamine antagonists: D27.505.519.625.375.425, D27.505.696.577.375.425
drug industry: J01.576.318
exanthema: C17.800.257
goats: B01.050.150.900.649.077.380.513
bromhexine: D02.092.146.271, D02.092.384.175
sarcoplasmic reticulum: A10.690.552.500.500.850, A11.284.430.214.190.875.248.310.800
quinolinic acid: D03.383.725.822.700
disease susceptibility: C23.550.291.687, G07.100.250
hypertension, renal: C12.777.419.331, C13.351.968.419.331, C14.907.489.631
bass: B01.050.150.900.493.602.105
alpha-glucosidases: D08.811.277.450.420.050
leucine: D12.125.070.637, D12.125.142.441
electrooculography: E01.370.380.230.285, E01.370.405.265
pallor: C23.888.885.500
evoked potentials, visual: G07.265.500.425, G11.561.270.425, G14.330
quipazine: D03.383.606.827, D03.438.810.850
serotonin receptor agonists: D27.505.519.625.850.800, D27.505.696.577.850.800
vitamin b complex: D27.505.696.377.605.600.708
disulfiram: D02.241.081.251.869.220.250, D02.886.520.150.175, D02.886.706.200.200
dopamine beta-hydroxylase: D08.811.682.690.708.292
dimethyldithiocarbamate: D02.241.081.251.869.210, D02.886.706.175
protein tyrosine phosphatases: D08.811.277.352.650.775
orthopedics: H02.403.810.494
vertebrates: B01.050.150.900
caffeine: D03.132.960.175, D03.438.759.758.824.175
edetic acid: D02.092.782.258.368.250, D02.241.081.018.253
griseofulvin: D03.438.127.275
gills: A13.421
pyruvate kinase: D08.811.913.696.620.695
glyceraldehyde-3-phosphate dehydrogenases: D08.811.682.657.163.750
phosphofructokinases: D08.811.913.696.620.225.850
glyceraldehyde: D02.047.587, D09.546.894.449
motivation: F01.658, F01.752.543.500.750
acetic acid: D02.241.081.018.165, D10.251.400.045.500
food coloring agents: D27.720.233.674, D27.720.368.355
cross reactions: G12.425.143.281
inclusion bodies: A11.284.420
calpain: D08.811.277.656.262.500.120, D08.811.277.656.300.200.120
peritoneal cavity: A01.923.047.025.600.678
san francisco: Z01.107.567.875.580.200.700, Z01.107.567.875.760.200.700, Z01.433.875
bays: G01.311.625.080
fallopian tubes: A05.360.319.114.373, A13.706.500
hysterectomy: E04.950.300.399
sterilization: N06.850.780.200.450.850
bicuculline: D03.132.098.077, D03.438.531.085.077
surgical instruments: E07.858.700
microdissection: E01.370.225.500.620.520, E01.370.225.750.600.520, E01.370.225.998.221.580, E04.221.580, E05.200.750.600.520, E05.200.998.221.580, E05.591.560
endocardial cushion defects: C14.240.400.560.350, C14.280.400.560.350, C16.131.240.400.560.350
heart septal defects: C14.240.400.560, C14.280.400.560, C16.131.240.400.560
barbital: D03.383.742.698.253.150
fibroadenoma: C04.557.450.565.590.595.350, C04.557.470.625.350
fibroma: C04.557.450.565.590.340
fucose: D09.254.488, D09.546.359.313
phosphotungstic acid: D01.029.260.700.675.750, D01.695.625.675.750, D01.940.700
open reading frames: G05.360.335.760.640, G05.360.340.024.340.137.650
dna primers: D13.695.578.424.450.275, D27.720.470.530.600.223.600
ethylmaleimide: D02.241.081.337.502.524.418, D02.478.440.418, D03.383.129.578.399.418
sulfhydryl reagents: D27.720.470.410.700
osmium tetroxide: D01.640.500, D01.650.550.600
zinc compounds: D01.975
anterior horn cells: A08.186.854.080, A08.663.655.500.050, A11.671.655.500.050
skin diseases: C17.800
hematuria: C12.777.934.442, C13.351.968.934.442, C23.550.414.849
water deprivation: F01.658.938
rosaniline dyes: D02.092.146.755
thyrotrophs: A06.407.747.500.968, A06.688.357.750.500.968, A08.186.211.730.317.357.352.435.500.500.968, A08.713.357.750.500.968, A11.382.984, A11.436.925
pituitary gland, anterior: A06.407.747.500, A06.688.357.750.500, A08.186.211.730.317.357.352.435.500.500, A08.713.357.750.500
corticotrophs: A06.407.747.500.500, A06.688.357.750.500.500, A08.186.211.730.317.357.352.435.500.500.500, A08.713.357.750.500.500, A11.382.500, A11.436.267
goldfish: B01.050.150.900.493.200.244.248.480
sperm maturation: G04.299.151.650.624.700, G08.686.785.760.310.760.700
trigeminal nerve diseases: C10.292.775
gallium: D01.268.556.289, D01.552.544.289
pentazocine: D03.132.577.249.106.700, D04.615.723.795.106.700
lymphocyte count: E01.370.225.500.195.107.595.500, E01.370.225.625.107.595.500, E05.200.500.195.107.595.500, E05.200.625.107.595.500, E05.242.195.107.595.500, G04.170.107.595.500, G09.188.105.595.500
tablets: D26.255.830, D27.720.280.830
glycogen synthase: D08.811.913.400.450.460.375
protein kinases: D08.811.913.696.620.682
glycogen phosphorylase: D08.811.913.400.450.460.400.186
hospital records: E05.318.308.940.425, L01.280.900.425, N04.452.859.380, N05.715.360.300.715.380, N06.850.520.308.940.425
mental disorders: F03
hypoglycemic agents: D27.505.696.422
nutritive sweeteners: D27.720.364.609.750, D27.720.888.750, J02.500.512.400.700.750
meals: F01.145.407.432.500, F01.145.466.349.500, J02.500.590
patulin: D03.830.670, D23.946.587.725
sorghum: B01.650.940.800.575.100.822.894
constipation: C23.888.821.150
aspergillus: B01.300.381.081
mycotoxicosis: C25.723.680
selenious acid: D01.810.900
gastroschisis: C05.660.417, C16.131.621.417, C23.300.707.374.500
beak: A13.114
fetal mortality: E05.318.308.985.550.362, L01.280.975.550.362, N01.224.935.698.300, N06.850.505.400.975.550.362, N06.850.520.308.985.550.362
reversal learning: F02.463.425.798
gravidity: G08.686.340, G08.686.785.760.769.213, N06.850.490.812.250
isotopes: D01.496
visual cortex: A08.186.211.730.885.287.500.571.735
night vision: F02.830.816.964.249, G11.561.600.810.964.249, G14.640.816.249
glutaral: D02.047.532
laparotomy: E04.406
immersion: E05.466
menstrual cycle: G08.686.605
symporters: D12.776.157.530.450.625, D12.776.543.585.450.625
france: Z01.542.286
diphenylamine: D02.092.146.350
tin: D01.268.556.875, D01.552.544.875
acenaphthenes: D02.455.426.559.847.638.059, D04.615.638.059
heterocyclic compounds: D03
terphenyl compounds: D02.455.426.559.389.805
fluorenes: D02.455.426.559.847.389, D04.615.389
acetylene: D02.455.326.397.259
sulfoxides: D02.886.640
time-to-pregnancy: G08.686.210.500
growth hormone: D06.472.699.631.525.425, D12.644.548.691.525.425
castration: E04.270.282, E04.950.165
prosthesis failure: C23.550.767.865, E05.325.771
arteritis: C14.907.184, C14.907.940.090
oryzias: B01.050.150.900.493.850.139.650
blood cells: A11.118, A15.145.229
touch: F02.830.816.850, G11.561.600.810.850
mercury poisoning, nervous system: C10.720.475.600, C25.723.647.500
electrolysis: E05.301.250
nephrolithiasis: C12.777.419.600, C12.777.967.249, C13.351.968.419.600, C13.351.968.967.249
oxalates: D02.241.081.337.593
dairy products: J02.500.350
dna, complementary: D13.444.308.497.220, D13.444.600.223.500, D27.720.470.530.600.223.260
baculoviridae: B04.280.065, B04.525.100
response elements: G02.111.570.080.689.330.700, G02.111.570.080.689.675.700, G05.360.080.689.330.700, G05.360.080.689.675.700, G05.360.340.024.340.137.750.249.765, G05.360.340.024.340.137.750.680.765
ovulation induction: E02.875.800.984, E05.820.800.984
trophoblasts: A11.382.992, A16.254.500.766, A16.710.802
placentation: G08.686.785.760.769.491
urokinase-type plasminogen activator: D08.811.277.656.300.760.910, D08.811.277.656.959.350.910, D12.776.124.125.662.884
caspase inhibitors: D27.505.519.389.745.325.500
metestrus: G08.686.195.750
vaginal douching: E05.927.852
proestrus: G08.686.195.875
taiwan: Z01.252.474.872, Z01.639.850
shoes: J01.637.215.800
cathartics: D27.505.954.483.396
household articles: J01.494
mycelium: A19.687
seminoma: C04.557.465.330.800
thermometers: E07.900
oncogenes: G05.360.340.024.340.375.500
laundering: J01.576.549
sphingomyelins: D09.400.410.420.525.870, D10.390.470.675.870, D10.570.755.893, D10.570.877.360.612.870
phosphatidylinositols: D10.570.755.375.760.400.942
nerve regeneration: G11.561.600.615, G16.100.856.611
energy intake: G07.610.240.340
iceland: Z01.542.433, Z01.639.490
coronary circulation: G09.330.190.163.324
cytochrome p-450 cyp2e1: D08.244.453.040.972, D08.811.682.662.582.338, D08.811.682.690.708.170.040.777, D12.776.422.220.453.040.944
dihydrotestosterone: D04.808.054.040.248, D06.472.334.851.968.964
camphor: D02.455.849.575.781.234.326, D02.522.376
nails: A17.600
papillary muscles: A02.633.580.680, A07.541.510.619, A07.541.704.750, A07.541.749
heart failure: C14.280.434
echocardiography: E01.370.350.130.750, E01.370.350.850.220, E01.370.370.380.220
artemia: B01.050.500.131.365.060.050
astronauts: M01.770.100
arachidonate 5-lipoxygenase: D08.811.682.690.416.583.500.055, D12.776.556.579.374.568.500.020
prostaglandin-endoperoxide synthases: D08.811.600.720, D08.811.682.690.708.715
respiratory burst: G03.495.278.620, G04.299.305.620
thromboxanes: D10.251.355.255.100.825, D10.251.355.255.775, D23.469.050.175.800
lipoxygenase: D08.811.682.690.416.583.625, D12.776.556.579.374.568.750
cyclooxygenase inhibitors: D27.505.519.389.310, D27.505.696.663.850.014.040.500.500, D27.505.954.158.030.500, D27.505.954.329.030.500
prostaglandins e: D10.251.355.255.100.637.250, D10.251.355.255.550.250, D23.469.050.175.725.780
hydroxyeicosatetraenoic acids: D10.251.355.096.450, D10.251.355.255.100.300
cyclooxygenase 1: D08.811.600.720.500
phospholipases: D08.811.277.352.100.680, D08.811.277.352.640.700
anti-anxiety agents: D27.505.696.277.950.015, D27.505.954.427.210.950.015, D27.505.954.427.700.872.015
growth and development: G07.700.320
globins: D12.776.422.316
peripheral nervous system: A08.800
precursor cell lymphoblastic leukemia-lymphoma: C04.557.337.428.600, C15.604.515.560.600, C20.683.515.528.600
referral and consultation: N04.452.758.849
long-term potentiation: G11.561.600.635.350
phorbol esters: D02.455.849.291.500.510
thrombosis: C14.907.355.830
punctures: E02.800, E04.665
hemosiderin: D12.776.556.526
perches: B01.050.150.900.493.602.600
axoneme: A11.284.430.214.190.750.602.309
mercaptoethanol: D02.033.375.534, D02.886.489.409
cell cycle proteins: D12.776.167
transcriptional activation: G05.355.315.800
intracellular signaling peptides and proteins: D12.644.360, D12.776.476
map kinase signaling system: G02.111.087.800.560, G02.149.115.800.560, G03.495.553.560, G04.299.880.560
small cell lung carcinoma: C04.588.894.797.520.109.220.624, C08.381.540.140.750, C08.785.520.100.220.750
birth order: F01.829.263.132, I01.240.361.160, N01.224.361.160, N06.850.505.400.400.160
methyl parathion: D02.705.400.625.600.500, D02.705.539.345.600.500, D02.886.300.692.600.500
phosphocreatine: D12.125.373.603, D12.125.740.675
histones: D12.776.660.470, D12.776.664.469
glutamate-cysteine ligase: D08.811.464.259.850.400
parturition: G08.686.785.760.769.490
cooking: J01.576.423.200.200
bandages: E07.101
wnt1 protein: D12.776.467.984.100, D12.776.624.664.700.967, D23.529.984.100
deoxyribonuclease (pyrimidine dimer): D08.811.277.352.335.350.137
escherichia coli proteins: D12.776.097.275
arteries: A07.231.114
healthy worker effect: N05.715.350.350.375, N06.850.490.734.750
central nervous system diseases: C10.228
protective devices: E07.700, J01.637.708
cranial nerves: A08.800.800.120
trans fatty acids: D10.251.355.920
sphingomyelin phosphodiesterase: D08.811.277.352.640.750
serine c-palmitoyltransferase: D08.811.913.050.668
sphingolipids: D10.570.877, D10.808
hypercalciuria: C23.888.942.337
arthralgia: C05.550.091, C23.888.646.130, F02.830.816.444.350, G11.561.600.810.444.350
venezuela: Z01.107.757.943
inferior colliculi: A08.186.211.132.659.727.407, A08.186.211.653.727.249
hippurates: D02.065.277.431, D02.241.223.100.100.400, D02.241.755.360, D02.455.426.559.389.127.085.460
hearing tests: E01.370.382.375
tocopherols: D03.438.150.909.750, D03.830.219.909.750
ellagic acid: D03.438.150.500, D03.830.219.500
bipolar disorder: F03.600.150.150
united states occupational safety and health administration: I01.409.137.500.992, N03.540.348.500.500.992
granulosa cell tumor: C04.557.475.750.656, C04.588.322.455.398, C13.351.500.056.630.705.398, C13.351.937.418.685.398, C19.344.410.398, C19.391.630.705.398
2-methyl-4-chlorophenoxyacetic acid: D02.241.081.018.386.682.500, D02.241.511.316.682.224
retinal ganglion cells: A08.663.650.850.875, A09.371.729.831.875, A11.671.650.850.875
geniculate bodies: A08.186.211.730.317.826.701.444
bronchodilator agents: D27.505.696.663.050.110, D27.505.954.796.050.100
dietary sucrose: D09.301.325, D09.698.629.305.770.200, J02.500.362.325
play and playthings: I03.450.642.693
sperm tail: A05.360.490.890.840, A11.284.180.290.835, A11.497.760.500
eosine yellowish-(ys): D02.455.426.559.847.885.347.325, D03.494.953.275.325, D04.615.885.347.325
solanum tuberosum: B01.650.940.800.575.100.905.725.777, J02.500.850.790
bread: J02.500.100
benzoyl peroxide: D02.241.223.100.133, D02.455.426.559.389.127.133
peroxides: D01.248.497.158.685.750, D01.339.431.374, D01.650.550.750, D02.389.338, D02.737
color perception: F02.463.593.932.217
electromagnetic radiation: G01.358.500.505, G01.750.250
fetal movement: G07.700.320.500.325.235.374, G08.686.785.760.170.157.374
zygote: A05.360.490.690.970, A11.497.497.950, A16.950
drug interactions: G07.690.812.240, G07.700.680.240
hepacivirus: B04.450.410, B04.820.250.475, B04.909.777.310.475
asthenia: C23.888.089
indicators and reagents: D27.720.470.410
fluorobenzenes: D02.455.526.510.432
oxadiazoles: D03.383.129.462.580
sulfonamides: D02.065.884, D02.886.590.700
ictaluridae: B01.050.150.900.493.080.148
catfishes: B01.050.150.900.493.080
antibody formation: G12.425.071
estuaries: G01.311.625.540
phagocytes: A11.733, A15.382.680
vibrio: B03.440.450.900.859, B03.660.250.830.830
bidens: B01.650.940.800.575.100.100.137
plant leaves: A18.024.812
swallows: B01.050.150.900.248.620.750.725
clutch size: G08.686.160
ponds: G01.311.718, G16.500.275.280.625, N06.230.232.625
islands: G16.500.275.505, N06.230.295, Z01.639
diestrus: G08.686.195.374
ultrasonography: E01.370.350.850
interferon-gamma: D12.644.276.374.440.893, D12.644.276.374.480.350, D12.644.276.374.480.615.350, D12.644.276.718.550, D12.776.467.374.440.893, D12.776.467.374.480.350, D12.776.467.374.480.615.350, D12.776.467.718.550, D23.529.374.440.893, D23.529.374.480.350, D23.529.374.480.615.350, D23.529.718.550
labetalol: D02.033.100.291.460, D02.065.793.324, D02.092.063.291.460
pindolol: D02.033.100.624.698.699, D02.033.755.624.698.699, D02.092.063.624.698.699
propanolamines: D02.033.100.624, D02.033.755.624, D02.092.063.624
myelin p0 protein: D12.776.395.550.200.250.500, D12.776.395.570, D12.776.543.550.200.250.500, D12.776.543.620.570, D12.776.641.580.550, D23.050.301.350.250.500
myelin-associated glycoprotein: D12.776.395.550.570, D12.776.503.921.049, D12.776.543.550.555, D12.776.543.620.530, D12.776.641.580.500, D23.050.301.264.035.913.049, D23.101.100.110.929.049
gonadal steroid hormones: D06.472.334.851
mandibular nerve: A08.800.800.120.760.500
football: I03.450.642.845.300
cell fractionation: E05.242.251
individuality: F01.752.488
endothelium-dependent relaxing factors: D27.505.954.411.918.500
inulin: D05.750.078.562.855.750, D09.698.350.500, D09.698.365.855.750
desoxycorticosterone: D04.808.745.745.654.339, D06.472.040.585.611
digestive system: A03
extracorporeal membrane oxygenation: E02.880.301, E04.292.451
hyperbilirubinemia: C23.550.429
cholestasis: C06.130.120.135
aquaculture: J01.040.168
gametogenesis: G04.299.151.650, G08.686.785.760.310
infant mortality: E05.318.308.985.550.475, L01.280.975.550.475, N01.224.935.698.489, N06.850.505.400.975.550.475, N06.850.520.308.985.550.475
parthenogenesis: G08.686.785.760.830.500
phenylcarbamates: D02.241.081.251.583
juvenile hormones: D06.472.445.573.666
hydroxysteroid dehydrogenases: D08.811.682.047.436
cerebellar diseases: C10.228.140.252
scrotum: A05.360.444.661
ventricular fibrillation: C14.280.067.922, C23.550.073.922
printing: L01.737.787
cleft lip: C07.465.409.225, C07.465.525.164, C07.650.525.164, C16.131.850.525.164
morbidity: E05.318.308.985.525, L01.280.975.525, N01.224.935.597, N06.850.505.400.975.525, N06.850.520.308.985.525
matrix metalloproteinase 2: D08.811.277.656.300.480.205.352, D08.811.277.656.300.480.252.420, D08.811.277.656.300.480.525.700.150, D08.811.277.656.675.374.205.352, D08.811.277.656.675.374.252.420, D08.811.277.656.675.374.525.700.150
matrix metalloproteinase 9: D08.811.277.656.300.480.205.360, D08.811.277.656.300.480.252.445, D08.811.277.656.300.480.525.700.350, D08.811.277.656.675.374.205.360, D08.811.277.656.675.374.252.445, D08.811.277.656.675.374.525.700.350
oocyte retrieval: E02.875.800.976, E04.936.537.625, E05.820.800.976
extracellular matrix: A11.284.295.310
fenitrothion: D02.705.400.625.300, D02.705.539.345.300, D02.886.300.692.300
perciformes: B01.050.150.900.493.602
gas chromatography-mass spectrometry: E05.196.181.349.500, E05.196.566.500
respiratory protective devices: E07.700.700, J01.637.708.700
physical exertion: G11.427.590.780
maze learning: F02.463.425.507
conditioning, operant: F02.463.425.179.509
tetrazoles: D03.383.129.617
latvia: Z01.542.248.136.560, Z01.586.950.140.560
mental processes: F02.463
mesenteric arteries: A07.231.114.565
theca cells: A05.360.319.114.630.535.400, A06.407.312.497.535.600, A11.329.850
epistaxis: C08.460.261, C09.603.261, C23.550.414.712
schools: I02.233.659, I02.783
atrioventricular block: C14.280.067.558.230, C23.550.073.425.062
nadp transhydrogenases: D08.811.682.608.540
meglumine: D02.033.800.813.550, D09.067.342.600, D09.853.813.550
sunlight: G01.358.500.505.650.836, G01.750.250.650.836, G01.750.770.578.836, G16.500.275.063.725.525, G16.500.750.775.525, N06.230.300.100.725.525
cotinine: D03.383.773.812.180
african americans: M01.686.508.100.100, M01.686.754.100
new york city: Z01.107.567.875.350.530.530, Z01.107.567.875.500.530.530, Z01.433.741
middle east: Z01.252.245.500, Z01.586.500
bradycardia: C14.280.067.319, C23.550.073.300
heart conduction system: A07.541.409
withholding treatment: E02.760.952, N02.421.585.952
evoked potentials, somatosensory: G07.265.500.400, G11.561.270.400
dopamine plasma membrane transport proteins: D12.776.157.530.450.625.124, D12.776.157.530.562.374.500.500, D12.776.543.585.450.625.124, D12.776.543.585.562.374.500.500
tropanes: D02.145.074.722, D03.132.889, D03.605.869, D04.075.080.875.099.722
dicofol: D02.455.426.559.389.261.220, D02.455.526.439.202.190
tilapia: B01.050.150.900.493.602.200.800
niacin: D03.066.515.475, D03.383.725.547.475
day care: E02.760.246, N02.421.585.246
disease progression: C23.550.291.656
spectrum analysis: E05.196.867
lacquer: J01.637.597.422
flour: J02.500.484
paranasal sinuses: A04.531.621
mexico: Z01.107.567.589
outpatients: M01.643.630
inpatients: M01.643.470
hypogonadism: C19.391.482
limb buds: A16.567
triethyltin compounds: D02.691.850.900.910
deafness: C09.218.458.341.186, C10.597.751.418.341.186, C23.888.592.763.393.341.186
pilocarpine: D03.132.672
sweat glands: A10.336.899, A17.815.830
tritium: D01.435.719, D01.496.749.925
protein binding: G02.111.087.680, G02.149.115.680, G03.495.800
magnesium chloride: D01.210.450.150.500, D01.524.475
phenolphthalein: D02.455.426.559.389.657.625.555
colorectal neoplasms: C04.588.274.476.411.307, C06.301.371.411.307, C06.405.249.411.307, C06.405.469.158.356, C06.405.469.491.307, C06.405.469.860.180
hymenoptera: B01.050.500.131.617.479
ivermectin: D02.540.505.330
oceania: Z01.678
pest control: N06.850.780.200.650
asia: Z01.252
thyroxine-binding proteins: D12.776.124.885, D12.776.157.785, D12.776.395.832
retinoids: D02.455.326.271.665.202.495, D02.455.426.392.368.367.379.249.700, D02.455.849.131.495, D23.767.261.700
neurotic disorders: F03.650
muscle cramp: C05.651.475, C10.597.613.500, C23.888.592.608.500
occult blood: E01.370.225.925, E05.200.925
neuronal plasticity: G11.561.600.635
inositol: D02.033.800.519, D09.853.519
n-acetylneuraminic acid: D02.241.081.844.562.668.050, D02.241.511.902.562.668.050, D09.067.687.668.030, D09.811.589.668.030
lactate dehydrogenases: D08.811.682.047.551
lymphocytosis: C15.378.553.475.604
knee: A01.378.610.450
synovial membrane: A02.835.583.443.800
lymphocyte subsets: A11.118.637.555.567.550, A15.145.229.637.555.567.550, A15.382.490.555.567.550
dental porcelain: D25.264.377, D25.339.376, J01.637.051.264.377, J01.637.051.339.376
ultrafiltration: E04.292.975, E05.196.454.807, G01.595.280.807, G02.149.767.600.807, G02.842.750.600.807
bacillus subtilis: B03.300.390.400.158.218.725, B03.510.100.100.218.725, B03.510.415.400.158.218.725, B03.510.460.410.158.218.725
amines: D02.092
startle reaction: E01.370.376.550.650.800, E01.370.600.550.650.800, F02.830.702.807, G11.561.600.765.869
epitopes: D23.050.550
copepoda: B01.050.500.131.365.160
molting: G07.700.320.500.550.750
cardiovascular abnormalities: C14.240, C16.131.240
melanosomes: A11.284.430.214.190.500.560, A11.284.430.214.190.875.190.190.560, A11.436.265.531.560, A11.436.613.560
fasciculation: C10.597.613.250, C23.888.592.608.250
stillbirth: G08.686.785.760.769.530.500
archives: K01.400.152, L01.346.208
clubfoot: C05.330.495.150, C05.660.585.512.380.500, C16.131.621.585.380.500
multiple birth offspring: M01.438
labor unions: N03.540.571
in situ hybridization: E01.370.225.500.620.670.325, E01.370.225.750.600.670.325, E05.200.500.620.670.325, E05.200.750.600.670.325, E05.393.661.475
plasmids: G05.360.600
diuron: D02.455.426.559.389.703.397, D02.948.681.397
sulfonylurea compounds: D02.886.590.795, D02.948.828
hypopharyngeal neoplasms: C04.588.443.665.710.485, C07.550.745.436, C09.647.710.485, C09.775.549.485
calcineurin: D08.811.277.352.650.625.150, D12.644.360.087, D12.776.476.087
tacrolimus: D02.540.505.810
renal plasma flow: G08.852.796.700.740, G09.330.190.163.812.740
corpus callosum: A08.186.211.730.885.362
dihydropyridines: D03.383.725.203
cerebrovascular disorders: C10.228.140.300, C14.907.253
advisory committees: N03.706.742.500
arthrodermataceae: B01.300.107.650.080
lip: A01.456.505.631.515, A14.549.336
dermatitis: C17.800.174
torsades de pointes: C14.280.067.845.940.700, C23.550.073.845.940.700
syncope: C10.597.606.358.800.600, C23.888.592.604.359.800.600
ontario: Z01.107.567.176.639
calcitonin: D06.472.699.150, D12.644.400.095, D12.644.548.150, D12.776.641.650.095
hypercalcemia: C18.452.174.451, C18.452.950.340
protein-serine-threonine kinases: D08.811.913.696.620.682.700
telecommunications: L01.178.847
tartrates: D02.241.081.337.864, D02.241.081.844.759, D02.241.511.902.759, D09.811.779
leukemia, lymphocytic, chronic, b-cell: C04.557.337.428.080.125, C15.604.515.560.080.125, C20.683.515.528.080.125
marketing: J01.219.687
neurodegenerative diseases: C10.574
chaetomium: B01.300.107.800.150
slovakia: Z01.542.248.797, Z01.586.250.750
ascomycota: B01.300.107
microbiology: H01.158.273.540
amino acid transport system x-ag: D12.776.157.530.200.249.500, D12.776.543.585.200.249.500
membrane transport proteins: D12.776.157.530, D12.776.543.585
membrane glycoproteins: D12.776.395.550, D12.776.543.550
ganglia: A08.340
cystathionine beta-synthase: D08.811.520.241.300.200
hyperhomocysteinemia: C16.320.565.100.480, C18.452.603.378, C18.452.648.100.480, C18.654.521.500.133.699.418
methylenetetrahydrofolate reductase (nadph2): D08.811.682.662.290, D12.776.331.775
homocysteine: D02.886.030.498, D12.125.166.498
tunica intima: A07.231.330.800, A07.231.700, A10.272.491.355.800
metabolic networks and pathways: G03.495.553
keratinocytes: A11.436.397
benzalkonium compounds: D02.092.877.096.040, D02.675.276.080
thimerosal: D02.691.750.100.347.850
autistic disorder: F03.550.325.125
vaccines: D20.215.894
vaccination: E02.095.465.425.400.530.890, E05.478.550.600.890, N02.421.726.758.310.890, N06.850.780.200.425.900, N06.850.780.680.310.890
developmental disabilities: F03.550.362
gaba antagonists: D27.505.519.625.240.300, D27.505.696.577.240.300
astacoidea: B01.050.500.131.365.190.070
benzodiazepines: D03.438.079.080
hoof and claw: A13.491
neuromuscular junction: A08.800.550.550.550, A08.850.550.550, A11.284.149.165.420.780.550.550
ionophores: D27.505.519.562.374, D27.720.395
guanosine monophosphate: D03.438.759.646.454.525, D13.695.667.454.525, D13.695.827.426.525
cerebellar cortex: A08.186.211.132.810.428.200.212, A08.186.211.865.428.200.212
olivary nucleus: A08.186.211.132.810.406.574, A08.186.211.865.467.500.574
alcoholism: C25.775.100.250, F03.900.100.350
benzocaine: D02.241.223.100.050.500.687, D02.455.426.559.389.127.020.937.687
para-aminobenzoates: D02.241.223.100.050.500, D02.455.426.559.389.127.020.937
eye abnormalities: C11.250, C16.131.384
monocytes: A11.118.637.555.652, A11.148.580, A11.627.624, A11.733.547, A15.145.229.637.555.652, A15.378.316.580, A15.382.490.555.652, A15.382.680.547, A15.382.812.547
maximal midexpiratory flow rate: E01.370.386.700.660.225.510, G09.772.650.300.670
busulfan: D02.033.455.125.125, D02.455.326.146.100.050.500.100, D02.886.645.600.055.050.510.100
complement activation: G12.425.255
pyrazolones: D03.383.129.539.850
dihydroxyphenylalanine: D02.092.311.200, D12.125.072.050.685.400, D12.125.072.050.875.130
adrenal glands: A06.407.071
adrenergic antagonists: D27.505.519.625.050.200, D27.505.696.577.050.200
heme oxygenase-1: D08.811.682.690.708.410.500
subtraction technique: E01.370.350.760
gluconeogenesis: G02.111.087.160.500, G02.149.115.160.500, G03.495.256.500
pyruvate carboxylase: D08.811.464.257.500
tryptophan: D12.125.072.050.850, D12.125.142.875
phosphoenolpyruvate: D02.241.511.701
phosphoenolpyruvate carboxykinase (atp): D08.811.520.224.125.500
islets of langerhans: A03.734.414, A06.407.414
b-lymphocytes: A11.063.438, A11.118.637.555.567.562, A15.145.229.637.555.567.562, A15.382.032.438, A15.382.490.555.567.562
defecation: G10.261.326.210
traction: E04.555.720
color vision defects: C10.597.751.941.256, C11.966.256, C23.888.592.763.941.256
visual acuity: E01.370.380.850.950, F02.463.593.932.901, G14.940
pediatrics: H02.403.670
endometriosis: C13.351.500.163
blastula: A16.331.099
dopaminergic neurons: A08.663.278, A11.671.270
calcitonin receptor-like protein: D12.776.543.750.100.011
adrenomedullin: D06.472.699.077, D12.644.548.017
receptor activity-modifying protein 3: D12.776.476.024.412.300, D12.776.543.725.300
receptor activity-modifying protein 2: D12.776.476.024.412.200, D12.776.543.725.200
water-electrolyte balance: G02.111.635.500, G03.615.500, G07.700.345.810.500
characidae: B01.050.150.900.493.130.150
academies and institutes: N03.540.052
phenyl ethers: D02.355.726, D02.455.426.559.389.657.654
songbirds: B01.050.150.900.248.620.750
passeriformes: B01.050.150.900.248.620
myosins: D05.750.078.730.475, D08.811.277.040.025.193.750, D12.776.210.500.600, D12.776.220.525.475
cyclin g1: D12.644.360.262.200.100, D12.776.167.218.200.100, D12.776.476.262.200.100
cyclins: D12.644.360.262, D12.776.167.218, D12.776.476.262
mice, knockout: B01.050.050.136.500.500, B01.050.150.900.649.865.635.505.500.550.455, B01.050.150.900.649.865.635.505.500.800.500
intercellular signaling peptides and proteins: D12.644.276, D12.776.467, D23.529
cyclin d: D12.644.360.262.150, D12.776.167.218.150, D12.776.476.262.150
diagnostic and statistical manual of mental disorders: L01.453.245.945.200
data collection: E05.318.308, L01.280, N05.715.360.300, N06.850.520.308
noise: G01.750.770.776.567, G16.500.275.600, N06.230.400, N06.850.460.610
diagnostic self evaluation: E01.370.360, F01.752.747.792.220
leptin: D06.472.699.042.500, D12.644.276.024.500, D12.644.548.011.500, D12.776.467.024.500, D23.529.024.500
paraventricular hypothalamic nucleus: A08.186.211.730.317.357.342.400
neurosecretory systems: A06.688, A08.713
peer review: F01.829.316.549, I01.880.604.640, N03.706.700
bursa of fabricius: A10.549.175, A13.163, A15.382.520.604.114
endocrine glands: A06.407
poisson distribution: E05.318.740.994.750, G17.820.750, N05.715.360.750.750.620, N06.850.520.830.994.750
hospitalization: E02.760.400, N02.421.585.400
alligators and crocodiles: B01.050.150.900.833.100
dental materials: D25.339, D27.720.102.339, J01.637.051.339
ribosomes: A11.284.430.214.190.875.811
bufonidae: B01.050.150.900.090.180.210
amphibians: B01.050.150.900.090
methylmalonic acid: D02.241.081.337.540.500
vitamin b 12 deficiency: C18.654.521.500.133.699.923
knee prosthesis: E07.695.400.410
knee joint: A02.835.583.475
autoimmune diseases: C20.111
receptor, platelet-derived growth factor beta: D08.811.913.696.620.682.725.400.900.750, D12.776.543.750.060.625.400, D12.776.543.750.750.400.630.400
platelet-derived growth factor: D12.644.276.910, D12.776.124.625, D12.776.467.910, D23.529.910
coumestrol: D03.438.150.266.450.400.187, D03.438.150.446.350, D03.830.219.266.450.400.187, D03.830.219.446.350
reverse transcription: G02.111.087.847.500, G02.149.115.847.500, G05.355.310.700.500
xeroderma pigmentosum: C04.834.867, C16.131.831.936, C16.320.850.970, C17.800.600.925, C17.800.621.936, C17.800.804.936, C17.800.827.970, C18.452.284.975
common bile duct: A03.159.183.079.300
bone matrix: A10.165.265.166
diaphyses: A02.835.232.169
epiphyses: A02.835.232.251
hydrolases: D08.811.277
cervical vertebrae: A02.835.232.834.151
personal satisfaction: F01.145.677
benzoflavones: D03.438.150.266.450.175, D03.830.219.266.450.175
laboratory chemicals: D27.720.470
microcephaly: C05.660.207.620, C10.500.507.500, C16.131.621.207.620, C16.131.666.507.500
fever: C23.888.119.344
wallerian degeneration: C23.550.737.750
muscle spindles: A08.663.650.915.750.500, A08.800.950.750.500, A10.690.552.500.750, A11.671.650.915.750.500
heart atria: A07.541.358
sorbitol: D02.033.800.813, D09.853.813
osmosis: G01.154.100.600, G01.595.100.600, G02.111.087.640, G02.149.115.640, G02.149.535, G02.149.767.645, G02.685.495, G02.842.700.495, G02.842.750.645
gpi-linked proteins: D12.776.395.550.448, D12.776.543.484.500, D12.776.543.550.418
pneumoencephalography: E01.370.350.578.937.620, E01.370.350.700.560.620, E01.370.350.700.625.620, E01.370.376.537.750.620, E05.629.937.620
retinal diseases: C11.768
salamandridae: B01.050.150.900.090.608.700
rna, messenger, stored: D13.444.735.544.527
staphylococcal protein a: D12.776.097.820, D23.050.161.821
vitelline membrane: A16.690.886
pan troglodytes: B01.050.150.900.649.801.400.112.400.620
dietetics: H02.533.290
polydactyly: C05.660.585.600, C16.131.621.585.600
syndactyly: C05.116.099.370.894.819, C05.660.585.800, C05.660.906.819, C16.131.621.585.800, C16.131.621.906.819
viperidae: B01.050.150.900.833.672.875
potassium chloride: D01.210.450.150.750, D01.745.625
disulfoton: D02.705.400.625.230, D02.705.539.345.230, D02.886.300.692.230
quinine: D03.132.206.719, D03.438.810.762, D03.605.687.762
food preferences: F01.145.407.516
nutritional status: G07.610.650, N01.224.425.525
chorda tympani nerve: A08.800.800.120.250.120
phosphoramides: D01.029.260.700.675.374.425, D01.695.625.675.650.425, D02.705.672
areca: B01.650.940.800.575.100.093.088
herbal medicine: H01.158.273.118.598.500, H01.158.703.060.500, H02.628.190
philippines: Z01.252.145.671, Z01.639.790
phytotherapy: E02.190.755
culicidae: B01.050.500.131.617.289.275
methylphenidate: D02.241.223.601.600, D03.383.621.460
aircraft: J01.937.285.100
radiation protection: N06.850.810.425
oligonucleotides: D13.695.578.424
paraoxon: D02.705.400.650
parathion: D02.705.400.625.600, D02.705.539.345.600, D02.886.300.692.600
muscarinic antagonists: D27.505.519.625.120.200.500, D27.505.696.577.120.200.500
dioxolanes: D03.383.246.238
rna, antisense: D13.150.650, D13.444.600.150.760, D13.444.735.150, D27.720.470.530.600.150.760
organizational innovation: N04.452.610
human growth hormone: D06.472.699.631.525.425.875, D12.644.548.691.525.425.875
deer: B01.050.150.900.649.077.380.373
phytoestrogens: D27.505.696.399.472.277.540.500
estrogen antagonists: D06.347.360.315, D27.505.696.399.450.360.315
isoflavones: D03.438.150.266.450.400, D03.830.219.266.450.400
melatonin: D03.438.473.914.481, D06.472.506
malate dehydrogenase: D08.811.682.047.820.496
isocitrate dehydrogenase: D08.811.682.047.820.475
nadh dehydrogenase: D08.811.682.608.504.500, D12.776.157.427.374.375.863.500, D12.776.331.887, D12.776.556.579.374.375.140.500
ciona intestinalis: B01.050.150.200.727.300, B01.050.500.272.727.300
chordata: B01.050.150
pyridones: D03.383.725.791
receptors, nicotinic: D12.776.157.530.400.400.100.500, D12.776.543.550.425.500.100.500, D12.776.543.585.400.500.100.500, D12.776.543.750.051.687, D12.776.543.750.720.360.550
cholinergic antagonists: D27.505.519.625.120.200, D27.505.696.577.120.200
pit and fissure sealants: D25.339.773, J01.637.051.339.773
saliva: A12.200.666
cyclobutanes: D02.455.426.392.368.201
tetrahydronaphthalenes: D02.455.426.559.847.638.960, D04.615.638.960
body temperature regulation: G07.110.232, G07.700.345.421, G16.100.057.500.535
thermogenesis: G07.110.232.778, G07.700.345.421.778, G16.100.057.500.535.778
terbutaline: D02.033.100.291.905, D02.092.063.291.905
tocolytic agents: D27.505.696.875.825, D27.505.954.705.825
serotonin plasma membrane transport proteins: D12.776.157.530.450.625.311, D12.776.157.530.562.374.875, D12.776.543.585.450.625.374, D12.776.543.585.562.374.875
adenylate cyclase: D08.811.520.650.200, D12.644.360.050, D12.776.476.050
health personnel: M01.526.485, N02.360
ducks: B01.050.150.900.248.050.200, B01.050.150.900.248.617.345
oryza sativa: B01.650.940.800.575.100.822.616, J02.500.200.700
singing: G09.772.770.680.500
conservation of natural resources: J01.256, N06.230.080
nutritive value: G07.610.660, J01.576.423.850.730.750, N06.850.601.750
dna-formamidopyrimidine glycosylase: D08.811.074.249.500, D08.811.277.450.430.099.500
dna glycosylases: D08.811.074.249, D08.811.277.450.430.099
complement c1: D12.776.124.486.274.050
retinoid x receptor alpha: D12.776.260.698.701.500.500, D12.776.826.701.500.500, D12.776.930.669.701.500.500
elastic modulus: G01.374.590.605
parietal lobe: A08.186.211.730.885.287.500.670
aliivibrio fischeri: B03.440.450.900.050.860, B03.660.250.830.050.860
soaps: D27.720.877.265.861, J01.516.872
chlorophyta: B01.650.940.150
anti-bacterial agents: D27.505.954.122.085
anti-mullerian hormone: D06.472.334.984.500
carbanilides: D02.065.199.326, D02.455.426.559.389.703.202, D02.948.681.202
nitrogen dioxide: D01.362.635.600, D01.625.550.525, D01.650.550.587.625
isocitrates: D02.241.081.901.434.498
oviducts: A13.706
alpha-globulins: D12.776.124.790.106, D12.776.377.715.085
glycosylation: G02.111.087.160.812, G02.149.115.160.812, G02.149.465.350, G02.607.750.350, G03.495.256.812
gangliosides: D09.400.410.420.025.475, D10.390.470.025.475, D10.570.877.360.025.475
glucosamine: D09.067.342.531
glycoproteins: D09.400.430, D12.776.395
retinoblastoma protein: D12.776.260.704, D12.776.624.776.745, D12.776.660.807, D12.776.744.770
transcription factor 3: D12.776.260.103.500.875, D12.776.260.108.092.875, D12.776.930.125.500.875, D12.776.930.127.092.875
biotin: D03.383.129.308.080, D08.211.096
heart defects, congenital: C14.240.400, C14.280.400, C16.131.240.400
morphogenesis: G07.700.320.500
smegmamorpha: B01.050.150.900.493.850
endocardium: A07.541.207
epithelial-mesenchymal transition: G04.299.335.500, G07.700.320.500.325.180.781, G08.686.785.760.170.104.812
endocardial cushions: A07.541.459.374, A16.378.303.662
cytochrome p-450 cyp3a: D08.244.453.040.986, D08.811.682.662.582.353, D08.811.682.690.708.170.040.888, D12.776.422.220.453.040.972
1-acylglycerophosphocholine o-acyltransferase: D08.811.913.050.175
acyltransferases: D08.811.913.050
septal nuclei: A08.186.211.464.750.800, A08.186.211.730.885.750.800
panic: F01.470.361.585
government: I01.409, N03.540.348
ireland: Z01.542.467, Z01.639.587
dna methylation: G02.111.087.029.538.161, G02.111.087.218, G02.149.115.029.538.161, G02.149.115.218, G03.495.130.538.161, G05.355.190
methylation: G02.111.087.029.538, G02.149.115.029.538, G02.149.465.040.538, G02.607.750.040.538, G03.495.130.538
sulfites: D01.248.497.158.904, D01.875.750
two-hybrid system techniques: E05.393.220.870, E05.393.525.870, E05.601.690.650
fluorescence polarization: E05.196.712.516.600.390
mineral waters: D01.455.900.600, D01.650.550.925.600
carbonated beverages: J02.200.300
nitrites: D01.248.497.158.635, D01.625.600.600, D02.633
losartan: D02.455.426.559.389.185.475, D03.383.129.308.507, D03.383.129.617.467
captopril: D12.125.072.401.623.270
retinoid x receptors: D12.776.260.698.701.500, D12.776.826.701.500, D12.776.930.669.701.500
receptors, retinoic acid: D12.776.260.698.701, D12.776.826.701, D12.776.930.669.701
tretinoin: D02.455.326.271.665.202.495.818.500, D02.455.426.392.368.367.379.249.700.860.500, D02.455.849.131.495.818.800, D23.767.261.700.780
choriocarcinoma: C04.557.465.955.207, C04.557.465.955.416.202, C04.557.470.200.025.455, C04.850.908.416.186, C13.703.720.949.416.218
philadelphia chromosome: A11.284.187.520.300.325.345.500, A11.284.187.520.300.505.515.500, C23.550.210.870.680, G05.360.162.520.300.325.345.700, G05.360.162.520.300.505.515.700, G05.365.590.175.870.680
transforming growth factor beta2: D12.644.276.374.687.200, D12.644.276.954.800.720.200, D12.644.276.963.720.200, D12.776.467.374.687.200, D12.776.467.942.800.720.200, D12.776.467.960.720.200, D23.529.374.687.200, D23.529.942.800.720.200, D23.529.960.720.200
endometrial neoplasms: C04.588.945.418.948.585, C13.351.500.852.762.200, C13.351.937.418.875.200
microarray analysis: E05.196.630.570, E05.588.570
genetic fitness: G05.347
courtship: F01.145.802.279
protein kinase c-delta: D08.811.913.696.620.682.700.725.400
recycling: J01.256.675, N06.850.780.200.800.800.525, N06.850.860.510.244
vehicle emissions: D20.832
receptors, progesterone: D12.776.260.698.750.765, D12.776.826.750.765, D12.776.930.669.750.765
north carolina: Z01.107.567.875.075.475, Z01.107.567.875.750.530
emulsions: D20.280.260, D26.255.165.260
social security: N03.219.521.346.506.849, N03.219.521.576.823
lipoproteins: D10.532, D12.776.521
personality disorders: F03.675
students: I02.233.748, I02.851, M01.848
prostaglandins a: D10.251.355.255.100.637.100, D10.251.355.255.550.100, D23.469.050.175.725.740
vasoactive intestinal peptide: D06.472.317.950, D06.472.699.952, D12.644.400.875, D12.644.548.952, D12.776.641.650.875
myenteric plexus: A08.800.050.050.500, A08.800.050.150.500, A08.800.800.060.500
submucous plexus: A08.800.050.050.850, A08.800.050.150.750, A08.800.800.060.840
neuropeptide y: D12.644.400.500, D12.776.641.650.500
isoflurophate: D02.705.429.750.249
fenthion: D02.705.400.625.320, D02.705.539.345.320, D02.886.300.692.320
hypothermia: C23.888.119.565
miosis: C10.597.690.362, C11.710.528, C23.888.592.708.362
ussr: Z01.586.950
tryptases: D08.811.277.656.300.760.902, D08.811.277.656.959.350.902
nasal lavage fluid: E05.927.573.500
basophils: A11.118.637.415.120, A11.627.340.120, A15.145.229.637.415.120, A15.382.490.315.120
dental technicians: M01.526.485.067.105.503, N02.360.067.105.503
genetic markers: D23.101.387, G05.695.450
hla-dq beta-chains: D12.776.395.550.509.400.430.750, D12.776.543.550.423.400.430.750, D23.050.301.500.400.400.430.750, D23.050.301.500.450.400.430.750, D23.050.705.552.410.400.430.750, D23.050.705.552.450.400.430.750
histocompatibility antigens class ii: D12.776.395.550.509, D12.776.543.550.423, D23.050.301.500.400, D23.050.705.552.410
histocompatibility antigens class i: D12.776.395.550.489, D12.776.543.550.421, D23.050.301.500.100, D23.050.705.552.100
metformin: D02.078.370.141.450
1-propanol: D02.033.755.600
1-butanol: D02.033.415.110.175, D10.289.110.175
eicosapentaenoic acid: D10.212.302.380.410.385, D10.251.355.255.200, D10.251.355.337.290, D10.627.430.450.390
fatty acids, omega-3: D10.212.302.380.410, D10.251.355.337, D10.627.430.450
fish oils: D10.627.430
hematoxylin: D03.438.150.600, D03.830.219.600
periodic acid: D01.029.260.675, D01.475.705
alkaloids: D03.132
quinolizines: D03.438.834
azocines: D03.383.113
pyrrolidines: D03.383.773
ditiocarb: D02.241.081.251.869.220, D02.886.706.200
biotechnology: H01.158.550, J01.897.120
polychaeta: B01.050.500.091.700
interphase: G04.299.134.500
quality control: J01.897.608
crowns: E06.323.428.100, E06.323.528.250, E06.780.345.250, E06.780.345.737.100, E07.695.190.190.150
heel: A01.378.610.250.510
hydrocarbons, chlorinated: D02.455.526.439
karyotyping: E01.370.225.500.385.315, E05.200.500.385.315, E05.242.385.315, E05.393.285.475
heterozygote: G05.380.383
dolphins: B01.050.150.900.649.189.267
cell communication: G04.299.122
sodium selenite: D01.810.900.500, D01.857.850
charybdotoxin: D12.644.115, D20.888.065.830.150, D23.946.833.065.830.150
apamin: D20.888.065.115.060, D23.946.833.065.115.060
biological factors: D23
dental pulp cavity: A14.549.167.900.265
root canal filling materials: D25.339.859, J01.637.051.339.859
bismuth: D01.268.556.100, D01.552.544.100
shorthand: L01.143.506.423.906.539.750
health services needs and demand: N03.349.380.420, N05.300.450
sodium hydroxide: D01.045.250.750, D01.455.824, D01.857.745
nebraska: Z01.107.567.875.510.520
ribose: D09.546.627.651
carboxylic acids: D02.241
cholecystokinin: D06.472.317.152, D12.644.120, D12.644.400.105, D12.776.641.650.105
acinar cells: A11.031
executive function: F02.463.217
sleep initiation and maintenance disorders: C10.886.425.800.800, F03.870.400.800.800
educational status: N01.824.196
amnesia: C10.597.606.525.100, C23.888.592.604.529.100, F01.700.625.100, F03.087.200
anemia, aplastic: C15.378.071.085, C15.378.190.196
interleukin-1alpha: D12.644.276.374.465.501.300, D12.644.276.374.500.400.300, D12.776.467.374.465.501.300, D12.776.467.374.500.400.300, D23.529.374.465.501.300, D23.529.374.500.400.300
isoelectric point: E05.301.300.663.500, G02.300.500
orchitis: C12.294.829.493, C19.391.829.493
humidity: G16.500.275.063.725.310, G16.500.750.775.310, N06.230.150.372, N06.230.300.100.725.310
pyroglyphidae: B01.050.500.131.166.132.419.600
third ventricle: A08.186.211.276.840
malaysia: Z01.252.145.487
academic medical centers: N02.278.020
spherocytes: A11.118.290.330.802, A11.443.240.330.802, A15.145.229.334.330.802
georgia: Z01.107.567.875.075.250, Z01.107.567.875.750.370
single-blind method: E05.318.780.850, N05.715.360.780.730, N06.850.520.445.850
phenanthrolines: D03.494.669
phenanthrenes: D02.455.426.559.847.723, D04.615.723
xanthenes: D03.494.953
diathermy: E02.565.280, E02.779.496.280
muscle tonus: G11.427.565
los angeles: Z01.107.567.875.580.200.450, Z01.107.567.875.760.200.450, Z01.433.565
hla-dr antigens: D12.776.395.550.509.400.440, D12.776.543.550.423.400.440, D23.050.301.500.400.400.440, D23.050.301.500.450.400.440, D23.050.705.552.410.400.440, D23.050.705.552.450.400.440
sodium nitrite: D01.625.600.600.800, D01.857.775
guanfacine: D02.078.370.465, D02.241.223.601.329
skin abnormalities: C16.131.831, C17.800.804
proadifen: D02.241.081.944.550
pineal gland: A06.407.635, A06.688.733, A08.186.211.730.317.200.620, A08.713.733
bedding and linens: E07.325.137, J01.494.221
marriage: F01.829.263.315.500.500, I01.240.361.500.500, I01.880.225.423.500.500, N01.224.361.500.500, N01.824.308.500.500
cheese: J02.500.350.200
raphanus: B01.650.940.800.575.100.157.711
internship and residency: I02.358.399.644
utah: Z01.107.567.875.760.800
missouri: Z01.107.567.875.510.515
conflict (psychology): F01.658.209
aeromonas hydrophila: B03.440.450.019.025.380, B03.660.250.017.025.380
gram-negative bacterial infections: C01.252.400
ventricular septum: A07.541.459.750
morphine: D03.132.577.249.562.571, D03.549.686.607.587, D03.605.497.607.587, D04.615.723.795.576.571
injections: E02.319.267.530
otters: B01.050.150.900.649.147.550.600
nova scotia: Z01.107.567.176.589
mink: B01.050.150.900.649.147.550.500
amides: D02.065
cardiac complexes, premature: C14.280.067.325, C23.550.073.325
ppar gamma: D12.776.260.698.239.588, D12.776.826.239.588, D12.776.930.669.239.588
expressed sequence tags: G05.360.340.024.340.137.275
aging: G07.700.320.124
west virginia: Z01.107.567.875.075.900, Z01.107.567.875.750.900
world war ii: K01.400.504.968.901
microvessels: A07.231.461
apigenin: D03.438.150.266.450.260.110, D03.830.219.266.450.260.110
sulfotransferases: D08.811.913.817.400
cocarcinogenesis: C04.697.098.875, C23.550.727.098.750
fertility agents: D27.505.696.875.552, D27.505.954.705.552
luminescence: G01.358.500.505.650.665, G01.590.540.665, G01.750.250.650.665, G01.750.770.578.665
nitrobenzenes: D02.455.426.559.389.565, D02.640.529
calcium carbonate: D01.146.275, D01.200.275.150.150, D01.578.200
hardness: G01.374.647
aviation: J01.937.285
risk-taking: F01.145.722
listeria monocytogenes: B03.510.100.500.500, B03.510.460.400.410.485.500
cathepsin l: D08.811.277.656.224.407, D08.811.277.656.262.500.157, D08.811.277.656.300.200.157
acute-phase reaction: C23.550.470.099
acute-phase proteins: D12.776.124.050
higher nervous activity: F02.463.247, G11.561.600.370
rotation: G01.595.560.703
methyltransferases: D08.811.913.555.500
prealbumin: D12.776.034.841.450, D12.776.124.727.450
industrial oils: J01.637.450
united states public health service: I01.409.137.500.600.650, N03.540.348.500.500.600.650
dicarboxylic acids: D02.241.081.337
bile acids and salts: D04.808.105
financial management: N03.219.463
digitalis: B01.650.940.800.575.100.892.333
digitalis glycosides: D04.808.155.580.130.500, D09.408.180.261
parasites: B01.050.500.714
animals, domestic: B01.050.050.116
ascites: C23.550.081
extracellular fluid: A11.284.295.260, A12.207.270
poultry diseases: C22.131.728
blood volume: G09.188.130, G09.330.380.092
tumor burden: E05.041.124.892
sample size: E05.318.780.762, E05.581.500.902, N05.715.360.780.692, N06.850.520.445.762
point mutation: G05.365.590.675
retinoblastoma: C04.557.465.625.600.725, C04.557.470.670.725, C04.557.580.625.600.725, C04.588.364.818.760, C11.319.475.760, C11.768.717.760
tumor suppressor protein p53: D12.776.260.820, D12.776.624.776.775, D12.776.660.825, D12.776.744.845
alopecia: C17.800.329.937.122, C23.300.035
estriol: D04.808.365.415.331, D06.472.334.851.437.750
mental health: F02.418, N01.400.500
myalgia: C05.651.542, C10.597.617.231.249, C10.668.491.525, F02.830.816.353.500, G11.561.600.810.353.500
intradermal tests: E01.370.225.812.871.300, E05.200.812.871.300, E05.478.594.890.300
anophthalmos: C11.250.080, C16.131.384.159
microphthalmos: C11.250.566, C16.131.384.666
maltose: D09.698.365.450, D09.698.629.305.523
psychoacoustics: E01.370.382.375.060.530, E01.370.685.628, F04.096.753.628, F04.732.628
postal service: I01.451.617
audiometry: E01.370.382.375.060
finasteride: D04.808.054.079.500, D04.808.925.100.250
trenbolone acetate: D04.808.365.415.930
child development: F01.525.200, G07.700.320.374.750
checklist: N05.715.360.300.179
mexican americans: M01.686.754.441.500
child behavior: F01.145.179
neocortex: A08.186.211.730.885.287.500.420
railroads: J01.937.690
dichlorvos: D02.705.400.130
diphtheria-tetanus-acellular pertussis vaccines: D20.215.894.135.290, D20.215.894.135.535.295, D20.215.894.691.263.290, D20.215.894.691.824.290, D20.215.894.815.149, D20.215.894.860.900.267
diphtheria: C01.252.410.040.246.388
tetanus: C01.252.410.222.864
whooping cough: C01.252.400.143.740, C01.539.739.969, C08.730.969
speech disorders: C10.597.606.150.500.800, C23.888.592.604.150.500.800
inhibition (psychology): F01.145.544, F02.463.425.475, F02.739.794.405
household products: J01.516
weapons: J01.637.870
nanostructures: J01.637.512
nanotubes: J01.637.512.850
language development disorders: C10.597.606.150.500.550, C23.888.592.604.150.500.550
tics: C10.597.350.700, C23.888.592.350.700
amphotericin b: D02.540.505.050
osteopontin: D12.644.276.374.625, D12.776.395.700.837, D12.776.467.374.625, D12.776.860.300.762, D23.529.374.625
insulin-like growth factor binding protein 1: D12.776.157.420.250
puromycin: D02.241.223.200.380, D03.438.759.590.138.711, D09.408.051.788, D13.570.583.138.711
transcriptome: G02.111.087.847.750, G02.149.115.847.750, G05.355.310.700.750, G05.360.920
support vector machines: L01.224.050.500, L01.224.065.815, L01.725.750
12-hydroxy-5,8,10,14-eicosatetraenoic acid: D10.251.355.096.450.425, D10.251.355.255.100.300.425
membrane fluidity: G01.154.500, G02.111.550, G04.570
phospholipases a2: D08.811.277.352.100.680.750.937
chromogranin a: D12.776.641.199.249
endocrine cells: A11.382
contraception: E02.875.194
biomphalaria: B01.050.500.644.400.750.185
apoptosis regulatory proteins: D12.644.360.075, D12.776.476.075
critical pathways: N04.590.233.624.625, N04.590.275
vesicular acetylcholine transport proteins: D12.776.157.530.450.162.887.500.249, D12.776.157.530.562.750.500.249, D12.776.543.585.450.162.887.500.249, D12.776.543.585.562.750.500.249
toxicogenetics: H01.158.273.343.750.850, H01.158.703.052.850, H01.158.703.795.850, H02.628.479.850, H02.628.795.850
gene regulatory networks: G05.360.080.689.360
quantum dots: E07.705, J01.637.512.600.650
proteolysis: G02.111.087.710, G02.149.115.710, G03.495.802
chimera: B01.050.050.530, B01.650.085, B05.200
green fluorescent proteins: D12.776.532.265
luminescent proteins: D12.776.532
floors and floorcoverings: J01.086.339.140
endangered species: B01.050.050.565, G16.500.275.157.049.250, J01.256.214, N06.230.080.200, N06.230.124.049.250
thyronines: D06.472.931.740, D12.125.072.050.767.741
dietary carbohydrates: D09.301, J02.500.362
myosin heavy chains: D05.750.078.730.475.100, D08.811.277.040.025.193.750.249, D12.776.210.500.600.100, D12.776.220.525.475.100
ventricular function, left: G09.330.190.962.800
polysaccharides: D09.698
medline: L01.470.750.500.650.500, L01.700.508.280.710.500, L01.700.508.280.750.500, L01.700.508.300.188.300.650.500, L01.700.508.300.710.500, L01.700.508.300.742.650.500
fermentation: G02.111.087.160.249, G02.149.115.160.249, G03.495.256.249
galactosamine: D09.067.342.356
trypsin inhibitors: D27.505.519.389.745.800.900
strontium: D01.268.552.850, D01.268.556.825, D01.552.539.861, D01.552.544.825
cell membrane permeability: G03.495.166.335, G04.175
reticular formation: A08.186.211.132.772
hymecromone: D03.438.150.446.912.531, D03.830.219.446.912.531
nitrophenols: D02.455.426.559.389.657.566, D02.640.743
lipoprotein lipase: D08.811.277.352.100.430
inhalant abuse: C25.775.467, F03.900.467
narcotics: D27.505.696.277.600, D27.505.696.663.850.014.760, D27.505.954.427.040.550, D27.505.954.427.210.600
palmitic acids: D10.251.694
physical therapists: M01.526.485.067.739, N02.360.067.735
embryo transfer: E02.875.800.500, E05.820.800.500
mercury compounds: D01.538
acridines: D03.494.046
chemokines: D12.644.276.374.200, D12.776.467.374.200, D23.125.300, D23.469.200, D23.529.374.200
snacks: F01.145.407.432.500.775, F01.145.466.349.500.775, J02.500.590.780
silicone elastomers: D05.750.900.850.900, D25.720.327.900, D25.720.900.850.900, J01.637.051.720.327.900, J01.637.051.720.900.850.900, J01.637.412.900
y chromosome: A11.284.187.865.983, G05.360.162.865.983
bowman capsule: A05.810.453.736.560.254
austria: Z01.542.088
arylsulfotransferase: D08.811.913.817.400.300
western australia: Z01.338.800
erythrocyte deformability: G09.188.370.249
osmotic fragility: E01.370.225.625.550, E05.200.625.550, G09.188.640
recurrence: C23.550.291.937
ethiopia: Z01.058.290.120.310
hiv infections: C02.782.815.616.400, C02.800.801.400, C20.673.480
dactinomycin: D03.494.200, D04.345.566.252, D12.644.641.252
protein synthesis inhibitors: D27.505.519.389.760
copulation: F01.145.113.252.748.200
fluorescent dyes: D27.720.233.348, D27.720.470.330.348, D27.720.470.410.505.500
adherens junctions: A11.284.149.165.420.020
gingiva: A14.549.167.646.480
cysteine proteases: D08.811.277.656.262
peptide hydrolases: D08.811.277.656
endopeptidases: D08.811.277.656.300
metalloproteases: D08.811.277.656.675
dentin: A14.549.167.900.280
muscle spasticity: C05.651.512, C10.597.613.550.550, C23.888.592.608.550.550
basilar membrane: A09.246.631.246.125, A10.615.179.124
genetic structures: G05.360
local lymph node assay: E01.370.225.812.871.450, E05.200.812.871.450, E05.478.594.890.450
documentation: L01.453.245
kidney tubules, proximal: A05.810.453.736.560.570
amino acid chloromethyl ketones: D12.125.065
acetophenones: D02.522.120
benzopyrans: D03.438.150, D03.830.219
population dynamics: I01.240.600, N01.224.625, N06.850.505.400.700
delirium, dementia, amnestic, cognitive disorders: F03.087
firefighters: M01.526.373.400
fires: N06.230.216
pregnancy complications: C13.703
chemokine ccl4: D12.644.276.374.200.110.200, D12.644.276.374.200.600.200, D12.776.467.374.200.110.200, D12.776.467.374.200.600.200, D23.125.300.110.200, D23.125.300.600.750, D23.469.200.110.200, D23.529.374.200.110.200, D23.529.374.200.600.200
interleukin-13: D12.644.276.374.465.513, D12.776.467.374.465.513, D23.529.374.465.513
chemokine ccl5: D12.644.276.374.200.110.250, D12.776.467.374.200.110.250, D23.125.300.110.250, D23.469.200.110.250, D23.529.374.200.110.250
interleukin-12 subunit p40: D12.644.276.374.465.512.500, D12.644.276.374.465.759.249, D12.776.467.374.465.512.500, D12.776.467.374.465.759.249, D23.529.374.465.512.500, D23.529.374.465.550.249
coxsackievirus infections: C02.782.687.359.213
vitellins: D12.776.290.812
methoprene: D06.472.445.573.666.500
chloralose: D02.033.455.250.130.150, D09.408.348.150
t-2 toxin: D02.455.849.765.850.870, D04.345.891.870, D23.946.587.933.870
microalgae: B05.080.500.600.500
brachyura: B01.050.500.131.365.190.110
chlorella: B01.650.940.150.469
paraphimosis: C12.294.494.684.587
perinatal mortality: E05.318.308.985.550.700, L01.280.975.550.700, N01.224.935.698.739, N06.850.505.400.975.550.700, N06.850.520.308.985.550.700
pyelonephritis: C12.777.419.570.643.790, C12.777.419.570.821.717, C13.351.968.419.570.643.790, C13.351.968.419.570.821.717
crepis: B01.650.940.800.575.100.100.255
diquat: D03.383.725.762.352
plant cells: A11.750
spindle apparatus: A11.284.430.214.190.750.820
dermatophagoides pteronyssinus: B01.050.500.131.166.132.419.600.215
mites: B01.050.500.131.166.132.419
arthropod proteins: D12.776.092
cysteine endopeptidases: D08.811.277.656.262.500, D08.811.277.656.300.200
serine: D12.125.154.800, D12.125.837
hsp27 heat-shock proteins: D12.776.580.216.270.625
hydroxy acids: D02.241.511
receptors, thyroid hormone: D12.776.260.698.850, D12.776.624.664.700.830, D12.776.826.850, D12.776.930.669.850
thyroid hormone receptors beta: D12.776.260.698.850.750, D12.776.624.664.700.830.750, D12.776.826.850.750, D12.776.930.669.850.750
thyroid hormone receptors alpha: D12.776.260.698.850.500, D12.776.624.664.700.830.500, D12.776.826.850.500, D12.776.930.669.850.500
breast feeding: F01.145.407.199, G07.610.220.500.500, G07.610.593.185, G07.700.620.185
brazil: Z01.107.757.176
urbanization: I01.880.526.726
language: F01.145.209.399, L01.143.506
umbilical cord: A16.378.693
lighting: N06.230.150.410
impulsive behavior: F01.145.527
polydipsia: C23.550.759, C23.888.663
turtles: B01.050.150.900.833.848
oncorhynchus kisutch: B01.050.150.900.493.817.750.705.580.410
salmonidae: B01.050.150.900.493.817.750
emigration and immigration: I01.240.600.525.500, N01.224.625.525.500, N06.850.505.400.700.525.500
hyperphosphatemia: C18.452.750.199
nf-kappa b: D12.776.260.600, D12.776.660.600, D12.776.930.600
mycophenolic acid: D02.241.081.193.678, D10.251.618
pelvic inflammatory disease: C01.539.635.500, C13.351.500.056.750
baltimore: Z01.107.567.875.500.500.100, Z01.433.100
uterine neoplasms: C04.588.945.418.948, C13.351.500.852.762, C13.351.937.418.875
intrauterine devices: E07.190.250.520
color perception tests: E01.370.380.850.150
cyproterone acetate: D04.808.745.432.219.150, D04.808.883.419.150
ketoconazole: D03.383.606.560
gastroscopy: E01.370.372.250.250.325, E01.370.388.250.250.250.320, E04.210.240.250.320, E04.800.250.250.250.320
water resources: G01.311.910
viper venoms: D20.888.850.960, D23.946.833.850.960
venous pressure: G09.330.380.076.732
gap-43 protein: D12.776.395.550.400, D12.776.543.550.400, D12.776.641.400
growth cones: A08.663.300, A11.284.180.075.249, A11.284.180.225.340, A11.284.180.610.345, A11.671.137.340, A11.671.240.340, A11.671.300
receptor, angiotensin, type 2: D12.776.543.750.100.047.687, D12.776.543.750.720.600.150.687, D12.776.543.750.750.130.875, D12.776.543.750.750.555.150.875
neprilysin: D08.811.277.656.300.480.600, D08.811.277.656.675.374.600, D23.050.285.550, D23.050.301.264.035.550, D23.101.100.110.550, D23.101.840.500
receptor, angiotensin, type 1: D12.776.543.750.100.047.625, D12.776.543.750.720.600.150.625, D12.776.543.750.750.130.750, D12.776.543.750.750.555.150.750
diclofenac: D02.241.223.601.210
intercellular adhesion molecule-1: D12.776.395.550.200.450, D12.776.543.550.200.450, D23.050.301.264.035.400, D23.050.301.350.450, D23.101.100.110.400
thioinosine: D02.886.759.800, D03.438.759.590.616.900, D13.570.583.616.900, D13.570.800.573.900, D13.570.900.800
semen preservation: E02.792.833.890, E05.760.833.890
sperm-ovum interactions: G08.686.785.760.277.800
colony-forming units assay: E01.370.225.500.383, E05.200.500.383, E05.242.383
raptors: B01.050.150.900.248.815
hawks: B01.050.150.900.248.250.400, B01.050.150.900.248.815.350.400
sphingosine: D02.033.100.700, D02.033.455.843, D02.092.063.700
duodenitis: C06.405.205.462.249, C06.405.469.275.600, C06.405.469.326.750
molasses: J02.500.662
south africa: Z01.058.290.175.735
animal feed: J02.500.300.100
liver extracts: D20.777.351
phosphorylcholine: D02.092.877.883.333.700, D02.675.276.232.700
heptanoic acids: D10.251.450
hydrophobic and hydrophilic interactions: G02.842.312
rest: I03.450.769.647
salmo salar: B01.050.150.900.493.817.750.705.790
nuclear microscopy: E01.370.350.515.744, E05.595.744
sick building syndrome: C20.543.312.750, C21.223.750
angiotensin ii type 1 receptor blockers: D27.505.519.162.500
tetrahydroisoquinolines: D03.438.531.820
spironolactone: D02.540.679, D04.808.745.745.855
sulfadimethoxine: D02.065.884.725.760, D02.092.146.807.760, D02.886.590.700.725.760
cypriniformes: B01.050.150.900.493.200
electronic waste: N06.850.460.710.189
trimetrexate: D03.438.786.925
pubmed: L01.470.750.500.650, L01.700.508.280.750, L01.700.508.300.188.300.650, L01.700.508.300.742.650
transforming growth factor beta1: D12.644.276.374.687.100, D12.644.276.954.800.720.100, D12.644.276.963.720.100, D12.776.467.374.687.100, D12.776.467.942.800.720.100, D12.776.467.960.720.100, D23.529.374.687.100, D23.529.942.800.720.100, D23.529.960.720.100
peritoneum: A01.923.047.025.600, A10.615.789.596
transforming growth factor beta: D12.644.276.374.687, D12.644.276.954.800.720, D12.644.276.963.720, D12.776.467.374.687, D12.776.467.942.800.720, D12.776.467.960.720, D23.529.374.687, D23.529.942.800.720, D23.529.960.720
peritoneal fibrosis: C06.844.610, C23.550.355.625
cell transdifferentiation: G04.299.335
matrix metalloproteinases: D08.811.277.656.300.480.525, D08.811.277.656.675.374.525
granulocyte colony-stimulating factor: D12.644.276.374.410.240.350, D12.776.395.240.200, D12.776.467.374.410.240.350, D23.529.374.410.240.350
fibroblast growth factor 2: D12.644.276.624.120, D12.776.467.624.120, D23.529.624.120
principal component analysis: E05.318.740.562
virulence: G06.930
ppar alpha: D12.776.260.698.239.500, D12.776.826.239.500, D12.776.930.669.239.500
peroxisome proliferator-activated receptors: D12.776.260.698.239, D12.776.826.239, D12.776.930.669.239
bile ducts: A03.159.183
dermatology: H02.403.225
tryptamines: D02.092.211.215.801, D03.438.473.914
arsenites: D01.075.050, D01.248.497.158.055, D02.691.088.047
kentucky: Z01.107.567.875.075.400, Z01.107.567.875.510.400
aromatase inhibitors: D27.505.519.389.099
hand disinfection: N06.850.780.200.412.500
cholestenone 5 alpha-reductase: D08.811.682.660.200
3-oxo-5-alpha-steroid 4-dehydrogenase: D08.811.682.660.465
azoxymethane: D02.172.080
aberrant crypt foci: C04.834.020
atrial fibrillation: C14.280.067.198, C23.550.073.198
complement c3: D12.776.124.050.140, D12.776.124.486.274.250
autoreceptors: D12.776.543.750.050, D12.776.543.750.720.670.100
receptor, muscarinic m2: D12.776.543.750.100.475.200, D12.776.543.750.720.360.500.200
snails: B01.050.500.644.400.750
ecdysterone: D04.808.247.222.265.165.750, D06.472.445.573.271.750
sesquiterpenes: D02.455.849.765
myocytes, smooth muscle: A11.620.520
embolectomy: E04.100.814.445
caspase 2: D08.811.277.656.262.500.126.550.200, D08.811.277.656.300.200.126.550.200, D12.644.360.075.405.550.200, D12.776.476.075.405.550.200
retinal neovascularization: C11.768.725, C23.550.589.500.725
retinal pigment epithelium: A09.371.670.500, A09.371.729.887
p-glycoprotein: D12.776.157.530.100.652.500, D12.776.157.530.450.074.500.500.750, D12.776.395.550.020.610.610, D12.776.543.550.192.610.610, D12.776.543.585.100.610.500, D12.776.543.585.450.074.500.500.750
p-glycoproteins: D12.776.157.530.100.652, D12.776.157.530.450.074.500.500.875, D12.776.395.550.020.610, D12.776.543.550.192.610, D12.776.543.585.100.610, D12.776.543.585.450.074.500.500.875
cyclosporine: D04.345.566.235.300, D12.644.641.235.300
drug resistance, multiple: G07.690.320.300
synaptophysin: D12.776.543.488.875, D12.776.543.990.840, D12.776.641.800, D23.101.840.800
chemoprevention: E02.319.162
thyroid neoplasms: C04.588.322.894, C04.588.443.915, C19.344.894, C19.874.788
weather: G16.500.275.063.725, G16.500.750.775, N06.230.300.100.725
ketanserin: D03.383.621.365, D03.438.786.830.333
cacao: B01.650.940.800.575.100.915.144
anhedonia: C10.597.606.057, C23.888.592.604.039, F01.700.039
silage: J02.500.300.100.800
poaceae: B01.650.940.800.575.100.822
workers' compensation: N03.219.521.346.866, N03.219.521.576.300.900
muscle development: G07.700.320.500.325.377.625.590, G11.427.590.560.590
developing countries: I01.615.500.300
elbow: A01.378.800.420
fluorescein-5-isothiocyanate: D02.455.426.559.847.885.347.400, D02.500.375.250, D02.886.250.250, D03.494.953.275.400, D04.615.885.347.400
laser scanning cytometry: E01.370.225.500.386.400.500, E01.370.350.515.395.500, E05.196.712.516.600.240.400.500, E05.200.500.386.400.500, E05.242.386.400.500, E05.595.395.500
water purification: N06.850.780.200.800.800.900.900, N06.850.860.510.900.900
growth plate: A02.835.232.251.352
ilium: A02.835.232.043.825.434
osteonecrosis: C05.116.852, C23.550.717.732
propiophenones: D02.522.818
helminths: B01.050.500.500
nematoda: B01.050.500.500.294
disorders of sex development: C12.706.316, C13.351.875.253, C16.131.939.316, C19.391.119, F03.800.399
polymyxin b: D04.345.566.780.750, D10.477.750.750, D12.644.050.600.750, D12.644.641.780.750, D12.776.543.695.054.600.750
neomycin: D09.408.051.623
c-reactive protein: D12.776.034.145, D12.776.124.050.120, D12.776.124.486.157
endotoxemia: C01.539.757.100.275, C01.539.861.375, C23.550.470.790.500.100.275
pancreas: A03.734
singlet oxygen: D01.339.431.500
reducing agents: D27.720.470.410.690
gamma-cyclodextrins: D04.345.103.444, D09.698.365.855.400.375.444
sonication: E05.848
spin trapping: E05.196.885
pyrroles: D03.383.129.578
solutions: D26.776
interleukin-4: D12.644.276.374.465.504, D12.776.467.374.465.504, D23.529.374.465.504
cyclin b2: D12.644.360.262.120.200, D12.776.167.218.120.200, D12.776.476.262.120.200
myeloid cell leukemia sequence 1 protein: D12.644.360.075.718.984, D12.776.476.075.718.968, D12.776.624.664.700.169.500
sweat: A12.200.849
hl-60 cells: A11.251.210.190.465, A11.251.860.180.465, A11.627.340.360.500
sequence deletion: G05.355.600.800, G05.365.590.762
crows: B01.050.150.900.248.620.750.150
trail making test: F04.711.513.838
flavoring agents: D27.720.364, J02.500.512.400
bronchiolitis obliterans: C08.127.446.135.140, C08.381.495.146.135.140
leishmania major: B01.268.475.868.488.405
apolipoprotein a-i: D10.532.091.200.100, D12.776.070.400.200.100, D12.776.521.120.200.100
florida: Z01.107.567.875.750.350
ppar-beta: D12.776.260.698.239.530, D12.776.826.239.530, D12.776.930.669.239.530
primary cell culture: E01.370.225.500.223.500, E05.200.500.223.500, E05.240.249.500, E05.242.223.500
iodide peroxidase: D08.811.682.732.525
thyroglobulin: D12.776.377.856, D12.776.395.768, D12.776.486.706
neurochemistry: H01.158.201.687, H01.158.610.110, H01.181.122.709
embryonal carcinoma stem cells: A11.251.860.590, A11.872.190.500, A11.872.650.500
calcium signaling: G02.111.087.800.800.100, G02.149.115.800.800.100, G03.495.166.500.100, G04.299.880.800.100
tension-type headache: C10.228.140.546.399.875
nocebo effect: N05.715.350.350.625.500, N06.850.490.734.875.500
semantics: L01.143.506.598.745
gestures: F01.145.209.530.538.445
gentian violet: D02.092.146.400
cell movement: G04.299.283, G07.700.560.500.180
water pollutants, chemical: D27.888.284.903.655
adsorption: G02.149.047, G02.149.767.029, G02.842.750.029
cues: F02.463.425.234
lens diseases: C11.510
schistosomiasis: C03.335.865.859
succimer: D02.241.081.337.759.500, D02.886.489.750
introduced species: B01.050.050.580, G16.500.275.157.049.400, N06.230.124.049.400
pleura: A04.716, A10.615.789.736
embolism: C14.907.355.350
incubators: E07.461
midwifery: H02.478.676.416
plankton: B05.080.500
annelida: B01.050.500.091
mustard plant: B01.650.940.800.575.100.157.200.500, J02.500.300.100.575, J02.500.850.537
brassica: B01.650.940.800.575.100.157.200, J02.500.850.150
vapor pressure: G01.374.715.951
sinapis: B01.650.940.800.575.100.157.811
trifolium: B01.650.940.800.575.100.401.906
fossil fuels: D20.345, N06.230.132.258
power plants: E07.305.437, J01.780
environmental health: H02.229
nuclear envelope: A11.284.149.165.630, A11.284.149.450.700, A11.284.430.106.279.692, A11.284.835.514.700
affective symptoms: F01.145.126.100
poliomyelitis: C02.182.600.700, C02.182.700, C02.782.687.359.764, C10.228.228.210.575.750, C10.228.228.210.650, C10.228.228.618.850, C10.228.854.525.850, C10.228.854.641, C10.668.864
child development disorders, pervasive: F03.550.325
methimazole: D02.886.489.600, D03.383.129.308.535
adrenal medulla: A06.407.071.265
health policy: I01.655.500.608.400, I01.880.604.825.608.400, N03.623.500.608.428
bone morphogenetic protein 7: D12.644.276.954.200.700, D12.776.467.942.200.700, D23.529.942.200.700
activin receptors: D08.811.913.696.620.682.700.062, D12.776.543.750.750.400.820.500
chromatin immunoprecipitation: E05.393.170, E05.478.605.160
neural cell adhesion molecules: D12.776.395.550.200.250.520, D12.776.543.550.200.250.520, D23.050.301.350.250.520
sialyltransferases: D08.811.913.400.800
gene library: G05.360.325
indazoles: D03.383.129.539.487, D03.438.449
wound infection: C01.539.947, C26.951
burns: C26.200
nitric oxide donors: D27.505.519.656, D27.505.954.411.590
gene silencing: G05.355.315.203.374
textile industry: J01.576.885
apoptosis inducing factor: D08.811.682.608.047, D12.644.360.075.311, D12.776.331.161, D12.776.476.075.311
annexin a5: D12.776.157.125.050.100
pheochromocytoma: C04.557.465.625.650.700.725, C04.557.580.625.650.700.725
fluorescein: D02.455.426.559.847.885.347.390, D03.494.953.275.390, D04.615.885.347.390
deoxyribonucleases: D08.811.277.352.335
transient receptor potential channels: D12.776.157.530.400.901, D12.776.543.585.400.901
non-nutritive sweeteners: D27.720.364.609.500, D27.720.888.500, J02.500.512.400.700.500
terpenes: D02.455.849
construction materials: J01.637.241
heptachlor epoxide: D02.455.526.439.516.350
mirex: D02.455.526.439.659
counseling: F02.784.176, F04.408.413, N02.421.143.303, N02.421.461.363
elastic tissue: A10.165.400
neurology: H02.403.600
chlorophyllides: D03.383.129.578.840.374.180, D03.383.129.578.840.500.640.220.180, D03.549.909.374.180, D03.549.909.500.640.220.180, D04.345.783.374.180, D04.345.783.500.640.220.180, D23.767.727.220.180, D23.767.727.640.220.180
nutritionists: M01.526.485.067.676, N02.360.067.676
phosgene: D02.522.741
argon: D01.268.613.050, D01.362.641.113
antimutagenic agents: D27.505.696.706.080, D27.720.799.042
milk proteins: D12.776.256.626, J02.500.350.525.520, J02.500.428.626
caseins: D12.776.256.626.207, D12.776.744.150
plasma cells: A11.063.438.725, A11.118.637.555.567.562.725, A15.145.229.637.555.567.562.725, A15.382.032.438.725, A15.382.490.555.567.562.725
cervical rib: A02.835.232.904.567.150
peroneal nerve: A08.800.800.720.450.760.640
autonomic pathways: A08.800.050.050, A08.800.800.060
s-adenosylmethionine: D02.886.030.676.180, D03.438.759.590.138.264, D12.125.166.676.180, D13.570.583.138.264, D13.570.800.096.264
fas ligand protein: D12.644.276.374.750.249, D12.644.276.972.249, D12.776.395.550.312, D12.776.467.374.750.249, D12.776.467.972.249, D12.776.543.550.312, D23.050.301.264.035.284, D23.101.100.110.283, D23.529.374.750.249, D23.529.972.249
cytoskeletal proteins: D12.776.220
microtubule-associated proteins: D12.776.220.600.450, D12.776.641.560
tea: D20.215.784.875, J02.200.900
microelectrodes: E07.305.250.500
carbenoxolone: D02.455.849.919.530.444.250
metabolomics: H01.158.201.586, H01.158.273.180.599, H01.181.122.638
sodium acetate: D02.241.081.018.165.500
1,2-dipalmitoylphosphatidylcholine: D10.570.755.375.760.400.800.224
alcian blue: D03.438.473.050
ecdysteroids: D04.808.247.222.265.165, D04.808.247.808.756.143, D06.472.445.573.271
falconiformes: B01.050.150.900.248.250, B01.050.150.900.248.815.350
maternal age: G08.686.560, N05.715.350.075.550, N06.850.490.250.550
synaptic vesicles: A08.850.840, A11.284.430.214.190.875.190.880.830
universities: I02.783.850
iraq: Z01.252.245.500.360, Z01.586.500.360
fibroblast growth factor 9: D12.644.276.624.190, D12.776.467.624.190, D23.529.624.190
interleukin-5: D12.644.276.374.465.505, D12.776.467.374.465.505, D23.529.374.465.505
thionins: D12.644.050.800, D12.776.543.695.054.800
nicotine: D03.132.760.570, D03.383.725.518
aspergillus fumigatus: B01.300.381.081.295
precipitin tests: E01.370.225.812.735.645, E05.196.150.639.500, E05.200.812.735.645, E05.478.594.760.645, E05.478.605.492
safflower oil: D10.212.302.380.750, D10.212.507.750, D10.627.700.840, D20.215.784.750.840, J02.500.375.400.700
cyclohexanecarboxylic acids: D02.241.223.268, D02.455.426.392.368.367.218
neuralgia: C10.597.617.682, C10.668.829.600, C23.888.592.612.664, C23.888.646.508
adiponectin: D06.472.699.042.249, D12.644.276.024.249, D12.644.548.011.249, D12.776.467.024.249, D23.529.024.249
adipokines: D06.472.699.042, D12.644.276.024, D12.644.548.011, D12.776.467.024, D23.529.024
atrial premature complexes: C14.280.067.325.250, C23.550.073.325.050
bundle-branch block: C14.280.067.558.323, C23.550.073.425.100
ventricular premature complexes: C14.280.067.325.500, C23.550.073.325.800
activities of daily living: E02.831.067, I03.050, N02.421.784.110
heart arrest: C14.280.383
tropism: G07.700.320.249.845, G15.744.900
rehabilitation: E02.831, H02.403.680.600, N02.421.784
glucose transporter type 5: D12.776.157.530.500.500.968, D12.776.543.585.500.500.968
interleukin-1beta: D12.644.276.374.465.501.600, D12.644.276.374.500.400.600, D12.776.467.374.465.501.600, D12.776.467.374.500.400.600, D23.529.374.465.501.600, D23.529.374.500.400.600
activating transcription factor 3: D12.776.260.108.061.875, D12.776.930.127.061.875
proto-oncogene proteins c-sis: D12.644.276.910.650, D12.776.124.625.650, D12.776.260.690, D12.776.467.910.650, D12.776.624.664.700.195, D23.529.910.650
photic stimulation: E05.723.729
fatty acid-binding proteins: D12.776.157.170
oxotremorine: D03.383.773.812.498
nitrobenzoates: D02.241.223.100.600, D02.455.426.559.389.127.650
consensus: F01.829.316.068, F02.463.785.373.433
term birth: G08.686.785.760.769.490.500
infant, very low birth weight: M01.060.703.520.460.600
griffonia: B01.650.940.800.575.100.401.318
lectins: D12.776.503
peripheral nervous system agents: D27.505.696.663
occupational health physicians: M01.526.485.810.675, N02.360.810.675
edwardsiella ictaluri: B03.440.450.425.260.340, B03.660.250.150.160.340
batrachoidiformes: B01.050.150.900.493.039
antibody-producing cells: A11.063, A15.382.032
spatio-temporal analysis: E05.318.740.933.500, N05.715.360.750.746.500, N06.850.520.830.933.500
scenedesmus: B01.650.940.150.800
starvation: C18.654.521.750
staurosporine: D03.132.436.750, D03.438.473.144.750, D03.438.473.402.750, D03.494.148.750
mecamylamine: D02.455.849.575.781.500
nicotinic antagonists: D27.505.519.625.120.200.700, D27.505.696.577.120.200.700
dimethylphenylpiperazinium iodide: D03.383.606.390
nicotinic agonists: D27.505.519.625.120.140.700, D27.505.696.577.120.140.700
buffers: D27.720.470.280
iloprost: D10.251.355.255.550.700.125, D23.469.700.275
cholera toxin: D08.811.913.400.725.115.180, D23.946.123.194, D23.946.330.150
scopolamine hydrobromide: D02.145.074.722.822.775, D03.132.760.180.848, D03.132.889.601.775, D03.605.869.822.775, D04.075.080.875.099.722.822.775
ficus: B01.650.940.800.575.100.750.500
calcium-calmodulin-dependent protein kinase type 2: D08.811.913.696.620.682.700.125.200, D12.644.360.100.200, D12.776.476.100.200
excitatory postsynaptic potentials: G04.580.887.249, G07.265.337.900.750.199, G07.265.750.887.249, G07.700.240.900.750.199, G11.561.570.918.249, G11.561.600.835.750.199
neurosurgery: H02.403.810.425
calcium-calmodulin-dependent protein kinases: D08.811.913.696.620.682.700.125, D12.644.360.100, D12.776.476.100
waist circumference: E01.370.600.115.100.160.560, E05.041.124.160.875, G07.100.100.160.560
cholesterol, hdl: D10.532.432.400, D10.570.938.208.270, D12.776.521.479.470
glycemic index: G03.345, G07.610.660.500, J01.576.423.850.730.750.500, N06.850.601.750.500
cholesterol, ldl: D10.532.515.500, D10.570.938.208.275, D12.776.521.550.500
phytochemicals: D03.787, D20.663
flavanones: D03.438.150.266.450.252, D03.830.219.266.450.252
androgen-binding protein: D12.776.157.065
disaccharides: D09.698.629.305
oligosaccharides: D09.698.629
lissencephaly: C10.500.507.249, C16.131.666.507.186
genetic therapy: E02.095.301, E05.393.420.301
cognitive reserve: F02.463.188.331
birefringence: G01.590.080
pelvis: A01.923.600
retroelements: D13.444.308.760, G02.111.570.080.708.330.800, G05.360.080.708.330.800, G05.360.340.024.425.800
cyclin-dependent kinase 5: D08.811.913.696.620.682.700.200.067.875, D08.811.913.696.620.682.700.646.500.500.500, D12.644.360.250.067.875, D12.776.167.200.067.875, D12.776.476.250.067.875
germ layers: A16.504
luteolin: D03.438.150.266.450.260.555, D03.830.219.266.450.260.555
ocimum: B01.650.940.800.575.100.575.647
eugenol: D02.241.223.200.054.500
rho(d) immune globulin: D12.776.124.486.485.114.619.393.700, D12.776.124.790.651.114.619.393.700, D12.776.377.715.548.114.619.393.700
ethics: F01.829.500.519, K01.559.411, K01.752.566.479, N05.350
cottonseed oil: D10.212.302.380.380, D10.212.507.350, D10.627.700.263, D20.215.784.750.263, J02.500.375.400.300
anterior hypothalamic nucleus: A08.186.211.730.317.357.342.063
receptors, adrenergic: D12.776.543.750.070.300.300, D12.776.543.750.100.150.300, D12.776.543.750.720.300.300.300
sex: G08.686.810
ceramics: D25.264, J01.637.051.264, J01.637.153
silver compounds: D01.847
chlorambucil: D02.455.526.728.650.156
uridine diphosphate: D03.383.742.686.850.600, D13.695.740.850.600, D13.695.827.919.600
charadriiformes: B01.050.150.900.248.150
acclimatization: G07.700.062.133, G16.100.057.500.133
argentina: Z01.107.757.077
hemopexin: D12.776.124.050.350, D12.776.124.790.223.338, D12.776.377.715.182.338, D12.776.395.401
alpha-2-hs-glycoprotein: D12.776.124.790.106.304.500, D12.776.157.125.283.500, D12.776.215.625.500, D12.776.377.715.085.304.500, D12.776.395.086
capillary permeability: G03.495.166.330, G09.330.165
vitamin d-binding protein: D12.776.157.920
brain ischemia: C10.228.140.300.150, C14.907.253.092
librarians: M01.526.555
hydrogen bonding: G02.149.767.620, G02.842.750.620
occupational health services: N02.421.143.740
thioctic acid: D02.241.803, D02.886.778.827, D08.211.906, D10.251.941
arterioles: A07.231.114.060, A07.231.461.080
p-selectin: D12.776.395.550.200.700.775, D12.776.395.550.625.905, D12.776.503.843.775, D12.776.543.550.200.700.775, D12.776.543.550.625.905, D23.050.301.264.035.912.775, D23.050.301.350.700.775, D23.101.100.110.918.775
hydralazine: D03.383.710.605.500
population groups: M01.686, N01.224.708
ovalbumin: D12.644.861.560, D12.776.034.614, D12.776.256.317.663, D12.776.290.663, D12.776.872.560
telangiectasis: C14.907.823
intracellular space: A10.082.750, A11.284.430
graphite: D01.268.150.300, D01.578.300
schizophrenia: F03.700.750
chewing gum: D05.750.078.739.249, D09.698.700.249, D20.215.721.249.249, J02.500.140.200
neurilemmoma: C04.557.465.625.650.595, C04.557.580.600.610.595, C04.557.580.625.650.595
nociception: F02.463.593.504.500
hemosiderosis: C18.452.565.500.500
persistent vegetative state: C10.228.140.140.627, C10.597.606.358.800.400, C23.888.592.604.359.800.400
aged: M01.060.116.100
keratin-20: D05.750.078.593.450.300.950, D12.776.220.475.450.300.950, D12.776.860.607.300.950
epidermal growth factor: D06.472.317.350, D12.644.276.561, D12.776.467.561, D23.529.561
butyric acid: D02.241.081.114.750, D10.251.400.143.500
neuroectodermal tumors: C04.557.465.625, C04.557.580.625
karyotype: G05.360.162.679
periaqueductal gray: A08.186.211.132.659.822.595, A08.186.211.653.822.595
diplopia: C10.597.751.941.339, C11.966.339, C23.888.592.763.941.339
blepharoptosis: C11.338.204
basal ganglia: A08.186.211.730.885.287.249
gait ataxia: C10.597.350.090.750, C10.597.404.450, C23.888.592.350.090.600, C23.888.592.413.450
vestibular nuclei: A08.186.211.132.810.428.600.800, A08.186.211.865.428.600.800
mouth mucosa: A10.615.550.599, A14.549.512
uranium: D01.268.033.950, D01.268.271.100.950, D01.268.556.900, D01.552.020.940, D01.552.544.900
glucuronic acid: D02.241.081.844.915.162.249, D02.241.152.811.162.500, D02.241.511.902.915.162.500, D09.811.922.162.500
tertiary healthcare: N04.452.758.849.887, N05.300.787
spain: Z01.542.846
daunorubicin: D02.455.426.559.847.562.050.200, D04.615.562.050.200, D09.408.051.059.200
pinch strength: E01.370.600.425.500.500, G11.427.560.500.500
gastric lavage: E05.927.441
histone-lysine n-methyltransferase: D08.811.913.555.500.800.400
tetraisopropylpyrophosphamide: D02.705.672.750
anguilla: B01.050.150.900.493.338.282
eels: B01.050.150.900.493.338
microscopy, electron, transmission: E01.370.350.515.402.580, E05.595.402.580
functional food: J02.500.525.425
chromones: D03.438.150.266, D03.830.219.266
glucosides: D09.408.348
deception: F01.145.813.157
propylthiouracil: D03.383.742.698.875.842.708
erythropoietin: D12.644.276.374.410.240.150, D12.776.395.240.150, D12.776.467.374.410.240.150, D23.529.374.410.240.150
hepatocyte growth factor: D12.644.276.374.420, D12.776.467.374.420, D23.529.374.420
scalp: A01.456.810
dissent and disputes: F01.829.401.094, F02.463.785.373.476
acceleration: G01.595.560.107
quinone reductases: D08.811.682.608.800
veterinarians: M01.526.485.905, N02.360.905
clergy: M01.526.213
paracentrotus: B01.050.500.408.578.600
palaemonidae: B01.050.500.131.365.190.615
decapoda (crustacea): B01.050.500.131.365.190
echinodermata: B01.050.500.408
prothrombin time: E01.370.225.625.115.610, E05.200.625.115.610, G09.188.680
cassia: B01.650.940.800.575.100.401.100
international normalized ratio: E01.370.225.625.115.320, E05.200.625.115.320
liver transplantation: E04.210.650, E04.936.450.490, E04.936.580.490
intensive care: E02.760.190.400, N02.421.585.190.400
transgenes: G05.360.340.024.340.825
iodine: D01.268.380.400
iodides: D01.248.497.158.490, D01.475.410
hypernatremia: C18.452.950.452
ketosis: C18.452.076.176.652
hemofiltration: E02.870.350, E02.912.400, E04.292.471, E04.292.975.300, E05.196.454.807.300
sports: I03.450.642.845
antimitotic agents: D27.505.519.593.249, D27.505.954.248.147
thiobarbiturates: D03.383.742.698.253.800
chloroplasts: A11.284.430.214.190.875.700.140
continental population groups: M01.686.508
interleukin-12: D12.644.276.374.465.512, D12.776.467.374.465.512, D23.529.374.465.512
receptors, death domain: D12.776.543.750.073
young adult: M01.060.116.815
perchlorates: D01.029.260.650, D01.210.675
amitrole: D03.383.129.799.100
sulfamethoxazole: D02.065.884.725.867, D02.092.146.807.867, D02.886.590.700.725.867
phloroglucinol: D02.455.426.559.389.657.684
thiocyanates: D02.262.775, D02.886.728
charities: I01.880.787.190, N03.540.125
airway remodeling: C23.300.017, G09.772.029
poloxamer: D02.033.455.250.700.682, D05.750.741.667, D25.720.741.667, J01.637.051.720.741.667
phosphatidylglycerols: D10.570.755.375.760.400.885
interleukin-17: D12.644.276.374.465.517, D12.776.467.374.465.517, D23.529.374.465.517
morpholines: D03.383.533.640
immunoprecipitation: E05.196.150.639, E05.478.605
neurotransmitter transport proteins: D12.776.157.530.562, D12.776.543.585.562
ubiquitins: D12.776.947
ghrelin: D06.472.699.301, D12.644.548.322
polyvinylpyridine n-oxide: D02.455.326.271.884.533.660, D03.383.725.740
globus pallidus: A08.186.211.730.885.287.249.487.397
neuroimaging: E01.370.350.578, E01.370.376.537, E05.629
intracranial hypertension: C10.228.140.631
second messenger systems: G02.111.087.800.800, G02.149.115.800.800, G04.299.880.800
ppar delta: D12.776.260.698.239.555, D12.776.826.239.555, D12.776.930.669.239.555
faculty: I02.463, M01.526.339
alpha-fetoproteins: D12.776.124.790.106.092, D12.776.320.525.500, D12.776.377.228.500, D12.776.377.715.085.092, D23.101.840.050
beta catenin: D12.776.091.249, D12.776.220.145.500, D12.776.930.130
mytilus: B01.050.500.644.080.537.500
fisheries: J01.040.168.300
alaska: Z01.107.567.875.580.100
large-conductance calcium-activated potassium channels: D12.776.157.530.400.600.150.500, D12.776.543.550.425.750.150.500, D12.776.543.585.400.750.150.500
achilles tendon: A02.880.176
gene transfer techniques: E05.393.350
tendons: A02.880
glucose intolerance: C18.452.394.952.500
national institute of environmental health sciences (u.s.): I01.409.137.500.600.480.455, N03.540.348.500.500.600.480.455
osmoregulation: G02.111.635, G03.615, G07.700.345.810
mesoderm: A16.504.660
hypokinesia: C10.597.350.400, C23.888.592.350.400
u937 cells: A11.251.210.190.880, A11.251.860.180.880, A11.627.482.665.500, A11.627.624.249.500, A11.627.635.675.750.500
k562 cells: A11.251.210.190.510, A11.251.860.180.510, A11.443.240.497.480
deet: D02.065.277.194, D02.241.223.100.100.230, D02.455.426.559.389.127.085.230
pyridostigmine bromide: D03.383.725.762.740
sarin: D02.705.429.750.500
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid: D03.383.129.385.025
gulf war: K01.400.504.968.400
veterans: M01.930
indian ocean: Z01.756.342
neurofibrillary tangles: A08.663.609.520, A11.284.430.214.190.750.640.520, A11.671.573.520
dopamine and camp-regulated phosphoprotein 32: D12.776.641.249, D12.776.744.459
receptors, ampa: D12.776.157.530.400.400.500.100, D12.776.543.550.425.500.200.100, D12.776.543.585.400.500.200.100, D12.776.543.750.720.200.450.400.100
war: I01.880.735.944
lung compliance: E01.370.386.700.475, G09.772.540
chemokine ccl11: D12.644.276.374.200.110.550, D12.776.467.374.200.110.550, D23.125.300.110.550, D23.469.200.110.550, D23.529.374.200.110.550
povidone: D02.455.326.271.884.533.699, D03.383.773.812.615, D05.750.716.721.838, D25.720.716.721.838, J01.637.051.720.716.721.838
chloroquine: D03.438.810.050.180
chlorpropham: D02.241.081.251.583.177
phenylurea compounds: D02.455.426.559.389.703, D02.948.681
benzothiadiazines: D02.886.590.700.135, D02.886.655.500, D03.438.174
cesium: D01.268.549.125, D01.268.556.165, D01.552.528.160, D01.552.544.165
arousal: F02.830.104, G11.561.600.042
kinesin: D08.811.277.040.025.193.500, D12.776.220.600.450.450, D12.776.641.560.450
neurosciences: H01.158.610
corrosion: G02.149.200
phagosomes: A11.284.430.214.190.875.190.700
methylhydrazines: D02.442.600
ginkgo biloba: B01.650.940.800.575.400.300
bromocriptine: D03.132.327.412.100, D03.549.439.131, D03.549.562.100
lactation disorders: C13.703.844.506, C17.800.090.937
beta-thalassemia: C15.378.071.141.150.875.150, C15.378.420.826.150, C16.320.070.875.150, C16.320.365.826.150
fat necrosis: C23.550.717.365
anemia, sickle cell: C15.378.071.141.150.150, C15.378.420.155, C16.320.070.150, C16.320.365.155
serum globulins: D12.776.124.790, D12.776.377.715
malingering: F01.145.126.925
neuropsychology: F04.096.795.600, H01.158.782.795.110
bungarotoxins: D20.888.850.325.139, D23.946.833.850.325.139
cell membrane structures: A11.284.149.165
butyrylthiocholine: D02.092.877.883.333.800.200, D02.675.276.232.800.200, D02.886.489.789.200
acetylthiocholine: D02.092.877.883.333.800.030, D02.675.276.232.800.030, D02.886.489.789.030
hormesis: G07.700.370
organothiophosphates: D02.705.400.625, D02.705.539.345, D02.886.300.692
tennessee: Z01.107.567.875.075.775
cell adhesion: G04.299.117
ribosomal proteins: D12.776.835
clusterin: D12.776.395.207, D12.776.580.215
rosacea: C17.800.716
gonadotrophs: A06.407.747.500.750, A06.688.357.750.500.750, A08.186.211.730.317.357.352.435.500.500.750, A08.713.357.750.500.750, A11.382.750, A11.436.319
n-methylscopolamine: D02.145.074.722.822.550, D03.132.889.601.550, D03.605.869.822.550, D04.075.080.875.099.722.822.550
hemicholinium 3: D02.092.877.435, D02.675.276.435
piperidines: D03.383.621
receptors, muscarinic: D12.776.543.750.100.475, D12.776.543.750.720.360.500
catalepsy: C10.597.350.200, C23.888.592.350.200
neurosecretion: G11.561.600.640
cytokinesis: G04.299.134.220.250
surface properties: G02.842.850
aspergillus nidulans: B01.300.381.081.420
papaver: B01.650.940.800.575.100.795.500
organic agriculture: J01.040.895
saccharum: B01.650.940.800.575.100.822.835
self concept: F01.752.747.792
nevada: Z01.107.567.875.760.550
canes: E07.858.442.250
vitallium: D01.220.175.950, D01.552.033.182.900, D25.058.224.735, D25.339.208.224.959, J01.637.051.058.224.735, J01.637.051.339.208.224.959
osteolysis: C05.116.264.579, G11.427.590.195.150.570
chemotaxis: G04.299.283.424
apolipoproteins e: D10.532.091.500, D12.776.070.400.500, D12.776.521.120.500
prehypertension: C14.907.653
bayes theorem: E05.318.740.600.200, N05.715.360.750.625.150, N06.850.520.830.600.200
national center for health statistics (u.s.): I01.409.137.500.600.650.425, N03.540.348.500.500.600.650.425
brachiocephalic trunk: A07.231.114.145
isoprostanes: D10.251.355.255.100.375, D10.251.355.411
patch-clamp techniques: E05.242.800
multidrug resistance-associated proteins: D12.776.157.530.100.304, D12.776.157.530.450.074.500.500.500, D12.776.543.585.100.304, D12.776.543.585.450.074.500.500.500
azacitidine: D02.145.150, D03.383.742.680.245.217, D13.570.685.245.217, D13.570.800.286.300
aurora kinase b: D08.811.913.696.620.682.700.103.750, D12.776.167.049.750
kinetochores: A11.284.430.106.279.345.190.160.165.500, G05.360.160.165.500
chromosome segregation: G04.299.134.220.220.625, G05.355.105.220.625
genomic instability: C23.550.362, G05.365.590.335, G05.370
centrosome: A11.284.430.214.190.750.585.160, A11.284.430.214.190.750.820.500.500
two-dimensional difference gel electrophoresis: E05.196.401.250.500, E05.196.401.402.250.500, E05.301.300.230.500, E05.301.300.319.450.500
ventricular function: G09.330.190.962
fenofibrate: D02.241.081.114.968.500.625, D02.355.726.305.625, D02.455.426.559.389.115.124.750, D02.455.426.559.389.657.654.305.625, D02.522.223.750
coenzyme a: D03.438.759.646.138.382, D08.211.211, D13.695.667.138.382, D13.695.827.068.382
nasal obstruction: C08.460.525, C08.618.846.185.525, C09.603.525
environment: G16.500.275, N06.230
fourth ventricle: A08.186.211.276.500
thailand: Z01.252.145.841
abdominal pain: C23.888.646.100, C23.888.821.030
aquaporin 2: D12.776.157.530.400.500.040.437, D12.776.543.550.425.730.040.437, D12.776.543.585.400.730.040.530
mefloquine: D03.438.810.410
primaquine: D03.438.810.050.650
ischemia: C23.550.513
hydroxyurea: D02.948.395
clone cells: A11.251.353
thiazolidinediones: D02.886.675.933, D03.383.129.708.933
zeranol: D02.455.426.559.389.657.852.900.975, D02.540.950.975
meat products: J02.500.600.500
shoulder: A01.378.800.750
dystonia: C10.597.350.300, C23.888.592.350.300
dystonic disorders: C10.228.662.300
anura: B01.050.150.900.090.180
quinpirole: D03.438.810.842, D03.494.802
dopamine agonists: D27.505.519.625.150.151, D27.505.696.577.150.151
ketoprofen: D02.241.223.701.480
tropolone: D02.455.426.392.368.284.900
monoterpenes: D02.455.849.575
benserazide: D02.442.175
genetic variation: G05.365
plant extracts: D20.215.784.500, D26.667
connective tissue growth factor: D12.644.276.200.100, D12.776.467.200.100, D12.776.860.300.200.100, D23.529.237.100
genes: G05.360.340.024.340
ecdysone: D04.808.247.222.265.165.500, D06.472.445.573.271.500
fundulidae: B01.050.150.900.493.850.280.214
amino acid sequence: G02.111.570.060, L01.453.245.667.060
nitric oxide synthase type iii: D08.811.682.664.500.772.750
amp-activated protein kinases: D08.811.913.696.620.682.700.085, D12.644.360.062, D12.776.476.062
apoferritins: D12.776.070.345, D12.776.157.427.249.290, D12.776.556.579.249.290
proto-oncogene proteins c-akt: D08.811.913.696.620.682.700.755, D12.776.476.565, D12.776.624.664.700.168
weed control: J01.040.947
interleukin-2: D12.644.276.374.465.502, D12.644.276.374.480.372, D12.776.467.374.465.502, D12.776.467.374.480.372, D23.529.374.465.502, D23.529.374.480.372
cd8-positive t-lymphocytes: A11.118.637.555.567.569.220, A15.145.229.637.555.567.569.220, A15.382.490.555.567.569.220
vulnerable populations: M01.965
protein folding: G01.154.100.640, G01.595.100.640, G02.111.087.690, G02.149.115.690
dipeptidyl peptidase 4: D08.811.277.656.350.350.126, D08.811.277.656.959.250, D23.050.301.264.035.283, D23.050.301.264.894.160, D23.101.100.110.282, D23.101.100.894.160
protein tyrosine phosphatase, non-receptor type 1: D08.811.277.352.650.775.300.100, D12.644.360.585.100, D12.776.476.564.100
pseudopregnancy: G08.686.785.760.769.887
pituitary adenylate cyclase-activating polypeptide: D12.644.276.860.887, D12.644.400.625, D12.776.467.860.887, D12.776.641.600.887, D12.776.641.650.625, D23.529.850.887
deciduoma: A05.360.319.679.490.373.500, A16.710.289.500
needles: E07.612
decidua: A05.360.319.679.490.373, A16.710.289
plasminogen activator inhibitor 1: D12.644.822.750.695.500, D12.644.861.695.500, D12.776.124.125.640, D12.776.645.750.695.500, D12.776.872.695.500, D23.119.832.500
guanylate cyclase: D08.811.520.650.600, D12.644.360.350, D12.776.476.350
isometric contraction: G11.427.590.540.472
nitroglycerin: D02.033.800.421.560, D02.640.636
fuel oils: D20.345.630.500, N06.230.132.258.630.500
petroleum pollution: N06.850.460.660
wound healing: G16.100.856.891
helium: D01.268.613.350, D01.362.641.352
nanomedicine: H01.603.600, J01.897.115.625, J01.897.520.600.600
rain: G16.500.240.135.859, G16.500.275.063.725.395, G16.500.750.775.450, N06.230.300.100.725.450, N06.230.520
thiazoles: D02.886.675, D03.383.129.708
inflammation mediators: D23.469
guanosine: D03.438.759.590.454, D13.570.583.454, D13.570.800.453
cathepsin b: D08.811.277.656.224.125, D08.811.277.656.262.500.133, D08.811.277.656.300.200.133
chlorella vulgaris: B01.650.940.150.469.400
drug tolerance: G07.690.812.260, G07.700.680.260
thromboplastin: D12.776.124.125.900, D23.119.965
hela cells: A11.251.210.190.400, A11.251.860.180.400, A11.436.340
chemokine cxcl2: D12.644.276.374.200.120.100, D12.644.276.374.200.600.940, D12.776.467.374.200.120.100, D12.776.467.374.200.600.940, D23.125.300.120.100, D23.125.300.600.940, D23.469.200.120.100, D23.469.200.600.940, D23.529.374.200.120.100, D23.529.374.200.600.940
phosphatidylinositol 3-kinases: D08.811.913.696.620.500
flounder: B01.050.150.900.493.418.438
generalization (psychology): F02.463.425.357
photolysis: G02.149.767.690.685, G02.842.750.690.685
light: G01.358.500.505.650, G01.590.540, G01.750.250.650, G01.750.770.578
datura stramonium: B01.650.940.800.575.100.905.188.800
sea bream: B01.050.150.900.493.602.750
chin: A01.456.505.259, A02.835.232.781.324.502.632.130, A14.521.632.300
pecten: B01.050.500.644.080.660.600
proto-oncogene proteins c-myc: D12.776.260.676, D12.776.624.664.700.189, D12.776.660.765
cyclooxygenase 2 inhibitors: D27.505.519.389.310.500, D27.505.696.663.850.014.040.500.500.500, D27.505.954.158.030.500.500, D27.505.954.329.030.500.500
cyclooxygenase 2: D08.811.600.720.750
ventilation: N06.230.150.520
perception: F02.463.593
libraries: L01.346.596
vaginal neoplasms: C04.588.945.418.955, C13.351.500.894.834, C13.351.937.418.937
petrolatum: D02.455.699
porifera: B01.050.500.802
fluoroscopy: E01.370.350.700.225
adenylate kinase: D08.811.913.696.650.025
intra-abdominal fat: A10.165.114.830.500.500
orchiectomy: E04.270.282.679, E04.950.165.679, E04.950.774.860.618
rhodamines: D03.494.953.600
vanadium compounds: D01.960
investments: N03.219.702
iran: Z01.252.245.500.350, Z01.586.500.350
lubricants: D27.720.556
rheum: B01.650.940.800.575.100.825.700, J02.500.850.700
rhizome: A18.024.937.750, A18.400.750
anthracyclines: D02.455.426.559.847.562.050, D04.615.562.050, D09.408.051.059
memantine: D02.455.426.100.050.035.500
neuroprostanes: D10.251.355.337.250.500, D10.251.355.411.750
head kidney: A13.449, A16.835.400
enterocytes: A03.556.124.369.290, A10.615.550.444.290, A11.436.290
methomyl: D02.241.081.251.525, D02.886.706.537
methiocarb: D02.241.081.251.583.555
aromatic-l-amino-acid decarboxylases: D08.811.520.224.125.100
visual field tests: E01.370.380.850.962
cannabinoids: D02.455.849.090
anti-inflammatory agents, non-steroidal: D27.505.696.663.850.014.040.500, D27.505.954.158.030, D27.505.954.329.030
mumps: C02.782.580.600.680.500, C07.465.815.470.800.630
intention: F01.658.650, F02.463.306
dental caries: C07.793.720.210
intelligence tests: F04.711.141.493
beetles: B01.050.500.131.617.069
veterinary drugs: D26.939
antiparasitic agents: D27.505.954.122.250
clofibric acid: D02.241.081.114.968.500.500, D02.355.726.305.500, D02.455.426.559.389.657.654.305.500
phytoplankton: B05.080.500.600
carbamazepine: D03.494.240.127
fluoxetine: D02.092.831.280
simvastatin: D02.455.426.559.847.638.400.900, D04.615.638.400.900
return to work: I03.946.449, N01.824.245.725
phenylhydrazines: D02.442.726
paris: Z01.433.800, Z01.542.286.588
cochlear nerve: A08.800.800.120.910.120
allopurinol: D03.438.759.160
thiazides: D02.886.655
hypokalemia: C18.452.950.565
dyslipidemias: C18.452.584.500
dietary fats: D10.212.302, J02.500.375
urban population: N01.600.900
electrophysiology: H01.158.344.528, H01.158.782.236
diagonal band of broca: A08.186.211.730.885.380
cholinergic neurons: A08.663.127, A11.671.188
dystocia: C13.703.420.288
amidohydrolases: D08.811.277.087
deuterium oxide: D01.435.256.250, D01.455.900.200
cytomegalovirus: B04.280.382.150.150, B04.909.204.382.150.150
muromegalovirus: B04.280.382.150.500, B04.909.204.382.150.500
viral load: E01.370.225.875.950, E05.200.875.950, G06.920.850
cytomegalovirus infections: C02.256.466.245
immunosuppression: E02.095.465.425.450, E05.478.610
virology: H01.158.273.540.859
moths: B01.050.500.131.617.561.650
nootropic agents: D27.505.954.427.637
electromagnetic phenomena: G01.358.500
rare diseases: C23.550.291.906
protease inhibitors: D27.505.519.389.745
general practitioners: M01.526.485.810.485, N02.360.810.485
3t3-l1 cells: A11.251.210.100.775.800, A11.329.228.100.775.800
xanthines: D03.132.960, D03.438.759.758.824
anilides: D02.065.199
hip joint: A02.835.583.411
ecology: H01.158.273.248, H01.277.249
pregnanes: D04.808.745
gastrulation: G07.700.320.500.325.180.812
cortodoxone: D04.808.745.745.654.252, D06.472.040.585.478.225
hydroxyprogesterones: D04.808.745.745.654.829.395, D06.472.334.851.687.750.478
asthenozoospermia: C12.294.365.700.253
midwestern united states: Z01.107.567.875.510
chromatophores: A11.436.265
embryology: H01.158.100.529, H01.158.273.200.350
parental consent: I01.880.604.583.427.635.500, N03.706.535.489.635.500
cyclic gmp-dependent protein kinases: D08.811.913.696.620.682.700.150.150, D12.644.360.200.150, D12.776.476.200.150
pertussis toxin: D08.811.913.400.725.115.680, D23.946.123.946.690, D23.946.896.980.690
gtp-binding protein alpha subunits, gi-go: D08.811.277.040.330.300.200.100.200, D12.644.360.375.100.200, D12.776.157.325.332.100.200, D12.776.476.375.100.200, D12.776.543.325.100.200
glucagon-secreting cells: A03.734.414.065, A06.390.087, A06.407.414.043, A11.382.625.064, A11.436.294.064
carbazoles: D03.438.473.144, D03.494.148
gliadin: D12.776.765.725.500.500.400
streptokinase: D08.811.277.656.300.775, D12.776.124.125.662.537
antibodies, anti-idiotypic: D12.776.124.486.485.114.071, D12.776.124.790.651.114.071, D12.776.377.715.548.114.071
bacterial toxins: D23.946.123
phosphatidylserines: D10.570.755.375.760.400.971
keratin-18: D05.750.078.593.450.300.800, D12.776.220.475.450.300.800, D12.776.860.607.300.800
nitrofurantoin: D02.640.600.566, D03.383.312.649.566
mutism: C10.597.606.150.500.800.500, C23.888.592.604.150.500.800.500, F03.550.700
neurofibromatosis 1: C04.557.580.600.580.590.650, C04.700.645.650, C10.562.600.500, C10.574.500.549.400, C10.668.829.675, C16.320.400.560.400, C16.320.700.645.650
garlic: B01.650.940.800.575.100.610.100.300, J02.500.850.100.300
mevalonic acid: D02.241.511.579
head: A01.456
cpg islands: G02.111.570.080.380.160, G05.360.080.380.160, G05.360.340.024.159
5' untranslated regions: D13.444.735.544.875.885, D13.444.735.790.878.885, G05.360.340.024.220.880.885, G05.360.340.024.340.137.910.885
deoxycytidine: D03.383.742.680.245.500, D13.570.230.329, D13.570.685.245.500
butanones: D02.522.296
russia: Z01.252.122.500, Z01.542.248.775, Z01.586.200.775, Z01.586.950.775
fourier analysis: E05.377, G17.226, L01.224.800.625
oxazolone: D03.383.129.462.620
immunity, cellular: G12.450.050.400
pleural diseases: C08.528
fluorodeoxyglucose f18: D09.254.229.500
cold temperature: G01.906.595.272, G16.500.275.063.725.710.300, G16.500.750.775.710.300, N06.230.300.100.725.154, N06.230.300.100.725.710.300
pregnenolone carbonitrile: D02.626.745, D04.808.745.745.725.703
gonadal dysgenesis: C12.706.316.309, C13.351.875.253.309, C16.131.939.316.309, C19.391.119.309
matrix metalloproteinase 12: D08.811.277.656.300.480.525.700.500, D08.811.277.656.675.374.525.700.500
immune system processes: G12.425
pertussis vaccine: D20.215.894.135.535
sterol regulatory element binding protein 1: D12.776.260.103.500.750.500, D12.776.260.108.092.750.500, D12.776.930.125.500.750.500, D12.776.930.127.092.750.500
epigenomics: H01.158.273.180.350.074, H01.158.273.343.350.042
fatty acid synthases: D08.811.277.352.897.387, D08.811.520.241.300.287, D08.811.682.047.820.196.500, D08.811.913.050.134.029.500, D08.811.913.050.170.500
mesenchymal stromal cells: A11.329.830.500, A11.872.590.500
carbonic acid: D01.029.260.150, D01.200.275
caveolin 1: D12.644.360.024.264, D12.776.157.057.010, D12.776.476.024.280, D12.776.543.990.100.500, D12.776.744.287
caveolae: A11.284.149.165.175.160, A11.284.149.165.570.160, A11.284.430.214.190.875.190.880.180.160
endosomes: A11.284.430.214.190.875.190.880.337
cohort effect: N05.715.350.350.225, N06.850.490.734.500
clothing: J01.637.215
amyloid precursor protein secretases: D08.811.277.656.300.032
presenilins: D12.776.543.696
neural crest: A16.627
scoliosis: C05.116.900.800.875
adam proteins: D08.811.277.656.675.374.102, D09.400.430.500, D12.776.395.033
map kinase kinase 4: D08.811.913.696.620.682.700.565.400, D08.811.913.696.620.682.725.200.400, D12.644.360.440.400, D12.776.476.440.400
creatine kinase, mm form: D08.811.913.696.640.150.875
health status: I01.240.425, N01.224.425, N06.850.505.400.425
cola: B01.650.940.800.575.100.915.166
coca: B01.650.940.800.575.100.346.500
family: F01.829.263, I01.880.225
beta carotene: D02.455.326.271.665.202.123, D02.455.426.392.368.367.379.249.050, D02.455.849.131.123, D23.767.261.050
gene-environment interaction: G05.695.337
immunochemistry: H01.158.201.486, H01.181.122.605, H02.403.044.500
carotenoids: D02.455.326.271.665.202, D02.455.426.392.368.367.379.249, D02.455.849.131, D23.767.261
adrenodoxin: D12.776.157.427.374.375.025, D12.776.556.579.374.375.025
cholesterol side-chain cleavage enzyme: D08.244.453.915.212, D08.811.682.690.708.170.915.212, D08.811.682.690.708.783.212, D12.776.422.220.453.915.212
ferredoxin-nadp reductase: D08.811.682.667.076
cyclopropanes: D02.455.426.392.368.533
vascular cell adhesion molecule-1: D12.776.395.550.200.920, D12.776.543.550.200.920, D23.050.301.264.035.920, D23.050.301.350.920, D23.101.100.110.970
iris: A09.371.060.450, A09.371.894.513
zona glomerulosa: A06.407.071.140.960
placental insufficiency: C13.703.590.800
digoxigenin: D04.808.155.160.349.350
receptors, androgen: D12.776.260.698.750.150, D12.776.826.750.150, D12.776.930.669.750.150
sun protection factor: E05.196.867.917, E05.799.890
receptors, opioid, mu: D12.776.543.750.100.620.550, D12.776.543.750.720.600.610.550, D12.776.543.750.750.555.610.550
urologic neoplasms: C04.588.945.947, C12.758.820, C13.351.937.820
purinergic antagonists: D27.505.519.625.725.400, D27.505.696.577.725.400
insect control: N06.850.780.200.650.425
protein stability: G02.111.700
glyburide: D02.886.590.795.575, D02.948.828.575
subarachnoid hemorrhage: C10.228.140.300.535.800, C14.907.253.573.800, C23.550.414.913.850
g1 phase: G04.299.134.500.320
purines: D03.438.759
prostatitis: C12.294.565.750
prostatic diseases: C12.294.565
prostatic intraepithelial neoplasia: C04.557.470.200.240.500
fibroblast growth factors: D12.644.276.624, D12.776.467.624, D23.529.624
photoelectron spectroscopy: E05.196.867.618
vacuum: G01.374.715.902, G16.500.750.274.902, N06.230.300.100.185.902
calorimetry: E05.145, E05.196.131
ets-domain protein elk-1: D12.776.260.665.600.100, D12.776.624.664.700.175.600.100, D12.776.930.635.600.100
ga-binding protein transcription factor: D12.776.260.615.249, D12.776.930.618.249
nitro compounds: D02.640
somites: A16.504.660.750
cyclohexanes: D02.455.426.392.368.367
ameloblasts: A11.436.107
odontoblasts: A11.329.522
dentinogenesis: G07.700.320.500.325.377.186
odontogenesis: G07.700.320.500.325.377.750
dental enamel: A14.549.167.900.255
survival analysis: E05.318.740.998, N05.715.360.750.795, N06.850.520.830.998
likelihood functions: E05.318.740.500.475, E05.318.740.600.400, E05.599.835.500, N05.715.360.750.530.450, N05.715.360.750.625.450, N06.850.520.830.500.475, N06.850.520.830.600.400
dextrans: D05.750.078.562.272, D09.698.365.272
medicago sativa: B01.650.940.800.575.100.401.590.500, J02.500.300.100.555
polycystic kidney diseases: C12.777.419.403.875, C13.351.968.419.403.875
luteal phase: G08.686.605.410
ectromelia: C05.660.585.350, C16.131.621.585.350
hernia: C23.300.707
reactive nitrogen species: D01.625.700, D02.654.846
caco-2 cells: A11.251.210.190.160, A11.251.860.180.160, A11.436.140
police: I01.880.604.646, M01.526.373.750, M01.526.760
mineralocorticoid receptor antagonists: D06.347.700, D27.505.696.399.450.600, D27.505.696.560.500.726.249
vascular stiffness: G09.330.940
stat3 transcription factor: D12.644.360.024.342.300, D12.776.157.057.186.300, D12.776.476.024.421.300, D12.776.930.840.300
jewelry: J01.637.502
tocotrienols: D03.438.150.909.875, D03.830.219.909.875
drug and narcotic control: I01.880.604.605.250, N03.706.615.402.250, N04.452.706.310
cluster analysis: E05.318.740.250, N05.715.360.750.200, N06.850.520.830.250
insulin-secreting cells: A03.734.414.131, A06.390.131, A06.407.414.087, A11.382.625.092, A11.436.294.092
loperamide: D03.383.621.440
1-methyl-4-phenylpyridinium: D03.383.725.762.550
electron transport complex iii: D05.500.562.750.500, D08.811.600.250.875.500, D08.811.682.830.500, D12.776.157.427.374.375.954, D12.776.157.530.450.250.875.303, D12.776.543.277.875.500, D12.776.543.585.450.250.875.468, D12.776.556.579.374.375.142
anterior thalamic nuclei: A08.186.211.730.317.826.701.080
ethidium: D03.494.633.416
brain injuries: C10.228.140.199, C10.900.300.087, C26.260.118, C26.915.300.200
beta-glucans: D09.698.365.089
cell wall: A11.284.183
blastoderm: A16.331.024
gonadotropins: D06.472.699.322
viscosity: G02.842.925
fetal heart: A07.541.278, A16.378.303
myelin basic protein: D12.776.543.620.540, D12.776.641.580.510
oligodendroglia: A08.637.600, A11.650.600
gastrins: D06.472.317.413, D06.472.699.280, D12.644.400.320, D12.644.548.280, D12.776.641.650.320
helicobacter felis: B03.440.500.250, B03.660.150.280.350
helicobacter: B03.440.500, B03.660.150.280
felis: B01.050.150.900.649.147.354.250
social responsibility: K01.559.595, K01.752.566.599
receptors, dopamine d1: D12.776.543.750.070.300.400.400, D12.776.543.750.100.150.400.400, D12.776.543.750.720.300.300.400.400
methamphetamine: D02.092.471.683.152.619
central nervous system stimulants: D27.505.696.282, D27.505.954.427.220
north sea: Z01.756.092.650
dna-directed dna polymerase: D08.811.913.696.445.308.300
tinnitus: C09.218.458.670, C10.597.751.418.670, C23.888.592.763.393.670
locus coeruleus: A08.186.211.132.659.473, A08.186.211.132.810.428.600.500, A08.186.211.653.473, A08.186.211.865.428.600.500
stilbenes: D02.455.426.559.389.150.700
auditory cortex: A08.186.211.730.885.287.500.863.297
indium: D01.268.556.381, D01.552.544.381
speech perception: F02.463.593.071.875
tin compounds: D01.935
tissue inhibitor of metalloproteinase-2: D12.776.645.875.500
superior cervical ganglion: A08.340.315.350.850, A08.800.050.300.300.850, A08.800.050.800.300.850
hypoglossal nerve: A08.800.800.120.330
17-alpha-hydroxyprogesterone: D04.808.745.745.654.829.395.400, D06.472.334.851.687.750.478.400
national institutes of health (u.s.): I01.409.137.500.600.480, N03.540.348.500.500.600.480
activation analysis: E05.196.039
neutrons: G01.249.645
sodium azide: D01.625.100.750, D01.857.462
pepsinogen a: D08.622.509.700
pepsinogen c: D08.622.509.725
dyspepsia: C23.888.821.236
pepsinogens: D08.622.509
precancerous conditions: C04.834
arylamine n-acetyltransferase: D08.811.913.050.134.138
immune system diseases: C20
immunophenotyping: E01.370.225.812.447, E05.200.812.447, E05.478.594.450
bucladesine: D03.438.759.646.138.395.250, D13.695.462.200.250, D13.695.667.138.395.250, D13.695.827.068.395.250
coral reefs: G16.500.275.157.130, N06.230.124.130
anthozoa: B01.050.500.308.237
dizocilpine maleate: D02.455.426.559.847.181.384.380, D04.615.181.384.380
protein-tyrosine kinases: D08.811.913.696.620.682.725
raphe nuclei: A08.186.211.132.659.632, A08.186.211.132.810.507, A08.186.211.653.632, A08.186.211.865.507
serotonergic neurons: A08.663.895, A11.671.895
health food: J02.500.525.450
intestine, large: A03.556.124.526, A03.556.249.249
alpha-synuclein: D12.776.641.860.500
cyprus: Z01.542.580.500.300, Z01.639.640.300
residence characteristics: N01.224.791, N06.850.505.400.800
hemoglobinopathies: C15.378.420, C16.320.365
hemoglobin a: D12.776.124.400.405, D12.776.422.316.762.380
oliguria: C12.777.934.600, C13.351.968.934.600, C23.888.942.400
nitric acid: D01.029.260.550, D01.625.525
pakistan: Z01.252.245.723
nestin: D05.750.078.593.540, D12.776.220.475.540, D12.776.641.607
menarche: G08.686.760.410, G08.686.785.880.374.410
hyperlipidemias: C18.452.584.500.500
sex hormone-binding globulin: D12.776.124.790.223.800, D12.776.157.762, D12.776.377.715.182.800
progesterone reductase: D08.811.682.047.436.350.700, D08.811.682.047.820.500
kerosene: D20.345.630.600, N06.230.132.258.630.600
drug delivery systems: E02.319.300
peristalsis: G10.261.326.310.596
venous thrombosis: C14.907.355.830.925
fibrinolytic agents: D27.505.519.421.750, D27.505.954.411.320, D27.505.954.502.427
lymphopenia: C15.378.553.546.605, C20.673.627
formazans: D02.172.600
amyloid beta-peptides: D12.644.024, D12.776.049.407.249.500, D12.776.543.039.500
tetrazolium salts: D03.383.129.617.700
exocytosis: G04.299.490
leukoencephalopathies: C10.228.140.695
insect repellents: D27.505.696.706.434, D27.720.031.700.441, D27.720.723.441, D27.888.723.441
sitosterols: D04.808.247.222.857, D04.808.247.808.756.669
iridovirus: B04.280.410.400, B04.525.400
ambystoma: B01.050.150.900.090.608.080.068
sialorrhea: C07.465.815.815
uveal neoplasms: C04.588.364.978, C11.319.494, C11.941.855
eukaryotic cells: A11.450
magainins: D12.644.050.500, D12.776.543.695.054.500
xenopus proteins: D12.776.045.500
antimicrobial cationic peptides: D12.644.050, D12.776.543.695.054
iothalamic acid: D02.241.223.100.400.880.430, D02.455.426.559.389.127.375.880.430
methoxamine: D02.033.100.624.536, D02.033.755.624.536, D02.092.063.624.536, D02.092.471.683.661
adrenergic agonists: D27.505.519.625.050.100, D27.505.696.577.050.100
lysophospholipase: D08.811.277.352.100.680.510
methotrexate: D03.438.733.631.192.500
neurulation: G07.700.320.500.325.180.875
psoas muscles: A02.633.567.825
measles-mumps-rubella vaccine: D20.215.894.815.500, D20.215.894.899.390, D20.215.894.899.404.500, D20.215.894.899.488.500, D20.215.894.899.779.500
measles: C02.782.580.600.500.500
glutamate decarboxylase: D08.811.520.224.125.250
crystallins: D12.776.306.366
avidin: D12.776.034.614.300, D12.776.256.317.663.300, D12.776.290.663.100, D12.776.395.175
trabecular meshwork: A09.371.060.932
osteoprotegerin: D12.776.543.750.705.852.760.949.249
rank ligand: D12.644.276.374.750.562, D12.644.276.972.562, D12.776.467.374.750.562, D12.776.467.972.562, D23.529.374.750.562, D23.529.972.562
receptor activator of nuclear factor-kappa b: D12.776.543.750.705.852.760.345
eicosanoids: D10.251.355.255, D23.469.050.175
alpha7 nicotinic acetylcholine receptor: D12.776.157.530.400.400.100.500.500, D12.776.543.550.425.500.100.500.500, D12.776.543.585.400.500.100.500.500, D12.776.543.750.051.687.500, D12.776.543.750.720.360.550.500
benzoxazines: D03.383.533.249, D03.438.209
hla-dp beta-chains: D12.776.395.550.509.400.420.750, D12.776.543.550.423.400.420.750, D23.050.301.500.400.400.420.750, D23.050.301.500.450.400.420.750, D23.050.705.552.410.400.420.750, D23.050.705.552.450.400.420.750
pyramidal tracts: A08.186.854.633, A08.612.380.730
rana clamitans: B01.050.150.900.090.180.708.210
fats: D10.212
flavones: D03.438.150.266.450.260, D03.830.219.266.450.260
imidazolidines: D03.383.129.308.432
murinae: B01.050.150.900.649.865.635.505
sirolimus: D02.540.505.760
tor serine-threonine kinases: D08.811.913.696.620.682.700.931, D12.776.476.925
hormone replacement therapy: E02.319.452
fumarates: D02.241.081.337.302
metabolome: G03.500
pregnant women: M01.975.807
aminobutyrates: D02.241.081.114.500, D12.125.190
biosensing techniques: E05.601.123
x-ray microtomography: E01.370.350.700.810.810.900, E01.370.350.825.810.810.900
vacuolar proton-translocating atpases: D08.811.277.040.025.325.875, D08.811.913.696.650.150.500.875, D12.776.157.530.450.250.875.500.875, D12.776.543.585.450.250.875.500.875
eukaryota: B01
saccharomyces cerevisiae proteins: D12.776.354.750
basic-leucine zipper transcription factors: D12.776.260.108, D12.776.930.127
chromosome painting: E01.370.225.500.620.670.325.350.125, E01.370.225.750.600.670.325.350.125, E05.200.500.620.670.325.350.125, E05.200.750.600.670.325.350.125, E05.393.285.350.125, E05.393.661.475.350.125
heterogeneous-nuclear ribonucleoprotein group a-b: D12.776.157.725.500.500.100, D12.776.260.735.500, D12.776.660.235.700.500, D12.776.664.962.500.500.100
prunus: B01.650.940.800.575.100.842.500.625
drosophilidae: B01.050.500.131.617.289.310
oregon: Z01.107.567.875.560.550, Z01.107.567.875.580.550
food, organic: J02.500.519
nf-e2-related factor 2: D12.776.260.108.737, D12.776.930.127.737
pons: A08.186.211.132.810.428.600, A08.186.211.865.428.600
thapsigargin: D02.455.426.392.368.284.500.888, D02.455.849.765.793.888
lanthanoid series elements: D01.268.477, D01.268.558.362, D01.552.550.399
dihydrotachysterol: D04.808.247.222.387, D04.808.247.222.474.250, D04.808.247.808.337, D04.808.247.808.412.250, D04.808.812.768.462.250, D10.570.938.359
urodela: B01.050.150.900.090.608
desiccation: E05.196.335, G02.149.767.530, G02.842.750.530
climate change: G16.500.240.135.374
dermatitis, photoallergic: C17.800.174.255.100.600, C17.800.600.325, C17.800.815.255.100.600, C20.543.418.150.600
fatty alcohols: D02.033.415, D10.289
toxaphene: D02.455.526.439.913, D02.455.849.575.781.795
skin temperature: G07.110.753, G13.750.844
radar: L01.178.847.500
automobiles: J01.937.500.100
cardiovascular physiological phenomena: G09.330
vestibulocochlear nerve: A08.800.800.120.910
waist-hip ratio: E01.370.600.115.100.960, E05.041.124.946, G07.100.100.960
body composition: G02.111.097, G03.180, G07.100.049
health promotion: N02.370, N02.421.726.507
cytosine: D03.383.742.698.421
atp-binding cassette transporters: D12.776.157.530.100, D12.776.395.550.020, D12.776.543.550.192, D12.776.543.585.100
tight junction proteins: D12.776.543.984
otitis media: C09.218.705.663
women's health: N01.400.900
diamines: D02.092.782.258
adiposity: E01.370.600.115.100.062.500, G02.111.097.134.500, G03.180.134.500, G07.100.049.134.500
abdominal fat: A10.165.114.830.500
vulva: A05.360.319.887
seychelles: Z01.639.520.750
selenomethionine: D02.712.700, D02.886.030.676.900, D12.125.166.676.900
spinal dysraphism: C10.500.680.800, C16.131.666.680.800
receptors, fibroblast growth factor: D12.776.543.750.750.400.370
quinazolines: D03.438.786
tyrphostins: D02.455.426.559.389.150.795, D02.626.886, D03.438.857.885
sanitary engineering: H02.229.656, J01.293.821, N06.850.780.200.800.800, N06.850.860.510
bronchoscopy: E01.370.386.105, E01.370.388.250.100, E04.800.250.100, E04.928.600.080
mast cells: A11.329.427, A15.382.652
hydronephrosis: C12.777.419.307, C13.351.968.419.307
tribulus: B01.650.940.800.575.100.987.849
ectoderm: A16.504.273
argininosuccinate synthase: D08.811.464.259.300
embryoid bodies: A11.872.190.260
feeder cells: A11.251.538
octamer transcription factor-3: D12.776.260.655.500.300, D12.776.930.632.500.300
citric acid cycle: G02.111.087.165, G02.149.115.165, G03.495.335.342, G03.495.553.170
glycosphingolipids: D09.400.410.420, D10.390.470, D10.570.877.360
oximetry: E01.370.225.124.100.100.600, E01.370.370.380.600, E01.370.386.700.100.600, E05.200.124.100.100.600
thioamides: D02.065.900, D02.886.685
magnetics: H01.671.493
antidotes: D27.505.696.706.037, D27.720.799.037
hydrodynamics: G01.342
aquaporins: D12.776.157.530.400.500.040, D12.776.543.550.425.730.040, D12.776.543.585.400.730.040
secondary prevention: N02.421.726.825, N06.850.780.750
infusions, intraventricular: E02.319.267.510.692
nadph oxidase: D08.811.682.608.575, D12.776.331.894
follicular phase: G08.686.605.310
aggression: F01.145.126.125, F01.145.813.045
social behavior: F01.145.813
maternal behavior: F01.829.263.370.215
spectrometry, mass, matrix-assisted laser desorption-ionization: E05.196.566.755
inosine: D03.438.759.590.616, D13.570.583.616, D13.570.800.573
cholesterol 7-alpha-hydroxylase: D08.244.453.915.200, D08.811.682.690.708.170.915.200, D08.811.682.690.708.783.200, D12.776.422.220.453.915.200
organic anion transporters: D12.776.157.530.450.074.500, D12.776.543.585.450.074.500
taurocholic acid: D02.455.326.146.100.850.875, D02.886.645.600.055.850.800, D04.808.105.225.900, D04.808.221.430.873
tissue extracts: D20.777
lipidoses: C16.320.565.398.641, C18.452.584.687, C18.452.648.398.641
disasters: N06.230.100
lordosis: C05.116.900.800.750
tunisia: Z01.058.266.887
lost to follow-up: E05.318.780.438
holidays: I03.450.345
stratospheric ozone: D01.362.670.600.500, G16.500.275.063.700, N06.230.300.100.700
potassium citrate: D02.241.081.901.434.249.750
lysergic acid diethylamide: D03.132.327.287.572.522, D03.549.439.572.522
cerebral arteries: A07.231.114.228
oogonia: A05.360.490.690.700, A11.497.497.650
syringes: E07.877
neural pathways: A08.612
arecoline: D03.066.515.292, D03.132.080, D03.383.725.547.292
churg-strauss syndrome: C14.907.940.897.249.249, C15.604.515.292.015, C20.111.193.500
zona pellucida: A05.360.490.690.950, A11.284.295.310.990, A11.497.497.900, A16.690.900
rome: Z01.433.850, Z01.542.489.569
bronchopneumonia: C08.127.509, C08.381.677.127, C08.730.610.127
abscess: C01.539.830.025, C23.550.470.756.100
dental clinics: N02.278.192.250
specialization: H02.811
plasma: A12.207.152.693, A12.207.270.695, A15.145.693
ventromedial hypothalamic nucleus: A08.186.211.730.317.357.352.953
azides: D01.625.100, D02.159
long-term synaptic depression: G11.561.600.635.355
mother-child relations: F01.829.263.370.290.170
inheritance patterns: G05.420
alpha-methyltyrosine: D12.125.072.050.875.485.050
selegiline: D02.092.471.683.915
space perception: F02.463.593.778, F02.463.593.932.869
contractile proteins: D12.776.210
resins, synthetic: D05.750.716.822, D25.339.816, D25.720.716.822, J01.637.051.339.816, J01.637.051.720.716.822
protein biosynthesis: G02.111.087.675.871, G02.149.115.675.871, G03.495.770.871, G05.355.310.670
muscle weakness: C05.651.515, C10.597.613.593, C23.550.695, C23.888.592.608.593
lymnaea: B01.050.500.644.400.750.645
bisexuality: F01.145.802.975.200, G08.686.867.200
disseminated intravascular coagulation: C15.378.100.220, C15.378.463.250, C15.378.925.220
hemolytic-uremic syndrome: C12.777.419.936.463, C13.351.968.419.936.463, C15.378.071.141.610, C15.378.140.855.925.500
thalassemia: C15.378.071.141.150.875, C15.378.420.826, C16.320.070.875, C16.320.365.826
dysphonia: C08.360.940.325, C09.400.940.325, C10.597.975.325, C23.888.592.979.325
cranial nerve neoplasms: C04.588.614.300, C04.588.614.596.240, C10.292.225, C10.551.360
gastroesophageal reflux: C06.405.117.119.500.484
orphan nuclear receptors: D12.776.260.698.209, D12.776.826.209, D12.776.930.669.209
water wells: G01.311.355.875
hypophysectomy: E04.270.532, E04.525.400
stem cell factor: D12.644.276.374.410.800, D12.776.467.374.410.800, D23.529.374.410.800
proto-oncogene proteins c-kit: D08.811.913.696.620.682.725.400.050, D12.776.543.750.060.124, D12.776.543.750.705.852.150.100, D12.776.543.750.750.400.200.170, D12.776.624.664.700.183, D23.050.301.264.035.590, D23.101.100.110.590
cell line, tumor: A11.251.210.190, A11.251.860.180
oil and gas fields: G01.311.687
rheumatic diseases: C05.799, C17.300.775
cell shape: G04.320
wavelet analysis: E05.959, G17.915, L01.224.800.750
psychophysics: E01.370.685, F04.096.753, F04.732
mitogen-activated protein kinase 8: D08.811.913.696.620.682.700.567.513.500, D08.811.913.696.620.682.700.646.750.374.500, D12.644.360.450.340.500, D12.776.476.450.340.500
acetyl-coa carboxylase: D08.811.464.257.050, D08.811.641.249
phosphatidylinositol 3-kinase: D08.811.913.696.620.500.100
phosphatidylethanolamine binding protein: D12.644.360.562, D12.776.157.661, D12.776.476.555
laser capture microdissection: E01.370.225.998.221.580.500, E05.200.998.221.580.500, E05.591.560.500
hydroxymethylglutaryl-coa synthase: D08.811.913.050.612
taste threshold: F02.463.593.710.790, G11.561.600.810.724.880, G11.561.840
introns: G05.360.340.024.220.400, G05.360.340.024.340.137.515
cercopithecus aethiops: B01.050.150.900.649.801.400.112.199.120.126.110
ovariectomy: E04.270.282.685, E04.950.165.685, E04.950.300.680
sicily: Z01.542.489.751, Z01.542.580.500.751, Z01.639.640.751
chytridiomycota: B01.300.283
vitis: B01.650.940.800.575.100.965.500
polyphenols: D02.455.426.559.389.657.715, D03.438.150.266.450.260.777
lipogenesis: G02.111.087.525, G02.149.115.525, G03.495.520.249
glucose transporter type 4: D12.776.157.530.500.500.937, D12.776.543.585.500.500.937
renal insufficiency, chronic: C12.777.419.780.750, C13.351.968.419.780.750
astragalus membranaceus: B01.650.940.800.575.100.401.087.750
triterpenes: D02.455.849.919
osteocytes: A11.329.629.500
nfatc transcription factors: D12.776.930.608
amniocentesis: E01.370.225.500.384.050, E01.370.225.998.329.309, E01.370.378.630.050, E04.665.600.309, E05.200.500.384.050, E05.200.998.329.309, E05.242.384.050
biological specimen banks: N02.278.065
stereocilia: A11.284.180.800
phalloidine: D04.345.566.735, D12.644.456.735, D12.644.641.735, D23.946.587.755
dysarthria: C10.597.606.150.500.800.150.200, C23.888.592.604.150.500.800.150.200
injections, subcutaneous: E02.319.267.530.620
abducens nerve diseases: C10.292.150
caribbean region: Z01.107.084
diiodothyronines: D06.472.931.740.180, D12.125.072.050.767.741.180
candida glabrata: B01.300.381.147.400, B01.300.930.176.400
yeasts: B01.300.930
fish proteins: D12.776.325
naproxen: D02.455.426.559.847.638.472.500, D04.615.638.472.450
gemfibrozil: D02.241.081.114.968.500.750, D02.241.081.944.509.350, D02.355.726.305.750, D02.455.426.559.389.657.654.305.750, D10.251.400.895.593.350
salicylic acid: D02.241.223.100.300.595.608, D02.241.511.390.595.608, D02.455.426.559.389.127.281.595.608, D02.455.426.559.389.657.410.595.608
fenbendazole: D02.241.081.251.320, D03.438.103.450
pten phosphohydrolase: D08.811.277.352.650.850, D12.776.476.590, D12.776.624.776.695
neuropil: A08.637.500, A08.663.703, A11.650.500, A11.671.685
dehydration: C18.452.950.179, C23.550.274
nitric oxide synthase type i: D08.811.682.664.500.772.249
organophosphate poisoning: C25.723.717
megakaryocytes: A11.148.479, A15.378.316.479
infant behavior: F01.145.179.500
puma: B01.050.150.900.649.147.354.630
apoptotic protease-activating factor 1: D12.644.360.024.131.124, D12.644.360.075.358.124, D12.776.157.057.004.124, D12.776.476.024.139.124, D12.776.476.075.358.124
activating transcription factor 6: D12.644.360.011, D12.776.260.108.061.968, D12.776.476.011, D12.776.930.127.061.968
eif-2 kinase: D08.811.913.696.620.682.700.300, D12.644.360.275, D12.776.476.275
factor x: D12.776.124.125.400, D23.119.400
thermal conductivity: G01.906.730
ceramides: D02.065.313, D09.400.410.420.525.200, D10.390.470.675.200, D10.570.877.360.612.200
cyclin-dependent kinase inhibitor p16: D12.644.360.225.200, D12.776.167.187.200, D12.776.476.225.200, D12.776.624.776.355.200
mya: B01.050.500.644.080.535
antithyroid agents: D06.347.100, D27.505.696.399.450.100
dental staff: M01.526.485.290, N02.360.290
craniocerebral trauma: C10.900.300, C26.260, C26.915.300
unithiol: D02.886.489.180.900
diagnostic errors: E01.354, N02.421.450.280
stomatitis: C07.465.864
niobium: D01.268.556.615, D01.268.956.687, D01.552.544.615
inlays: E06.323.428.275, E06.780.345.737.500, E06.780.345.817, E07.695.190.190.350
supine position: G11.427.695.625
informed consent: I01.880.604.473.650.718, I01.880.604.583.427, N03.706.437.650.312, N03.706.535.489
chorionic villi: A10.615.284.473.200, A16.254.750.473.200, A16.710.189
wind: G16.500.240.135.249.200, G16.500.275.063.725.154.200, G16.500.750.775.780, N06.230.132.644.875, N06.230.300.100.150.185.200, N06.230.300.100.725.780
biological oxygen demand analysis: N06.850.460.350.080.500, N06.850.780.375.349
piracetam: D02.065.064.650, D02.241.081.018.110.650, D03.383.773.812.555
behavioral symptoms: F01.145.126
heat stroke: C26.522.500
myofibroblasts: A11.329.228.975, A11.620.520.500
hepatic stellate cells: A11.561
liver cirrhosis: C06.552.630
decapodiformes: B01.050.500.644.116.150
synapsins: D12.776.641.750, D12.776.744.840
neurotrophin 3: D12.644.276.860.775, D12.776.467.860.775, D12.776.641.600.775, D23.529.850.775
cladosporium: B01.300.381.200
trichoderma: B01.300.381.910
mitosporic fungi: B01.300.381
streptomyces: B03.300.390.400.810.768, B03.510.024.049.775.775, B03.510.415.400.810.768, B03.510.460.410.810.768
receptors, adrenergic, alpha-1: D12.776.543.750.070.300.300.300.700, D12.776.543.750.100.150.300.300.700, D12.776.543.750.720.300.300.300.300.100
enzyme assays: E05.196.427
cumulus cells: A05.360.319.114.630.535.200.500, A06.407.312.497.535.300.500, A11.382.812.500, A11.436.329.500
mice, inbred strains: B01.050.050.157.520, B01.050.050.199.520.520, B01.050.150.900.649.865.635.505.500.400
castor oil: D10.212.507.300, D10.627.700.132, D20.215.784.750.132
hormone antagonists: D06.347, D27.505.696.399.450
forearm injuries: C26.088.268
bufanolides: D04.808.155.580.064
cerebral hemorrhage: C10.228.140.300.535.200, C14.907.253.573.200, C23.550.414.913.100
alternaria: B01.300.381.075
rhizopus: B01.300.300.500.800
myxomycetes: B01.046.550.550
mucormycosis: C01.703.980.600
basidiomycota: B01.300.179
phytohemagglutinins: D12.776.395.560.825, D12.776.503.499.750, D12.776.765.678.750
thyroid function tests: E01.370.374.750
piloerection: F02.830.702.607, G11.561.600.765.482, G13.750.829.690
quantitative trait loci: G05.360.340.024.380.937
genetic linkage: G05.540
angiogenesis inducing agents: D27.505.696.377.077.077
prazosin: D03.438.786.750
dicumarol: D03.438.150.446.520.203, D03.830.219.446.520.203
pinctada: B01.050.500.644.080.670
lavandula: B01.650.940.800.575.100.575.428
ibuprofen: D02.241.223.701.430
citrus: B01.650.940.800.575.100.875.177
polymorphism, genetic: G05.365.795
chelation therapy: E02.319.155
pica: F03.375.600, F03.550.400.600
bed rest: E02.075
head-down tilt: G11.427.695.300
social conditions: I01.880.578, N01.824.827
specimen handling: E01.370.225.998, E05.200.998
chloramines: D02.065.884.344, D02.886.590.700.344
thiosulfate sulfurtransferase: D08.811.913.817.500.500
cystathionine gamma-lyase: D08.811.520.300.250
sulfurtransferases: D08.811.913.817.500
greece: Z01.542.383, Z01.586.035.450
anti-inflammatory agents: D27.505.954.158
presbycusis: C09.218.458.341.887.772, C10.597.751.418.341.887.772, C23.888.592.763.393.341.887.772
spiral ganglion: A08.340.390.800, A08.800.350.800, A08.800.800.120.910.120.800, A09.246.631.246.900
auditory threshold: F02.463.593.071.173, F02.463.593.710.190
auditory fatigue: F02.463.593.071.173.095
cystine: D01.248.497.158.874.390.369, D01.875.350.850.150.369, D02.886.030.230.369, D02.886.520.150.087, D12.125.095.369, D12.125.119.369, D12.125.166.230.369
adipogenesis: G04.299.151.149
lymphopoiesis: G04.299.151.825.597.500, G09.188.124.544.597.500
hemiarthroplasty: E04.555.110.110.482, E04.650.110.482
cartilage: A02.165, A10.165.382
gabaergic neurons: A08.663.289, A11.671.285
retirement: I03.702
patient rights: I01.880.604.473.650, N03.706.437.650
receptor, erbb-2: D08.811.913.696.620.682.725.400.150, D12.776.543.750.060.374, D12.776.543.750.750.400.350, D12.776.624.664.700.642, D23.101.840.642
hemocytes: A11.118.480, A15.145.229.480
defensins: D12.644.050.200, D12.776.543.695.054.200
caloric tests: E01.370.382.900.150
cholesterol esters: D04.808.247.222.284.200, D04.808.247.808.197.200, D10.570.938.208.250
food contamination: J01.576.423.850.730.500.249, N06.850.460.400, N06.850.601.500.249
metabolic diseases: C18.452
ovoviviparity: G08.686.655
lotus: B01.650.940.800.575.100.401.562
carbonic anhydrases: D08.811.520.241.300.150
microscopy, electron, scanning: E01.370.350.515.402.541, E05.595.402.541
maf transcription factors: D12.776.260.108.500, D12.776.930.127.500
cytochrome p-450 cyp2d6: D08.244.453.040.944, D08.811.682.690.708.170.040.555, D12.776.422.220.453.040.888
mephenytoin: D03.383.129.308.432.555.620
chlorzoxazone: D03.438.221.346
zirconium: D01.268.556.950, D01.268.956.937, D01.552.544.950
hepatic encephalopathy: C06.552.308.500.356, C10.228.140.163.360, C18.452.132.360
liver failure: C06.552.308.500
fat body: A13.365
appetite: F02.830.071, G07.610.390.070, G10.261.390.070
ras-grf1: D12.644.360.325.300.700.500, D12.776.402.300.700.500, D12.776.476.325.300.700.500
amnion: A10.615.284.277, A16.254.750.277
pleural cavity: A01.923.761.800.650
nanowires: J01.637.512.925
arctic regions: Z01.208
sodium cyanide: D01.625.400.100.875, D01.857.660
meperidine: D03.066.399.450, D03.383.621.349.450
exhumation: I01.198.780.937.422
homicide: I01.198.240.470, I01.880.735.344
poverty: I01.880.735.634, I01.880.840.535, N01.824.600
colonoscopy: E01.370.372.250.250.200, E01.370.388.250.250.250.160, E04.210.240.250.160, E04.800.250.250.250.160
macroglobulins: D12.776.124.790.720, D12.776.377.715.647
synucleins: D12.776.641.860
synaptic potentials: G04.580.887, G07.265.337.900.750, G07.265.750.887, G07.700.240.900.750, G11.561.570.918, G11.561.600.835.750
antiporters: D12.776.157.530.450.162, D12.776.543.550.190, D12.776.543.585.450.162
cell extracts: D20.777.162
hepatoblastoma: C04.557.435.380
hypoproteinemia: C15.378.147.607
tricarboxylic acids: D02.241.081.901
laser-doppler flowmetry: E01.370.370.475, E05.830.500
encephalitis: C02.182.500, C10.228.140.430, C10.228.228.210.150, C10.228.228.245
bias (epidemiology): N05.715.350.150, N06.850.490.500
ubiquitin thiolesterase: D08.811.277.352.897.850
ubiquitin: D12.776.947.500
muscle, skeletal: A02.633.567, A10.690.552.500
dermatitis, phototoxic: C17.800.174.255.400.225, C17.800.600.335, C17.800.815.255.400.225
pulse wave analysis: E01.370.370.680
radial artery: A07.231.114.740
subcutaneous fat: A10.165.114.830.750
electrophoretic mobility shift assay: E05.196.401.500
crops, agricultural: B01.650.510.344, J02.500.300
dendritic spines: A08.663.256.200, A11.284.180.225.169, A11.671.240.169
negotiating: F01.145.209.520, F01.829.401.520, F02.463.785.373.520, L01.143.620, N04.452.677.430
gene rearrangement: G05.355.330
nitrous oxide: D01.362.635.625, D01.625.550.550, D01.650.550.587.650
nitroparaffins: D02.455.326.146.672, D02.640.720
benzothiazoles: D03.383.129.708.089, D03.438.185
metribolone: D04.808.365.415.550
nonsteroidal anti-androgens: D06.347.065.500, D27.505.696.399.450.065.500
danazol: D04.808.745.432.235
cyproterone: D04.808.745.432.219, D04.808.883.419
tosyl compounds: D02.455.426.559.389.832.661, D02.886.590.887
phosphotyrosine: D12.125.072.050.875.750, D12.125.740.740
hematologic tests: E01.370.225.625, E05.200.625
onium compounds: D02.675
gastroenterology: H02.403.429.405
bithionol: D02.455.426.559.389.657.120
salicylanilides: D02.065.199.860, D02.065.793.650
clitoris: A05.360.319.887.436
nuclear receptor coactivator 1: D08.811.913.050.134.407.100, D12.644.360.024.308.100, D12.776.157.057.080.100, D12.776.476.024.394.100, D12.776.660.675.100, D12.776.930.617.100
p300-cbp transcription factors: D08.811.913.050.134.440, D12.776.930.622
co-repressor proteins: D12.776.930.700.625
gastroenteritis: C06.405.205
vasculitis: C14.907.940
gene deletion: G05.355.600.800.320, G05.365.590.762.320
acetyltransferases: D08.811.913.050.134
primary prevention: N02.421.726.758, N06.850.780.680
transcytosis: G03.495.166.962, G04.299.482.685, G04.299.490.790
skin pigmentation: E01.370.600.620.750, G13.750.829.833, G16.690.890
leukopenia: C15.378.553.546
tomography: E01.370.350.825
ryanodine: D02.455.849.291.686, D03.132.740, D03.383.129.578.805
transcription factor ap-1: D12.776.260.108.875, D12.776.930.127.875
pain threshold: F02.463.593.710.560, F02.830.816.444.700, G11.561.600.810.444.700
pain management: E02.745, N04.590.607.500
analgesia: E03.091
trans-activators: D12.776.260.755, D12.776.930.900, D12.776.964.925.984
fatty acid transport proteins: D12.776.157.530.300, D12.776.543.585.300
fetal diseases: C13.703.277, C16.300
chlorpromazine: D02.886.369.198, D03.494.741.198
promethazine: D02.092.831.690, D02.886.369.670, D03.494.741.670
matrix metalloproteinase 1: D08.811.277.656.300.480.205.351, D08.811.277.656.300.480.525.700.100, D08.811.277.656.675.374.205.351, D08.811.277.656.675.374.525.700.100
tissue inhibitor of metalloproteinase-1: D12.776.645.875.450
nucleotide motifs: G02.111.570.080.611, G02.111.570.790.486.662, G05.360.080.611, G05.360.580.662
transcription initiation site: G05.360.340.024.340.137.750.840
partial thromboplastin time: E01.370.225.625.115.600, E05.200.625.115.600, G09.188.660
skin ulcer: C17.800.893
silver nitrate: D01.625.525.550.850, D01.847.900
spinal cord diseases: C10.228.854
publication bias: L01.737.813
mastectomy: E04.466
thoracic wall: A01.923.761.850
micrornas: D13.150.650.319, D13.444.735.150.319, D13.444.735.790.552.500
cardia: A03.556.875.875.163
medication adherence: F01.145.488.500.500, N05.300.150.600.600.500
acute disease: C23.550.291.125
emergency service, hospital: N02.278.354.422.336, N02.421.297.195, N04.452.442.422.336
electroporation: E05.242.448, E05.301.500
luteinization: G08.686.785.760.690.355
agoraphobia: F03.080.100
nasal provocation tests: E01.370.386.550
phosphamidon: D02.705.400.700
excitatory amino acid antagonists: D27.505.519.625.190.300, D27.505.696.577.190.300
receptors, tumor necrosis factor, type ii: D12.776.543.750.705.852.760.798, D23.050.301.264.035.910, D23.101.100.110.916
gene knockout techniques: E05.393.335.750
receptors, tumor necrosis factor, type i: D12.776.543.750.073.750, D12.776.543.750.705.852.760.597, D23.050.301.264.035.908, D23.101.100.110.912
hares: B01.050.150.900.649.521.400
plant diseases: G15.556
follicular cyst: C04.182.300
ovarian cysts: C04.182.612, C13.351.500.056.630.580, C19.391.630.580
luteinizing hormone, beta subunit: D06.472.699.322.576.463.500, D06.472.699.631.525.343.463.500, D12.644.548.691.525.343.463.500
follicle stimulating hormone, beta subunit: D06.472.699.322.576.288.500, D06.472.699.631.525.343.288.500, D12.644.548.691.525.343.288.500
elasticity: G01.374.590
prophase: G04.299.134.220.220.781.906, G04.299.134.220.220.875, G05.355.105.220.781.906, G05.355.105.220.875
chromosome pairing: G04.299.134.220.220.687.444.299, G04.299.134.220.220.875.500.299, G05.355.105.220.687.500.299, G05.355.105.220.875.500.299
abnormal karyotype: C23.550.210.024, G05.360.162.679.500, G05.365.590.175.024
asterias: B01.050.500.408.765.070
starfish: B01.050.500.408.765
arcuate nucleus: A08.186.211.730.317.357.352.081
photosynthesis: G02.111.087.160.937, G02.111.087.678.700, G02.149.115.160.937, G02.149.115.678.700, G02.149.767.690.921, G02.842.750.690.921, G03.495.256.937, G03.495.553.700, G03.495.795.700, G15.744.700
gene expression regulation: G05.355.315
uricosuric agents: D27.505.954.329.337.900, D27.505.954.613.860
benzbromarone: D03.438.127.110
xanthine oxidase: D08.811.682.047.928
gout suppressants: D27.505.954.329.337
ruthenium red: D01.210.837, D01.625.800, D01.765.765
carbonyl cyanide p-trifluoromethoxyphenylhydrazone: D02.442.288.220, D02.626.270
proton-translocating atpases: D08.811.277.040.025.325, D08.811.913.696.650.150.500, D12.776.157.530.450.250.875.500, D12.776.543.585.450.250.875.500
anthocidaris: B01.050.500.408.578.050
clodronic acid: D02.705.429.500.200
liposomes: D25.479.517, D26.255.260.517, D27.720.280.260.517, J01.637.051.479.517, J01.637.087.500.517
macrophage activation: G12.425.270.500
pulmonary eosinophilia: C08.381.750, C15.378.553.231.549.750
cresols: D02.455.426.559.389.657.239
comb and wattles: A13.242
dna repair enzymes: D08.811.074
flicker fusion: E01.370.380.245, F02.463.593.932.458, G14.370
antigen-presenting cells: A11.066, A15.382.066
sutures: E07.858.690.820
amyloid beta-protein precursor: D12.776.049.407.249, D12.776.543.039, D12.776.645.468.500, D12.776.811.050
muscarinic agonists: D27.505.519.625.120.140.500, D27.505.696.577.120.140.500
glaucoma: C11.525.381
patient compliance: F01.145.488.500, N05.300.150.600.600
pentose phosphate pathway: G02.111.087.160.875, G02.149.115.160.875, G03.495.256.875, G03.495.335.693, G03.495.553.695
albuterol: D02.033.100.291.057, D02.092.063.291.057, D02.092.471.683.061
carboxypeptidases: D08.811.277.656.350.245
urinary bladder calculi: C12.777.829.720, C12.777.967.500.925, C13.351.968.829.521, C13.351.968.967.500.925, C23.300.175.850.875
pollen: A18.024.249.500.249.500
ligaments: A02.513
nuclear energy: G01.595.630, N06.230.132.580
chorea: C10.228.662.262.249, C10.597.350.250, C23.888.592.350.250
sorbus: B01.650.940.800.575.100.842.500.793
polonium: D01.268.185.600, D01.268.271.680, D01.268.513.875
presynaptic terminals: A08.663.542.145.750, A08.850.700, A11.284.149.165.420.780.700, A11.671.137.750
mobility limitation: C23.888.550
kisspeptins: D12.644.276.836, D12.644.400.430, D12.776.624.776.546
liquid-liquid extraction: E05.196.155.650
jurkat cells: A11.251.210.190.495, A11.251.860.180.495, A15.382.490.555.567.569.440
polycyclic compounds: D04
dna modification methylases: D08.811.150.240, D08.811.913.555.500.350
dna (cytosine-5-)-methyltransferase: D08.811.913.555.500.350.100.500
vinca: B01.650.940.800.575.100.081.972
trematode infections: C03.335.865
paper: J01.576.154.600, J01.637.650
sexual partners: M01.778
body surface area: E01.370.600.115.100.231, E05.041.124.231, G07.100.100.231
multidetector computed tomography: E01.370.350.350.810.800.500, E01.370.350.600.350.700.810.800.500, E01.370.350.700.700.810.800.500, E01.370.350.700.810.810.800.249, E01.370.350.825.810.810.800.249
neoplastic stem cells: A11.872.650
hallucinogens: D27.505.696.388, D27.505.954.427.300, D27.505.954.427.700.372
designer drugs: D26.200
crack cocaine: D02.145.074.722.388.250, D03.132.889.354.250, D03.605.869.388.250, D04.075.080.875.099.722.388.250, D26.878.250
prenatal care: E02.760.786, N02.421.143.620.704, N02.421.585.786
pollination: G08.686.785.760.743, G15.744.800
nesting behavior: F01.145.113.252.478
plant nectar: D20.215.780
hydrophyllaceae: B01.650.940.800.575.100.531
hydantoins: D03.383.129.308.432.555
aminoimidazole carboxamide: D03.383.129.308.030
sex chromosomes: A11.284.187.865, G05.360.162.865
8-bromo cyclic adenosine monophosphate: D03.438.759.646.138.395.225, D13.695.462.200.225, D13.695.667.138.395.225, D13.695.827.068.395.225
cumulative trauma disorders: C26.844.150
phosmet: D02.705.400.625.670, D02.705.539.345.670, D02.886.300.692.670, D03.438.513.750.625
azinphosmethyl: D02.705.400.625.060, D02.705.539.345.060, D02.886.300.692.060
phosphatidylinositol phosphates: D10.570.755.375.760.400.942.625
subcellular fractions: A11.284.835
gene conversion: G05.355.760.615.475
carbolines: D03.383.725.150, D03.438.473.155, D03.494.154
cyclin-dependent kinases: D08.811.913.696.620.682.700.200, D08.811.913.696.620.682.700.646.500, D12.644.360.250, D12.776.167.200, D12.776.476.250
cyclin e: D12.644.360.262.180, D12.776.167.218.180, D12.776.476.262.180
interferon regulatory factor-1: D12.644.360.024.302.124, D12.776.157.057.050.124, D12.776.260.108.374, D12.776.260.504.124, D12.776.476.024.385.124, D12.776.930.127.374, D12.776.930.332.124
fibrosarcoma: C04.557.450.565.590.350, C04.557.450.795.350
dental pulp: A14.549.167.900.260
dentition: A03.556.500.379, A14.549.167
periodontal ligament: A14.549.167.646.771
tooth: A14.549.167.860
sulfoglycosphingolipids: D09.400.410.420.025.837, D10.390.470.025.837, D10.570.877.360.025.837
myelin-oligodendrocyte glycoprotein: D12.776.395.550.583, D12.776.543.550.572, D12.776.543.620.550, D12.776.641.580.530, D23.050.422.625
alpha-crystallin b chain: D12.776.306.366.100.300, D12.776.580.157.300
g(m1) ganglioside: D09.400.410.420.025.475.390, D10.390.470.025.475.390, D10.570.877.360.025.475.390
neurophysiology: H01.158.610.268, H01.158.782.562
northwestern united states: Z01.107.567.875.560
plant gums: D05.750.078.739, D09.698.700, D20.215.721.249
galactans: D09.698.360
dextrins: D09.698.365.855.400
calcinosis: C18.452.174.130
dna probes: D13.444.600.223, D27.505.259.750.600.223, D27.720.470.530.600.223
benzodioxoles: D03.383.246.118, D03.438.115
clinical protocols: E02.183, N05.715.360.775.225
carcinoma: C04.557.470.200
head and neck neoplasms: C04.588.443
osseointegration: G11.427.590.195.140.570, G16.100.856.150.150.570
soman: D02.705.429.750.750
proline: D12.125.072.401.623
darkness: G01.590.540.233
ceftazidime: D02.065.589.099.249.210.150, D02.886.665.074.210.150, D04.075.080.875.099.221.249.210.150
candida albicans: B01.300.381.147.326, B01.300.930.176.326
silver sulfadiazine: D02.065.884.725.755.800, D02.092.146.807.755.800, D02.886.590.700.725.755.800
aspergillus niger: B01.300.381.081.450
kanamycin: D09.408.051.476
argyria: C17.800.621.166, C25.723.068
staphylococcus: B03.300.390.400.800.750, B03.510.100.750.750, B03.510.400.790.750
gram-positive bacteria: B03.510
gram-negative bacteria: B03.440
microbial sensitivity tests: E01.370.225.875.595, E05.200.875.595, E05.337.550.400
cloxacillin: D02.065.589.099.750.625.150, D02.886.108.750.625.150, D03.438.260.825.625.150, D03.605.084.737.625.150, D04.075.080.875.099.221.750.625.150
ampicillin: D02.065.589.099.750.750.050, D02.886.108.750.750.050, D03.438.260.825.750.050, D03.605.084.737.750.050, D04.075.080.875.099.221.750.750.050
bacteremia: C01.252.100, C01.539.757.100, C23.550.470.790.500.100
genetic counseling: H01.158.273.343.315.384, N02.421.308.400
cytidine: D03.383.742.680.245, D13.570.685.245, D13.570.800.286
carcinoma, renal cell: C04.557.470.200.025.390, C04.588.945.947.535.160, C12.758.820.750.160, C12.777.419.473.160, C13.351.937.820.535.160, C13.351.968.419.473.160
von hippel-lindau tumor suppressor protein: D08.811.464.938.750.875, D12.776.624.776.865
ubiquitination: G02.111.087.675.871.790.600.925, G02.111.087.693.600.775, G02.149.115.675.871.790.600.831, G02.149.115.693.600.850, G03.495.770.871.790.600.831, G05.355.315.670.600.831
fructose-bisphosphate aldolase: D08.811.520.224.062.400
repressor proteins: D12.776.260.703, D12.776.930.700
peritoneal neoplasms: C04.588.033.513, C04.588.274.780, C06.301.780, C06.844.620
conjunctivitis: C11.187.183
respiratory system agents: D27.505.954.796
lagomorpha: B01.050.150.900.649.521
gallic acid: D02.241.223.100.300.200, D02.241.511.390.200, D02.455.426.559.389.127.281.200, D02.455.426.559.389.657.410.200
mood disorders: F03.600
awards and prizes: K01.150
leisure activities: I03.450
agricultural workers' diseases: C24.080
tolonium chloride: D02.886.369.869, D03.494.741.869
enoyl-coa hydratase: D08.811.520.241.300.250
barbiturates: D03.383.742.698.253
biocompatible materials: D25.130, D27.720.102.130, J01.637.051.130
catenins: D12.776.220.145
resistin: D06.472.699.042.750, D12.644.276.024.750, D12.644.548.011.750, D12.776.467.024.750, D23.529.024.750
wine: J02.200.100.900
sodium-glucose transporter 1: D12.776.157.530.450.625.437.500, D12.776.157.530.500.750.500, D12.776.543.585.450.625.562.500, D12.776.543.585.500.750.500
phlorhizin: D09.408.702
arginase: D08.811.277.913.292
gadolinium: D01.268.477.484, D01.268.558.362.484, D01.552.550.399.484
trpm cation channels: D12.776.157.530.400.901.555, D12.776.543.585.400.901.555
growth inhibitors: D27.505.696.377.450
barium compounds: D01.103
polyunsaturated alkamides: D02.065.160, D02.455.326.271.060, D02.455.326.397.675
arachidonic acids: D10.251.355.096, D10.251.355.255.100, D10.251.355.310.166
endocannabinoids: D10.251.265
medicare: N03.219.521.346.506.564.663, N03.219.521.576.343.840, N03.706.615.696
thyrotropin-releasing hormone: D06.472.699.327.740.880, D12.644.400.400.740.880, D12.644.456.837, D12.644.548.365.740.880, D12.776.641.650.405.740.880, D12.776.641.650.810
1-methyl-3-isobutylxanthine: D03.438.759.758.824.751.500
prostaglandins f: D10.251.355.255.100.637.400, D10.251.355.255.550.400, D23.469.050.175.725.790
2-propanol: D02.033.755.615
circular dichroism: E05.196.867.151
amylose: D09.698.365.855.361
nucleic acid hybridization: E05.393.661, G02.111.087.620, G02.149.115.620
chemokine ccl2: D12.644.276.374.200.110.990.600, D12.776.467.374.200.110.990.600, D23.125.300.110.990.600, D23.469.200.110.990.600, D23.529.374.200.110.990.500
nitrogen oxides: D01.362.635, D01.625.550, D01.650.550.587
chymotrypsin: D08.811.277.656.300.760.176, D08.811.277.656.959.350.176
ubiquitinated proteins: D12.776.938
leupeptins: D12.644.456.580
pyrrolidinones: D03.383.773.812
chorioallantoic membrane: A10.615.284.375, A13.350.575, A16.331.400
receptors, n-methyl-d-aspartate: D12.776.157.530.400.400.500.500, D12.776.543.550.425.500.200.500, D12.776.543.585.400.500.200.500, D12.776.543.750.720.200.450.400.500
magnets: J01.637.507
eclampsia: C13.703.395.124
acrodynia: C10.668.829.025, C10.720.475.600.150, C25.723.647.500.100
dimercaprol: D02.886.489.180
peripheral nerve injuries: C10.668.829.712, C10.900.575, C26.915.650
hsp40 heat-shock proteins: D12.776.580.216.292
cytoprotection: G07.690.812.195, G07.700.680.195
gaba-a receptor antagonists: D27.505.519.625.240.300.500, D27.505.696.577.240.300.500
argemone: B01.650.940.800.575.100.795.124
acetogenins: D02.033.415.054, D02.455.326.146.049, D02.540.205, D03.383.312.200, D10.289.054
annona: B01.650.940.800.575.100.065.500
molluscacides: D27.720.031.700.596, D27.720.723.596, D27.888.723.596
benzophenanthridines: D03.132.089, D03.494.633.207, D03.549.131
berberine alkaloids: D03.132.098.057, D03.549.168
norbornanes: D02.455.849.575.781
isoindoles: D03.438.513
time perception: F02.463.593.857
comprehension: F02.463.188.357
hepatitis b: C02.256.430.400, C02.440.435, C06.552.380.705.437
language development: F01.525.200.310
amino acid transport systems: D12.776.157.530.200, D12.776.543.585.200
retinal rod photoreceptor cells: A08.663.650.850.625.670.650, A08.663.650.915.937.670.650, A08.800.950.937.670.650, A09.371.729.831.625.670.650, A11.671.650.850.625.670.650, A11.671.650.915.937.670.650
retinal pigments: D23.767.930
ganglionic blockers: D27.505.696.663.050.340
pentolinium tartrate: D03.383.773.700
androstanols: D04.808.054.040
azure stains: D02.886.369.080, D03.494.741.080
blood group antigens: D23.050.301.290, D23.050.705.230
secretory pathway: G03.495.166.925, G04.299.490.580
solid phase extraction: E05.196.155.800
placental extracts: D20.777.608
ozone depletion: G16.500.240.547, N06.230.300.100.700.500
mosaicism: G05.365.590.175.595
neptune: G01.060.249.730.700.796
hydroxycholesterols: D04.808.247.222.284.478, D04.808.247.808.197.561, D10.570.938.208.603
episode of care: E02.760.300, N02.421.585.300
lipid metabolism disorders: C18.452.584
diphenhydramine: D02.092.471.320, D02.455.426.559.389.115.250
cimetidine: D02.078.370.200, D03.383.129.308.130
ketamine: D02.455.426.392.368.367.652
receptors, histamine: D12.776.543.750.070.450, D12.776.543.750.720.300.450
histamine h1 antagonists: D27.505.519.625.375.425.400, D27.505.696.577.375.425.400
heredity: G05.355.380
climate: G16.500.275.071, N06.230.300.100.250
anticarcinogenic agents: D27.505.696.706.018, D27.505.954.248.125, D27.720.799.018
chitin: D05.750.078.139, D09.698.211
alginates: D09.698.068
hexuronic acids: D02.241.081.844.915.400, D02.241.152.811.400, D02.241.511.902.915.400, D09.811.922.400
dietary fiber: J02.500.400
speech therapy: E02.831.727.552
diphtheria-tetanus vaccine: D20.215.894.135.310, D20.215.894.691.263.310, D20.215.894.691.824.310, D20.215.894.815.320
encopresis: C23.888.821.266, F01.145.126.837, F03.550.375.300
diphtheria-tetanus-pertussis vaccine: D20.215.894.135.300, D20.215.894.135.535.300, D20.215.894.691.263.300, D20.215.894.691.824.300, D20.215.894.815.300
general practice: H02.403.340
enuresis: C12.777.934.284, C13.351.968.934.252, F01.145.126.856, F03.550.375.400
tropomyosin: D05.750.078.730.800, D12.776.210.500.895, D12.776.220.525.800
troponin: D05.750.078.730.825, D12.776.210.500.910, D12.776.220.525.825
indenes: D02.455.426.559.847.486, D04.615.486
volatilization: G01.595.680.750, G02.149.767.680.933, G02.842.750.680.933
acetanilides: D02.065.199.092
retinoid x receptor gamma: D12.776.260.698.701.500.750, D12.776.826.701.500.750, D12.776.930.669.701.500.750
fadrozole: D02.626.400, D03.383.129.308.270
lactoferrin: D08.811.277.656.300.760.471, D08.811.277.656.959.350.471, D12.776.157.427.750.249, D12.776.256.626.632.507, D12.776.377.457.507, D12.776.395.507, D12.776.556.579.750.249
biomechanical phenomena: G01.154.090, G01.374.089
great lakes region: Z01.107.567.875.350
columbidae: B01.050.150.900.248.165.150
sexually transmitted diseases: C01.539.778, C02.800, C12.294.668, C13.351.500.711
azepines: D03.383.066
coproporphyrinogen oxidase: D08.811.682.660.250
digitonin: D04.808.155.580.130.500.236, D09.408.180.261.236
coproporphyrinogens: D03.383.129.578.840.500.700.250, D03.549.909.500.700.250, D04.345.783.500.700.250
benzydamine: D03.383.129.539.487.130, D03.438.449.130
piroxicam: D02.886.665.500, D03.383.855.500
secondary care: N04.452.758.849.775, N05.300.745
cardiolipins: D10.570.755.375.760.400.885.185, D23.050.550.480.330
skin aging: G13.750.829.826
fracture healing: G16.100.856.891.500
adenoviridae: B04.280.030, B04.909.204.097
sodium channel agonists: D27.505.519.562.625
voltage-gated sodium channels: D12.776.157.530.400.875.750, D12.776.543.550.425.875.750, D12.776.543.585.400.875.750, D12.776.641.960
colonic diseases: C06.405.469.158
melanosis: C17.800.621.430.530
sugar acids: D02.241.081.844, D02.241.511.902, D09.811
benzyl alcohols: D02.033.160, D02.455.426.559.389.140.200
nitrosation: G02.111.087.612, G02.149.115.612, G02.149.465.620, G02.607.750.620, G03.495.655
myasthenia gravis: C10.114.656, C10.668.758.725, C20.111.258.500
annexin a7: D12.776.157.125.050.120
electroacupuncture: E02.186.250, E02.190.044.244, E02.342.543, E02.779.468.399, E03.091.823.500, E03.155.519
apolipoprotein e3: D10.532.091.500.500, D12.776.070.400.500.500, D12.776.521.120.500.500
peromyscus: B01.050.150.900.649.865.635.680.510
neurobiology: H01.158.273.610, H01.158.610.080
lytechinus: B01.050.500.408.578.500
meiotic prophase i: G04.299.134.220.220.687.444, G04.299.134.220.220.875.500, G05.355.105.220.687.500, G05.355.105.220.875.500
delayed diagnosis: E01.110, E02.288
isopoda: B01.050.500.131.365.400
brassica napus: B01.650.940.800.575.100.157.200.249
germination: G07.700.320.625.249, G15.744.300
portugal: Z01.542.727
egg shell: A13.316
adipose tissue, white: A10.165.114.830
hazardous waste sites: N06.850.780.200.800.800.900.449.500, N06.850.860.510.900.700.500
diglycerides: D10.351.303
niacinamide: D03.066.515.530, D03.383.725.547.530
interferons: D12.644.276.374.440, D12.644.276.718, D12.776.467.374.440, D12.776.467.718, D23.529.374.440, D23.529.718
animal husbandry: J01.040.090
tilt-table test: E01.370.370.750
chemoreceptor cells: A08.663.650.915.500, A08.800.950.500, A11.671.650.915.500
xenon: D01.268.613.900, D01.362.641.918
dermatologic agents: D27.505.954.444
citrate (si)-synthase: D08.811.913.050.368
diabetic nephropathies: C12.777.419.192, C13.351.968.419.192, C19.246.099.875
ownership: I01.880.604.583.594, N04.452.633
in situ hybridization, fluorescence: E01.370.225.500.620.670.325.350, E01.370.225.750.600.670.325.350, E05.200.500.620.670.325.350, E05.200.750.600.670.325.350, E05.393.285.350, E05.393.661.475.350
institute of medicine (u.s.): N03.540.608.500
connectin: D08.811.913.696.620.682.324, D12.776.210.500.246
alpha-crystallins: D12.776.306.366.100, D12.776.580.157
intravitreal injections: E02.319.267.530.475.500
retinal degeneration: C11.768.585
respiratory tract infections: C01.539.739, C08.730
nomifensine: D03.438.531.535
mazindol: D03.438.513.500
macrophages, alveolar: A11.329.372.600, A11.627.482.600, A11.733.397.600, A15.382.680.397.600, A15.382.812.522.600
adaptive immunity: G12.450.050
laryngitis: C08.360.535, C08.730.368, C09.400.535
veratridine: D03.132.920.256.679, D03.549.256.679
malus: B01.650.940.800.575.100.842.500.444
rheumatology: H02.403.429.730
centrioles: A11.284.430.214.190.750.585.160.130, A11.284.430.214.190.750.820.500.500.130
phenazines: D03.494.704
jamaica: Z01.107.084.900.525, Z01.639.880.525
rats, inbred strains: B01.050.050.157.760, B01.050.050.199.520.760, B01.050.150.900.649.865.635.505.700.400
sincalide: D06.472.317.152.700, D12.644.120.700
acaricides: D27.720.723.070
bacillus thuringiensis: B03.300.390.400.158.218.800, B03.510.100.100.218.800, B03.510.415.400.158.218.800, B03.510.460.410.158.218.800
phosphorous acids: D01.029.260.700.700, D01.695.625.700
macrolides: D02.540.505, D02.540.576.500, D04.345.674.500
dioxoles: D03.383.246
spiro compounds: D02.455.426.559.847.885, D04.615.885
lipid bilayers: D10.570.510, J01.637.087.500.510
beds: E07.325.220
elevators and escalators: J01.086.339.115
life change events: F01.829.458.410
breast diseases: C17.800.090
riluzole: D02.886.675.651, D03.383.129.708.089.611, D03.438.185.611
methylprednisolone: D04.808.745.432.769.795.539
glucocorticoids: D06.472.040.543, D27.505.696.399.472.488
resuscitation: E02.365.647
ion-selective electrodes: E07.305.250.471
consumer product safety: N06.850.210
suppressor of cytokine signaling proteins: D12.644.360.024.374, D12.776.157.057.249, D12.776.476.024.437
collagen type v: D05.750.078.280.300.400, D12.776.860.300.250.300.400
pepsin a: D08.811.277.656.074.500.700, D08.811.277.656.300.048.700
guanidine: D02.078.370.472
discrimination learning: F02.463.425.280
reticulin: D05.750.078.850, D12.776.860.823
collagen type iii: D05.750.078.280.300.300, D12.776.860.300.250.300.300
androstanes: D04.808.054
chromatography, gel: E05.196.181.400.250
protein kinase c beta: D08.811.913.696.620.682.700.725.049
imprinting (psychology): F02.463.425.448
protein kinase c-alpha: D08.811.913.696.620.682.700.725.100
amlodipine: D03.383.725.203.065
prostaglandin d2: D10.251.355.255.100.637.200.200, D10.251.355.255.550.200.200, D23.469.050.175.725.770.720
adrenergic beta-agonists: D27.505.519.625.050.100.200, D27.505.696.577.050.100.200
synchrotrons: E07.710.680.700
french guiana: Z01.107.757.435
ki-67 antigen: D12.776.660.625.500, D23.050.290.500, D23.101.840.400
sensitivity training groups: F01.829.316.697, F04.754.864.581.813
soil pollutants: D27.888.284.756
physics: H01.671
maxilla: A02.835.232.781.324.502.645, A14.521.645
mandible: A02.835.232.781.324.502.632, A14.521.632
minisatellite repeats: G02.111.570.080.708.800.550, G05.360.080.708.800.550, G05.360.340.024.850.550
comorbidity: N05.715.350.225, N06.850.490.687
gynecomastia: C17.800.090.875
isoquinolines: D03.438.531
genitalia: A05.360
glycerophosphates: D09.894.299, D10.570.755.375
shrews: B01.050.150.900.649.473.751
daucus carota: B01.650.940.800.575.100.075.288, J02.500.850.311
cyclotrons: E07.710.680.250
camptothecin: D03.132.151
poly adenosine diphosphate ribose: D09.408.620.569.070.125.600, D13.695.578.550.530, D13.695.827.708.070.125.600
muscle rigidity: C05.651.504, C10.597.613.550.500, C23.888.592.608.550.500
streptococcus pneumoniae: B03.510.400.800.872.550, B03.510.550.737.872.550
peptic ulcer: C06.405.469.275.800, C06.405.608, C06.405.748.586
stupor: C10.597.606.358.800.500, C23.888.592.604.359.800.500
national health programs: N03.349.550
glucagon-like peptide 1: D06.472.317.469.500.500
promegestone: D04.808.668.651.443.680
insemination: G08.686.785.760.363
cnidaria: B01.050.500.308
marital status: F01.829.263.315.500, I01.240.361.500, I01.880.225.423.500, N01.224.361.500, N01.824.308.500
transcobalamins: D12.776.124.790.900, D12.776.157.800, D12.776.377.715.900
tanzania: Z01.058.290.120.840
optic nerve diseases: C10.292.700, C11.640
folic acid deficiency: C18.654.521.500.133.699.308
maternal deprivation: F01.829.263.370.240
nanospheres: E07.595, J01.637.512.600.612
thiones: D02.886.753
src-family kinases: D08.811.913.696.620.682.725.800
mucins: D12.776.395.560.631
hsp90 heat-shock proteins: D12.776.580.216.380
uterine hemorrhage: C13.351.500.852.691, C23.550.414.993
aurothioglucose: D02.691.675.249
indonesia: Z01.252.145.380, Z01.639.580
zimbabwe: Z01.058.290.175.960
air sacs: A13.048
data mining: L01.470.625, L01.700.508.280.199
integrins: D12.776.543.750.705.408
clathrin: D12.776.543.990.200
family health: N01.400.300
intervention studies: E05.318.760.565, N05.715.360.775.390, N06.850.520.450.565
boron: D01.268.108, D01.268.513.500
cation transport proteins: D12.776.157.530.450.250, D12.776.543.585.450.250
rac1 gtp-binding protein: D08.811.277.040.330.300.400.700.100.500, D12.644.360.525.700.100.100, D12.776.157.325.515.700.100.100, D12.776.476.525.700.100.100
ras proteins: D08.811.277.040.330.300.400.500, D12.644.360.525.500, D12.776.157.325.515.500, D12.776.476.525.500
rhoa gtp-binding protein: D08.811.277.040.330.300.400.700.200, D12.644.360.525.700.200, D12.776.157.325.515.700.200, D12.776.476.525.700.200
tokyo: Z01.252.474.463.709, Z01.433.900
sterol regulatory element binding protein 2: D12.776.260.103.500.750.750, D12.776.260.108.092.750.750, D12.776.930.125.500.750.750, D12.776.930.127.092.750.750
isomerism: G02.575.249, G02.607.500
parenteral nutrition solutions: D26.776.708.733, D27.505.954.578.733, D27.720.280.775.733
parenteral nutrition: E02.421.505, E02.642.500.505
plant preparations: D20.215.784
neural stem cells: A11.872.653
stem cell transplantation: E04.936.225.687
ventral tegmental area: A08.186.211.132.659.822.820, A08.186.211.653.822.820
nuclear proteins: D12.776.660
head protective devices: E07.700.380, J01.637.708.380
6-aminonicotinamide: D03.066.515.530.248, D03.383.725.547.530.248
dimethadione: D03.383.129.462.175
lithium chloride: D01.210.450.150.450, D01.510.500
penicillin g: D02.065.589.099.750.750, D02.886.108.750.750, D03.438.260.825.750, D03.605.084.737.750, D04.075.080.875.099.221.750.750
receptors, interleukin-6: D12.776.543.750.705.852.420.400
dna-directed rna polymerases: D08.811.913.696.445.735.270
paraparesis: C10.597.636.500, C23.888.592.643.500
malaria: C03.752.530
ceratopogonidae: B01.050.500.131.617.289.208
cell aggregation: G04.299.283.251
telencephalon: A08.186.211.730.885
myofibrils: A10.690.552.875, A11.284.430.214.190.750.620, A11.620.249.850, A11.620.500.500
follistatin: D12.776.157.247
activins: D06.472.334.500, D06.472.699.009, D12.644.548.009, D12.776.395.022
inhibin-beta subunits: D06.472.334.500.500, D06.472.334.968.500, D06.472.699.009.500, D06.472.699.337.500, D12.644.548.009.500, D12.644.548.387.500, D12.776.395.022.500, D12.776.395.439.500
adenine: D03.438.759.138
plant lectins: D12.776.503.499, D12.776.765.678
stearates: D10.251.882.800
computer terminals: L01.224.230.260.115.500
cyclin d2: D12.644.360.262.150.200, D12.776.167.218.150.200, D12.776.476.262.150.200
cyclin-dependent kinase inhibitor p27: D12.644.360.225.600, D12.776.167.187.600, D12.776.476.225.600, D12.776.624.776.355.600
receptors, estradiol: D12.776.260.698.750.350.350, D12.776.826.750.350.350, D12.776.930.669.750.350.350
follicular atresia: G08.686.785.280
flagella: A11.284.180.290
pensions: N01.824.417.510
hydroxysteroids: D04.808.528
ranavirus: B04.280.410.700, B04.909.204.490.700
penicillamine: D02.886.030.786, D12.125.166.786
prilocaine: D02.065.199.750
diabetic neuropathies: C10.668.829.300, C19.246.099.937
autografts: A01.941.750
iron regulatory protein 1: D08.811.520.241.300.050.500, D12.776.157.427.374.375.960, D12.776.157.725.374, D12.776.494.500, D12.776.556.579.374.375.960, D12.776.664.962.374
iron regulatory protein 2: D08.811.520.241.300.050.750, D12.776.157.427.374.375.961, D12.776.157.725.437, D12.776.494.750, D12.776.556.579.374.375.962, D12.776.664.962.437
iron-regulatory proteins: D12.776.494
receptors, transferrin: D12.776.157.905.500, D12.776.543.750.850
metrial gland: A13.600
miotics: D27.505.696.663.050.495
deae-cellulose: D09.698.365.180.247
neuregulins: D12.644.276.860.550, D12.776.467.860.550, D12.776.641.600.550, D23.529.850.550
estrogen replacement therapy: E02.319.452.150
oxidative phosphorylation coupling factors: D12.776.691
mitochondrial proton-translocating atpases: D08.811.277.040.025.325.750, D08.811.913.696.650.150.500.750, D12.776.157.530.450.250.875.500.750, D12.776.543.585.450.250.875.500.750, D12.776.543.585.475.625, D12.776.575.750.625
interleukin-18: D12.644.276.374.465.518, D12.776.467.374.465.518, D23.529.374.465.518
costa rica: Z01.107.169.238
metalloendopeptidases: D08.811.277.656.300.480, D08.811.277.656.675.374
fibroblast growth factor 8: D12.644.276.624.180, D12.776.467.624.180, D23.529.624.180
photography: E01.370.350.600, E05.712
corticotropin-releasing hormone: D06.472.699.327.740.140, D12.644.400.400.740.140, D12.644.548.365.740.140, D12.776.641.650.405.740.140
reperfusion injury: C14.907.725, C23.550.767.877
hydrostatic pressure: G01.374.715.352
ulna: A02.835.232.087.090.850
apocynaceae: B01.650.940.800.575.100.081
acyl-coa dehydrogenases: D08.811.682.660.150
acyl-coa dehydrogenase, long-chain: D08.811.682.660.150.150, D12.776.331.102
filamins: A11.284.430.214.190.750.050.414, D05.750.078.730.315, D12.776.210.249, D12.776.220.525.315
chromosomal instability: C23.550.210.110, C23.550.362.180, G05.365.590.175.165, G05.370.180
chemical safety: N06.850.135.060.075.199
learning curve: F02.784.629.529.274
niger: Z01.058.290.190.560
israel: Z01.252.245.500.375, Z01.586.500.375
chloramphenicol o-acetyltransferase: D08.811.913.050.134.170
bisacodyl: D02.455.426.559.389.657.239.132
technetium tc 99m mertiatide: D02.691.825.775, D12.644.456.805
flank pain: C23.888.646.451
lithotripsy: E02.600, E04.943.500
nonprescription drugs: D26.530
trimedoxime: D02.092.570.665.850, D03.383.725.762.900
pokeweed mitogens: D12.776.503.499.875, D12.776.765.678.875
pronephros: A16.835
czech republic: Z01.542.248.395, Z01.586.250.395
monocrotophos: D02.705.400.550
anovulation: C13.351.500.056.630.050, C19.391.630.050, G08.686.785.760.690.080
unilamellar liposomes: D25.479.517.500, J01.637.051.479.517.500, J01.637.087.500.517.500
surface tension: G02.842.850.816
apolipoprotein c-i: D10.532.091.400.500, D12.776.070.400.400.500, D12.776.521.120.400.500
apolipoprotein c-ii: D10.532.091.400.750, D12.776.070.400.400.750, D12.776.521.120.400.750
apolipoproteins b: D10.532.091.300, D12.776.070.400.300, D12.776.521.120.300
apolipoproteins a: D10.532.091.200, D12.776.070.400.200, D12.776.521.120.200
i-kappa b proteins: D12.644.360.378, D12.776.260.420, D12.776.476.381, D12.776.930.326
myeloid progenitor cells: A11.148.378.590, A11.627.635, A11.872.378.590, A15.378.316.378.590
sterigmatocystin: D03.494.953.852.777, D23.946.587.850
indole alkaloids: D03.132.436, D03.438.473.402
isocoumarins: D03.438.150.446.598, D03.830.219.446.598
sequence homology: G02.111.810, G05.810
renal artery: A07.231.114.745
aminobenzoates: D02.241.223.100.050, D02.455.426.559.389.127.020
craniofacial abnormalities: C05.660.207, C16.131.621.207
spasm: C10.597.613.750, C23.888.592.608.750
interleukins: D12.644.276.374.465, D12.776.467.374.465, D23.529.374.465
chemokine cxcl1: D12.644.276.374.200.120.050, D12.776.467.374.200.120.050, D12.776.624.664.700.049, D23.125.300.120.050, D23.469.200.120.050, D23.529.374.200.120.050
hyperkalemia: C18.452.950.396
ascaris suum: B01.050.500.500.294.700.100.100.108.700
cercopithecidae: B01.050.150.900.649.801.400.112.199
hordeum: B01.650.940.800.575.100.822.481, J02.500.200.333
zona reticularis: A06.407.071.140.970
hydroxytestosterones: D04.808.054.079.429.824.375
thiouracil: D03.383.742.698.875.842
snrnp core proteins: D12.776.157.725.500.875.700, D12.776.660.625.750, D12.776.664.962.500.875.700, D23.050.290.875, D23.050.422.750
nanocomposites: J01.637.512.150
aluminum silicates: D01.056.050.075, D01.578.725.025, D01.650.550.050.075, D01.837.725.700.760.050
magnesium silicates: D01.524.500, D01.578.725.500, D01.837.725.700.760.535
characiformes: B01.050.150.900.493.130
national academy of sciences (u.s.): N03.540.608
evans blue: D02.172.560, D02.455.426.559.847.638.555.400, D02.886.645.600.080.050.650.300, D04.615.638.555.400
iodine radioisotopes: D01.496.448.496, D01.496.749.474
spinal cord injuries: C10.228.854.770, C10.900.850, C26.819
fluorouracil: D03.383.742.698.875.404
molecular structure: G02.111.570, G02.575, G02.842.575
embalming: I01.076.201.450.550.250
patient admission: E02.760.400.600, N02.421.585.400.600
gynecological examination: E01.370.600.293
cystatin c: D12.776.215.300
cerebral infarction: C10.228.140.300.150.477.200, C10.228.140.300.775.200.200, C14.907.253.092.477.200, C14.907.253.855.200.200
calcium compounds: D01.146
fibrin: D12.776.124.270
chrysanthemum: B01.650.940.800.575.100.100.206
dental alloys: D25.339.208, J01.637.051.339.208
palladium: D01.268.556.680, D01.268.956.718, D01.552.544.680
biostatistics: E05.318.740.237
diphtheria toxoid: D20.215.894.691.263
cone opsins: D12.776.306.466.249, D23.767.930.750.249
alpha-globins: D12.776.124.400.434.320, D12.776.422.316.762.403.320
acari: B01.050.500.131.166.132
butanes: D02.455.326.146.216
hemiterpenes: D02.455.849.486
caspase 10: D08.811.277.656.262.500.126.550.910, D08.811.277.656.300.200.126.550.910, D12.644.360.075.405.550.910, D12.776.476.075.405.550.910
glycogen synthase kinase 3: D05.500.117.875, D08.811.913.696.620.682.700.429.500, D08.811.913.696.620.682.700.646.625, D12.644.360.300.500, D12.776.476.081.875, D12.776.476.300.500
tauopathies: C10.574.945
asparagine: D12.125.068.060, D12.125.095.165, D12.125.154.049
catha: B01.650.940.800.575.100.197.155
organic chemicals: D02
femur head: A02.835.232.043.650.247.343
infertility, male: C12.294.365.700
maillard reaction: G02.149.465.500, G02.607.750.500
agonistic behavior: F01.145.126.125.100
silanes: D01.837.700, D02.715.625
pediatric obesity: C18.654.726.500.720
stearoyl-coa desaturase: D08.811.682.690.708.392.625
ccaat-enhancer-binding protein-alpha: D12.776.260.108.124.500, D12.776.660.167.500, D12.776.930.127.124.500
pandemics: N06.850.290.200.600
reinforcement (psychology): F02.463.425.770
nanocapsules: D26.255.260.575, D27.720.280.260.575, E02.319.300.380.575, J01.637.512.600.575
hydrogels: D20.280.320.375, D26.255.165.320.375
hydrogel: D02.033.455.250.700.485, D05.750.741.485, D25.720.741.485, D26.255.165.320.375.375, J01.637.051.720.741.485
tannins: D05.750.078.937
trisomy: C23.550.210.050.750, C23.550.210.182.500, G05.365.590.175.050.750, G05.365.590.175.183.500, G05.700.131.750
chromosome deletion: C23.550.210.050.500.500, G05.355.600.800.180, G05.365.590.029.530.175, G05.365.590.175.050.500.500, G05.365.590.762.180, G05.700.131.500.500
nutrition policy: I01.655.500.608.400.650, I01.880.604.825.608.400.650, N03.623.500.608.428.650
caspase 7: D08.811.277.656.262.500.126.350.700, D08.811.277.656.300.200.126.350.700, D12.644.360.075.405.350.700, D12.776.476.075.405.350.700
callosities: C17.800.428.200
hemolysin proteins: D12.776.543.695.444
phytosterols: D04.808.247.808.756
sterols: D04.808.247.808, D10.570.938, D10.851
cholesterol ester transfer proteins: D09.400.430.750, D12.776.124.197, D12.776.157.165, D12.776.395.199
deoxycholic acid: D04.808.105.225.272, D04.808.221.430.342
receptor, serotonin, 5-ht2a: D12.776.543.750.070.800.200.100, D12.776.543.750.100.800.200.100, D12.776.543.750.720.300.800.200.100
cadaverine: D02.092.211.415.261, D02.092.782.258.174
cyclodextrins: D04.345.103, D09.698.365.855.400.375
chlorogenic acid: D02.241.223.200.185, D02.241.223.268.220
diterpenes: D02.455.849.291
photosensitizing agents: D27.505.954.444.600, D27.505.954.600.710
photochemotherapy: E02.186.500, E02.319.685, E02.774.722
retinal vessels: A07.231.611
perfusion imaging: E01.370.350.710.600, E01.370.384.730.354
uridine diphosphate glucuronic acid: D03.383.742.686.850.600.677.375, D09.408.620.569.727.375, D13.695.740.850.600.677.375, D13.695.827.708.727.375, D13.695.827.919.600.677.375
aminophenols: D02.092.146.100, D02.455.426.559.389.657.050
glucokinase: D08.811.913.696.620.250
class ia phosphatidylinositol 3-kinase: D08.811.913.696.620.500.100.100.100, D08.811.913.696.620.500.200.100.100, D12.776.476.162.100
new mexico: Z01.107.567.875.760.560
ependymoglial cells: A08.637.300, A11.650.300
grooming: F01.145.113.111.453
cocos: B01.650.940.800.575.100.093.211
antigens, viral, tumor: D23.050.285.062, D23.050.327.062
thyroid diseases: C19.874
mammography: E01.370.350.700.500
idaho: Z01.107.567.875.560.380
infant, premature: M01.060.703.520.520
benzoxazoles: D03.438.221
silica gel: D01.837.725.700.379, D20.280.320.687, D26.255.165.320.687
acetonitriles: D02.626.080
nanofibers: J01.637.512.300
molecular chaperones: D12.776.580
vibrissae: A13.950
t-lymphocyte subsets: A11.118.637.555.567.550.500, A11.118.637.555.567.569.500, A15.145.229.637.555.567.550.500, A15.145.229.637.555.567.569.500, A15.382.490.555.567.550.500, A15.382.490.555.567.569.500
haemophilus influenzae type b: B03.440.450.600.450.330.150, B03.660.250.550.290.330.150
reptiles: B01.050.150.900.833
asperger syndrome: F03.550.325.100
immunization schedule: E02.095.465.425.400.470, E05.478.550.545
rubella: C02.782.930.700.700
chondrogenesis: G07.700.320.500.325.377.625.180, G11.427.590.560.180
isoleucine: D12.125.070.577, D12.125.142.383
emetics: D27.505.696.329, D27.505.696.663.050.225, D27.505.954.427.270, D27.505.954.483.560
enterotoxins: D23.946.330
aflatoxin m1: D03.438.150.119.100, D03.830.219.119.100, D23.946.587.142.100
bacillus cereus: B03.300.390.400.158.218.252, B03.510.100.100.218.252, B03.510.415.400.158.218.252, B03.510.460.410.158.218.252
depsipeptides: D04.345.566.297, D12.644.641.297
staphylococcus aureus: B03.300.390.400.800.750.100, B03.510.100.750.750.100, B03.510.400.790.750.100
furylfuramide: D02.640.600.330, D03.383.312.649.330
american heart association: N03.540.630.780.110
ccaat-enhancer-binding proteins: D12.776.260.108.124, D12.776.660.167, D12.776.930.127.124
northwest territories: Z01.107.567.176.564
anseriformes: B01.050.150.900.248.050
picrates: D02.455.426.559.389.657.566.690, D02.640.743.690
abruptio placentae: C13.703.420.078, C13.703.590.132
epithelioid cells: A11.329.372.300, A11.627.482.300, A11.733.397.300, A15.382.680.397.300, A15.382.812.522.300
dextran sulfate: D09.698.365.272.300
colitis: C06.405.205.265, C06.405.469.158.188
notophthalmus viridescens: B01.050.150.900.090.608.700.500.480
odonata: B01.050.500.131.617.634
long interspersed nucleotide elements: G02.111.570.080.708.330.800.400, G05.360.080.708.330.800.400, G05.360.340.024.425.800.400
phosphorus, dietary: D01.695.635
rotifera: B01.050.500.500.770
autonomic nervous system diseases: C10.177
hepatitis c: C02.440.440, C02.782.350.350, C06.552.380.705.440
antiviral agents: D27.505.954.122.388
tetraethyl lead: D02.691.950
ambulatory care facilities: N02.278.035
neural cell adhesion molecule l1: D12.776.395.550.200.250.520.578, D12.776.543.550.200.250.520.578, D23.050.301.350.250.520.578
extraembryonic membranes: A10.615.284, A16.254.750
felodipine: D03.383.725.203.250
metoprolol: D02.033.100.624.698.573, D02.033.755.624.550, D02.033.755.624.698.573, D02.092.063.624.698.573
substrate specificity: G02.111.835
naphthoquinones: D02.455.426.559.847.638.721, D02.806.550, D04.615.638.721
1-octanol: D02.033.415.600.600, D10.289.600.610
reticulocyte count: E01.370.225.500.195.107.330.725, E01.370.225.625.107.330.725, E05.200.500.195.107.330.725, E05.200.625.107.330.725, E05.242.195.107.330.725, G04.170.107.330.725, G09.188.105.330.725
antibody-dependent cell cytotoxicity: G12.425.270.070
muscle cells: A11.620
mineral fibers: D01.578.500
silicates: D01.578.725, D01.837.725.700.760
mesonephros: A16.599
ecuador: Z01.107.757.362
pigmentation disorders: C17.800.621
transforming growth factor alpha: D12.644.276.963.700, D12.776.467.960.700, D23.529.960.700
chloroacetates: D02.241.081.018.214, D02.455.526.439.196
perindopril: D03.438.473.766
indapamide: D02.065.884.540, D02.886.590.700.540, D03.438.473.391
haptoglobins: D12.776.124.050.300, D12.776.124.790.106.394, D12.776.377.715.085.394, D12.776.395.560.373
longitudinal ligaments: A02.513.514.350, A02.835.583.512.350
ligamentum flavum: A02.513.514.287, A02.835.583.512.287
vegetable proteins: D12.776.256.920, D12.776.765.836, J02.500.428.920, J02.500.850.900
ossification of posterior longitudinal ligament: C05.116.900.480, C23.550.751.500
spondylosis: C05.116.900.938
melphalan: D02.455.526.728.650.594, D12.125.072.050.685.500
octoxynol: D02.033.455.250.700.660, D05.750.741.610, D25.720.741.610, J01.637.051.720.741.610
mechlorethamine: D02.455.526.728.650.529
s-adenosylhomocysteine: D02.886.030.498.050, D03.438.759.590.138.240, D12.125.166.498.050, D13.570.583.138.240, D13.570.800.096.262
kallikrein-kinin system: G02.111.635.500.500, G03.495.553.485, G03.615.500.500, G07.700.345.810.500.500, G09.330.190.400.500
apolipoprotein b-48: D10.532.091.300.240, D12.776.070.400.300.240, D12.776.521.120.300.240
lipoproteins, vldl: D10.532.599, D12.776.521.622
new hampshire: Z01.107.567.875.550.580
contraceptive devices: E07.190
rana ridibunda: B01.050.150.900.090.180.708.360
phenylacetates: D02.241.223.601
acetazolamide: D02.886.675.867.060, D03.383.129.708.867.060
osteomalacia: C05.116.198.816.640, C18.452.174.845.640, C18.654.521.500.133.770.734.640
antimycin a: D02.540.505.075
spices: J02.500.250.725
receptors, ldl: D12.776.543.750.710.450
arachnoid: A08.186.566.166
gonadotropins, pituitary: D06.472.699.322.576, D06.472.699.631.525.343, D12.644.548.691.525.343
ceruloplasmin: D08.811.682.226, D12.776.124.050.130, D12.776.124.790.106.214, D12.776.157.160, D12.776.377.715.085.214, D12.776.556.151
hepatolenticular degeneration: C06.552.413, C10.228.140.079.493, C10.228.140.163.100.360, C10.228.662.400, C10.574.500.487, C16.320.400.361, C16.320.565.189.360, C16.320.565.618.403, C18.452.132.100.360, C18.452.648.189.360, C18.452.648.618.403
victoria: Z01.338.740
occipital lobe: A08.186.211.730.885.287.500.571
mississippi: Z01.107.567.875.750.500
genitalia, male: A05.360.444
deoxycytosine nucleotides: D03.383.742.686.246.425, D13.695.201.150, D13.695.740.246.425
interleukin-2 receptor alpha subunit: D12.776.543.750.705.852.420.320.500, D23.050.301.264.035.401, D23.101.100.110.401
singapore: Z01.252.145.774
phyllanthus emblica: B01.650.940.800.575.100.350.622.500
phyllanthus: B01.650.940.800.575.100.350.622
tissue inhibitor of metalloproteinase-3: D12.776.645.875.550
masoprocol: D02.455.426.559.389.140.450.582, D02.455.426.559.389.657.166.550
lipoxygenase inhibitors: D27.505.519.389.480
gelatinases: D08.811.277.656.300.480.252, D08.811.277.656.675.374.252
multiple chemical sensitivity: C20.543.312.500, C21.223.500
dopamine agents: D27.505.519.625.150, D27.505.696.577.150
eurotium: B01.300.107.320.218
mycology: H01.158.273.540.553
urinary tract: A05.810
amsacrine: D03.494.046.250.225
anhydrides: D02.113
wheat germ agglutinins: D12.776.503.499.968, D12.776.765.678.968
length of stay: E02.760.400.480, N02.421.585.400.480
endoscopy: E01.370.388.250, E04.800.250
curcuma: B01.650.940.800.575.100.975.900.166
oxazepam: D03.438.079.080.070.663
threonine: D12.125.142.815, D12.125.154.900, D12.125.901
consultants: M01.120
iridocyclitis: C11.941.375.360, C11.941.879.780.880.400
palpation: E01.370.600.600
leukocyte elastase: D08.811.277.656.300.760.560.500, D08.811.277.656.959.350.560.500
gymnema sylvestre: B01.650.940.800.575.100.099.222.500
nicotinic acids: D03.066.515, D03.383.725.547
psychology: F04.096.628
bornanes: D02.455.849.575.781.234
local government: I01.409.700, N03.540.348.750
steroid 16-alpha-hydroxylase: D08.244.453.915.737, D08.811.682.690.708.170.915.737, D08.811.682.690.708.783.737, D12.776.422.220.453.915.737
fenoprofen: D02.241.223.701.350
flurbiprofen: D02.241.081.751.161, D02.455.426.559.389.185.350
thiophenes: D02.886.778, D03.383.903
geologic sediments: G01.311.330, G16.500.320
laurates: D10.251.500.410
linoleic acids: D10.251.355.310.515, D10.251.355.343.500
aminoglycosides: D09.408.051
receptors, adrenomedullin: D12.776.543.750.100.041, D12.776.543.750.750.049
nephelometry and turbidimetry: E05.196.712.650
retinol-binding proteins, cellular: D12.776.157.700.249
rubidium: D01.268.549.650, D01.268.556.800, D01.552.528.759, D01.552.544.800
5-methylcytosine: D03.383.742.698.421.500
genetic vectors: G05.360.337
rhodamine 123: D03.494.953.600.500
paraffin embedding: E01.370.225.500.620.720.610, E01.370.225.750.600.720.610, E05.200.500.620.720.610, E05.200.750.600.720.610
beryllium: D01.268.552.075, D01.268.557.080, D01.552.547.080
vocabulary: L01.143.506.598.901
illusions: C10.597.606.762.400, C23.888.592.604.764.400, F01.700.750.400, F02.463.593.446
phosphenes: F02.830.816.964.500, G11.561.600.810.964.500, G14.640.816.500
vision, ocular: F02.830.816.964, G02.111.087.800.480.900, G02.149.115.800.480.900, G04.299.880.480.900, G11.561.600.810.964, G14.640.816
blindness: C10.597.751.941.162, C11.966.075, C23.888.592.763.941.162
rhombencephalon: A08.186.211.132.810, A08.186.211.865
phorate: D02.705.400.625.650, D02.705.539.345.650, D02.886.300.692.650
thymopentin: D06.472.910.800.850
sclera: A09.371.784
histological techniques: E01.370.225.750, E05.200.750
pulmonary disease, chronic obstructive: C08.381.495.389
thymectomy: E04.928.770
aldehyde oxidoreductases: D08.811.682.657.163
lactalbumin: D12.776.034.398, D12.776.256.626.506
microtubule-organizing center: A11.284.430.214.190.750.585
gamma-crystallins: D12.776.306.366.850
keto acids: D02.241.755
schiff bases: D02.491.784
cell lineage: G04.172, G07.700.320.500.325.180.500, G08.686.155, G08.686.785.760.170.104.249
chlorfenvinphos: D02.705.400.120
sp1 transcription factor: D12.776.260.522.750.249, D12.776.930.375.750.249
nuclear receptor co-repressor 1: D12.776.930.700.625.374
cos cells: A11.251.210.172.500, A11.329.228.220
flavin-adenine dinucleotide: D03.438.733.315.650.249, D03.438.759.646.138.506, D03.494.507.650.249, D08.211.474.650.249, D13.695.667.138.506, D13.695.827.068.506, D23.767.405.650.249
nadph dehydrogenase: D08.811.682.608.550
cytidine diphosphate: D03.383.742.686.246.150, D13.695.740.246.150, D13.695.827.232.150
bone morphogenetic proteins: D12.644.276.954.200, D12.776.467.942.200, D23.529.942.200
self report: E05.318.308.750.500, L01.280.800.655, N05.715.360.300.695.500, N06.850.520.308.750.500
e-selectin: D12.776.395.550.200.700.300, D12.776.503.843.300, D12.776.543.550.200.700.300, D23.050.301.264.035.912.300, D23.050.301.350.700.300, D23.101.100.110.918.300
von willebrand factor: D12.776.124.125.920, D23.119.985
strigiformes: B01.050.150.900.248.815.550, B01.050.150.900.248.870
stress fibers: A11.284.430.214.190.750.050.830
opossums: B01.050.150.900.649.573.575
indans: D02.455.426.559.847.486.487, D04.615.486.487
proton-motive force: G02.149.767.710, G02.842.750.710, G03.495.335.770
